Our	O
data	O
also	O
suggest	O
that	O
these	O
alterations	O
may	O
reflect	O
underlying	O
functional	O
epigenetic	O
alterations	O
to	O
genes	O
important	O
in	O
placental	O
growth	O
and	O
development	O
.	O

Children	O
of	O
school	O
age	O
are	O
highly	O
susceptible	O
to	O
environmental	O
stimuli	O
such	O
as	O
marketing	O
and	O
food	O
availability	O
.	O

In	O
many	O
high	O
-	O
income	O
countries	O
and	O
those	O
with	O
emerging	O
economies	O
,	O
there	O
is	O
evidence	O
of	O
an	O
increase	O
in	O
late	O
preterm	O
deliveries	O
due	O
to	O
elective	O
inductions	O
and	O
caesareans	O
without	O
clear	O
medical	O
indication	O
[	O
38	O
].	O

Methods	O
The	O
cross	O
sectional	O
study	O
was	O
carried	O
out	O
in	O
the	O
Buea	O
Health	O
District	O
,	O
one	O
of	O
the	O
18	O
health	O
districts	O
in	O
the	O
South	O
West	O
Region	O
of	O
Cameroon	O
with	O
an	O
estimated	O
population	O
of	O
86	O
,	O
272	O
inhabitants	O
[	O
9	O
].	O

Furthermore	O
,	O
the	O
divergence	O
of	O
results	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
reported	O
throughout	O
this	O
work	O
suggests	O
that	O
these	O
repetitive	O
element	O
methylation	O
markers	O
are	O
distinct	O
measures	O
and	O
may	O
not	O
represent	O
true	O
,	O
and	O
potentially	O
interchangeable	O
,	O
surrogates	O
of	O
“	O
global	O
”	O
methylation	O
.	O

Similar	O
findings	O
concerning	O
PFAS	O
exposure	O
have	O
been	O
reported	O
elsewhere	O
[	O
5	O
,	O
19	O
].	O

30	O
µL	O
aliquots	O
were	O
injected	O
into	O
an	O
HPLC	O
mass	O
spectrometer	O
system	O
consisting	O
of	O
a	O
Waters	O
Alliance	O
2690	O
Separations	O
Module	O
(	O
Waters	O
Corporation	O
,	O
Milford	O
,	O
MA	O
,	O
USA	O
),	O
followed	O
by	O
an	O
Ion	O
Max	O
APCI	O
source	O
on	O
a	O
Finnigan	O
TSQ	O
Quantum	O
Ultra	O
AM	O
triple	O
quadrapole	O
mass	O
spectrometer	O
,	O
all	O
controlled	O
by	O
Finnigan	O
Xcalibur	O
software	O
(	O
Thermo	O
Electron	O
Corporation	O
,	O
San	O
Jose	O
,	O
CA	O
,	O
USA	O
).	O

Such	O
benefits	O
are	O
not	O
just	O
limited	O
to	O
nutrition	O
;	O
advantageous	O
chemically	O
induced	O
epigenetic	O
changes	O
have	O
also	O
been	O
reported	O
.	O

Nutrition	O
for	O
the	O
primary	O
care	O
provider	O
This	O
book	O
focuses	O
on	O
the	O
various	O
nutritional	O
aspects	O
of	O
the	O
current	O
needs	O
of	O
the	O
society	O
at	O
large	O
and	O
for	O
the	O
health	O
practitioners	O
.	O

These	O
concerns	O
had	O
been	O
attributed	O
to	O
inadequate	O
infrastructure	O
and	O
poor	O
compliance	O
with	O
preventive	O
treatment	O
,	O
among	O
others	O
[	O
34	O
].	O

The	O
authors	O
reported	O
that	O
the	O
link	O
was	O
particularly	O
significant	O
in	O
males	O
.	O

There	O
is	O
no	O
universal	O
standard	O
for	O
which	O
neurodevelopmental	O
tests	O
are	O
most	O
appropriate	O
for	O
use	O
in	O
children	O
of	O
varying	O
ages	O
and	O
at	O
what	O
age	O
meaningful	O
differences	O
in	O
neurocognitive	O
development	O
can	O
be	O
detected	O
[	O
29	O
].	O

Considerable	O
controversy	B
still	O
exists	O
over	O
the	O
optimal	O
extent	O
of	O
primary	O
surgical	O
resection	O
.	O

Although	O
there	O
are	O
contradicting	B
epidemiological	O
and	O
experimental	O
results	O
regarding	O
the	O
direct	O
influence	O
of	O
smoking	O
on	O
total	O
and	O
specific	O
IgE	O
production	O
,[	O
97	O
,	O
98	O
]	O
smoking	O
should	O
nevertheless	B
be	O
avoided	O
for	O
obvious	O
reasons	O
,	O
such	O
as	O
carcinogenic	O
smoke	O
constituents	O
and	O
the	O
vasoconstrictive	O
effect	O
of	O
nicotine	O
.	O

The	O
occurrence	O
of	O
MTC	O
in	O
both	O
sporadic	O
and	O
familial	O
forms	O
makes	O
the	O
clinical	O
approach	O
to	O
this	O
tumour	O
different	O
from	O
that	O
to	O
other	O
thyroid	O
tumours	O
.	O

Four	O
(	O
16	O
.	O
7	O
%)	O
of	O
the	O
subjects	O
in	O
the	O
IG	O
were	O
suffering	O
from	O
a	O
mild	O
vitamin	O
D	O
deficiency	O
,	O
which	O
was	O
reduced	O
to	O
one	O
(	O
4	O
.	O
2	O
%)	O
after	O
the	O
intervention	O
.	O

Methods	O
This	O
work	O
studied	O
the	O
first	O
two	O
generations	O
of	O
offspring	O
(	O
F1	O
and	O
F2	O
)	O
of	O
Swiss	O
mice	O
from	O
mothers	O
fed	O
one	O
of	O
two	O
diets	O
:	O
SC	O
(	O
standard	O
chow	O
)	O
or	O
VitD	O
-	O
(	O
vitamin	O
D	O
-	O
deficient	O
).	O

Hughes	O
et	O
al	O
.	O

Thus	O
,	O
the	O
rate	O
of	O
refusal	O
was	O
relatively	O
low	O
,	O
of	O
only	O
2	O
.	O
5	O
%	O
of	O
all	O
the	O
women	O
invited	O
to	O
participate	O
in	O
the	O
study	O
.	O

Recruitment	O
Recruitment	O
and	O
enrollment	O
took	O
place	O
at	O
various	O
obstetric	O
clinics	O
in	O
an	O
urban	O
area	O
of	O
the	O
South	O
East	O
from	O
January	O
–	O
April	O
2011	O
.	O

Preterm	O
birth	O
is	O
a	O
problem	O
that	O
we	O
all	O
share	O
;	O
therefore	O
,	O
the	O
solutions	O
must	O
also	O
be	O
shared	O
,	O
and	O
won	O
through	O
cooperation	O
,	O
collaboration	O
and	O
coordination	O
of	O
the	O
many	O
constituencies	O
and	O
stakeholders	O
.	O

Interventions	O
that	O
have	O
been	O
identified	O
through	O
global	O
reviews	O
of	O
the	O
evidence	O
are	O
summarised	O
elsewhere	O
[	O
4	O
-	O
6	O
]	O
and	O
shown	O
in	O
Figure1	O
.	O

Variables	O
influencing	O
the	O
formation	O
of	O
previtamin	O
D3	O
in	O
the	O
skin	O
include	O
skin	O
pigmentation	O
and	O
intensity	O
of	O
the	O
solar	O
UV	O
light	O
[	O
52	O
]–[	O
55	O
].	O

A	O
larger	O
sample	O
size	O
also	O
enabled	O
subgroup	O
analysis	O
by	O
PTB	O
subtype	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
among	O
women	O
with	O
a	O
previous	O
PTB	O
.	O

1	O
.	O

A	O
robust	O
,	O
dose	O
-	O
dependent	O
,	O
causal	O
relationship	O
among	O
a	O
specific	O
environmental	O
exposure	O
,	O
an	O
epigenetic	O
change	O
and	O
an	O
adverse	O
public	O
health	O
outcome	O
is	O
required	O
to	O
classify	O
a	O
chemical	O
as	O
an	O
epigenetic	O
toxicant	O
.	O

Current	O
NICE	O
guidance	O
states	O
clearly	O
that	O
pregnant	O
women	O
are	O
informed	O
,	O
at	O
their	O
first	O
antenatal	O
booking	O
,	O
of	O
the	O
importance	O
of	O
adequate	O
vitamin	O
D	O
during	O
pregnancy	O
and	O
after	O
,	O
to	O
maintain	O
their	O
own	O
and	O
their	O
baby	O
'	O
s	O
health	O
.	O

All	O
mothers	O
are	O
asked	O
details	O
about	O
any	O
other	O
food	O
or	O
drink	O
(	O
including	O
infant	O
formula	O
,	O
medicine	O
and	O
supplements	O
)	O
given	O
to	O
the	O
infant	O
.	O

The	O
differing	O
outcomes	O
between	O
each	O
of	O
the	O
perinatal	O
undernutrition	O
approaches	O
reported	O
here	O
are	O
likely	O
to	O
reflect	O
these	O
confounders	O
of	O
severity	O
and	O
timing	O
.	O

In	O
our	O
cohort	O
,	O
dietary	O
energy	O
,	O
protein	O
and	O
fat	O
were	O
significantly	O
higher	O
during	O
extended	O
summer	O
,	O
while	O
carbohydrates	O
,	O
glycaemic	O
index	O
,	O
glycaemic	O
load	O
,	O
physical	O
activity	O
and	O
well	O
-	O
being	O
were	O
no	O
different	O
across	O
seasons	O
.	O

Homes	O
with	O
high	O
pet	O
activities	O
have	O
been	O
shown	O
to	O
have	O
greater	O
levels	O
of	O
pesticide	O
residues	O
in	O
sampled	O
carpet	O
dust	O
than	O
homes	O
with	O
low	O
pet	O
activities	O
[	O
31	O
,	O
32	O
].	O

The	O
mixed	O
ration	O
is	O
made	O
by	O
using	O
agricultural	O
by	O
-	O
products	O
(	O
soybean	O
curd	O
cake	O
and	O
pomace	O
of	O
citrus	O
,	O
apple	O
,	O
and	O
carrot	O
)	O
[	O
96	O
].	O

Currently	O
,	O
the	O
ICDS	O
scheme	O
symbolizes	O
one	O
of	O
the	O
most	O
extensive	O
and	O
the	O
unique	O
initiative	O
for	O
safeguarding	O
early	O
childhood	O
development	O
,	O
catering	O
to	O
more	O
than	O
100	O
million	O
under	O
-	O
six	O
year	O
children	O
under	O
the	O
different	O
provisions	O
available	O
in	O
the	O
scheme	O
(	O
2	O
).	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Bacterial	O
culture	O
of	O
nasopharyngeal	O
swab	O
At	O
1	O
month	O
of	O
age	O
,	O
specimens	O
were	O
collected	O
through	O
the	O
nose	O
with	O
a	O
cotton	O
-	O
tipped	O
swab	O
(	O
Copan	O
Swab	O
Applicator	O
,	O
Copan	O
Diagnostics	O
,	O
Brescia	O
,	O
Italy	O
).	O

For	O
example	O
,	O
chemicals	O
can	O
have	O
far	O
-	O
reaching	O
benefits	O
to	O
society	O
,	O
from	O
agriculture	O
to	O
medicine	O
and	O
food	O
/	O
product	O
safety	O
to	O
the	O
development	O
of	O
new	O
technologies	O
.	O

Indeed	O
,	O
there	O
are	O
many	O
examples	O
in	O
the	O
literature	O
of	O
how	O
single	O
polymorphisms	O
(	O
SNPs	O
)	O
can	O
affect	O
the	O
response	O
of	O
individuals	O
and	O
populations	O
to	O
different	O
environmental	O
exposures	O
.	O

In	O
addition	O
,	O
fruits	O
,	O
vegetables	O
,	O
and	O
low	O
-	O
fat	O
dairy	O
intake	O
among	O
them	O
is	O
low	O
;	O
however	B
,	O
legumes	O
intake	O
is	O
good	O
in	O
the	O
mentioned	O
population	O
[	O
28	O
].	O

We	O
controlled	O
for	O
intervention	O
grouping	O
in	O
the	O
multiple	O
linear	O
regression	O
models	O
.	O

A	O
recent	O
systematic	O
review	O
concluded	O
that	O
antenatal	O
vitamin	O
D	O
supplementation	O
is	O
effective	O
in	O
improving	O
the	O
vitamin	O
D	O
status	O
of	O
Asian	O
and	O
white	O
women	O
,	O
improves	O
growth	O
in	O
the	O
first	O
year	O
of	O
life	O
in	O
South	O
Asian	O
babies	O
and	O
therefore	O
may	O
contribute	O
to	O
reducing	O
the	O
incidence	O
of	O
rickets	O
in	O
this	O
latter	O
group	O
,	O
without	O
evidence	O
of	O
harm	O
.	O

We	O
evaluated	O
growth	O
,	O
timing	O
of	O
reproductive	O
maturation	O
and	O
adult	O
ovarian	O
function	O
.	O

We	O
stored	O
the	O
serum	O
samples	O
at	O
−	O
20	O
°	O
C	O
and	O
analysed	O
them	O
at	O
the	O
end	O
of	O
our	O
study	O
with	O
IDS	O
-	O
iSYS	O
Multi	O
-	O
Discipline	O
Automated	O
Chemiluminescent	O
assay	O
(	O
Immunodiagnostic	O
Systems	O
Ltd	O
,	O
Tyne	O
and	O
Wear	O
,	O
UK	O
)	O
at	O
the	O
Manchester	O
Royal	O
Infirmary	O
,	O
Manchester	O
,	O
UK	O
(	O
Supra	O
-	O
Regional	O
Vitamin	O
D	O
Reference	O
Laboratories	O
accredited	O
to	O
ISO9001	O
:	O
2000	O
and	O
ISO13485	O
:	O
2003	O
and	O
participating	O
in	O
the	O
Vitamin	O
D	O
Quality	O
Assurance	O
Scheme	O
).	O

The	O
primary	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
impact	O
of	O
GWG	O
,	O
maternal	O
eating	O
and	O
exercise	O
behaviors	O
,	O
and	O
psychosocial	O
factors	O
on	O
offspring	O
weight	O
status	O
.	O

SAS	O
version	O
9	O
.	O
3	O
(	O
SAS	O
Institute	O
Inc	O
.,	O
Cary	O
,	O
NC	O
,	O
USA	O
)	O
was	O
used	O
to	O
conduct	O
all	O
analyses	O
.	O

While	B
the	O
remaining	O
studies	O
do	O
not	O
necessarily	O
demonstrate	O
causality	O
,	O
they	O
do	O
provide	O
additional	O
mechanistic	O
associations	O
between	O
exposure	O
(	O
again	O
largely	O
high	O
dose	O
)	O
to	O
BPA	O
,	O
formaldehyde	O
,	O
nickel	O
,	O
phthalates	O
,	O
TCDD	O
,	O
alcohol	O
,	O
undernutrition	O
,	O
2	O
-	O
amino	O
-	O
1	O
-	O
methyl	O
-	O
6	O
-	O
phenyl	O
-	O
imidazo	O
[	O
4	O
,	O
5	O
-	O
b	O
]	O
pyridine	O
(	O
PhIP	O
),	O
peanut	O
,	O
cigarette	O
smoke	O
,	O
nicotine	O
or	O
NKK	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
.	O

They	O
were	O
more	O
interested	O
in	O
having	O
an	O
indebt	O
knowledge	O
on	O
how	O
complications	O
arising	O
during	O
pregnancy	O
could	O
be	O
managed	O
.	O

The	O
mean	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
levels	O
in	O
case	O
and	O
control	O
groups	O
were	O
compared	O
with	O
independent	O
t	O
test	O
.	O

This	O
study	O
'	O
s	O
focus	O
was	O
on	O
predictors	O
of	O
large	O
for	O
gestational	O
age	O
at	O
birth	O
and	O
6	O
months	O
,	O
but	O
future	O
research	O
is	O
needed	O
to	O
examine	O
predictors	O
of	O
small	O
for	O
gestational	O
age	O
,	O
which	O
may	O
also	O
predispose	O
offspring	O
to	O
increased	O
fat	O
mass	O
and	O
incidence	O
of	O
metabolic	O
syndrome	O
as	O
children	O
and	O
adults	O
[	O
53	O
].	O

It	O
is	O
an	O
unrecognized	O
epidemic	O
common	O
among	O
children	O
,	O
adults	O
and	O
pregnant	O
women	O
throughout	O
the	O
world	O
,	O
across	O
ethnicity	O
and	O
season	O
.	O

Control	O
We	O
used	O
usual	O
iron	O
supplementation	O
program	O
as	O
the	O
comparator	O
.	O

During	O
lactation	O
,	O
a	O
special	O
diet	O
for	O
the	O
mother	O
(	O
or	O
,	O
if	O
not	O
breast	O
-	O
feeding	O
,	O
hypoallergenic	O
formula	O
nutrition	O
for	O
the	O
infant	O
)	O
should	O
be	O
considered	O
only	O
in	O
individuals	O
with	O
an	O
established	O
atopy	O
risk	O
or	O
existing	O
allergy	O
[	O
82	O
,	O
115	O
].	O

Du	O
et	O
al	O
[	O
17	O
]	O
suggested	O
that	O
a	O
shift	O
in	O
development	O
of	O
mesenchymal	O
stem	O
cells	O
from	O
myogenesis	O
to	O
adipogenesis	O
may	O
increase	O
IMF	O
deposition	O
later	O
in	O
life	O
.	O

For	O
this	O
model	O
,	O
gender	O
,	O
birth	O
weight	O
,	O
season	O
of	O
measurement	O
and	O
ethnicity	O
were	O
covariates	O
.	O

PFAS	O
levels	O
were	O
similar	O
across	O
women	O
’	O
s	O
reported	O
reasons	O
for	O
ending	O
breastfeeding	O
,	O
and	O
the	O
researchers	O
saw	O
no	O
clear	O
differences	O
between	O
primiparous	O
and	O
multiparous	O
mothers	O
.	O
24	O
“	O
You	O
have	O
three	O
studies	O
telling	O
a	O
similar	O
story	O
from	O
different	O
parts	O
of	O
the	O
world	O
.	O

The	O
large	O
number	O
of	O
23	O
PCBs	O
examined	O
in	O
this	O
study	O
meant	O
that	O
the	O
BHLM	O
performed	O
more	O
aggressive	O
shrinkage	O
on	O
the	O
model	O
regression	O
coefficients	O
for	O
this	O
class	O
.	O

We	O
used	O
PyNAST	O
alignment	O
[	O
37	O
]	O
with	O
Greengenes	O
core	O
reference	O
[	O
38	O
,	O
39	O
]	O
to	O
build	O
OTU	O
tables	O
and	O
assign	O
taxonomy	O
[	O
39	O
,	O
40	O
].	O

Substantial	O
progress	O
is	O
still	O
needed	O
for	O
the	O
reduction	O
of	O
maternal	O
and	O
newborn	O
deaths	O
,	O
especially	O
for	O
effective	O
,	O
high	O
quality	O
at	O
the	O
vital	O
contact	O
times	O
(	O
e	O
.	O
g	O
.,	O
skilled	O
attendant	O
at	O
birth	O
and	O
postnatal	O
care	O
)	O
[	O
29	O
].	O

Recommendations	O
should	O
be	O
made	O
on	O
informing	O
women	O
of	O
the	O
importance	O
of	O
maintaining	O
adequate	O
vitamin	O
D	O
stores	O
in	O
pregnancy	O
,	O
particularly	O
for	O
those	O
at	O
greatest	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

Just	O
as	O
it	O
is	O
no	O
longer	O
acceptable	O
for	O
people	O
with	O
HIV	O
/	O
AIDS	O
to	O
remain	O
untreated	O
because	O
they	O
live	O
in	O
poor	O
countries	O
,	O
it	O
is	O
no	O
longer	O
acceptable	O
for	O
women	O
to	O
die	O
while	O
giving	O
birth	O
.	O

We	O
,	O
therefore	O
,	O
wanted	O
to	O
examine	O
both	O
the	O
potential	O
public	O
health	O
concerns	O
and	O
the	O
resulting	O
regulatory	O
implications	O
of	O
such	O
toxicity	O
.	O

Methods	O
An	O
observational	O
analytic	O
cross	O
-	O
sectional	O
study	O
was	O
carried	O
out	O
amongst	O
pregnant	O
women	O
attending	O
selected	O
government	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
.	O

Caption	O
(	O
FIG	O
)	O
The	O
western	O
sandpiper	O
,	O
one	O
of	O
the	O
Arctic	O
species	O
studied	O
UK	O
Organic	O
Certifier	O
Says	O
No	O
to	O
Nanomaterials	O
The	O
Soil	O
Association	O
,	O
a	O
nonprofit	O
UK	O
organization	O
that	O
certifies	O
the	O
majority	O
of	O
that	O
nation	O
’	O
s	O
organic	O
products	O
,	O
announced	O
in	O
January	O
2008	O
it	O
will	O
no	O
longer	O
allow	O
man	O
-	O
made	O
nanomaterials	O
(	O
materials	O
with	O
a	O
mean	O
size	O
of	O
less	O
than	O
200	O
nm	O
)	O
to	O
be	O
used	O
in	O
goods	O
carrying	O
its	O
certification	O
label	O
.	O

The	O
results	O
of	O
imputed	O
analyses	O
were	O
compared	O
with	O
those	O
from	O
complete	O
-	O
case	O
analyses	O
,	O
and	O
further	O
sensitivity	O
analyses	O
were	O
also	O
conducted	O
for	O
the	O
primary	O
outcome	O
on	O
the	O
assumption	O
that	O
data	O
were	O
Missing	O
Not	O
At	O
Random	O
(	O
MNAR	O
).	O

College	O
Station	O
,	O
TX	O
:	O
StataCorp	O
LP	O
).	O

GDM	O
diagnosis	O
and	O
birth	O
size	O
were	O
obtained	O
from	O
medical	O
records	O
.	O

The	O
gene	O
underlying	O
the	O
mutation	O
in	O
Skm2	O
mice	O
,	O
Flnb	O
,	O
encodes	O
filamin	O
B	O
,	O
a	O
member	O
of	O
a	O
family	O
of	O
cytoplasmic	O
proteins	O
including	O
filamin	O
A	O
and	O
filamin	O
C	O
.	O
These	O
proteins	O
provide	O
a	O
scaffold	O
for	O
the	O
cytoskeletal	O
network	O
by	O
crosslinking	O
actin	O
to	O
the	O
cytoskeleton	O
,	O
thereby	O
regulating	O
intracellular	O
signaling	O
and	O
protein	O
trafficking	O
(	O
Stossel	O
et	O
al	O
.	O

After	O
supplementation	O
with	O
MMN	O
the	O
relative	O
risk	O
of	O
anaemia	O
(<	O
12g	O
/	O
dL	O
)	O
was	O
0	O
.	O
59	O
(	O
0	O
.	O
46	O
,	O
0	O
.	O
76	O
)	O
compared	O
to	O
placebo	O
.	O

Since	O
the	O
exogenous	O
desmopressin	O
is	O
deaminated	O
at	O
the	O
N	O
-	O
terminus	O
,	O
it	O
can	O
escape	O
the	O
degrading	O
effect	O
of	O
the	O
vasopressinase	O
and	O
is	O
considered	O
the	O
treatment	O
of	O
choice	O
in	O
patients	O
with	O
gestational	O
diabetes	O
insipidus	O
as	O
demonstrated	O
by	O
Schrier	O
[	O
4	O
].	O

Safety	O
of	O
Asthma	O
and	O
Allergy	O
Medication	O
in	O
Pregnancy	O
The	O
ideal	O
situation	O
during	O
pregnancy	O
is	O
"	O
no	O
pharmacological	O
therapy	O
,"	O
especially	O
during	O
the	O
first	O
trimester	O
.	O

Discussion	O
3	O
.	O
1	O
.	O

We	O
observed	O
a	O
negative	O
association	O
between	O
fruit	O
intake	O
and	O
OTUs	O
of	O
the	O
genus	O
Bifidobacterium	O
and	O
a	O
positive	O
association	O
with	O
OTUs	O
in	O
the	O
Clostridiaceae	O
family	O
in	O
the	O
infant	O
gut	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2d	O
).	O

The	O
treatment	O
also	O
enhanced	O
UCP1	O
protein	O
levels	O
in	O
BAT	O
,	O
via	O
stimulation	O
of	O
the	O
sympathetic	O
nervous	O
system	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

Results	O
Identification	O
of	O
the	O
Skm	O
mutants	O
During	O
our	O
ENU	O
mutagenesis	O
screen	O
for	O
infectious	O
disease	O
susceptibility	O
,	O
we	O
identified	O
two	O
mutations	O
that	O
contribute	O
to	O
skeletal	O
malformations	O
in	O
mice	O
.	O

(	O
B	O
)	O
Skm1	O
mice	O
show	O
kyphotic	O
spines	O
and	O
kinked	O
tails	O
(	O
left	O
)	O
and	O
elongated	O
bodies	O
(	O
right	O
).	O

To	O
validate	O
the	O
nutritional	O
knowledge	O
questionnaire	O
,	O
item	O
analysis	O
was	O
performed	O
to	O
determine	O
item	O
difficulty	O
and	O
item	O
discrimination	O
indices	O
to	O
increase	O
reliability	O
.	O

Univariate	O
associations	O
of	O
exposures	O
and	O
demographics	O
with	O
birth	O
weight	O
percentile	O
status	O
or	O
with	O
LINE	O
-	O
1	O
and	O
AluYb8	O
extent	O
were	O
examined	O
using	O
Kruskal	O
–	O
Wallis	O
tests	O
for	O
continuous	O
covariates	O
and	O
chi	O
-	O
square	O
tests	O
for	O
categorical	O
covariates	O
.	O

In	O
the	O
case	O
of	O
cockroach	O
sensitivity	O
,	O
over	O
60	O
%	O
of	O
inner	O
-	O
city	O
residents	O
with	O
asthma	O
test	O
positive	O
for	O
cockroach	O
allergen	O
[	O
79	O
],	O
with	O
black	O
children	O
and	O
those	O
receiving	O
public	O
assistance	O
most	O
likely	O
to	O
be	O
sensitized	O
[	O
70	O
].	O

Thus	O
,	O
occurrence	O
of	O
gastrointestinal	O
symptoms	O
is	O
usually	O
considered	O
as	O
a	O
critical	O
adverse	O
effect	O
on	O
which	O
a	O
tolerable	O
upper	O
intake	O
level	O
for	O
iron	O
is	O
based	O
for	O
an	O
individual	O
.	O

Informed	O
consent	O
was	O
obtained	O
from	O
all	O
participants	O
.	O

Women	O
who	O
reported	O
a	O
preference	O
for	O
shadow	O
had	O
a	O
higher	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
in	O
our	O
study	O
.	O

These	O
results	O
were	O
in	O
line	O
with	O
Northstone	O
et	O
al	O
.	O

[	O
20	O
]	O
reported	O
that	O
only	O
1	O
.	O
7	O
%	O
of	O
women	O
consumed	O
fish	O
oil	O
supplements	O
not	O
affecting	O
outcomes	O
,	O
however	B
,	O
this	O
study	O
did	O
not	O
consider	O
supplements	O
other	B
than	O
fish	O
oil	O
.	O

Full	O
lines	O
indicate	O
stimulatory	O
effects	O
,	O
whereas	O
dotted	O
lines	O
represent	O
inhibitory	O
ones	O
.	O

Earlier	O
research	O
suggested	O
the	O
adverse	O
effect	O
of	O
vitamin	O
D	O
on	O
fertility	O
after	O
a	O
discovery	O
of	O
a	O
molecular	O
similarity	O
of	O
its	O
transporting	O
protein	O
,	O
the	O
vitamin	O
D	O
binding	O
protein	O
(	O
VDBP	O
),	O
to	O
anti	O
-	O
sperm	O
antibodies	O
.	O

Two	O
spectrophotometric	O
readings	O
of	O
the	O
DNA	O
samples	O
were	O
averaged	O
to	O
determine	O
the	O
concentration	O
,	O
which	O
had	O
a	O
ratio	O
of	O
A260to	O
A280between	O
1	O
.	O
8	O
and	O
2	O
.	O
0	O
and	O
was	O
free	O
of	O
RNA	O
and	O
protein	O
contamination	O
.	O

Regarding	O
the	O
differences	B
between	O
male	O
and	O
female	O
offspring	O
,	O
CC	O
females	O
showed	O
an	O
increase	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
in	O
liver	O
,	O
but	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
γ	O
in	O
PAT	O
(	O
Figures6A	O
,	O
B	O
).	O

Our	O
results	O
are	O
consistent	O
with	O
other	O
data	O
showing	O
that	O
early	O
nutrition	O
alters	O
the	O
central	O
appetite	O
regulatory	O
network	O
.	O
22Effects	O
of	O
the	O
maternal	O
diet	O
on	O
the	O
hypothalamic	O
expression	O
of	O
food	O
intake	O
regulatory	O
pathways	O
were	O
found	O
in	O
lambs	O
of	O
ewes	O
fed	O
a	O
diet	O
that	O
exceeded	O
their	O
energy	O
requirement	O
.	O

Exposure	O
assessment	O
Data	O
on	O
maternal	O
diet	O
in	O
pregnancy	O
were	O
collected	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)	O
at	O
32	O
weeks	O
gestation	O
,	O
covering	O
all	O
the	O
main	O
foods	O
consumed	O
in	O
Britain	O
[	O
13	O
].	O

It	O
is	O
clear	O
that	O
a	O
deficiency	O
of	O
paternal	O
micronutrients	O
could	O
affect	O
the	O
development	O
of	O
offspring	O
through	O
epigenetic	O
regulation	O
.	O

According	O
to	O
the	O
inclusion	O
criteria	O
,	O
the	O
mothers	O
were	O
of	O
Caucasian	O
origin	O
without	O
regular	O
medication	O
and	O
with	O
singleton	O
pregnancy	O
.	O

In	O
this	O
study	O
,	O
we	O
observed	O
marginal	O
sex	O
-	O
specific	O
differences	B
between	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
where	O
by	O
high	O
vitamin	O
D	O
status	O
and	O
carrying	O
a	O
male	O
fetus	O
was	O
moderately	O
associated	O
with	O
decreasing	O
the	O
risk	O
of	O
having	O
any	O
pregnancy	O
complication	O
.	O

Raw	O
data	O
are	O
captured	O
and	O
saved	O
in	O
password	O
protected	O
Microsoft	O
Access	O
documents	O
with	O
passwords	O
known	O
only	O
to	O
the	O
operator	O
responsible	O
for	O
data	O
imputing	O
and	O
the	O
principal	O
investigators	O
.	O

Women	O
enrolled	O
at	O
a	O
median	O
(	O
interquartile	O
range	O
)	O
gestational	O
age	O
of	O
9	O
.	O
6	O
weeks	O
(	O
8	O
.	O
4	O
–	O
11	O
.	O
4	O
).	O

Fetal	O
growth	O
may	O
have	O
later	O
health	O
implications	O
also	O
within	O
the	O
normal	O
-	O
birth	O
-	O
weight	O
range	O
[	O
14	O
].	O

Cesarean	O
sections	O
are	O
also	O
more	O
common	O
,	O
and	O
GDM	O
is	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
pre	O
-	O
eclampsia	O
.	O
9	O
–	O
11	O
Exposure	O
of	O
the	O
fetus	O
to	O
hyperglycemia	O
may	O
also	O
predispose	O
the	O
child	O
to	O
a	O
diabetes	O
phenotype	O
in	O
later	O
life	O
.	O

There	O
are	O
very	O
few	O
data	O
on	O
25	O
(	O
OH	O
)	O
D	O
in	O
cord	O
blood	O
in	O
the	O
Hispanic	O
population	O
and	O
no	O
data	O
looking	O
specifically	O
at	O
the	O
relative	O
increase	O
over	O
time	O
based	O
on	O
cord	O
25	O
(	O
OH	O
)	O
D	O
[	O
11	O
].	O

2007	O
;	O
Sinclair	O
et	O
al	O
.	O

The	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
reduced	O
risk	O
of	O
PTB	O
was	O
consistent	O
across	O
race	O
/	O
ethnic	O
groups	O
.	O

Another	B
possible	O
explanation	O
may	O
be	O
that	O
the	O
frequent	O
intake	O
of	O
fish	O
and	O
PUFA	O
may	O
be	O
advantageous	O
in	O
lower	O
doses	O
but	B
disadvantageous	O
in	O
higher	O
doses	O
.	O

Thus	O
,	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
Thai	O
people	O
is	O
generally	O
low	O
.	O

Birth	O
size	O
,	O
including	O
birth	O
weight	O
(	O
kg	O
),	O
length	O
(	O
cm	O
),	O
and	O
head	O
circumference	O
(	O
cm	O
),	O
was	O
measured	O
by	O
midwives	O
according	O
to	O
standard	O
procedure	O
.	O

In	O
general	O
,	O
Stanford	O
type	O
A	O
dissections	O
involve	O
the	O
ascending	O
aorta	O
and	O
are	O
managed	O
surgically	O
while	O
type	O
B	O
dissections	O
involved	O
the	O
descending	O
aorta	O
and	O
are	O
managed	O
medically	O
.	O

Data	O
,	O
experimental	O
design	O
,	O
materials	O
and	O
methods	O
Liver	O
samples	O
Sows	O
were	O
divided	O
randomly	O
into	O
control	O
and	O
betaine	O
groups	O
(	O
8	O
per	O
group	O
)	O
while	O
sows	O
were	O
fed	O
basal	O
diet	O
and	O
received	O
betaine	O
-	O
supplemented	O
(	O
3	O
g	O
/	O
kg	O
)	O
diet	O
respectively	O
throughout	O
the	O
pregnancy	O
.	O

In	O
The	O
Gambia	O
,	O
as	O
in	O
other	O
parts	O
of	O
sub	O
-	O
Saharan	O
Africa	O
,	O
seasonal	O
multiple	O
micronutrient	O
deficiencies	O
are	O
common	O
(	O
Bates	O
et	O
al	O
1984	O
,	O
Powers	O
and	O
Bates	O
1987	O
),	O
and	O
maternal	O
anaemia	O
and	O
its	O
sequelae	O
remain	O
frequent	O
problems	O
,	O
particularly	O
in	O
rural	O
areas	O
(	O
Powers	O
and	O
Bates	O
1987	O
,	O
Topley	O
1968	O
).	O

Weak	O
Infrastructure	O
and	O
Political	O
Commitment	O
The	O
efforts	O
of	O
World	O
Food	O
Programme	O
(	O
WFP	O
)	O
in	O
overcoming	O
micronutrient	O
deficiencies	O
in	O
nutritionally	O
-	O
vulnerable	O
groups	O
and	O
low	O
-	O
income	O
food	O
-	O
deficit	O
countries	O
continue	O
to	O
be	O
thwarted	O
by	O
challenges	O
such	O
as	O
technical	O
and	O
managerial	O
capacity	O
constraints	O
,	O
the	O
need	O
for	O
systematic	O
compliance	O
with	O
procurement	O
specifications	O
and	O
quality	O
control	O
,	O
clearer	O
policies	O
on	O
micronutrient	O
content	O
labeling	O
,	O
and	O
the	O
need	O
for	O
cash	O
resources	O
to	O
support	O
many	O
aspects	O
associated	O
with	O
local	O
processing	O
and	O
fortification	O
activities	O
[	O
57	O
].	O

Humans	O
also	O
evolved	O
to	O
adapt	O
to	O
environmental	O
daily	O
and	O
seasonal	O
changes	O
,	O
with	O
a	O
central	O
biological	O
clock	O
located	O
in	O
the	O
suprachiasmatic	O
nucleus	O
of	O
the	O
hypothalamus	O
,	O
responsible	O
for	O
timing	O
of	O
metabolism	O
,	O
physiology	O
and	O
behaviours	O
[	O
17	O
].	O

At	O
that	O
time	O
no	O
trials	O
had	O
reported	O
the	O
effects	O
of	O
IFA	O
on	O
neonatal	O
mortality	O
,	O
although	O
these	O
supplements	O
were	O
known	O
to	O
benefit	O
both	O
maternal	O
and	O
infant	O
health	O
[	O
3	O
].	O

Cord	O
25	O
(	O
OH	O
)	O
D	O
averaged	O
14	O
.	O
9	O
ng	O
/	O
mL	O
and	O
BMC	O
at	O
one	O
week	O
of	O
life	O
averaged	O
70	O
.	O
3	O
g	O
for	O
the	O
2	O
Caucasian	O
infants	O
who	O
did	O
not	O
return	O
at	O
3	O
months	O
.	O

Since	O
there	O
were	O
few	O
adverse	O
events	O
being	O
reported	O
,	O
chloral	O
hydrate	O
has	O
been	O
the	O
preferred	O
medication	O
for	O
infant	O
lung	O
function	O
tests	O
for	O
over	O
20	O
years	O
at	O
US	O
and	O
Europe	O
[	O
21	O
].	O

Furthermore	O
,	O
understanding	O
the	O
associations	O
of	O
maternal	O
diet	O
and	O
nutritional	O
status	O
during	O
pregnancy	O
with	O
birth	O
outcomes	O
,	O
as	O
well	O
as	O
offspring	O
health	O
and	O
development	O
in	O
the	O
South	O
African	O
population	O
will	O
form	O
the	O
basis	O
for	O
the	O
development	O
of	O
context	O
-	O
specific	O
nutrition	O
interventions	O
that	O
may	O
improve	O
birth	O
outcomes	O
and	O
long	O
-	O
term	O
quality	O
of	O
life	O
of	O
the	O
mother	O
and	O
her	O
offspring	O
.	O

There	O
may	O
also	O
be	O
a	O
role	O
for	O
hand	O
cleansing	O
options	O
that	O
are	O
waterless	O
or	B
that	O
can	O
confer	O
residual	O
bacteriostatic	O
benefit	O
to	O
improve	O
the	O
convenience	O
and	O
thereby	O
the	O
frequency	O
of	O
hand	O
cleansing	O
,	O
or	B
the	O
effects	O
of	O
even	O
infrequent	O
hand	O
cleansing	O
.	O

One	O
possible	O
interpretation	O
for	O
these	O
data	O
is	O
that	O
a	O
vagal	O
withdrawal	O
,	O
rather	B
than	O
a	O
sympathetic	O
overactivity	O
,	O
could	O
precede	O
the	O
development	O
of	O
hypertension	O
and	O
other	O
cardiometabolic	O
diseases	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

Ionization	O
was	O
in	O
positive	O
mode	O
and	O
Q2	O
had	O
1	O
.	O
2	O
mTorr	O
of	O
argon	O
.	O

¶	O
Fisher	O
'	O
s	O
exact	O
test	O
.	O

Adolescence	O
In	O
addition	O
to	O
developmental	O
risks	O
carried	O
from	O
earlier	O
life	O
,	O
by	O
adolescence	O
the	O
cumulative	O
effects	O
of	O
social	O
disadvantage	O
on	O
obesity	O
become	O
apparent	O
.	O

(	O
2015	O
)	O
*	O
Metals	O
:	O
Arsenic	O
(	O
As	O
)	O
LifetimeAdulthoodSkin	O
abnormalitiesDNA	O
methylationPaul	O
et	O
al	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Regulated	O
pathways	O
in	O
liver	O
tissue	O
between	O
ontogenetic	O
stages	O
and	O
diets	O
.	O

Cost	O
-	O
effectiveness	O
analysis	O
The	O
economic	O
evaluation	O
will	O
take	O
a	O
societal	O
perspective	O
.	O

Therefore	O
,	O
it	O
seems	O
reasonable	O
to	O
recommend	O
that	O
when	O
there	O
is	O
no	O
medical	O
or	O
obstetric	O
contraindication	O
,	O
women	O
with	O
GDM	O
should	O
maintain	O
a	O
sensible	O
level	O
of	O
light	O
and	O
moderate	O
intensity	O
physical	O
activity	O
until	O
the	O
latter	O
stages	O
of	O
the	O
pregnancy	O
.	O

Over	O
the	O
past	O
several	O
decades	O
,	O
continuing	O
research	O
has	O
been	O
conducted	O
,	O
and	O
much	O
literature	O
has	O
been	O
published	O
that	O
has	O
supported	O
the	O
existence	O
of	O
the	O
links	O
between	O
autism	O
and	O
factors	O
that	O
relate	O
to	O
pre	O
-,	O
peri	O
-,	O
and	O
neonatal	O
care	O
.	O

1	O
The	O
flow	O
chart	O
of	O
sampling	O
The	O
mean	O
age	O
of	O
the	O
participants	O
was	O
26	O
.	O
31	O
±	O
4	O
.	O
59	O
.	O

Women	O
with	O
a	O
small	O
increase	O
in	O
25OHD	O
(	O
0	O
–	O
30	O
nmol	O
/	O
L	O
)	O
had	O
significantly	O
higher	O
OR	O
of	O
SGA	O
(	O
OR	O
=	O
2	O
.	O
6	O
,	O
p	O
=	O
0	O
.	O
019	O
)	O
and	O
preterm	O
delivery	O
(	O
OR	O
=	O
2	O
.	O
9	O
,	O
p	O
=	O
0	O
.	O
047	O
)	O
as	O
well	O
as	O
a	O
trend	O
toward	O
significance	O
for	O
LBW	O
(	O
OR	O
=	O
3	O
.	O
1	O
,	O
p	O
=	O
0	O
.	O
056	O
),	O
compared	O
to	O
women	O
with	O
a	O
large	O
increase	O
.	O

Data	O
are	O
available	O
on	O
maternal	O
vitamin	O
use	O
during	O
pregnancy	O
for	O
1051	O
cases	O
and	O
1919	O
controls	O
from	O
eight	O
geographic	O
areas	O
in	O
North	O
America	O
,	O
Europe	O
,	O
and	O
Israel	O
.	O

Sampling	O
frame	O
and	O
sample	O
size	O
To	O
detect	O
a	O
25	O
%	O
reduction	O
in	O
neonatal	O
mortality	O
(	O
33	O
neonatal	O
deaths	O
/	O
1000	O
live	O
births	O
in	O
control	O
to	O
24	O
.	O
8	O
neonatal	O
deaths	O
/	O
1000	O
live	O
births	O
in	O
the	O
intervention	O
group	O
),	O
with	O
90	O
%	O
power	O
,	O
5	O
%	O
two	O
-	O
sided	O
alpha	O
,	O
1	O
:	O
1	O
ratio	O
of	O
treatment	O
allocation	O
and	O
intra	O
-	O
cluster	O
correlation	O
coefficient	O
(	O
ICC	O
)	O
of	O
0	O
.	O
0245	O
,	O
we	O
require	O
100	O
clusters	O
(	O
each	O
covering	O
an	O
average	O
of	O
4000	O
households	O
),	O
or	O
50	O
clusters	O
per	O
treatment	O
group	O
,	O
with	O
a	O
total	O
of	O
30	O
,	O
000	O
live	O
births	O
over	O
one	O
year	O
.	O

Objectives	O
To	O
determine	O
if	O
the	O
reported	O
inverse	O
relationship	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
risk	O
could	O
be	O
replicated	O
at	O
MUSC	O
,	O
an	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
.	O

The	O
same	O
relationship	O
was	O
observed	O
for	O
women	O
with	O
9	O
–	O
12	O
years	O
of	O
formal	O
education	O
regarding	O
folic	O
acid	O
use	O
(	O
p	O
<	O
.	O
001	O
),	O
iron	O
(	O
p	O
=	O
.	O
001	O
)	O
and	O
multivitamins	O
(	O
p	O
<	O
.	O
001	O
).	O

Such	O
an	O
approach	O
would	O
have	O
to	O
encompass	O
emerging	O
knowledge	O
about	O
how	O
obesity	O
is	O
the	O
consequence	O
of	O
complex	O
factors	O
acting	O
at	O
many	O
stages	O
throughout	O
a	O
person	O
'	O
s	O
lifetime	O
.	O

Additional	O
recent	O
studies	O
about	O
pregnancy	O
diets	O
reveal	O
that	O
components	O
other	B
than	O
specific	O
allergens	O
,	O
such	O
as	O
fat	O
,	O
may	O
influence	O
atopy	O
outcomes	O
[	O
103	O
,	O
104	O
].	O

Fewer	O
children	O
in	O
the	O
S	O
-	O
ECC	O
group	O
were	O
reported	O
as	O
having	O
good	O
or	O
very	O
good	O
oral	O
health	O
compared	O
to	O
controls	O
(	O
19	O
.	O
4	O
%	O
vs	O
.	O
95	O
.	O
9	O
%,	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
mean	O
GD	O
was	O
7	O
%	O
smaller	O
(	O
81	O
.	O
0	O
±	O
0	O
.	O
6	O
µm	O
)	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1	O
-	O
SC	O
mice	O
(	O
87	O
.	O
2	O
±	O
0	O
.	O
6	O
µm	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

2	O
.	O
2	O
.	O

Outliers	O
(	O
n	O
=	O
18	O
)	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
identified	O
with	O
Normal	O
probability	O
plot	O
of	O
residuals	O
,	O
Leverage	O
and	O
Cook	O
’	O
s	O
Distance	O
diagnostic	O
tests	O
,	O
and	O
omitted	O
from	O
the	O
analyses	O
.	O

When	O
body	O
weight	O
at	O
three	O
months	O
was	O
included	O
as	O
a	O
covariate	O
in	O
this	O
analysis	O
,	O
changes	O
in	O
BMC	O
remained	O
significant	O
,	O
p	O
=	O
0	O
.	O
03	O
,	O
but	O
changes	O
in	O
BMD	O
were	O
not	O
(	O
p	O
=	O
0	O
.	O
06	O
).	O

Access	O
to	O
IFA	O
supplements	O
is	O
through	O
antenatal	O
care	O
,	O
however	O
,	O
in	O
rural	O
Bangladesh	O
,	O
the	O
median	O
gestation	O
that	O
women	O
commence	O
antenatal	O
care	O
is	O
5	O
.	O
2	O
months	O
,	O
and	O
44	O
%	O
of	O
women	O
report	O
no	O
use	O
of	O
antenatal	O
care	O
[	O
5	O
].	O

This	O
review	O
critically	O
evaluates	O
literature	O
on	O
fish	O
intake	O
in	O
pregnant	O
women	O
,	O
with	O
a	O
focus	O
on	O
the	O
association	O
between	O
neurodevelopmental	O
outcomes	O
in	O
the	O
offspring	O
and	O
maternal	O
fish	O
intake	O
during	O
pregnancy	O
.	O

The	O
observation	O
that	O
early	O
registration	O
with	O
a	O
physician	O
in	O
pregnancy	O
was	O
associated	O
with	O
folic	O
acid	O
intake	O
could	O
indicate	O
the	O
recognised	O
importance	O
of	O
early	O
prenatal	O
care	O
.	O

The	O
capillaries	O
were	O
not	O
arranged	O
in	O
lobules	O
and	O
rather	O
were	O
dispersed	O
among	O
spicules	O
of	O
mineralized	O
bone	O
.	O

Neither	O
BMI	O
,	O
nor	O
percent	O
fat	O
were	O
found	O
to	O
correlate	O
with	O
cathelicidin	O
concentration	O
.	O

But	O
the	O
implementation	O
of	O
this	O
recommendation	O
is	O
inadequate	O
.	O

Curiously	O
,	O
it	O
has	O
recently	O
been	O
shown	O
that	O
dynamin	O
1	O
-	O
like	O
protein	O
is	O
also	O
important	O
for	O
mitochondrial	O
fission	O
and	O
general	O
morphology	O
[	O
33	O
].	O

Intervention	O
Participants	O
assigned	O
to	O
the	O
control	O
condition	O
were	O
excused	O
immediately	O
after	O
completing	O
the	O
baseline	O
survey	O
.	O

Unlike	B
the	O
previously	O
published	O
data	O
on	O
vitamin	O
D	O
in	O
the	O
Auckland	O
cohort	O
[	O
20	O
],	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
measured	O
using	O
the	O
IDS	O
-	O
iSYS	O
chemiluminescent	O
-	O
based	O
assay	O
(	O
Abacus	O
,	O
ALS	O
)	O
as	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

Furthermore	O
,	O
it	O
has	O
been	O
established	O
that	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
is	O
recommended	O
during	O
pregnancy	O
and	O
lactation	O
[	O
7	O
].	O

In	O
contrast	O
to	O
BMP7	O
and	O
BMP8B	O
,	O
BMP4	O
was	O
shown	O
to	O
promote	O
the	O
differentiation	O
of	O
mesenchymal	O
stem	O
cells	O
into	O
white	O
adipocytes	O
,	O
inducing	O
fat	O
storage	O
and	O
decreasing	O
energy	O
expenditure	O
in	O
rodents	O
(	O
Modica	O
and	O
Wolfrum	O
,	O
2013	O
;	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

Third	O
,	O
we	O
did	O
not	O
power	O
the	O
sample	O
size	O
to	O
analyze	O
effects	O
by	O
trimester	O
of	O
vaccination	O
and	O
so	O
may	O
have	O
missed	O
important	O
effects	O
.	O

Castration	O
of	O
bulls	O
increases	O
IMF	O
deposition	O
in	O
most	O
cattle	O
breeds	O
.	O

Discussion	O
Iron	O
deficiency	O
is	O
associated	O
with	O
increased	O
risk	O
of	O
maternal	O
death	O
,	O
preterm	O
delivery	O
,	O
impaired	O
foetal	O
growth	O
and	O
development	O
,	O
low	O
birth	O
weight	O
,	O
increased	O
neonatal	O
mortality	O
and	O
impaired	O
infant	O
development	O
[	O
17	O
].	O

We	O
included	O
primiparous	O
mothers	O
for	O
the	O
handwashing	O
study	O
because	O
we	O
anticipated	O
that	O
they	O
would	O
be	O
at	O
a	O
uniquely	O
teachable	O
moment	O
[	O
15	O
,	O
16	O
].	O

Some	O
effects	O
of	O
maternal	O
diet	O
were	O
more	O
apparent	O
in	O
exclusively	O
breastfed	O
infants	O
;	O
however	O
,	O
we	O
were	O
unable	O
to	O
compare	O
to	O
exclusively	O
formula	O
-	O
fed	O
infants	O
since	O
most	O
infants	O
received	O
some	O
breast	O
milk	O
.	O

The	O
patients	O
were	O
randomly	O
assigned	O
into	O
intervention	O
group	O
(	O
IG	O
)	O
and	O
control	O
group	O
(	O
CG	O
).	O

Third	O
,	O
a	O
large	O
percentage	O
of	O
infants	O
in	O
the	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
group	O
were	O
male	O
,	O
although	B
our	O
previous	O
study	O
found	O
no	O
gender	O
difference	O
in	O
the	O
infant	O
lung	O
function	O
test	O
[	O
18	O
].	O

We	O
therefore	O
undertook	O
this	O
study	O
to	O
determine	O
whether	B
SNPs	O
within	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
known	O
to	O
modify	O
vitamin	O
D	O
status	O
are	O
also	O
associated	O
with	O
the	O
response	O
to	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O

Subjects	O
returned	O
for	O
a	O
repeat	O
DXA	O
scan	O
and	O
a	O
serum	O
sample	O
was	O
obtained	O
for	O
25	O
(	O
OH	O
)	O
D	O
and	O
parathyroid	O
hormone	O
(	O
PTH	O
)	O
levels	O
.	O

Lactation	O
support	O
includes	O
breastfeeding	O
-	O
related	O
counseling	O
and	O
education	O
from	O
trained	O
specialists	O
both	O
in	O
the	O
hospital	O
shortly	O
after	O
birth	O
and	O
at	O
home	O
for	O
the	O
first	O
months	O
of	O
the	O
baby	O
’	O
s	O
life	O
.	O
9	O
While	O
an	O
absolute	O
inability	O
to	O
lactate	O
is	O
rare	O
,	O
estimated	O
to	O
occur	O
in	O
less	O
than	O
2	O
%	O
of	O
mothers	O
,	O
10	O
“	O
we	O
have	O
no	O
idea	O
about	O
the	O
prevalence	O
of	O
women	O
who	O
are	O
lactating	O
less	O
than	O
optimally	O
,	O
who	O
may	O
be	O
unable	O
to	O
exclusively	O
breastfeed	O
a	O
baby	O
no	O
matter	O
how	O
frequently	O
and	O
thoroughly	O
they	O
breastfeed	O
,”	O
says	O
Nommsen	O
-	O
Rivers	O
.	O

UNIMMAP	O
is	O
a	O
balanced	O
preparation	O
of	O
15	O
vitamins	O
and	O
minerals	O
formulated	O
by	O
an	O
Expert	O
Committee	O
of	O
the	O
United	O
Nations	O
Children	O
'	O
s	O
Fund	O
,	O
World	O
Health	O
Organization	O
and	O
the	O
United	O
Nations	O
University	O
,	O
primarily	O
for	O
use	O
by	O
pregnant	O
and	O
lactating	O
women	O
.	O

The	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O
Visfatin	O
has	O
extensive	O
effects	O
on	O
pregnancy	O
physiology	O
and	O
pathology	O
,	O
maternal	O
and	O
especially	O
neonatal	O
outcomes	O
,	O
and	O
its	O
effect	O
is	O
different	O
in	O
normal	O
weight	O
and	O
overweight	O
women	O
.	O

Preventive	O
pharmacotherapy	O
and	O
immunotherapy	O
will	O
not	O
be	O
discussed	O
.	O

In	O
reporting	O
the	O
results	O
,	O
we	O
use	O
the	O
lowest	O
level	O
of	O
assigned	O
taxonomy	O
available	O
,	O
which	O
is	O
most	O
commonly	O
the	O
genus	O
,	O
but	O
ranges	O
from	O
the	O
family	O
to	O
the	O
species	O
level	O
.	O

Lower	O
vitamin	O
D	O
levels	O
have	O
been	O
found	O
in	O
many	O
autoimmune	O
diseases	O
,	O
such	O
as	O
rheumatoid	O
arthritis	O
,	O
systemic	O
lupus	O
erythematosus	O
,	O
systemic	O
sclerosis	O
,	O
type	O
1	O
diabetes	O
mellitus	O
,	O
multiple	O
sclerosis	O
,	O
inflammatory	O
bowel	O
diseases	O
,	O
autoimmune	O
thyroid	O
diseases	O
[	O
6	O
,	O
7	O
].	O

Antiepileptic	O
drugs	O
and	O
oral	O
supplements	O
may	O
play	O
a	O
role	O
in	O
later	O
onset	O
.	O

Age	O
had	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
18	O
and	O
39	O
,	O
respectively	O
.	O

Interaction	O
between	O
diet	O
and	O
sex	O
was	O
found	O
in	O
the	O
plasma	O
levels	O
of	O
bilirubin	O
and	O
ALT	O
(	O
Table1	O
),	O
and	O
an	O
almost	O
significant	O
interaction	O
in	O
leptin	O
levels	O
[	O
F	O
(	O
1	O
,	O
18	O
)=	O
3	O
.	O
349	O
,	O
P	O
=	O
0	O
.	O
084	O
].	O

The	O
exposed	O
neonates	O
were	O
more	O
likely	O
to	O
be	O
born	O
premature	O
,	O
were	O
admitted	O
more	O
often	O
to	O
the	O
neonatal	O
intensive	O
care	O
unit	O
,	O
presented	O
with	O
poor	O
neonatal	O
adaptation	O
signs	O
and	O
had	O
higher	O
rates	O
of	O
congenital	O
malformations	O
.	O

However	O
,	O
due	O
to	O
heavy	O
clinical	O
demand	O
,	O
only	O
31	O
.	O
5	O
%	O
of	O
the	O
162	O
women	O
seen	O
after	O
the	O
change	O
in	O
practice	O
received	O
best	O
-	O
practice	O
individual	O
dietitian	O
review	O
at	O
their	O
first	O
visit	O
.	O

In	B
contrast	I
,	O
the	O
LDL	O
was	O
two	O
-	O
fold	O
increased	O
in	O
the	O
plasma	O
of	O
RC	O
females	O
,	O
which	O
is	O
strongly	O
associated	O
with	O
artherosclerosis	O
within	O
the	O
artery	O
wall	O
and	O
poses	O
a	O
risk	O
for	O
cardiovascular	O
disease	O
.	O

Much	O
of	O
the	O
attrition	O
was	O
attributable	O
to	O
redeployments	O
and	O
,	O
thus	O
,	O
lack	O
of	O
access	O
to	O
participants	O
at	O
the	O
Madigan	O
clinic	O
.	O

Of	O
these	O
,	O
267	O
provided	O
blood	O
and	O
urine	O
samples	O
so	O
the	O
researchers	O
could	O
look	O
for	O
markers	O
of	O
biological	O
damage	O
.	O
23The	O
average	O
age	O
of	O
study	O
participants	O
was	O
51	O
.	O
5	O
years	O
.	O

However	B
,	O
folate	O
had	O
fewer	O
effects	O
on	O
the	O
hypothalamus	O
of	O
offspring	O
born	O
to	O
HV	O
dams	O
.	O

A	O
report	O
of	O
the	O
Young	O
Finns	O
Study	O
followed	O
offspring	O
in	O
relation	O
to	O
parental	O
BMI	O
from	O
3	O
to	O
18	O
years	O
and	O
later	O
again	O
when	O
children	O
were	O
24	O
–	O
39	O
years	O
old	O
.	O

Maternal	O
characteristics	O
,	O
as	O
described	O
in	O
Table1	O
,	O
did	O
not	O
differ	O
between	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
or	O
summer	O
.	O

PubMed	O
Central	O
:	O

As	O
far	O
as	O
the	O
vacancy	O
status	O
is	O
concerned	O
,	O
almost	O
33	O
.	O
9	O
%,	O
35	O
%,	O
7	O
.	O
1	O
%,	O
and	O
7	O
.	O
2	O
%	O
of	O
CDPOs	O
,	O
Supervisors	O
,	O
Anganwadi	O
workers	O
and	O
Anganwadi	O
helpers	O
posts	O
are	O
still	O
vacant	O
in	O
the	O
country	O
.	O

Other	O
measures	O
of	O
neurodevelopment	O
not	O
significant	O
in	O
either	O
direction	O
.	O
QualityNeutralPositivePositiveNeutral	O
Studies	O
were	O
heterogeneous	O
in	O
methodology	O
in	O
regard	O
to	O
the	O
covariates	O
,	O
neurological	O
assessment	O
tools	O
,	O
length	O
of	O
follow	O
up	O
statistical	O
analyses	O
.	O

study	O
which	O
showed	O
that	O
“	O
health	O
conscious	O
”	O
dietary	O
patterns	O
were	O
negatively	O
associated	O
with	O
decreasing	O
educational	O
level	O
,	O
age	O
,	O
and	O
socioeconomic	O
status	O
[	O
21	O
].	O

All	O
dietary	O
variables	O
were	O
modeled	O
as	O
continuous	O
variables	O
.	O

Implement	O
•	O
Use	O
evidence	O
-	O
based	O
standards	O
to	O
prevent	O
or	O
treat	O
preterm	O
births	O
;	O
implement	O
training	O
;	O
and	O
update	O
curricula	O
with	O
evidence	O
-	O
based	O
interventions	O
.	O

There	O
is	O
emerging	O
evidence	O
,	O
both	O
from	O
animal	O
and	O
human	O
studies	O
,	O
of	O
an	O
association	O
between	O
maternal	O
obesity	O
and	O
significantly	O
higher	O
risks	O
of	O
impaired	O
offspring	O
cognitive	O
,	O
motor	O
and	O
behavioural	O
aspects	O
of	O
neurodevelopment	O
[	O
44	O
–	O
46	O
].	O

[	O
32	O
]	O
Role	O
of	O
vitamin	O
D	O
in	O
newborn	O
and	O
infant	O
Adequate	O
maternal	O
vitamin	O
D	O
levels	O
are	O
also	O
important	O
for	O
fetal	O
and	O
child	O
health	O
.	O

In	O
our	O
study	O
,	O
the	O
definition	O
of	O
psychotic	O
-	O
like	O
symptoms	O
was	O
based	O
on	O
self	O
-	O
reported	O
frequency	O
of	O
psychosis	O
-	O
like	O
experiences	O
.	O

In	O
this	O
cohort	O
,	O
we	O
have	O
collected	O
detailed	O
information	O
on	O
social	O
and	O
environmental	O
influences	O
on	O
the	O
child	O
'	O
s	O
development	O
and	O
in	O
a	O
number	O
of	O
other	O
publications	O
address	O
this	O
question	O
,	O
including	O
cultural	O
and	O
familial	O
influences	O
.	O

Medical	O
history	O
of	O
bone	O
mineral	O
metabolic	O
disease	O
;	O
2	O
).	O

Whenever	B
possible	O
,	O
the	O
operation	O
should	O
be	O
performed	O
during	O
the	O
second	O
trimester	O
or	O
after	O
delivery37	O
.	O

Although	O
folate	O
has	O
been	O
shown	O
to	O
be	O
an	O
active	O
participant	O
in	O
methyltransfer	O
reactions	O
,	O
12global	O
methylation	O
was	O
not	O
affected	O
by	O
either	O
the	O
gestational	O
or	O
post	O
-	O
weaning	O
diet	O
.	O

However	B
,	O
the	O
previous	O
study	O
was	O
based	O
on	O
cortical	O
and	O
hippocampal	O
tissue	O
from	O
adult	O
female	O
animals	O
,	O
whereas	B
the	O
current	O
study	O
was	O
based	O
on	O
tissue	O
from	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
male	O
animals	O
.	O

Vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
the	O
origin	O
for	O
a	O
host	O
of	O
future	O
perils	O
for	O
the	O
child	O
,	O
especially	O
effect	O
on	O
neurodevelopment	O
and	O
immune	O
system	O
.	O

Pregnancy	O
status	O
requires	O
much	O
more	O
accuracy	O
in	O
assessing	O
levothyroxine	O
dosage	O
to	O
protect	O
the	O
foetus	O
from	O
maternal	O
hypothyroidism	O
because	O
,	O
as	O
mentioned	O
above	O
,	O
the	O
mother	O
is	O
the	O
only	O
source	O
of	O
thyroid	O
hormones	O
for	O
the	O
embryo	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
.	O

Mice	O
that	O
lack	O
functional	O
Flnb	O
have	O
been	O
generated	O
that	O
exhibit	O
impaired	O
development	O
of	O
the	O
microvascular	O
and	O
skeletal	O
systems	O
,	O
including	O
lack	O
of	O
invertebral	O
discs	O
and	O
kyphotic	O
and	O
scoliotic	O
spines	O
(	O
Farrington	O
-	O
Rock	O
et	O
al	O
.	O

Finally	O
,	O
Guinchat	O
et	O
al	O
.	O

Concerning	O
to	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
during	O
the	O
post	O
-	O
weaning	O
period	O
(	O
Figure2D	O
),	O
we	O
found	O
a	O
main	O
effect	O
of	O
time	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
1712	O
.	O
38	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
30	O
.	O
20	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

Therefore	O
,	O
the	O
current	O
study	O
includes	O
133	O
women	O
who	O
received	O
SGA	O
medications	O
during	O
pregnancy	O
and	O
133	O
matched	O
healthy	O
women	O
(	O
N	O
=	O
266	O
).	O

A	O
moderate	O
maternal	O
caloric	O
restriction	O
produces	O
sex	O
-	O
dimorphic	O
effects	O
in	O
feeding	O
and	O
body	O
weight	O
gain	O
only	O
after	O
weaning	O
The	O
dams	O
exposed	O
to	O
undernutrition	O
during	O
prenatal	O
stages	O
exhibited	O
a	O
reduction	O
in	O
their	O
body	O
weight	O
gain	O
and	O
caloric	O
intake	O
during	O
gestation	O
that	O
contrasts	O
with	O
the	O
increase	O
in	O
their	O
body	O
weight	O
during	O
lactation	O
with	O
normal	O
nutrition	O
.	O

Nulliparous	O
women	O
carrying	O
a	O
singleton	O
pregnancy	O
were	O
recruited	O
between	O
November	O
2004	O
and	O
September	O
2008	O
in	O
Adelaide	O
(	O
Australia	O
)	O
and	O
Auckland	O
(	O
New	O
Zealand	O
).	O

Higher	O
vaccination	O
among	O
pregnant	O
women	O
with	O
high	O
-	O
risk	O
pregnancies	O
could	O
have	O
caused	O
a	O
selection	O
bias	O
as	O
those	O
vaccinated	O
women	O
would	O
have	O
been	O
at	O
higher	O
risk	O
for	O
adverse	O
pregnancy	O
outcomes	O
compared	B
to	I
unvaccinated	O
women	O
.	O

We	O
then	O
evaluated	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
by	O
MLR	O
models	O
,	O
including	O
variables	O
measured	O
after	O
-	O
vaccination	O
:	O
delivery	O
hospital	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
reporting	O
at	O
least	O
one	O
episode	O
of	O
influenza	O
-	O
like	O
illness	O
during	O
pregnancy	O
(	O
ILI	O
),	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
influenza	O
circulation	O
.	O

Statistical	O
analysis	O
indicated	O
a	O
significant	O
decrease	O
in	O
body	O
weight	O
gain	O
and	O
caloric	O
intake	O
in	O
the	O
calorie	O
-	O
restricted	O
dams	O
after	O
gestation	O
.	O

De	O
novo	O
methylation	O
is	O
established	O
by	O
the	O
de	O
novo	O
DNMTs	O
3A	O
and	O
3B	O
,	O
which	O
preferentially	O
methylate	O
unmethylated	O
DNA	O
.	O

This	O
may	O
be	O
attributable	O
to	O
the	O
synergistic	O
effects	O
of	O
food	O
[	O
34	O
]	O
and	O
associated	O
with	O
fish	O
being	O
a	O
source	O
of	O
other	B
nutrients	O
which	O
are	O
important	O
for	O
infant	O
development	O
such	O
as	O
iodine	O
and	O
vitamin	O
D	O
.	O
Presently	O
,	O
there	O
have	O
been	O
no	O
randomised	O
control	O
trials	O
examining	O
neurocognitive	O
outcomes	O
associated	O
with	O
prenatal	O
multivitamin	O
use	O
and	O
infant	O
neurodevelopment	O
,	O
and	O
these	O
are	O
unlikely	O
to	O
occur	O
given	O
ethical	O
implications	O
of	O
such	O
[	O
35	O
].	O

Table	O
2presents	O
the	O
results	O
of	O
our	O
exploration	O
of	O
the	O
differences	O
in	O
the	O
measures	O
of	O
DNA	O
methylation	O
by	O
various	O
in	O
utero	O
exposures	O
.	O

GAS5	O
and	O
GR	O
α	O
were	O
the	O
predominant	O
transcripts	O
in	O
both	O
term	O
and	O
preterm	O
placentas	O
,	O
with	O
GAS5	O
being	O
primarily	O
localized	O
in	O
the	O
syncytiotrophoblasts	O
.	O

Delivering	O
high	O
doses	O
of	O
mHealth	O
interventions	O
has	O
implications	O
in	O
terms	O
of	O
cost	O
,	O
participant	O
burden	O
,	O
and	O
potential	O
“	O
wear	O
out	O
”	O
effects	O
(	O
ie	O
,	O
overexposure	O
).	O

Breastfeeding	O
,	O
child	O
fish	O
consumption	O
,	O
maternal	O
dental	O
&	O
lifestyle	O
questionnaires	O
.	O
Neurodevelopmental	O
testing	O
of	O
child	O
completed	O
by	O
mother	O
using	O
ALSPAC	O
adaption	O
of	O
the	O
MacArthur	O
Communicative	O
Development	O
Inventory	O
(	O
MCDI	O
)	O
at	O
15	O
months	O
and	O
Denver	O
Developmental	O
Screening	O
Test	O
(	O
DDST	O
)	O
at	O
18	O
months	O
of	O
age	O
.	O
Fish	O
and	O
seafood	O
intake	O
measured	O
via	O
a	O
validated	O
FFQ	O
(	O
calibrated	O
for	O
LC	O
n	O
-	O
3PUFAs	O
in	O
blood	O
)	O
at	O
28	O
weeks	O
gestation	O
.	O
Infant	O
cognition	O
measured	O
usingVisual	O
Recognition	O
Memory	O
(	O
VRM	O
)	O
paradigm	O
at	O
6	O
months	O
of	O
age	O
.	O
Seafood	O
consumption	O
assessed	O
at	O
32	O
weeks	O
gestation	O
via	O
FFQ	O
.	O
Postal	O
questionnaires	O
on	O
diet	O
,	O
education	O
,	O
social	O
,	O
behavioural	O
and	O
developmental	O
outcomes	O
at	O
child	O
age	O
:	O
6	O
,	O
18	O
,	O
30	O
,	O
42	O
,	O
and	O
81	O
months	O
.	O
Wechsler	O
Intelligence	O
Scale	O
for	O
Children	O
III	O
used	O
to	O
assess	O
Intelligence	O
Quotient	O
(	O
IQ	O
)	O
at	O
8	O
years	O
and	O
Strengths	O
and	O
Difficulties	O
Questionnaire	O
(	O
SDQ	O
)	O
conducted	O
.	O

In	O
many	O
ways	O
,	O
inconsistencies	B
in	O
the	O
literature	O
on	O
EAH	O
parallel	O
those	O
observed	O
in	O
the	O
general	O
literature	O
on	O
child	O
feeding	O
,	O
which	O
may	O
reflect	O
the	O
early	O
stage	O
of	O
the	O
work	O
in	O
the	O
field	O
.	O

For	O
all	O
women	O
included	O
in	O
the	O
study	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
obtained	O
from	O
weight	O
and	O
height	O
recorded	O
by	O
the	O
gynaecologist	O
during	O
the	O
first	O
prenatal	O
consultation	O
in	O
the	O
beginning	O
of	O
the	O
first	O
trimester	O
of	O
pregnancy	O
.	O

(	O
2012	O
)*	O
Jiang	O
et	O
al	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

We	O
will	O
train	O
the	O
evaluation	O
team	O
over	O
a	O
four	O
-	O
week	O
period	O
,	O
and	O
standardize	O
measurement	O
methods	O
and	O
retrain	O
as	O
needed	O
every	O
six	O
months	O
.	O

This	O
study	O
is	O
registered	O
withClinicalTrials	O
.	O
gov	O
,	O
numberNCT00548379	O
.	O

Lipid	O
-	O
derived	O
immune	O
modulators	O
will	O
be	O
determined	O
with	O
LCMSMS	O
[	O
75	O
].	O

Previous	O
papers	O
in	O
this	O
supplement	O
have	O
identified	O
gaps	O
in	O
coverage	O
,	O
quality	O
,	O
equity	O
and	O
metrics	O
for	O
care	O
during	O
preconception	O
,	O
pregnancy	O
and	O
care	O
of	O
preterm	O
newborns	O
[	O
4	O
-	O
6	O
].	O

Also	O
,	O
there	O
were	O
positive	O
nonsignificant	O
relationships	O
between	O
adherence	O
to	O
western	O
[	O
OR	O
1	O
.	O
31	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
68	O
-	O
2	O
.	O
51	O
),	O
P	O
=	O
0	O
.	O
28	O
]	O
and	O
healthy	O
[	O
OR	O
1	O
.	O
02	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
39	O
-	O
2	O
.	O
63	O
),	O
P	O
=	O
0	O
.	O
40	O
]	O
dietary	O
pattern	O
of	O
mothers	O
with	O
having	O
short	O
height	O
infant	O
in	O
the	O
final	O
adjusted	O
model	O
.	O

In	O
May	O
2014	O
,	O
Nicaragua	O
expanded	O
influenza	O
vaccination	O
to	O
all	O
pregnant	O
women	O
in	O
the	O
country	O
.	O

CT	O
revealed	O
a	O
Stanford	O
type	O
A	O
aortic	O
dissection	O
involving	O
the	O
ascending	O
and	O
descending	O
aorta	O
.	O

Inconsistencies	B
in	O
the	O
literature	O
may	O
also	O
reflect	O
other	B
causative	O
factors	O
in	O
which	O
vitamin	O
D	O
is	O
a	O
mediator	O
.	O

The	O
associations	O
of	O
other	O
maternal	O
dietary	O
factors	O
with	O
specific	O
infant	O
gut	O
microbes	O
were	O
also	O
somewhat	O
unexpected	O
,	O
namely	O
for	O
red	O
and	O
processed	O
meat	O
and	O
for	O
fruit	O
consumption	O
.	O

TG	O
synthesis	O
is	O
a	O
key	O
factor	O
for	O
IMF	O
deposition	O
[	O
69	O
].	O

(	O
2003	O
)	O
demonstrated	O
a	O
decrease	O
in	O
the	O
hypothalamic	O
levels	O
of	O
AEA	O
(	O
confirmed	O
by	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
)	O
and	O
an	O
absence	O
of	O
significant	O
changes	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Faah	O
in	O
the	O
hypothalamus	O
of	O
weaned	O
pups	O
after	O
a	O
maternal	O
undernutrition	O
throughout	O
the	O
last	O
part	O
of	O
pregnancy	O
and	O
/	O
or	O
lactation	O
.	O

Sociodemographics	O
The	O
demographic	O
variables	O
used	O
in	O
this	O
study	O
included	O
maternal	O
age	O
,	O
country	O
of	O
origin	O
,	O
ethnicity	O
,	O
education	O
,	O
language	O
preference	O
,	O
years	O
spent	O
in	O
the	O
US	O
,	O
parity	O
,	O
use	O
of	O
tobacco	O
,	O
alcohol	O
and	O
prenatal	O
vitamins	O
during	O
pregnancy	O
,	O
employment	O
,	O
and	O
participation	O
in	O
the	O
Special	O
Supplemental	O
Nutrition	O
Program	O
for	O
Women	O
,	O
Infants	O
and	O
Children	O
(	O
WIC	O
).	O

Adverse	O
health	O
outcomes	O
during	O
pregnancy	O
are	O
preeclampsia	O
;	O
gestational	O
diabetes	O
mellitus	O
and	O
caesarean	O
section	O
.	O

Specifically	O
,	O
POU2F1	O
binding	O
sites	O
were	O
overrepresented	O
among	O
loci	O
associated	O
with	O
both	O
LINE	O
-	O
1	O
and	O
AluYb8	O
extent	O
.	O

Glucose	O
can	O
also	O
be	O
used	O
as	O
a	O
substrate	O
for	O
FA	O
de	O
novo	O
synthesis	O
in	O
ruminants	O
.	O

[	O
15	O
]	O
evaluated	O
vitamin	O
D	O
status	O
in	O
a	O
younger	O
group	O
of	O
premenopausal	O
women	O
found	O
the	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
to	O
be	O
77	O
.	O
8	O
%,	O
which	O
was	O
as	O
high	O
as	O
the	O
rate	O
found	O
in	O
elderly	O
Thai	O
women	O
living	O
in	O
nursing	O
homes	O
.	O

The	O
size	O
of	O
each	O
point	O
indicates	O
the	O
log	O
-	O
ratio	O
transformed	O
relative	O
abundance	O
(	O
LRTA	O
)	O
of	O
each	O
OTU	O
(	O
LRTA	O
≥	O
30	O
,	O
LRTA	O
≥	O
20	O
,	O
or	O
LRTA	O
<	O
20	O
).	O

The	O
mean	O
score	O
was	O
11	O
.	O
0	O
(	O
95	O
%	O
CI	O
,	O
10	O
.	O
5	O
-	O
11	O
.	O
5	O
)	O
and	O
standard	O
deviation	O
was	O
4	O
.	O
8	O
(	O
Table	O
1	O
).	O

Sustained	O
advocacy	O
in	O
tackling	O
micronutrient	O
deficiencies	O
at	O
national	O
and	O
international	O
policy	O
levels	O
is	O
also	O
a	O
prerequisite	O
to	O
the	O
attainment	O
of	O
Millennium	O
Development	O
Goals	O
4	O
and	O
5	O
.	O

Feeding	O
the	O
HV	O
pup	O
diet	O
restored	O
POMC	O
and	O
BDNF	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
.	O

This	O
variable	O
was	O
calculated	O
in	O
stages	O
,	O
first	O
by	O
dividing	O
the	O
number	O
of	O
positive	O
influenza	O
samples	O
by	O
the	O
total	O
number	O
of	O
samples	O
tested	O
per	O
week	O
from	O
the	O
surveillance	O
data	O
and	O
then	O
assigning	O
the	O
cumulative	O
sum	O
of	O
the	O
influenza	O
positive	O
proportions	O
per	O
week	O
to	O
the	O
weeks	O
that	O
women	O
were	O
pregnant	O
;	O
we	O
dichotomized	O
this	O
variable	O
by	O
high	O
or	O
low	O
exposure	O
using	O
the	O
median	O
cumulative	O
influenza	O
exposure	O
as	O
a	O
cutoff	O
.	O

Vitamin	O
D	O
deficiency	O
during	O
early	O
pregnancy	O
significantly	O
increases	O
the	O
risk	O
for	O
gestational	O
diabetes	O
in	O
later	O
pregnancy	O
.	O

Pre	O
-	O
eclampsia	O
is	O
a	O
known	O
independent	O
risk	O
factor	O
for	O
SGA	O
.	O

APGAR	O
scores	O
were	O
0	O
,	O
4	O
,	O
and	O
7	O
at	O
one	O
,	O
five	O
,	O
and	O
ten	O
minutes	O
,	O
respectively	O
.	O

Introduction	O
Afghanistan	O
has	O
the	O
third	O
highest	O
mortality	O
of	O
children	O
younger	O
than	O
5	O
years	O
in	O
the	O
world	O
(	O
257	O
per	O
1000	O
livebirths	O
);	O
a	O
leading	O
cause	O
of	O
this	O
is	O
pneumonia	O
.	O

The	O
VD	O
levels	O
in	O
patients	O
with	O
clinical	O
pregnancy	O
(	O
30	O
.	O
95	O
%)	O
were	O
significantly	O
higher	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
compared	O
to	O
those	O
with	O
early	O
spontaneous	O
abortion	O
.	O

There	O
were	O
no	O
apparent	O
differences	O
in	O
the	O
intake	O
of	O
foods	O
containing	O
vitamin	O
D	O
between	O
the	O
S	O
-	O
ECC	O
and	O
caries	O
-	O
free	O
groups	O
,	O
including	O
the	O
frequency	O
of	O
milk	O
consumption	O
(	O
data	O
not	O
shown	O
).	O

*	O
Studies	O
directly	O
sampling	O
the	O
target	O
tissue	O
or	O
validating	O
the	O
same	O
change	O
in	O
the	O
blood	O
and	O
target	O
tissue	O
of	O
an	O
appropriate	O
in	O
vivo	O
model	O
.	O

Maternal	O
characteristics	O
in	O
Table	O
1are	O
described	O
only	O
as	O
un	O
-	O
imputed	O
values	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
List	O
and	O
proportion	O
of	O
psychotropic	O
medications	O
used	O
together	O
with	O
an	O
SGANPer	O
centSelective	O
serotonin	O
reuptake	O
inhibitor4634	O
.	O
6Benzodiazepine2115	O
.	O
8Anticonvulsant1914	O
.	O
3Serotonin	O
-	O
norepinephrine	O
reuptake	O
inhibitor1612	O
.	O
0Atypical	O
antidepressant129	O
.	O
0Non	O
-	O
benzo	O
hypnotic86	O
.	O
0Typical	O
antipsychotic53	O
.	O
8Serotonin	O
antagonist	O
and	O
reuptake	O
inhibitor43	O
.	O
0Tetracyclic	O
antidepressant43	O
.	O
0Tricyclic	O
antidepressant32	O
.	O
3Norepinephrine	O
reuptake	O
inhibitor21	O
.	O
5Synthetic	O
cannaboid21	O
.	O
5Psychostimulant10	O
.	O
8GABA	O
analogue10	O
.	O
8Other	O
dopamine	O
antagonist10	O
.	O
8	O
Women	O
taking	O
more	O
than	O
two	O
psychotropic	O
medications	O
may	O
be	O
included	O
in	O
more	O
than	O
one	O
category	O
.	O

However	B
,	O
the	O
tentative	B
nature	O
of	O
these	O
data	O
and	O
the	O
lack	O
of	O
equally	O
effective	O
substitutes	O
justify	O
their	O
use	O
in	O
pregnancy	O
for	O
this	O
life	O
-	O
threatening	O
emergency	O
.	O

Further	O
evaluation	O
of	O
the	O
vitamin	O
D	O
testing	O
and	O
supplementation	O
protocol	O
is	O
planned	O
.	O

This	O
questionnaire	O
has	O
been	O
well	O
validated	O
[	O
23	O
]	O
and	O
validated	O
in	O
pregnancy	O
[	O
24	O
].	O

Moreover	O
,	O
reimbursement	O
for	O
multivitamin	O
supplements	O
is	O
not	O
covered	O
by	O
insurance	O
in	O
Romania	O
,	O
suggesting	O
that	O
there	O
are	O
other	B
factors	O
contributing	O
to	O
their	O
use	O
.	O

A	O
random	O
sample	O
of	O
812	O
pregnant	O
women	O
was	O
selected	O
from	O
20	O
various	O
health	O
centers	O
by	O
the	O
multistage	O
cluster	O
random	O
sampling	O
method	O
.	O

Animals	O
were	O
housed	O
on	O
a	O
12	O
-	O
h	O
light	O
/	O
dark	O
cycle	O
(	O
lights	O
on	O
at	O
06	O
:	O
00	O
h	O
)	O
using	O
incandescent	O
lighting	O
,	O
to	O
avoid	O
ultraviolet	O
radiation	O
within	O
the	O
vitamin	O
D3action	O
spectrum	O
.	O

folate	O
,	O
vitamin	O
B6	O
and	O
B12	O
)	O
is	O
closely	O
linked	O
.	O
36	O
A	O
significant	O
weakness	O
of	O
the	O
study	O
arises	O
from	O
the	O
lack	O
of	O
measurement	O
of	O
gene	O
expression	O
at	O
different	O
stages	O
of	O
maturity	O
.	O

Based	O
on	O
the	O
behavioural	O
findings	O
in	O
DVD	O
-	O
deficient	O
rats	O
,	O
there	O
is	O
a	O
case	O
to	O
explore	O
proteomic	O
dysregulation	O
in	O
rats	O
after	O
exposure	O
to	O
drugs	O
known	O
to	O
disrupt	O
dopaminergic	O
and	O
glutaminergic	O
pathways	O
.	O

The	O
'	O
mTOR	O
signaling	O
'	O
acts	O
as	O
an	O
important	O
nutrient	O
sensing	O
pathway	O
that	O
controls	O
protein	O
synthesis	O
in	O
mammalian	O
cells	O
at	O
the	O
level	O
of	O
translation	O
[	O
31	O
].	O

It	O
is	O
important	O
to	O
note	O
that	O
not	O
all	O
environmentally	O
induced	O
adverse	O
phenotypes	O
have	O
been	O
associated	O
with	O
epigenetic	O
changes	O
.	O

Twenty	O
-	O
four	O
per	O
cent	O
of	O
women	O
in	O
this	O
earlier	O
study	O
reportedly	O
suffered	O
from	O
schizophrenia	O
,	O
a	O
severe	O
psychiatric	O
disorder	O
that	O
is	O
independently	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
small	O
for	O
gestational	O
age	O
and	O
low	O
birth	O
weight	O
births	O
.	O
17In	B
contrast	I
,	O
only	O
3	O
%	O
of	O
women	O
in	O
the	O
present	O
study	O
reported	O
a	O
diagnosis	O
of	O
schizophrenia	O
.	O

Expression	O
of	O
Placental	O
GAS5	O
and	O
GRs	O
Quantitative	O
RT	O
-	O
PCR	O
revealed	O
that	O
GAS5	O
and	O
all	O
GRs	O
were	O
expressed	O
in	O
human	O
placentas	O
(	O
n	O
=	O
23	O
);	O
13	O
were	O
preterm	O
labor	O
(<	O
37	O
gestational	O
weeks	O
)	O
and	O
10	O
were	O
term	O
(>	O
37	O
gestational	O
weeks	O
)	O
labor	O
,	O
with	O
GAS5	O
and	O
GR	O
α	O
being	O
the	O
predominant	O
transcripts	O
.	O

Introduction	O
In	O
2013	O
,	O
an	O
estimated	O
2	O
.	O
8	O
million	O
deaths	O
occurred	O
in	O
the	O
neonatal	O
period	O
globally	O
[	O
1	O
].	O

OTUs	O
classified	O
to	O
the	O
genus	O
Enterococcus	O
(	O
one	O
q	O
value	O
<	O
0	O
.	O
10	O
)	O
and	O
the	O
Lachnospiraceae	O
family	O
were	O
positively	O
related	O
with	O
and	O
OTUs	O
classified	O
to	O
the	O
family	O
Enterobacteriaceae	O
,	O
the	O
species	O
Escherichia	O
coli	O
and	O
the	O
genera	O
Streptococcus	O
and	O
Blautia	O
,	O
were	O
negatively	O
related	O
with	O
the	O
maternal	O
aMED	O
score	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5a	O
).	O

During	O
rapid	O
assessments	O
conducted	O
on	O
postnatal	O
days	O
4	O
-	O
5	O
,	O
the	O
proportion	O
of	O
households	O
observed	O
to	O
have	O
soap	O
and	O
water	O
at	O
a	O
handwashing	O
place	O
was	O
77	O
%	O
in	O
the	O
intervention	O
arm	O
and	O
27	O
%	O
in	O
the	O
control	O
arm	O
(	O
RR	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
2	O
.	O
11	O
–	O
4	O
.	O
15	O
,	O
p	O
<	O
.	O
0001	O
)	O
(	O
Figure	O
3	O
).	O

Interpretation	O
of	O
the	O
current	O
study	O
is	O
also	O
limited	O
because	O
of	O
the	O
lack	O
of	O
immunoblot	O
confirmation	O
of	O
the	O
differentially	O
expressed	O
spots	O
.	O

The	O
main	O
food	O
sources	O
of	O
Vitamin	O
D3	O
are	O
dairy	O
,	O
egg	O
,	O
fish	O
and	O
meat	O
.	O

However	B
,	O
a	O
weak	O
association	O
does	O
not	O
necessarily	O
imply	O
the	O
absence	O
of	O
causality	O
,	O
nor	O
is	O
a	O
strong	O
association	O
necessary	O
or	O
sufficient	O
for	O
causality	O
[	O
213	O
,	O
214	O
].	O

However	B
,	O
both	O
MS	O
and	O
QG	O
were	O
best	O
in	O
autumn	O
and	O
worst	O
in	O
spring	O
.	O

In	O
order	O
to	O
identify	O
molecular	O
pathways	O
affected	O
by	O
the	O
gestational	O
diets	O
we	O
first	O
analysed	O
differential	O
expression	O
between	O
the	O
dietary	O
groups	O
within	O
each	O
stage	O
separately	O
.	O

In	O
a	O
recent	O
mouse	O
study	O
,	O
exposure	O
to	O
smoke	O
in	O
utero	O
induced	O
a	O
higher	O
risk	O
of	O
sensitization	O
against	O
allergens	O
in	O
adult	O
age	O
in	O
the	O
offspring	O
[	O
70	O
].	O

We	O
also	O
obtained	O
anthropometric	O
data	O
(	O
height	O
and	O
weight	O
),	O
demographic	O
data	O
(	O
occupation	O
and	O
education	O
),	O
and	O
clinical	O
data	O
(	O
delivery	O
status	O
,	O
IUGR	O
and	O
history	O
of	O
preterm	O
birth	O
,	O
abortion	O
,	O
delivery	O
status	O
,	O
and	O
stillbirth	O
)	O
of	O
the	O
pregnant	O
women	O
.	O

analyzed	O
the	O
large	O
Vaccine	O
Safety	O
Datalink	O
dataset	O
(	O
n	O
=	O
57	O
,	O
554	O
pregnant	O
women	O
in	O
the	O
United	O
States	O
)	O
to	O
assess	O
these	O
associations	O
and	O
after	O
using	O
propensity	O
score	O
to	O
minimize	O
bias	O
introduced	O
by	O
the	O
probability	O
of	O
being	O
vaccinated	O
found	O
no	O
association	O
between	O
influenza	O
vaccination	O
during	O
pregnancy	O
and	O
risk	O
of	O
SGA	O
or	O
PTB	O
[	O
26	O
].	O

Curiously	O
,	O
it	O
has	O
been	O
shown	O
that	O
calcium	O
concentration	O
is	O
an	O
important	O
modulator	O
of	O
thimet	O
oligopeptidase	O
activity	O
[	O
41	O
],	O
thus	O
the	O
disruption	O
of	O
this	O
protein	O
may	O
also	O
be	O
down	O
-	O
stream	O
consequence	O
of	O
altered	O
calcium	O
buffering	O
.	O

From	O
652	O
children	O
during	O
five	O
separate	O
periods	O
of	O
testing	O
serum	O
calcifediol	O
,	O
only	O
one	O
child	O
in	O
each	O
of	O
two	O
testing	O
periods	O
had	O
results	O
greater	O
than	O
375	O
nmol	O
/	O
L	O
in	O
the	O
intervention	O
group	O
—	O
a	O
toxic	O
level	O
.	O

Bridging	O
this	O
gap	O
will	O
be	O
critical	O
for	O
saving	O
premature	O
babies	O
globally	O
,	O
and	O
must	O
be	O
linked	O
to	O
implementation	O
research	O
and	O
context	O
specific	O
adaptation	O
and	O
innovation	O
.	O

A	O
control	O
group	O
of	O
offspring	O
from	O
dams	O
fed	O
the	O
RV	O
diet	O
was	O
weaned	O
to	O
the	O
RV	O
pup	O
diet	O
for	O
29	O
weeks	O
.	O

The	O
existence	O
of	O
receptors	O
for	O
the	O
active	O
form	O
of	O
vitamin	O
D	O
(	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
)	O
in	O
the	O
brain	O
induces	O
a	O
direct	O
effect	O
.	O

Personal	O
Gestational	O
Weight	O
Gain	O
Target	O
When	O
asked	O
how	O
much	O
weight	O
they	O
thought	O
they	O
should	O
gain	O
during	O
their	O
pregnancy	O
,	O
25	O
%	O
of	O
participants	O
had	O
personal	O
weight	O
gain	O
targets	O
below	O
the	O
IOM	O
target	O
range	O
49	O
%	O
had	O
targets	O
within	O
the	O
recommended	O
range	O
15	O
%	O
had	O
weight	O
gain	O
targets	O
above	O
the	O
recommended	O
range	O
and	O
11	O
%	O
did	O
not	O
know	O
how	O
much	O
weight	O
to	O
gain	O
.	O

By	O
the	O
F2	O
generation	O
,	O
no	O
urinary	O
parameter	O
differed	O
between	O
the	O
VitD	O
-	O
and	O
SC	O
mice	O
.	O

Continuous	O
variables	O
were	O
evaluated	O
across	O
quintile	O
categories	O
of	O
dietary	O
pattern	O
scores	O
by	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
.	O

Receiving	O
advice	O
did	O
not	O
vary	O
by	O
pre	O
-	O
pregnancy	O
BMI	O
[	O
χ	O
(	O
2	O
)	O
2	O
=	O
0	O
.	O
421	O
,	O
p	O
=	O
0	O
.	O
810	O
].	O

Thyroid	O
nodules	O
in	O
pregnancy	O
are	O
often	O
misdiagnosed	O
because	O
of	O
physiological	O
thyroid	O
increases	O
during	O
pregnancy	O
,	O
but	B
clinical	O
and	O
ultrasound	O
findings	O
are	O
sufficient	O
to	O
suspect	O
malignancy	O
.	O

However	B
,	O
recently	O
published	O
findings	O
from	O
approximately	O
46	O
%	O
of	O
eligible	O
infants	O
at	O
6	O
months	O
of	O
age	O
(	O
698	O
of	O
1522	O
eligible	O
infants	O
assessed	O
)	O
suggest	O
a	O
very	O
small	O
reduction	O
in	O
subscapular	O
skinfold	O
thickness	O
measurement	O
of	O
~	O
0	O
.	O
4	O
mm	O
following	O
provision	O
of	O
the	O
antenatal	O
intervention	O
[	O
20	O
].	O

Study	O
staff	O
also	O
improved	O
access	O
to	O
handwashing	O
materials	O
in	O
the	O
physical	O
environment	O
to	O
facilitate	O
handwashing	O
[	O
18	O
,	O
19	O
].	O

A	O
previous	O
study	O
in	O
Viet	O
Nam	O
followed	O
women	O
of	O
reproductive	O
age	O
receiving	O
weekly	O
supplements	O
,	O
some	O
of	O
whom	O
became	O
pregnant	O
at	O
various	O
points	O
during	O
the	O
12	O
months	O
of	O
follow	O
-	O
up	O
.	O

Introduction	O
Birth	O
weight	O
has	O
been	O
considered	O
an	O
important	O
measure	O
for	O
assessing	O
fetal	O
growth	O
and	O
is	O
an	O
indicator	O
of	O
neonatal	O
morbidity	O
,	O
survival	O
,	O
and	O
development	O
in	O
children	O
[	O
1	O
–	O
3	O
].	O

Also	O
,	O
dietary	O
surveys	O
during	O
pregnancy	O
have	O
suggested	O
the	O
poor	O
diet	O
quality	O
and	O
quantity	O
of	O
low	O
socioeconomic	O
groups	O
[	O
27	O
].	O

Overall	O
,	O
there	O
was	O
no	O
relationship	O
between	O
changes	O
in	O
25	O
(	O
OH	O
)	O
D	O
and	O
BMC	O
(	O
Figure1	O
).	O

However	B
,	O
our	O
data	O
indicated	O
a	O
lower	O
preference	O
for	O
a	O
novel	O
highly	O
-	O
palatable	O
food	O
(	O
chocolate	O
mixture	O
)	O
than	O
the	O
familiar	O
standard	O
diet	O
in	O
RC	O
females	O
when	O
they	O
were	O
exposed	O
for	O
4	O
days	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
high	O
and	O
low	O
exposure	O
to	O
text4baby	O
messages	O
:	O
adjusted	O
and	O
unadjusted	O
GEE	O
models	O
.	O
Questionnaire	O
itemsHigh	O
vs	O
low	O
exposureUnadjustedAdjustedaOR	O
(	O
95	O
%	O
CI	O
)	O
P	O
OR	O
(	O
95	O
%	O
CI	O
)	O
P	O
Eating	O
5	O
or	O
more	O
fruits	O
and	O
vegetables	O
per	O
day	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
744	O
(	O
0	O
.	O
138	O
,	O
4	O
.	O
003	O
).	O
732	O
.	O
511	O
(	O
0	O
.	O
158	O
,	O
39	O
.	O
867	O
).	O
51Taking	O
a	O
prenatal	O
vitamin	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
760	O
(	O
0	O
.	O
115	O
,	O
5	O
.	O
000	O
).	O
774	O
.	O
216	O
(	O
0	O
.	O
201	O
,	O
88	O
.	O
417	O
).	O
35I	O
am	O
prepared	O
to	O
be	O
a	O
new	O
mother1	O
.	O
471	O
(	O
0	O
.	O
788	O
,	O
2	O
.	O
746	O
).	O
221	O
.	O
609	O
(	O
0	O
.	O
607	O
,	O
4	O
.	O
268	O
).	O
34If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
I	O
will	O
be	O
a	O
healthy	O
new	O
mother1	O
.	O
033	O
(	O
0	O
.	O
607	O
,	O
1	O
.	O
759	O
).	O
901	O
.	O
288	O
(	O
0	O
.	O
585	O
,	O
2	O
.	O
834	O
).	O
53If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
my	O
baby	O
will	O
be	O
healthy0	O
.	O
783	O
(	O
0	O
.	O
468	O
,	O
1	O
.	O
313	O
).	O
351	O
.	O
328	O
(	O
0	O
.	O
737	O
,	O
2	O
.	O
393	O
).	O
34Smoking	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
139	O
(	O
0	O
.	O
717	O
,	O
1	O
.	O
810	O
).	O
581	O
.	O
236	O
(	O
0	O
.	O
651	O
,	O
2	O
.	O
350	O
).	O
52Secondhand	O
smoke	O
will	O
not	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby	O
(	O
reverse	O
coded	O
*)	O
0	O
.	O
892	O
(	O
0	O
.	O
668	O
,	O
1	O
.	O
193	O
).	O
440	O
.	O
947	O
(	O
0	O
.	O
631	O
,	O
1	O
.	O
423	O
).	O
79Drinking	O
alcohol	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
088	O
(	O
0	O
.	O
655	O
,	O
1	O
.	O
808	O
).	O
740	O
.	O
803	O
(	O
0	O
.	O
451	O
,	O
1	O
.	O
431	O
).	O
45Taking	O
prenatal	O
vitamins	O
will	O
improve	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
090	O
(	O
0	O
.	O
782	O
,	O
1	O
.	O
520	O
).	O
611	O
.	O
378	O
(	O
0	O
.	O
861	O
,	O
2	O
.	O
204	O
).	O
18BehaviorsSince	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?	O
1	O
.	O
344	O
(	O
0	O
.	O
473	O
,	O
3	O
.	O
820	O
).	O
580	O
.	O
212	O
(	O
0	O
.	O
046	O
,	O
0	O
.	O
973	O
).	O
046In	O
the	O
last	O
30	O
days	O
,	O
did	O
you	O
smoke	O
?	O
0	O
.	O
938	O
(	O
0	O
.	O
490	O
,	O
1	O
.	O
794	O
).	O
851	O
.	O
271	O
(	O
0	O
.	O
406	O
,	O
3	O
.	O
980	O
).	O
68Ate	O
3	O
or	O
more	O
servings	O
of	O
fruit	O
a	O
day0	O
.	O
852	O
(	O
0	O
.	O
647	O
,	O
1	O
.	O
122	O
).	O
250	O
.	O
908	O
(	O
0	O
.	O
649	O
,	O
1	O
.	O
271	O
).	O
57Ate	O
3	O
or	O
more	O
servings	O
of	O
vegetables	O
a	O
day0	O
.	O
889	O
(	O
0	O
.	O
679	O
,	O
1	O
.	O
164	O
).	O
390	O
.	O
969	O
(	O
0	O
.	O
673	O
,	O
1	O
.	O
394	O
).	O
86Have	O
you	O
ever	O
gone	O
online	O
to	O
search	O
for	O
prenatal	O
care	O
information	O
?	O
0	O
.	O
992	O
(	O
0	O
.	O
661	O
,	O
1	O
.	O
488	O
).	O
970	O
.	O
893	O
(	O
0	O
.	O
519	O
,	O
1	O
.	O
536	O
).	O
68	O
aAdjusted	O
for	O
age	O
(	O
quintile	O
),	O
parity	O
,	O
imputed	O
marital	O
status	O
,	O
and	O
race	O
.	O

The	O
study	O
had	O
recruited	O
women	O
from	O
2004	O
–	O
2009	O
.	O

The	O
plasma	O
of	O
CC	O
and	O
RC	O
females	O
presented	O
a	O
higher	O
AST	O
/	O
ALT	O
ratio	O
than	O
the	O
plasma	O
of	O
CC	O
and	O
RC	O
males	O
,	O
respectively	O
(	O
Table1	O
).	O

Thus	O
doses	O
of	O
D	O
vitamin	O
and	O
calcium	O
supplementation	O
,	O
which	O
may	O
differ	B
from	O
those	O
recommended	O
in	O
normal	O
pregnancy	O
,	O
need	O
to	O
be	O
carefully	O
tailored	O
in	O
thyroidectomised	O
patients	O
.	O

In	O
addition	O
,	O
smoking	O
is	O
a	O
cause	O
of	O
reflux	O
and	O
should	O
be	O
avoided	O
.	O

have	O
shown	O
that	O
placental	O
GR	O
-	O
P	O
mRNA	O
levels	O
were	O
reduced	O
significantly	O
after	O
spontaneous	O
labor	O
[	O
20	O
].	O

Pooled	O
results	O
from	O
Angus	O
,	O
Shorthorn	O
,	O
Murray	O
Grey	O
,	O
and	O
Hereford	O
showed	O
that	O
the	O
grain	O
-	O
finishing	O
group	O
had	O
a	O
greater	O
IMF	O
%	O
than	O
the	O
grass	O
-	O
finishing	O
group	O
[	O
115	O
].	O

20	O
pairs	O
of	O
female	O
fieldworkers	O
visited	O
every	O
home	O
starting	O
from	O
streets	O
closest	O
to	O
the	O
hospital	O
and	O
radiating	O
out	O
until	O
we	O
reached	O
our	O
required	O
sample	O
size	O
.	O

Emphasis	O
is	O
given	O
to	O
spreading	O
the	O
dietary	O
intake	O
over	O
six	O
meals	O
daily	O
,	O
with	O
three	O
main	O
meals	O
and	O
three	O
snacks	O
,	O
in	O
order	O
to	O
avoid	O
large	O
carbohydrate	O
loads	O
at	O
any	O
time	O
.	O

Conclusions	O
This	O
review	O
assessed	O
the	O
hypothesis	O
that	O
fish	O
intake	O
during	O
pregnancy	O
improves	O
offspring	O
neurodevelopmental	O
outcomes	O
.	O

From	O
birth	O
to	O
PND	O
22	O
(	O
lactation	O
),	O
three	O
-	O
way	O
repeated	O
measures	O
ANOVA	O
showed	O
a	O
main	O
and	O
significant	O
effect	O
of	O
time	O
on	O
body	O
weight	O
[	O
F	O
(	O
22	O
,	O
145	O
)=	O
675	O
.	O
53	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
Figure2B	O
].	O

The	O
ADA	O
states	O
that	O
all	O
women	O
should	O
receive	O
individualized	O
counseling	O
to	O
provide	O
adequate	O
calories	O
and	O
nutrients	O
to	O
meet	O
the	O
needs	O
of	O
pregnancy	O
and	O
consistent	O
with	O
the	O
blood	O
glucose	O
goals	O
(	O
fasting	O
≤	O
105	O
mg	O
/	O
dl	O
[	O
5	O
.	O
8	O
mmol	O
/	O
L	O
],	O
1	O
hr	O
≤	O
155	O
mg	O
/	O
dl	O
[	O
8	O
.	O
6	O
mmol	O
/	O
L	O
],	O
and	O
2	O
hrs	O
≤	O
130	O
mg	O
/	O
dl	O
[	O
7	O
.	O
2	O
mmol	O
/	O
L	O
]).	O

The	O
lack	O
of	O
association	O
between	O
vitamin	O
D	O
status	O
and	O
cathelicidin	O
in	O
this	O
study	O
may	O
be	O
due	O
to	O
the	O
narrow	O
range	O
in	O
observed	O
25	O
(	O
OH	O
)	O
D	O
values	O
and	O
warrants	O
additional	O
studies	O
for	O
further	O
observation	O
.	O

Additionally	O
,	O
fewer	O
caregivers	O
of	O
children	O
with	O
S	O
-	O
ECC	O
indicated	O
that	O
their	O
child	O
’	O
s	O
overall	O
health	O
was	O
very	O
good	O
compared	O
to	O
those	O
whose	O
children	O
were	O
caries	O
-	O
free	O
(	O
58	O
.	O
3	O
%	O
vs	O
.	O
82	O
.	O
8	O
%,	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
secondary	O
hypotheses	B
are	O
that	O
the	O
early	O
availability	O
and	O
promotion	O
of	O
IFA	O
supplements	O
in	O
intervention	O
clusters	O
will	O
reduce	O
preterm	O
delivery	O
by	O
30	O
%	O
(	O
15	O
%	O
in	O
control	O
to	O
10	O
.	O
5	O
%	O
in	O
intervention	O
),	O
and	O
low	O
birth	O
weight	O
by	O
30	O
%	O
(	O
15	O
%	O
in	O
control	O
to	O
10	O
.	O
5	O
%	O
in	O
intervention	O
).	O

Dietary	O
therapy	O
It	O
is	O
generally	O
accepted	O
that	O
dietary	O
therapy	O
is	O
the	O
cornerstone	O
of	O
treatment	O
of	O
GDM	O
.	O

As	O
noted	O
,	O
military	O
women	O
’	O
s	O
health	O
is	O
an	O
understudied	O
topic	O
and	O
the	O
multiple	O
stressors	O
that	O
they	O
face	O
compared	O
to	O
civilian	O
women	O
suggest	O
that	O
it	O
deserves	O
greater	O
attention	O
from	O
mHealth	O
and	O
other	O
health	O
studies	O
[	O
34	O
,	O
41	O
].	O

GR	O
γ	O
is	O
a	O
ligand	O
-	O
dependent	O
transcription	O
factor	O
with	O
reduced	O
transactivating	O
activity	O
and	O
its	O
function	O
is	O
still	O
under	O
investigation	O
.	O

The	O
expression	O
and	O
activity	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
(	O
CYP27B1	O
)	O
was	O
evaluated	O
in	O
in	O
vitro	O
experiments	O
on	O
decidua	O
cell	O
cultures	O
collected	O
in	O
the	O
1st	O
and	O
3rd	O
trimesters	O
[	O
15	O
].	O

All	O
these	O
mechanisms	O
play	O
critical	O
roles	O
throughout	O
normal	O
mammalian	O
development	O
,	O
particularly	O
during	O
early	O
embryo	O
and	O
germ	O
cell	O
development	O
(	O
Cook	O
&	O
Blelloch2013	O
;	O
Beaujean2014	O
;	O
Dean2014	O
;	O
Hale	O
et	O
al	O
.	O
2014	O
;	O
Luk	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Mukherjee	O
et	O
al	O
.	O
2014	O
;	O
O	O
'	O
Doherty	O
&	O
McGettigan2014	O
;	O
Grote	O
&	O
Herrmann2015	O
;	O
Hogg	O
&	O
Western2015	O
;	O
Marcho	O
et	O
al	O
.	O
2015	O
).	O

This	O
was	O
a	O
single	O
-	O
blind	O
study	O
.	O

Further	O
studies	O
are	O
warranted	O
to	O
test	O
the	O
feasibility	O
of	O
early	O
nutritional	O
programming	O
for	O
regulating	O
IMF	O
deposition	O
in	O
cattle	O
.	O

Social	O
networks	O
seem	O
to	O
play	O
a	O
role	O
in	O
the	O
spread	O
of	O
obesity	O
in	O
both	O
adults	O
and	O
adolescents	O
.	O

Fatty	O
acids	O
of	O
dietary	O
origin	O
are	O
obtained	O
from	O
transporta	O
tion	O
of	O
TG	O
lipoprotein	O
and	O
subsequent	O
uptake	O
after	O
lipoprotein	O
lipase	O
hydrolysis	O
into	O
tissues	O
from	O
the	O
circulation	O
[	O
92	O
,	O
93	O
].	O

Formula	O
-	O
fed	O
infants	O
typically	O
consume	O
300	O
-	O
500	O
IU	O
/	O
day	O
from	O
their	O
formula	O
and	O
therefore	O
generally	O
meet	O
the	O
current	O
recommendations	O
without	O
an	O
additional	O
oral	O
supplement	O
of	O
vitamin	O
D	O
drops	O
especially	O
after	O
the	O
first	O
6	O
to	O
8	O
weeks	O
of	O
life	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
it	O
is	O
clinically	O
relevant	O
to	O
report	O
that	O
approximately	O
twice	O
as	O
many	O
neonates	O
exposed	O
to	O
polytherapy	O
were	O
LGA	O
(	O
13	O
.	O
6	O
%	O
vs	O
6	O
.	O
5	O
%).	O

Slight	O
modifications	O
to	O
the	O
standard	O
text4baby	O
messages	O
were	O
made	O
due	O
to	O
specific	O
health	O
care	O
resources	O
(	O
eg	O
,	O
toll	O
-	O
free	O
numbers	O
for	O
prenatal	O
health	O
information	O
)	O
available	O
to	O
military	O
women	O
[	O
23	O
,	O
25	O
].	O

2	O
.	O
10	O
.	O

The	O
fetal	O
vitamin	O
D	O
status	O
is	O
dependent	O
on	O
the	O
placental	O
-	O
fetal	O
circulation	O
.	O

Vitamin	O
D	O
status	O
of	O
children	O
with	O
severe	O
early	O
childhood	O
caries	O
:	O
a	O
case	O
–	O
control	O
study	O
Abstract	O
Background	O
Severe	O
Early	O
Childhood	O
Caries	O
(	O
S	O
-	O
ECC	O
)	O
affects	O
the	O
health	O
and	O
well	O
-	O
being	O
of	O
young	O
children	O
.	O

Families	O
used	O
it	O
for	O
cooking	O
,	O
drinking	O
,	O
and	O
cleaning	O
.	O

The	O
Born	O
Too	O
Soon	O
series	O
in	O
Reproductive	O
Health	O
was	O
funded	O
by	O
March	O
of	O
Dimes	O
and	O
Save	O
the	O
Children	O
.	O

Several	O
factors	O
,	O
including	O
MS	O
or	O
QG	O
,	O
feed	O
costs	O
,	O
and	O
carcass	O
prices	O
need	O
to	O
be	O
considered	O
to	O
determine	O
the	O
optimum	O
slaughter	O
weight	O
for	O
the	O
maximum	O
profit	O
.	O

Once	O
the	O
woman	O
reports	O
a	O
missed	O
period	O
,	O
the	O
SS	O
will	O
immediately	O
notify	O
the	O
Field	O
Implementers	O
by	O
mobile	O
phone	O
.	O

We	O
demultiplexed	O
and	O
divided	O
datasets	O
using	O
Illumina	O
MiSeq	O
Reporter	O
and	O
a	O
custom	O
Python	O
script	O
.	O

Those	O
presently	O
taking	O
vitamin	O
D	O
drops	O
also	O
had	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(	O
92	O
.	O
2	O
±	O
34	O
.	O
6	O
nmol	O
/	O
L	O
vs	O
.	O
72	O
.	O
2	O
±	O
28	O
.	O
2	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

Antenatal	O
corticosteroids	O
and	O
Kangaroo	O
Mother	O
Care	O
(	O
KMC	O
)	O
are	O
evidence	O
-	O
based	O
interventions	O
that	O
are	O
feasible	O
to	O
scale	O
up	O
in	O
low	O
-	O
resource	O
settings	O
and	O
may	O
serve	O
as	O
entry	O
points	O
for	O
strengthening	O
health	O
systems	O
[	O
20	O
,	O
21	O
].	O

Few	O
studies	O
of	O
school	O
eating	O
patterns	O
have	O
focused	O
on	O
kindergarten	O
and	O
early	O
elementary	O
years	O
,	O
but	O
in	O
third	O
grade	O
,	O
school	O
lunch	O
choices	O
begin	O
to	O
influence	O
children	O
'	O
s	O
overall	O
diets	O
(	O
92	O
).	O

Mass	O
calibration	O
was	O
performed	O
using	O
trypsin	O
autolysis	O
peaks	O
,	O
2211	O
.	O
11	O
Da	O
and	O
842	O
.	O
51	O
Da	O
as	O
internal	O
standards	O
.	O

Conclusion	O
Black	O
obese	O
mothers	O
on	O
Medicaid	O
without	O
prenatal	O
vitamin	O
use	O
were	O
at	O
the	O
highest	O
risk	O
of	O
delivering	O
neonates	O
with	O
vitamin	O
D	O
deficiency	O
.	O

Pregnancy	O
is	O
a	O
physiologically	O
unique	O
period	O
,	O
involving	O
hemodilution	O
and	O
hormonal	O
and	O
metabolic	O
changes	O
.	O

Overall	O
,	O
the	O
prevalence	O
of	O
handwashing	O
with	O
soap	O
at	O
both	O
these	O
times	O
was	O
low	O
,	O
even	O
in	O
the	O
intervention	O
group	O
(	O
8	O
%	O
before	O
breastfeeding	O
and	O
14	O
%	O
after	O
fecal	O
contact	O
).	O

Maternal	O
dairy	O
intake	O
was	O
positively	O
associated	O
with	O
OTUs	O
classified	O
to	O
the	O
species	O
Clostridium	O
neonatale	O
and	O
C	O
.	O
butyricum	O
and	O
the	O
genus	O
Staphylococcus	O
,	O
and	O
negatively	O
related	O
to	O
OTUs	O
classified	O
to	O
the	O
Lachnospiraceae	O
family	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2b	O
).	O

It	O
is	O
important	O
that	O
the	O
type	O
of	O
fish	O
consumed	O
is	O
low	O
in	O
mercury	O
.	O

During	O
the	O
3	O
-	O
hour	O
structured	O
observations	O
,	O
45	O
%	O
in	O
the	O
intervention	O
group	O
,	O
compared	O
to	O
17	O
%	O
in	O
the	O
control	O
group	O
,	O
were	O
observed	O
to	O
wash	O
hands	O
with	O
soap	O
and	O
water	O
at	O
least	O
once	O
.	O

The	O
integral	O
absorbance	O
values	O
were	O
measured	O
.	O

There	O
were	O
no	O
differences	O
in	O
neonatal	O
outcomes	O
.	O

Studies	O
have	O
been	O
done	O
determining	O
the	O
effects	O
of	O
smoking	O
in	O
a	O
pregnant	O
patient	O
and	O
the	O
risk	O
of	O
autism	O
in	O
the	O
mother	O
'	O
s	O
offspring	O
.	O

Since	O
then	O
,	O
numerous	O
other	B
observational	O
studies	O
have	O
shown	O
that	O
the	O
offspring	O
of	O
diabetic	O
pregnancies	O
have	O
a	O
higher	O
risk	O
of	O
developing	O
a	O
diabetes	O
phenotype	O
.	O
18	O
,	O
19There	O
is	O
also	O
concern	O
that	O
this	O
leads	O
to	O
an	O
intergenerational	O
effect	O
,	O
with	O
GDM	O
promoting	O
diabetes	O
in	O
the	O
offspring	O
,	O
with	O
perpetuation	O
of	O
the	O
vicious	O
cycle	O
when	O
the	O
offspring	O
herself	O
develops	O
GDM	O
,	O
thereby	O
predisposing	O
the	O
grandchild	O
to	O
the	O
development	O
of	O
diabetes	O
as	O
well	O
.	O
20It	O
is	O
unknown	O
however	B
,	O
what	O
degree	O
of	O
hyperglycemia	O
,	O
or	B
indeed	O
if	B
it	O
is	O
related	O
metabolic	O
disturbances	O
,	O
which	O
increases	O
the	O
risk	O
of	O
diabetes	O
to	O
the	O
offspring	O
.	O

Estimates	O
of	O
this	O
correlation	O
matrix	O
are	O
obtained	O
providing	O
estimates	O
of	O
correlations	O
between	O
the	O
different	O
groups	O
,	O
that	O
is	O
,	O
child	O
with	O
mother	O
,	O
child	O
with	O
father	O
and	O
so	O
on	O
,	O
together	O
with	O
p	O
values	O
.	O

Recurrent	O
PTB	O
rates	O
for	O
this	O
subgroup	O
were	O
42	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
mL	O
(	O
N	O
=	O
57	O
),	O
24	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
(	O
N	O
=	O
34	O
),	O
24	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
25	O
)	O
and	O
13	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
24	O
).	O

[	O
45	O
]	O
The	O
NICE	O
guidelines	O
for	O
antenatal	O
care	O
were	O
therefore	O
updated	O
in	O
2008	O
.	O

We	O
need	O
more	O
frontline	O
health	O
workers	O
who	O
are	O
skilled	O
and	O
confident	O
in	O
newborn	O
care	O
.	O

Similarly	O
to	O
human	O
cohort	O
studies	O
,	O
our	O
results	O
emphasize	O
the	O
importance	O
of	O
early	O
life	O
programming	O
as	O
the	O
exposure	O
to	O
undernutrition	O
during	O
early	O
development	O
increases	O
the	O
risk	O
from	O
suffering	O
features	O
of	O
metabolic	O
syndrome	O
and	O
cardiovascular	O
disease	O
later	O
in	O
life	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
,	O
2007b	O
;	O
Jimenez	O
-	O
Chillaron	O
et	O
al	O
.,	O
2005	O
;	O
Yura	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Theys	O
et	O
al	O
.,	O
2011	O
).	O

This	O
study	O
was	O
approved	O
by	O
the	O
University	O
of	O
Cincinnati	O
and	O
Cincinnati	O
Children	O
'	O
s	O
Hospital	O
Medical	O
Center	O
Institutional	O
Review	O
Boards	O
.	O

No	O
differences	O
in	O
the	O
caloric	O
intake	O
were	O
found	O
between	O
CC	O
and	O
RC	O
offspring	O
at	O
adolescence	O
(	O
Figure3C	O
).	O

Further	O
studies	O
are	O
required	O
to	O
confirm	O
these	O
findings	O
.	O

Repeated	O
episodes	O
of	O
GDM	O
are	O
associated	O
with	O
the	O
earlier	O
development	O
of	O
diabetes	O
,	O
and	O
this	O
has	O
been	O
postulated	O
to	O
be	O
due	O
to	O
the	O
increased	O
stress	O
that	O
the	O
β	O
-	O
cells	O
are	O
exposed	O
to	O
with	O
each	O
pregnancy	O
.	O
75By	O
treating	O
the	O
mother	O
with	O
glyburide	O
,	O
it	O
is	O
possible	O
that	O
this	O
accentuates	O
β	O
-	O
cell	O
stress	O
and	O
accelerates	O
their	O
decline	O
,	O
whereas	B
insulin	O
therapy	O
would	O
conversely	B
provide	O
a	O
degree	O
of	O
relief	O
to	O
the	O
β	O
-	O
cells	O
.	O

We	O
report	O
that	O
early	O
life	O
caloric	O
restriction	O
,	O
either	O
before	O
birth	O
or	O
during	O
lactation	O
,	O
consistently	O
accelerates	O
the	O
age	O
of	O
maturation	O
.	O

There	O
was	O
also	O
a	O
larger	O
,	O
statistically	O
significant	O
percentage	O
who	O
reported	O
consuming	O
3	O
or	O
more	O
vegetables	O
per	O
day	O
in	O
the	O
control	O
vs	O
treatment	O
group	O
:	O
37	O
.	O
8	O
%	O
(	O
95	O
%	O
CI	O
33	O
.	O
44	O
-	O
42	O
.	O
19	O
)	O
in	O
control	O
vs	O
30	O
.	O
0	O
%	O
(	O
95	O
%	O
CI	O
25	O
.	O
81	O
-	O
34	O
.	O
15	O
,	O
P	O
=.	O
046	O
)	O
in	O
the	O
treatment	O
group	O
,	O
respectively	O
.	O

Parity	O
was	O
categorised	O
into	O
nullipara	O
,	O
secundipara	O
and	O
multipara	O
(>	O
two	O
deliveries	O
).	O

After	O
delivery	O
,	O
thyroxine	O
dose	O
can	O
be	O
gradually	O
reduced	O
to	O
pre	O
-	O
pregnancy	O
levels	O
,	O
while	B
TSH	O
levels	O
should	O
be	O
constantly	O
monitored1015	O
.	O

25	O
(	O
OH	O
)	O
D	O
was	O
similar	O
at	O
baseline	O
between	O
the	O
two	O
groups	O
but	O
significantly	O
higher	O
in	O
the	O
women	O
randomized	O
to	O
cholecalciferol	O
at	O
34	O
weeks	O
of	O
gestation	O
[	O
mean	O
(	O
standard	O
deviation	O
),	O
67	O
.	O
3	O
(	O
20	O
.	O
8	O
)	O
nmol	O
/	O
L	O
]	O
compared	O
with	O
placebo	O
[	O
mean	O
(	O
standard	O
deviation	O
),	O
43	O
.	O
0	O
(	O
22	O
.	O
2	O
)	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

Animals	O
may	O
require	O
more	O
energy	O
to	O
meet	O
the	O
increased	O
maintenance	O
energy	O
requirements	O
.	O

Thus	O
it	O
is	O
possible	O
that	O
the	O
study	O
of	O
Suzuki	O
et	O
al	O
.	O

Care	O
of	O
premature	O
babies	O
is	O
primarily	O
an	O
action	O
gap	O
As	O
evidenced	O
by	O
the	O
large	O
survival	O
gap	O
between	O
babies	O
born	O
in	O
high	O
-	O
income	O
countries	O
and	O
those	O
born	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
,	O
effective	O
interventions	O
exist	O
to	O
reduce	O
death	O
and	O
disability	O
in	O
premature	O
babies	O
,	O
yet	O
this	O
care	O
does	O
not	O
reach	O
the	O
poor	O
and	O
most	O
disadvantaged	O
populations	O
where	O
the	O
burden	O
is	O
highest	O
[	O
6	O
].	O

Our	O
study	O
did	O
not	O
find	O
a	O
difference	O
in	O
self	O
-	O
reported	O
physical	O
activity	O
across	O
the	O
seasons	O
.	O

This	O
compares	O
to	O
estimates	O
by	O
the	O
National	O
Institute	O
of	O
Nutrition	O
that	O
only	O
20	O
%	O
of	O
pregnant	O
women	O
are	O
covered	O
by	O
the	O
national	O
antenatal	O
program	O
of	O
daily	O
iron	O
supplementation	O
for	O
which	O
there	O
is	O
no	O
costing	O
.[	O
18	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
7	O
Targets	O
for	O
action	O
by	O
2025	O
.	O

Adjusted	O
for	O
age	O
,	O
BMI	O
,	O
smoking	O
status	O
(	O
yes	O
/	O
no	O
),	O
physical	O
activity	O
(	O
strenuous	O
activity	O
more	O
than	O
once	O
per	O
week	O
,	O
yes	O
/	O
no	O
),	O
educational	O
achievement	O
(	O
A	O
levels	O
or	O
higher	O
,	O
yes	O
/	O
no	O
),	O
and	O
season	O
of	O
blood	O
sampling	O
(	O
winter	O
,	O
spring	O
,	O
summer	O
,	O
autumn	O
).	O

Before	O
the	O
tests	O
,	O
body	O
weight	O
was	O
measured	O
and	O
crown	O
—	O
heel	O
length	O
was	O
obtained	O
on	O
a	O
measuring	O
board	O
.	O

144	O
preschool	O
children	O
with	O
S	O
-	O
ECC	O
were	O
recruited	O
from	O
a	O
local	O
health	O
centre	O
on	O
the	O
day	O
of	O
their	O
slated	O
dental	O
surgery	O
under	O
general	O
anesthetic	O
.	O

The	O
dosage	O
is	O
based	O
on	O
dietary	O
intake	O
recommendations	O
[	O
10	O
,	O
11	O
].	O

Maternal	O
habitual	O
sleep	O
duration	O
and	O
snoring	O
was	O
obtained	O
from	O
self	O
-	O
report	O
,	O
and	O
thus	O
are	O
likely	O
susceptible	O
to	O
misclassification	O
.	O

MAW	O
conceived	O
,	O
designed	O
and	O
obtained	O
funding	O
for	O
the	O
study	O
.	O

Educational	O
level	O
There	O
was	O
insignificant	O
difference	O
using	O
the	O
Fisher	O
'	O
s	O
exact	O
test	O
,	O
with	O
regards	O
to	O
all	O
the	O
service	O
ratings	O
when	O
different	O
educational	O
levels	O
were	O
compared	O
(	O
Table	O
3	O
).	O

When	O
Grandjean	O
and	O
his	O
team	O
dug	O
a	O
little	O
deeper	O
,	O
they	O
saw	O
that	O
women	O
with	O
the	O
highest	O
PFAS	O
levels	O
in	O
their	O
blood	O
tended	O
to	O
spend	O
less	O
time	O
breastfeeding	O
their	O
babies	O
.	O
22	O
In	O
the	O
study	O
,	O
led	O
by	O
Timmermann	O
—	O
who	O
at	O
the	O
time	O
was	O
pursuing	O
her	O
PhD	O
under	O
Grandjean	O
’	O
s	O
supervision	O
—	O
the	O
researchers	O
estimated	O
the	O
average	O
duration	O
of	O
total	O
breastfeeding	O
(	O
i	O
.	O
e	O
.,	O
with	O
or	O
without	O
any	O
other	O
sources	O
of	O
nutrition	O
)	O
in	O
association	O
with	O
serum	O
levels	O
of	O
two	O
PFASs	O
,	O
perfluorooctane	O
sulfonic	O
acid	O
(	O
PFOS	O
)	O
and	O
perfluorooctanoic	O
acid	O
(	O
PFOA	O
).	O

Furthermore	O
,	O
that	O
study	O
was	O
unable	O
to	O
specifically	O
investigate	O
the	O
potential	O
role	O
of	O
maternal	O
intake	O
of	O
sugar	O
during	O
pregnancy	O
nor	O
the	O
specific	O
role	O
of	O
free	O
sugar	O
.	O

A	O
significant	O
percent	O
of	O
infants	O
with	O
a	O
history	O
of	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
bronchiolitis	O
infection	O
,	O
which	O
peaks	O
during	O
the	O
winter	O
season	O
,	O
develop	O
asthma	O
[	O
64	O
].	O

Stress	O
increases	O
circulating	O
concentrations	O
of	O
cortisol	O
,	O
a	O
typical	O
stress	O
marker	O
[	O
99	O
].	O

However	O
,	O
by	O
weeks	O
28	O
to	O
36	O
,	O
women	O
taking	O
the	O
daily	O
supplement	O
had	O
a	O
significantly	O
higher	O
prevalence	O
of	O
hemoconcentration	O
,	O
a	O
condition	O
defined	O
as	O
hemoglobin	O
levels	O
above	O
145	O
g	O
/	O
L	O
.	O

In	O
humans	O
,	O
PTEN	O
haploinsufficiency	O
was	O
shown	O
to	O
have	O
divergent	O
effects	O
,	O
as	O
they	O
increase	O
the	O
risk	O
of	O
obesity	O
,	O
while	B
decreasing	O
that	O
of	O
type	O
2	O
diabetes	O
by	O
markedly	O
improving	O
insulin	O
sensitivity	O
(	O
Pal	O
et	O
al	O
.,	O
2012	O
).	O

Not	O
alone	O
is	O
this	O
now	O
more	O
robust	O
,	O
but	O
also	O
it	O
is	O
a	O
substantial	O
scientific	O
addition	O
using	O
novel	O
data	O
to	O
build	O
on	O
our	O
previous	O
observation	O
.	O

A	O
developmental	O
perspective	O
considers	O
family	O
,	O
school	O
,	O
and	O
community	O
context	O
.	O

Treatment	O
with	O
LCF	O
prevented	O
further	O
symptomatic	O
hypercalcaemia	O
,	O
but	O
resulted	O
in	O
elevated	O
PTH	O
.	O

A	O
number	O
of	O
studies	O
have	O
shown	O
a	O
significant	O
rise	O
in	O
the	O
incidence	O
of	O
polytherapy	O
with	O
two	O
or	O
more	O
antidepressants	O
,	O
antipsychotics	O
and	O
sedative	O
-	O
hypnotics	O
,	O
as	O
well	O
as	O
an	O
increase	O
in	O
the	O
concomitant	O
prescription	O
of	O
an	O
antidepressant	O
and	O
antipsychotic	O
.	O
151619	O
–	O
24Although	O
polytherapy	O
involving	O
SGAs	O
and	O
other	O
psychotropic	O
medications	O
appears	O
to	O
be	O
increasingly	O
common	O
,	O
no	O
study	O
until	O
now	O
has	O
directly	O
compared	B
the	O
reproductive	O
safety	O
of	O
SGA	O
monotherapy	O
versus	O
polytherapy	O
with	O
other	O
medications	O
.	O

In	O
the	O
early	O
1960s	O
,	O
Williams	O
,	O
et	O
al	O
.	O

In	O
a	O
systematic	O
review	O
by	O
Halbreich	O
and	O
Karkun	O
,	O
the	O
studies	O
from	O
40	O
different	O
countries	O
were	O
reviewed	O
.	O

TL	O
,	O
T	O
lymphocytes	O
;	O
SNS	O
,	O
sympathetic	O
nervous	O
system	O
.	O

For	O
simplicity	O
of	O
language	O
we	O
abbreviated	O
'	O
relative	O
risk	O
ratio	O
'	O
to	O
'	O
relative	O
risk	O
'	O
(	O
RR	O
).	O

Therefore	O
,	O
strategies	O
that	O
up	O
-	O
regulate	O
both	O
hyperplasia	O
and	O
hypertrophy	O
of	O
fat	O
cells	O
are	O
effective	O
ways	O
to	O
improve	O
IMF	O
deposition	O
.	O

2011	O
).	O

Conclusions	O
and	O
public	O
health	O
implications	O
We	O
conclude	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
.	O

To	O
account	O
for	O
the	O
effect	O
of	O
gestation	O
duration	O
on	O
birth	O
weight	O
,	O
we	O
controlled	O
for	O
gestational	O
age	O
(	O
GA	O
)	O
non	O
-	O
parametrically	O
using	O
the	O
'	O
splines	O
'	O
package	O
in	O
R	O
[	O
40	O
].	O

Lastly	O
,	O
living	O
standards	O
data	O
are	O
obtained	O
to	O
allow	O
classification	O
according	O
to	O
the	O
Living	O
Standards	O
Measure	O
(	O
LSM	O
)	O
developed	O
by	O
the	O
South	O
African	O
Audience	O
Reference	O
Foundation	O
(	O
SAARF	O
)	O
[	O
32	O
].	O

Feeding	O
low	O
-	O
protein	O
diets	O
to	O
pregnant	O
rats	O
produces	O
a	O
broad	O
spectrum	O
of	O
disorders	O
in	O
their	O
offspring	O
(	O
7	O
):	O
hypertension	O
and	O
vascular	O
defects	O
(	O
8	O
,	O
9	O
),	O
altered	O
fetal	O
pancreatic	O
development	O
and	O
structure	O
(	O
10	O
),	O
altered	O
glucose	O
tolerance	O
(	O
11	O
),	O
altered	O
liver	O
structure	O
and	O
function	O
(	O
12	O
),	O
altered	O
gene	O
expression	O
(	O
13	O
),	O
and	O
possibly	O
type	O
2	O
diabetes	O
mellitus	O
(	O
10	O
).	O

For	O
this	O
purpose	O
,	O
we	O
searched	O
the	O
current	O
literature	O
on	O
epigenetic	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
and	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
rodent	O
models	O
in	O
PubMed	O
using	O
the	O
terms	O
in	O
Supplementary	O
Table	O
1	O
;	O
defining	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
as	O
environmental	O
factors	O
(	O
chemicals	O
,	O
radiation	O
and	O
lifestyle	O
factors	O
(	O
including	O
alcohol	O
,	O
nutrition	O
and	O
smoking	O
))	O
that	O
induce	O
adverse	O
effects	O
(	O
growth	O
retardation	O
,	O
fertility	O
problems	O
,	O
hormonal	O
changes	O
,	O
reproductive	O
and	O
/	O
or	O
other	O
organ	O
-	O
and	O
system	O
-	O
specific	O
abnormalities	O
(	O
including	O
immune	O
disorders	O
,	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
))	O
and	O
are	O
associated	O
with	O
epigenetic	O
mechanisms	O
(	O
histone	O
modifications	O
,	O
DNA	O
methylation	O
,	O
non	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
and	O
other	O
epigenetic	O
machinery	O
(	O
DNA	O
/	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
)).	O

On	O
the	O
present	O
evidence	O
,	O
it	O
is	O
not	O
possible	O
to	O
definitively	O
answer	O
the	O
question	O
of	O
how	O
season	O
of	O
birth	O
influences	O
glioma	O
risk	O
,	O
or	O
to	O
favor	O
any	O
specific	O
hypothesis	O
.	O

It	O
is	O
a	O
complex	O
condition	O
that	O
lacks	O
an	O
established	O
preventive	O
method	O
,	O
warranting	O
a	O
need	O
for	O
research	O
to	O
identify	O
possible	O
environmental	O
triggers	O
.	O

There	O
were	O
no	O
significant	O
associations	O
between	O
the	O
SNPs	O
at	O
rs12785878	O
(	O
DHCR7	O
)	O
and	O
rs6013897	O
(	O
CYP24A1	O
)	O
and	O
25	O
(	O
OH	O
)	O
D	O
at	O
34	O
weeks	O
of	O
gestation	O
(	O
Table	O
3	O
).	O

A	O
team	O
including	O
nutritionist	O
and	O
epidemiologist	O
Esther	O
Casanueva	O
of	O
the	O
National	O
Institute	O
of	O
Perinatology	O
Isidro	O
Espinosa	O
de	O
los	O
Reyes	O
(	O
INPerIER	O
)	O
in	O
Mexico	O
City	O
and	O
colleagues	O
elsewhere	O
in	O
Mexico	O
City	O
and	O
California	O
studied	O
116	O
women	O
receiving	O
prenatal	O
care	O
at	O
INPerIER	O
.	O

Several	O
studies	O
emphasize	O
the	O
importance	O
of	O
the	O
relationship	O
between	O
iron	O
,	O
folic	O
acid	O
or	O
multivitamin	O
intake	O
and	O
socio	O
-	O
demographic	O
factors	O
such	O
as	O
age	O
,	O
level	O
of	O
education	O
,	O
area	O
of	O
residence	O
,	O
marital	O
status	O
,	O
parity	O
,	O
economical	O
status	O
and	O
characteristics	O
of	O
prenatal	O
care	O
(	O
including	O
gestational	O
age	O
at	O
the	O
beginning	O
of	O
prenatal	O
care	O
and	O
the	O
number	O
of	O
prenatal	O
consultations	O
)	O
[	O
15	O
-	O
19	O
].	O

Level	O
of	O
nutritional	O
knowledge	O
was	O
associated	O
with	O
the	O
use	O
of	O
multivitamins	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
,	O
age	O
,	O
area	O
of	O
residence	O
and	O
level	O
of	O
education	O
,	O
which	O
could	O
suggest	O
that	O
the	O
decision	O
to	O
use	O
them	O
depends	O
on	O
other	B
factors	O
,	O
such	O
as	O
attitudes	O
towards	O
pregnancy	O
or	B
beliefs	B
about	O
the	O
importance	O
of	O
vitamins	O
during	O
pregnancy	O
,	O
areas	O
that	O
warrant	O
further	O
study	O
.	O

Clouds	O
and	O
rain	O
retard	O
vitamin	O
D	O
-	O
producing	O
ultraviolet	O
B	O
light	O
from	O
penetrating	O
the	O
atmosphere	O
.	O

It	O
is	O
important	O
to	O
continue	O
supplementing	O
non	O
-	O
human	O
models	O
with	O
human	O
-	O
derived	O
data	O
,	O
incorporating	O
new	O
technologies	O
to	O
maximize	O
data	O
collection	O
,	O
and	O
updating	O
and	O
re	O
-	O
evaluating	O
current	O
conclusions	O
as	O
novel	O
information	O
becomes	O
available	O
.	O

In	O
populations	O
with	O
similar	O
characteristics	O
,	O
quarterly	O
population	O
level	O
supplementation	O
of	O
vitamin	O
D	O
to	O
infants	O
and	O
young	O
children	O
is	O
not	O
a	O
policy	O
option	O
for	O
reducing	O
the	O
burden	O
of	O
pneumonia	O
in	O
children	O
.	O

Risk	O
factors	O
for	O
the	O
development	O
of	O
GDM	O
include	O
obesity	O
,	O
older	O
age	O
,	O
family	O
history	O
,	O
previous	O
history	O
of	O
GDM	O
or	O
poor	O
obstetric	O
outcomes	O
,	O
ethnicity	O
,	O
polycystic	O
ovary	O
syndrome	O
and	O
as	O
more	O
recently	O
noted	O
,	O
hypertension	O
.	O
4	O
,	O
5	O
The	O
major	O
significance	O
of	O
GDM	O
is	O
that	O
it	O
is	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
.	O

Congenital	O
spine	O
deformities	O
occur	O
with	O
an	O
approximate	O
frequency	O
of	O
0	O
.	O
5	O
–	O
1	O
per	O
1000	O
live	O
births	O
(	O
Sparrow	O
et	O
al	O
.	O

Twelve	O
weeks	O
after	O
the	O
administration	O
of	O
a	O
single	O
dose	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
this	O
figure	O
was	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%	O
for	O
the	O
IG	O
and	O
CG	O
,	O
respectively	O
.	O

The	O
immunomodulating	O
role	O
of	O
vitamin	O
D	O
was	O
also	O
confirmed	O
by	O
stimulation	O
of	O
NK	O
cells	O
(	O
Natural	O
Killer	O
CD56	O
+	O
ve	O
)	O
isolated	O
from	O
the	O
1sttrimester	O
decidua	O
.	O

A	O
limitation	O
of	O
this	O
study	O
was	O
that	O
nearly	O
two	O
-	O
thirds	O
of	O
the	O
women	O
(	O
63	O
%)	O
had	O
only	O
one	O
25	O
(	O
OH	O
)	O
D	O
test	O
during	O
pregnancy	O
,	O
which	O
prohibited	O
assessment	O
by	O
trimester	O
and	O
a	O
more	O
thorough	O
analysis	O
of	O
vitamin	O
D	O
benefit	O
among	O
those	O
with	O
low	O
initial	O
levels	O
.	O

In	B
contrast	I
,	O
rs10741657	O
(	O
CYP2R1	O
)	O
(	O
β	O
=	O
−	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
95	O
%	O
CI	O
,	O
−	O
8	O
.	O
2	O
to	O
−	O
2	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
rs2282679	O
(	O
GC	O
)	O
(	O
β	O
=	O
4	O
.	O
2	O
nmol	O
/	O
L	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
9	O
to	O
7	O
.	O
5	O
nmol	O
/	O
L	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
were	O
associated	O
with	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
status	O
following	O
supplementation	O
,	O
whereas	B
rs12785878	O
and	O
rs6013897	O
(	O
CYP24A1	O
)	O
were	O
not	O
.	O

String	O
beans	O
and	O
peas	O
also	O
correlated	O
inversely	O
with	O
ALL	O
risk	O
.	O

Results	O
In	O
the	O
study	O
population	O
97	O
%	O
were	O
vitamin	O
D	O
sufficient	O
[	O
25	O
(	O
OH	O
)	O
D	O
>	O
50	O
nmol	O
/	O
L	O
]	O
in	O
both	O
mothers	O
and	O
newborns	O
,	O
while	O
optimal	O
vitamin	O
D	O
status	O
[	O
25	O
(	O
OH	O
)	O
D	O
above	O
80	O
nmol	O
/	O
L	O
]	O
was	O
seen	O
in	O
52	O
%	O
of	O
the	O
mothers	O
and	O
45	O
%	O
of	O
the	O
newborns	O
.	O

To	O
this	O
end	O
,	O
one	O
of	O
the	O
very	O
useful	O
tools	O
is	O
the	O
use	O
of	O
rodent	O
strains	O
with	O
different	O
sensitivities	O
to	O
diet	O
-	O
induced	O
obesity	O
and	O
insulin	O
resistance	O
.	O

We	O
recognise	O
however	B
that	O
the	O
influence	O
of	O
central	O
gonadal	O
drivers	O
cannot	O
be	O
discounted	O
.	O

This	O
Zinc	O
-	O
finger	O
transcription	O
factor	O
induces	O
differentiation	O
of	O
brown	O
adipocytes	O
(	O
Seale	O
et	O
al	O
.,	O
2011	O
).	O

Key	O
constructs	O
addressed	O
in	O
the	O
handwashing	O
intervention	O
included	O
the	O
following	O
:	O
nurture	O
as	O
motivator	O
for	O
handwashing	O
(	O
to	O
have	O
healthy	O
baby	O
who	O
grows	O
well	O
,	O
mother	O
'	O
s	O
desire	O
to	O
take	O
good	O
care	O
of	O
baby	O
)	O
improved	O
convenience	O
(	O
three	O
handwashing	O
stations	O
were	O
provided	O
for	O
continuous	O
stocking	O
with	O
soap	O
and	O
water	O
,	O
including	O
in	O
the	O
room	O
where	O
the	O
baby	O
would	O
likely	O
spend	O
time	O
;	O
soap	O
was	O
replenished	O
by	O
study	O
staff	O
as	O
needed	O
throughout	O
the	O
perinatal	O
period	O
)	O
cues	O
to	O
action	O
(	O
encouraged	O
verbal	O
reminders	O
,	O
provided	O
cue	O
cards	O
with	O
times	O
for	O
handwashing	O
)	O
There	O
is	O
prior	O
observational	O
evidence	O
supporting	O
the	O
beneficial	O
effect	O
of	O
maternal	O
handwashing	O
before	O
contact	O
with	O
the	O
umbilical	O
cord	O
for	O
prevention	O
of	O
neonatal	O
infections	O
[	O
3	O
].	O

Similar	O
data	O
are	O
not	O
readily	O
available	O
in	O
pediatric	O
populations	O
.	O

Animal	O
studies	O
have	O
found	O
that	O
vitamin	O
D	O
deficiency	O
can	O
cause	O
deficits	O
in	O
lung	O
function	O
,	O
which	O
can	O
be	O
explained	O
by	O
a	O
change	O
in	O
lung	O
development	O
[	O
32	O
].	O

If	O
vitamin	O
D	O
supplementation	O
does	O
not	O
occur	O
during	O
pregnancy	O
,	O
it	O
may	O
be	O
imperative	O
to	O
identify	O
and	O
offer	O
additional	O
supplementation	O
beyond	O
the	O
routinely	O
recommended	O
400	O
IU	O
per	O
day	O
for	O
all	O
infants	O
.	O
28	O
There	O
were	O
several	O
limitations	O
to	O
our	O
study	O
.	O

Due	O
to	O
the	O
LP	O
diet	O
a	O
number	O
of	O
molecular	O
routes	O
related	O
to	O
cell	O
cycle	O
and	O
cellular	O
turnover	O
,	O
response	O
to	O
stimuli	O
,	O
as	O
well	O
as	O
energy	O
-,	O
lipid	O
-	O
and	O
amino	O
acid	O
metabolic	O
pathways	O
are	O
shifted	O
on	O
the	O
transcriptional	O
level	O
in	O
the	O
liver	O
at	O
prenatal	O
stages	O
under	O
the	O
direct	O
influence	O
of	O
limited	O
protein	O
and	O
/	O
or	O
amino	O
acid	O
supply	O
,	O
but	O
also	O
postnatal	O
.	O

The	O
authors	O
noted	O
that	O
the	O
ART	O
and	O
smoking	O
cessation	O
studies	O
exhibited	O
no	O
evidence	O
of	O
bias	O
and	O
had	O
significant	O
effects	O
on	O
reduced	O
viral	O
load	O
(	O
ART	O
)	O
and	O
biochemically	O
validated	O
smoking	O
cessation	O
[	O
11	O
].	O

The	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
this	O
cohort	O
is	O
comparable	O
to	O
several	O
other	O
European	O
populations	O
[	O
58	O
].	O

After	O
collection	O
the	O
cotton	O
bud	O
end	O
of	O
the	O
swab	O
with	O
the	O
collected	O
sample	O
is	O
immediately	O
preserved	O
in	O
RNAlater	O
(	O
Ambion	O
)	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
.	O

Records	O
included	O
ethnicity	O
,	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
socioeconomic	O
index	O
(	O
SEI	O
)	O
and	O
multivitamin	O
use	O
[	O
29	O
].	O

Among	O
women	O
with	O
BMI	O
<	O
25	O
kg	O
/	O
m2	O
,	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
during	O
the	O
first	O
trimester	O
(	O
seasonally	O
adjusted	O
OR	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
9	O
,	O
4	O
.	O
8	O
),	O
but	O
not	O
at	O
the	O
later	O
time	O
point	O
(	O
OR	O
1	O
.	O
4	O
,	O
95	O
%	O
CI	O
0	O
.	O
9	O
,	O
2	O
.	O
3	O
).	O

Data	O
on	O
cost	O
per	O
pregnancy	O
of	O
daily	O
iron	O
supplementation	O
is	O
quite	O
weak	O
.	O

Antiacids	O
During	O
Pregnancy	O
Recent	O
studies	O
have	O
indicated	O
that	O
acid	O
-	O
suppressing	O
medications	O
can	O
promote	O
sensitization	O
in	O
adults	O
[	O
86	O
,	O
87	O
].	O

However	B
,	O
familial	O
occurrences	O
(	O
Miller	O
et	O
al	O
.	O

The	O
minimum	O
sample	O
size	O
for	O
each	O
analysis	O
was	O
five	O
animals	O
per	O
group	O
.	O

Dietary	O
intake	O
of	O
omega	O
-	O
3	O
,	O
omega	O
-	O
6	O
fatty	O
acids	O
,	O
vitamin	O
D	O
and	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
by	O
the	O
level	O
of	O
fatty	O
acids	O
intake	O
is	O
shown	O
in	O
Table3	O
.	O

A	O
randomized	O
controlled	O
trial	O
of	O
vitamin	O
D	O
supplementation	O
on	O
perinatal	O
depression	O
:	O
in	O
Iranian	O
pregnant	O
mothers	O
Abstract	O
Background	O
Mood	O
disorders	O
in	O
pregnancy	O
and	O
post	O
-	O
partum	O
period	O
are	O
common	O
and	O
considered	O
as	O
a	O
public	O
health	O
issue	O
.	O

Combined	O
with	O
other	B
experimental	O
findings	O
,	O
the	O
current	O
study	O
lends	O
further	O
credibility	O
to	O
the	O
notion	O
that	O
developmental	O
vitamin	O
D	O
deficiency	O
impacts	O
adversely	O
on	O
normal	O
brain	O
development	O
[	O
30	O
].	O

Our	O
previous	O
study	O
showed	O
the	O
possible	O
involvement	O
of	O
DNA	O
methylation	O
in	O
regulating	O
tissue	O
-	O
specific	O
expression	O
of	O
PPARG	O
gene	O
in	O
IMF	O
and	O
muscle	O
of	O
beef	O
cattle	O
[	O
6	O
].	O

Our	O
study	O
was	O
implicitly	O
limited	O
to	O
congenital	O
cryptorchidism	O
because	O
the	O
literature	O
search	O
did	O
not	O
yield	O
any	O
case	O
–	O
control	O
or	O
cohort	O
studies	O
that	O
addressed	O
the	O
question	O
of	O
prenatal	O
exposure	O
to	O
estrogenic	O
compounds	O
and	O
acquired	O
cryptorchidism	O
in	O
humans	O
.	O

Surprisingly	O
,	O
the	O
change	O
in	O
vitamin	O
D	O
concentration	O
(	O
baseline	O
to	O
childbirth	O
)	O
was	O
not	O
correlated	O
with	O
changes	O
in	O
depression	O
scores	O
from	O
baseline	O
to	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
or	O
to	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

Thus	O
,	O
the	O
effects	O
of	O
the	O
maternal	O
caloric	O
restriction	O
on	O
the	O
energy	O
balance	O
of	O
male	O
and	O
female	O
offspring	O
should	O
be	O
interpreted	O
based	O
on	O
their	O
sex	O
-	O
dependent	O
basal	O
metabolism	O
.	O

The	O
effect	O
of	O
each	O
gene	O
is	O
further	O
diluted	O
by	O
variable	O
penetrance	O
[	O
61	O
].	O

Data	O
will	O
be	O
analysed	O
prospectively	O
to	O
determine	O
associations	O
between	O
variables	O
at	O
different	O
time	O
points	O
(	O
longitudinally	O
)	O
by	O
using	O
appropriate	O
statistical	O
methods	O
(	O
e	O
.	O
g	O
.	O

Missing	O
data	O
on	O
prepregnancy	O
smoking	O
as	O
number	O
of	O
cigarettes	O
daily	O
were	O
imputed	O
as	O
a	O
median	O
value	O
(=	O
zero	O
)	O
by	O
GDM	O
status	O
according	O
to	O
smoking	O
status	O
(	O
n	O
=	O
22	O
).	O

On	O
evaluation	O
of	O
this	O
recurrence	O
,	O
a	O
0	O
.	O
8	O
-	O
×	O
0	O
.	O
9	O
-	O
cm	O
friable	O
erythematous	O
papule	O
was	O
noted	O
under	O
the	O
onycholytic	O
distal	O
right	O
great	O
toenail	O
and	O
extended	O
distal	O
to	O
the	O
onychodermal	O
band	O
(	O
Fig	O
1	O
).	O

Weight	O
at	O
puberty	O
Offspring	O
that	O
were	O
exposed	O
to	O
altered	O
maternal	O
nutrition	O
(	O
either	O
maternal	O
undernutrition	O
or	O
high	O
fat	O
diet	O
)	O
all	O
showed	O
significantly	O
lower	O
body	O
weights	O
at	O
pubertal	O
onset	O
compared	O
to	O
Cont	O
offspring	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Table	O
1	O
).	O

A	O
recent	O
study	O
further	O
revealed	O
that	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
inversely	O
correlated	O
with	O
the	O
risk	O
of	O
transient	O
early	O
wheezing	O
[	O
11	O
].	O

Interaction	O
between	O
diet	O
and	O
sex	O
was	O
detected	O
in	O
the	O
gene	O
expression	O
of	O
Acaca	O
,	O
Fasn	O
,	O
Acox1	O
,	O
and	O
Insig1	O
in	O
liver	O
,	O
and	O
Scd1	O
and	O
Cpt1b	O
in	O
PAT	O
(	O
TableS3	O
).	O

With	O
respect	O
to	O
health	O
education	O
,	O
the	O
most	O
mentioned	O
topic	O
was	O
“	O
hygiene	O
and	O
nutrition	O
”	O
followed	O
by	O
“	O
malaria	O
prevention	O
”	O
(	O
Figure	O
3	O
).	O

In	O
animals	O
,	O
D3is	O
synthesized	O
in	O
the	O
skin	O
from	O
its	O
derivate	O
(	O
7	O
-	O
dehydrocholesterol	O
)	O
in	O
the	O
presence	O
of	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
),	O
while	O
D2is	O
made	O
in	O
fungi	O
and	O
yeast	O
.	O

Here	O
,	O
we	O
provide	O
further	O
information	O
about	O
the	O
regulation	O
of	O
this	O
transcript	O
by	O
cortisol	O
using	O
two	O
in	O
vitro	O
models	O
as	O
it	O
is	O
upregulated	O
by	O
cortisol	O
in	O
a	O
dose	O
-	O
independent	O
manner	O
.	O

In	O
addition	O
,	O
the	O
economics	O
of	O
preterm	O
birth	O
prevention	O
and	O
care	O
,	O
including	O
the	O
cost	O
-	O
benefit	O
and	O
cost	O
-	O
effectiveness	O
of	O
interventions	O
delivered	O
singly	O
or	O
as	O
a	O
package	O
across	O
the	O
continuum	O
of	O
care	O
and	O
in	O
different	O
settings	O
and	O
populations	O
as	O
well	O
as	O
the	O
costs	O
of	O
doing	O
nothing	O
,	O
need	O
to	O
be	O
better	O
studied	O
[	O
12	O
,	O
42	O
].	O

Follow	O
-	O
up	O
may	O
be	O
carried	O
out	O
on	O
a	O
regular	O
basis	O
with	O
ultrasound	O
techniques	O
and	O
thyroglobulin	O
assay	O
,	O
as	O
in	O
non	O
-	O
pregnant	O
women	O
.	O

In	O
a	O
community	O
dwelling	O
sample	O
of	O
2	O
,	O
751	O
middle	O
aged	O
men	O
and	O
women	O
,	O
Kumari	O
et	O
al	O
reported	O
that	O
short	O
sleep	O
duration	O
and	O
increased	O
sleep	O
disturbance	O
are	O
independently	O
associated	O
with	O
diurnal	O
slope	O
in	O
cortisol	O
secretion	O
[	O
45	O
].	O

Maternal	O
dairy	O
intake	O
was	O
associated	O
with	O
an	O
increased	O
odds	O
of	O
infants	O
belonging	O
to	O
the	O
high	O
Clostridium	O
cluster	O
in	O
infants	O
born	O
by	O
Cesarean	O
section	O
(	O
OR	O
(	O
95	O
%	O
CI	O
)	O
=	O
2	O
.	O
36	O
(	O
1	O
.	O
05	O
,	O
5	O
.	O
30	O
)).	O

25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
assessed	O
by	O
chemiluminescence	O
immunoassay	O
(	O
Liaison	O
automated	O
platform	O
;	O
Diasorin	O
,	O
Dartford	O
,	O
UK	O
).	O

Results	O
From	O
2005	O
to	O
2009	O
,	O
370	O
women	O
called	O
Motherisk	O
regarding	O
SGA	O
counselling	O
.	O

Although	O
the	O
HV	O
and	O
HFol	O
post	O
-	O
weaning	O
diets	O
had	O
similar	O
effects	O
on	O
food	O
intake	O
,	O
weight	O
gain	O
and	O
blood	O
glucose	O
response	O
by	O
preventing	O
the	O
negative	O
consequences	O
of	O
the	O
HV	O
gestational	O
diet	O
,	O
they	O
differed	B
in	O
their	O
impact	O
on	O
expression	O
in	O
food	O
intake	O
regulatory	O
genes	O
in	O
the	O
hypothalamus	O
.	O

This	O
transcription	O
factor	O
plays	O
a	O
role	O
in	O
the	O
control	O
of	O
a	O
wide	O
range	O
of	O
genes	O
,	O
including	O
small	O
nuclear	O
RNAs	O
,	O
immunoglobulins	O
,	O
histone	O
H2B	O
,	O
and	O
the	O
glucocorticoid	O
receptor	O
,	O
and	O
thus	O
has	O
a	O
central	O
role	O
in	O
controlling	O
various	O
functions	O
,	O
including	O
those	O
of	O
immunomodulation	O
and	O
steroid	O
homeostasis	O
in	O
the	O
placenta	O
(	O
Schonemann	O
et	O
al	O
.	O

2	O
.	O

Implement	O
•	O
Adapt	O
integrated	O
packages	O
of	O
care	O
,	O
considering	O
contexts	O
,	O
and	O
tailored	O
to	O
local	O
health	O
service	O
delivery	O
channels	O
.	O

Japan	O
and	O
Korea	O
have	O
developed	O
stage	O
-	O
specific	O
feeding	O
systems	O
to	O
produce	O
highly	O
marbled	O
beef	O
.	O

Vitamin	O
D3	O
can	O
be	O
synthesized	O
de	O
novo	O
.	O

The	O
RNA	O
samples	O
were	O
visualised	O
on	O
1	O
%	O
agarose	O
gels	O
containing	O
ethidium	O
bromide	O
to	O
check	O
RNA	O
integrity	O
.	O

Due	O
to	O
the	O
lack	O
of	O
conclusive	O
evidence	O
,	O
we	O
cannot	O
recommend	O
the	O
ubiquitous	O
use	O
of	O
prenatal	O
vitamins	O
,	O
in	O
particular	O
folate	O
,	O
in	O
men	O
attempting	O
to	O
plan	O
a	O
pregnancy	O
with	O
their	O
female	O
partner	O
at	O
this	O
time	O
.	O

In	O
contrast	O
to	O
infants	O
born	O
vaginally	O
,	O
maternal	O
dietary	O
fish	O
and	O
seafood	O
were	O
positively	O
associated	O
with	O
OTUs	O
in	O
the	O
genus	O
Bacteroides	O
including	O
the	O
species	O
B	O
.	O
uniformis	O
and	O
negatively	O
associated	O
with	O
OTUs	O
in	O
the	O
species	O
Clostridium	O
neonatale	O
and	O
other	O
OTUs	O
of	O
the	O
Streptococcus	O
genus	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5c	O
).	O

Pubertal	O
onset	O
and	O
adult	O
ovarian	O
function	O
is	O
dependent	O
on	O
maternal	O
nutritional	O
background	O
Pubertal	O
onset	O
in	O
control	O
offspring	O
Pubertal	O
age	O
of	O
offspring	O
born	O
to	O
control	O
dams	O
was	O
similar	O
to	O
that	O
reported	O
previously	O
[	O
38	O
].	O

We	O
didn	O
’	O
t	O
consider	O
placebo	O
because	O
WHO	O
and	O
Government	O
of	O
Bangladesh	O
have	O
a	O
recommendation	O
that	O
pregnant	O
women	O
should	O
receive	O
60	O
mg	O
of	O
iron	O
supplementation	O
.	O

1a	O
;	O
black	O
line	O
/	O
left	O
axis	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
grey	O
line	O
/	O
right	O
axis	O
average	O
hours	O
of	O
sunlight	O
).	O

For	O
adding	O
a	O
poly	O
-	O
A	O
tail	O
to	O
the	O
end	O
of	O
each	O
RNA	O
transcript	O
,	O
the	O
total	O
RNA	O
was	O
treated	O
with	O
the	O
Poly	O
(	O
A	O
)	O
Tailing	O
Kit	O
(	O
Ambion	O
,	O
AM1350	O
).	O

Additionally	O
,	O
genome	O
-	O
wide	O
and	O
spermatic	O
methylation	O
studies	O
were	O
performed	O
.	O

Approximately	O
40	O
-	O
80	O
%	O
of	O
the	O
oral	O
dose	O
is	O
absorbed	O
,	O
with	O
peak	O
serum	O
levels	O
measured	O
within	O
2	O
-	O
4	O
hour	O
,	O
and	O
the	O
half	O
-	O
life	O
of	O
the	O
administered	O
dose	O
is	O
approximately	O
1	O
week	O
.	O

Conclusion	O
This	O
paper	O
introduces	O
BHLM	O
as	O
a	O
method	O
for	O
tackling	O
multiple	O
correlated	O
exposures	O
in	O
relation	O
to	O
health	O
outcomes	O
and	O
compared	O
this	O
method	O
with	O
LASSO	O
and	O
Elastic	O
Net	O
.	O

Therefore	O
,	O
current	O
studies	O
are	O
inconsistent	B
in	O
their	O
results	O
and	O
conclusions	O
on	O
the	O
effects	O
of	O
dietary	O
protein	O
levels	O
affect	O
IMF	O
deposition	O
.	O

Urine	O
parameters	O
(	O
Table	O
2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Urine	O
parameters	O
.	O
ParametersF1	O
-	O
SCF1	O
-	O
VitD	O
-	O
F2	O
-	O
SCF2	O
-	O
VitD	O
-	O
WI	O
,	O
g	O
/	O
100	O
g	O
BM	O
/	O
day	O
16	O
.	O
3	O
±	O
1	O
.	O
014	O
.	O
4	O
±	O
1	O
.	O
615	O
.	O
2	O
±	O
1	O
.	O
113	O
.	O
3	O
±	O
1	O
.	O
3	O
Urine	O
output	O
0	O
.	O
05	O
±	O
0	O
.	O
0020	O
.	O
02	O
±	O
0	O
.	O
004	O
†	O
0	O
.	O
04	O
±	O
0	O
.	O
0060	O
.	O
04	O
±	O
0	O
.	O
004	O
Urea	O
,	O
mg	O
/	O
dL	O
36	O
.	O
5	O
±	O
3	O
.	O
8194	O
.	O
7	O
±	O
23	O
.	O
2	O
†	O
45	O
.	O
5	O
±	O
8	O
.	O
158	O
.	O
2	O
±	O
8	O
.	O
5	O
‡	O
Creatinine	O
,	O
mg	O
/	O
dL	O
1	O
.	O
2	O
±	O
0	O
.	O
13	O
.	O
3	O
±	O
0	O
.	O
2	O
†	O
1	O
.	O
0	O
±	O
0	O
.	O
11	O
.	O
4	O
±	O
0	O
.	O
1	O
‡	O
Uric	O
acid	O
,	O
mg	O
/	O
dL	O
0	O
.	O
6	O
±	O
0	O
.	O
21	O
.	O
2	O
±	O
0	O
.	O
60	O
.	O
5	O
±	O
0	O
.	O
10	O
.	O
9	O
±	O
0	O
.	O
3	O
Proteinuria	O
,	O
g	O
/	O
L	O
0	O
.	O
43	O
±	O
0	O
.	O
10	O
.	O
55	O
±	O
0	O
.	O
10	O
.	O
40	O
±	O
0	O
.	O
10	O
.	O
44	O
±	O
0	O
.	O
1	O
Data	O
were	O
kept	O
for	O
six	O
-	O
month	O
-	O
old	O
male	O
offspring	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

Of	O
all	O
pregnancies	O
,	O
1	O
–	O
14	O
%	O
are	O
affected	O
by	O
GDM	O
[	O
9	O
],	O
and	O
globally	O
GDM	O
prevalence	O
has	O
been	O
increasing	O
in	O
line	O
with	O
increasing	O
obesity	O
[	O
10	O
].	O

Considering	O
cut	O
-	O
off	O
point	O
of	O
≥	O
9	O
,	O
data	O
analysis	O
showed	O
that	O
a	O
lot	O
of	O
participants	O
(	O
more	O
than	O
50	O
%)	O
were	O
susceptible	O
to	O
prenatal	O
depression	O
at	O
26	O
–	O
28	O
weeks	O
.	O

While	O
the	O
results	O
are	O
mostly	O
unchanged	O
,	O
the	O
phthalates	O
and	O
BPA	O
exposures	O
were	O
associated	O
with	O
a	O
decrease	O
in	O
birth	O
weight	O
for	O
male	O
infants	O
compared	B
to	I
the	O
combined	O
analysis	O
(	O
3	O
g	O
decrease	O
compared	O
with	O
1	O
g	O
increase	O
).	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
providers	O
are	O
as	O
comfortable	O
discussing	O
weight	O
gain	O
restrictions	O
with	O
overweight	O
and	O
obese	O
women	O
as	O
they	O
are	O
with	O
normal	O
weight	O
women	O
,	O
but	B
that	O
overweight	O
and	O
obese	O
women	O
still	O
have	O
weight	O
gain	O
targets	O
in	O
excess	O
of	O
clinical	O
guidelines	O
.	O

None	O
of	O
the	O
term	O
or	O
preterm	O
women	O
were	O
administered	O
any	O
antidepressants	O
or	O
synthetic	O
glucocorticoids	O
during	O
pregnancy	O
.	O

Of	O
note	O
is	O
that	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
a	O
southern	O
United	O
States	O
climate	O
are	O
low	O
despite	O
sunshine	O
exposure	O
year	O
round	O
at	O
the	O
latitude	O
in	O
Houston	O
.	O

Strengths	O
and	O
limitations	O
of	O
this	O
study	O
A	O
cohort	O
study	O
using	O
a	O
prospectively	O
collected	O
database	O
,	O
including	O
comparison	O
groups	O
and	O
matching	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
8	O
Results	O
of	O
three	O
scenarios	O
of	O
preterm	O
-	O
specific	O
mortality	O
reduction	O
to	O
2025	O
.	O

Thirty	O
-	O
six	O
hours	O
after	O
birth	O
,	O
the	O
lightest	O
and	O
the	O
heaviest	O
piglet	O
within	O
one	O
litter	O
were	O
killed	O
by	O
i	O
.	O
m	O
.	O

This	O
was	O
based	O
on	O
the	O
independent	O
monitoring	O
survey	O
one	O
year	O
after	O
the	O
province	O
-	O
wide	O
expansion	O
of	O
the	O
program	O
,	O
at	O
which	O
time	O
81	O
%	O
of	O
surveyed	O
women	O
were	O
receiving	O
the	O
supplements	O
regularly	O
and	O
87	O
%	O
of	O
those	O
were	O
taking	O
75	O
%	O
or	O
more	O
of	O
the	O
supplied	O
supplements	O
[	O
13	O
].	O

There	O
is	O
probably	O
no	O
specific	O
etiologic	O
agent	O
acting	O
in	O
isolation	O
that	O
completely	O
explains	O
a	O
season	O
of	O
birth	O
association	O
with	O
adult	O
glioma	O
risk	O
.	O

)	O
52	O
.	O
50	O
±	O
14	O
.	O
25HF	O
(	O
n	O
.	O
u	O
.	O

[	O
16	O
]	O
Charatcharoen	O
-	O
witthaya	O
et	O
al	O
.	O

Increasing	O
awareness	O
amongst	O
health	O
providers	O
regarding	O
folic	O
acid	O
allergy	O
may	O
improve	O
the	O
identification	O
and	O
counselling	O
of	O
patients	O
with	O
this	O
allergy	O
.	O

First	O
,	O
in	O
cause	O
of	O
the	O
difficulties	O
in	O
performing	O
infant	O
lung	O
function	O
testing	O
,	O
relatively	O
small	O
number	O
of	O
mother	O
-	O
infant	O
pairs	O
was	O
enrolled	O
in	O
this	O
study	O
.	O

Prophylaxis	O
Iron	O
Supplements	O
The	O
overall	O
impact	O
of	O
interventions	O
on	O
iron	O
supplementation	O
under	O
field	O
conditions	O
has	O
been	O
limited	O
and	O
its	O
effectiveness	O
questioned	B
[	O
33	O
].	O

Our	O
findings	O
suggest	O
that	O
analysis	O
of	O
SNPs	O
may	O
have	O
an	O
important	O
role	O
in	O
identifying	O
high	O
-	O
risk	O
categories	O
of	O
individuals	O
who	O
are	O
likely	O
to	O
require	O
higher	O
doses	O
of	O
vitamin	O
D	O
to	O
achieve	O
repletion	O
,	O
and	O
studies	O
are	O
needed	O
to	O
establish	O
clinical	O
approaches	O
to	O
vitamin	O
D	O
supplementation	O
that	O
are	O
centered	O
on	O
individual	O
characteristics	O
.	O

It	O
will	O
also	O
serve	O
as	O
a	O
reminder	O
for	O
regular	O
consumption	O
and	O
safely	O
store	O
the	O
medicines	O
away	O
from	O
child	O
access	O
.	O

Trial	O
Registration	O
ClincalTrials	O
.	O
govNCT00697294	O
Background	O
Vitamin	O
D	O
has	O
been	O
given	O
to	O
infants	O
to	O
prevent	O
and	O
treat	O
rickets	O
for	O
almost	O
100	O
years	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaneous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
categorised	O
based	O
on	O
standardised	O
quartiles	O
and	O
clinical	O
definitions	O
of	O
vitamin	O
D	O
statusPregnancy	O
ComplicationsAll	O
womenAny	O
ComplicationPEGHGDMsPTBSGA	O
n	O
(%)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
Standardised	O
Quartiles	O
**	O
Low711	O
(	O
25	O
)	O
328	O
(	O
46	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
07	O
)	O
46	O
(	O
6	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
66	O
,	O
1	O
.	O
57	O
))	O
57	O
(	O
8	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
42	O
)	O
28	O
(	O
4	O
)	O
0	O
.	O
79	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
30	O
)	O
36	O
(	O
5	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
29	O
)	O
84	O
(	O
12	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
75	O
,	O
1	O
.	O
39	O
)	O
Low	O
-	O
Moderate755	O
(	O
27	O
)	O
318	O
(	O
42	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
90	O
,	O
1	O
.	O
12	O
)	O
42	O
(	O
6	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
64	O
)	O
65	O
(	O
9	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
74	O
,	O
1	O
.	O
52	O
)	O
25	O
(	O
3	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
39	O
,	O
1	O
.	O
16	O
)	O
33	O
(	O
4	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
56	O
,	O
1	O
.	O
3572	O
(	O
10	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
32	O
)	O
Moderate	O
-	O
High702	O
(	O
25	O
)	O
309	O
(	O
44	O
)	O
1	O
.	O
0	O
†	O
37	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
50	O
(	O
7	O
)	O
1	O
.	O
0	O
†	O
28	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
39	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
81	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
High630	O
(	O
23	O
)	O
258	O
(	O
41	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
82	O
,	O
1	O
.	O
06	O
)†	O
35	O
(	O
6	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
78	O
,	O
1	O
.	O
96	O
)	O
40	O
(	O
6	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
58	O
,	O
1	O
.	O
30	O
)	O
10	O
(	O
2	O
)	O
0	O
.	O
47	O
(	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
)	O
30	O
(	O
5	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
25	O
)	O
60	O
(	O
10	O
)	O
0	O
.	O
80	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
11	O
)	O
Vitamin	O
D	O
Status	O
<	O
25	O
nmol	O
/	O
L99	O
(	O
4	O
)	O
51	O
(	O
52	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
)	O
8	O
(	O
8	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
03	O
))	O
6	O
(	O
6	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
32	O
,	O
1	O
.	O
52	O
)	O
5	O
(	O
5	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
38	O
,	O
2	O
.	O
52	O
)	O
7	O
(	O
7	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
04	O
)	O
13	O
(	O
13	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
66	O
,	O
2	O
.	O
01	O
)	O
25	O
-	O
50	O
nmol	O
/	O
L673	O
(	O
24	O
)	O
301	O
(	O
45	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
83	O
,	O
1	O
.	O
03	O
)	O
45	O
(	O
7	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
80	O
,	O
1	O
.	O
75	O
)	O
59	O
(	O
9	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
71	O
,	O
1	O
.	O
34	O
)	O
26	O
(	O
4	O
)	O
0	O
.	O
89	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
47	O
)	O
29	O
(	O
4	O
)	O
0	O
.	O
75	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
16	O
)	O
74	O
(	O
11	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
24	O
)	O
>	O
50	O
-	O
75	O
nmol	O
/	O
L928	O
(	O
33	O
)	O
428	O
(	O
46	O
)	O
1	O
.	O
0	O
†	O
48	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
80	O
(	O
9	O
)	O
1	O
.	O
0	O
†	O
35	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
52	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
107	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
>	O
75	O
nmol	O
/	O
L1098	O
(	O
39	O
)	O
435	O
(	O
40	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
86	O
,	O
1	O
.	O
04	O
)	O
60	O
(	O
5	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
87	O
,	O
1	O
.	O
87	O
)	O
67	O
(	O
6	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
12	O
)†	O
26	O
(	O
2	O
)	O
0	O
.	O
78	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
28	O
)	O
51	O
(	O
5	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
26	O
)	O
104	O
(	O
9	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
12	O
)	O
*	O
Relative	O
risks	O
compared	O
to	O
all	O
women	O
were	O
adjusted	O
for	O
age	O
,	O
maternal	O
body	O
mass	O
index	O
,	O
ethnicity	O
(	O
non	O
Caucasian	O
vs	O
.	O
Caucasian	O
),	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
no	O
vs	O
.	O
yes	O
),	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
(	O
no	O
vs	O
yes	O
),	O
recreational	O
walking	O
(	O
1	O
-	O
3	O
×/	O
week	O
and	O
≥	O
4	O
×/	O
week	O
vs	O
.	O
never	O
)	O
and	O
recruitment	O
site	O
(	O
Auckland	O
vs	O
.	O
Adelaide	O
)	O
**	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
standardised	O
for	O
month	O
that	O
serum	O
was	O
sampled	O
based	O
as	O
previously	O
described	O
[	O
34	O
]	O
†	O
Reference	O
category	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
pregnancy	O
outcome	O
and	O
fetal	O
sex	O
As	O
there	O
is	O
evidence	O
to	O
suggest	O
that	O
vitamin	O
D	O
metabolism	O
within	O
the	O
placenta	O
may	O
differ	B
with	O
respect	O
to	O
fetal	O
sex	O
[	O
35	O
]	O
thus	O
,	O
we	O
assessed	O
the	O
effect	O
of	O
“	O
standardised	O
”	O
vitamin	O
D	O
status	O
on	O
pregnancy	O
outcome	O
stratified	O
by	O
fetal	O
sex	O
(	O
Table	O
3	O
).	O

There	O
were	O
several	O
limitations	O
to	O
the	O
study	O
.	O

In	O
his	O
invited	O
commentary	O
,	O
Dr	O
.	O
Eyles	O
asked	O
,	O
‘	O
Does	O
skin	O
colour	O
modify	O
the	O
risk	O
’	O
of	O
autism	O
,	O
noting	O
melanin	O
in	O
the	O
skin	O
is	O
an	O
effective	O
sunblock	O
.	O

In	O
previous	O
case	O
reports	O
,	O
the	O
investigators	O
believed	O
that	O
the	O
vascular	O
proliferation	O
in	O
both	O
AAOC	O
and	O
PG	O
were	O
induced	O
by	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
).	O
2	O
,	O
3	O
,	O
4Endothelial	O
cells	O
produce	O
signals	O
such	O
as	O
bone	O
morphogenic	O
protein	O
(	O
BMP	O
)	O
to	O
induce	O
metaplastic	O
differentiation	O
and	O
ectopic	O
bone	O
formation	O
.	O
9Osteoblasts	O
are	O
also	O
responsible	O
for	O
production	O
of	O
VEGF	O
.	O
10The	O
combination	O
of	O
VEGF	O
and	O
hypoxia	O
induce	O
BMP	O
expression	O
.	O
9Together	O
,	O
VEGF	O
and	O
BMP	O
are	O
the	O
most	O
likely	O
factors	O
that	O
induce	O
vascular	O
proliferation	O
and	O
bone	O
formation	O
in	O
AAOC	O
.	O

Because	O
of	O
its	O
steroid	O
structure	O
and	O
function	O
,	O
vitamin	O
D	O
plays	O
an	O
important	O
role	O
in	O
priming	O
cells	O
for	O
other	O
hormones	O
to	O
do	O
their	O
action	O
.	O

Therefore	O
,	O
podocin	O
expression	O
was	O
significantly	O
different	O
between	O
the	O
F1	O
and	O
F2	O
generations	O
among	O
VitD	O
-	O
offspring	O
at	O
weaning	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
at	O
6	O
months	O
of	O
age	O
(	O
P	O
=	O
0	O
.	O
004	O
).	O

The	O
decrease	O
in	O
OTUs	O
classified	O
to	O
the	O
species	O
Clostridium	O
neonatale	O
with	O
increased	O
maternal	O
fish	O
and	O
seafood	O
intake	O
in	O
infants	O
born	O
by	O
Cesarean	O
section	O
is	O
a	O
possibly	O
beneficial	O
change	O
to	O
infant	O
intestinal	O
microbial	O
communities	O
.	O

Prevalence	O
of	O
postpartum	O
depression	O
varies	B
throughout	O
the	O
world	O
;	O
however	B
researchers	O
have	O
used	O
different	B
scales	O
and	O
cut	O
off	O
points	O
to	O
describe	O
this	O
psychological	O
disorder	O
.	O

1RRs	O
and	O
95	O
%	O
CIs	O
are	O
adjusted	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

2008	O
;	O
Lu	O
et	O
al	O
.	O

The	O
mean	O
number	O
of	O
check	O
-	O
ups	O
with	O
the	O
obstetrician	O
was	O
4	O
.	O
7	O
±	O
3	O
.	O
07	O
;	O
but	O
16	O
.	O
5	O
%	O
of	O
women	O
did	O
not	O
see	O
an	O
obstetrician	O
during	O
their	O
pregnancy	O
.	O

The	O
initial	O
weight	O
of	O
the	O
child	O
was	O
also	O
included	O
in	O
the	O
regression	O
to	O
adjust	O
for	O
regression	O
towards	O
the	O
mean	O
.	O

With	O
respect	O
to	O
schizophrenia	O
,	O
several	O
of	O
proteins	O
identified	O
in	O
this	O
study	O
have	O
also	O
been	O
reported	O
to	O
be	O
disrupted	O
in	O
post	O
-	O
mortem	O
brain	O
tissue	O
from	O
patients	O
with	O
schizophrenia	O
.	O

Conclusions	O
These	O
observations	O
are	O
suggestive	O
of	O
two	O
distinct	O
developmental	O
pathways	O
leading	O
to	O
the	O
acceleration	O
of	O
pubertal	O
timing	O
but	B
with	O
different	O
consequences	O
for	O
ovarian	O
function	O
.	O

Our	O
results	O
are	O
similar	O
to	O
those	O
of	O
the	O
HAPO	O
trial	O
,	O
which	O
found	O
that	O
maternal	O
insulin	O
sensitivity	O
and	O
gestational	O
diabetes	O
were	O
not	O
associated	O
with	O
25OHD	O
[	O
7	O
].	O

Other	O
putative	O
candidates	O
include	O
harmonic	O
variation	O
in	O
population	O
mixing	O
,	O
diet	O
,	O
temperature	O
,	O
humidity	O
,	O
sunlight	O
/	O
photoperiod	O
,	O
levels	O
of	O
vitamin	O
D3	O
,	O
and	O
endogenous	O
hormones	O
[	O
6	O
,	O
7	O
].	O

demonstrated	O
no	O
adverse	O
effects	O
on	O
offspring	O
neurodevelopment	O
with	O
maternal	O
fish	O
consumption	O
during	O
pregnancy	O
equal	O
to	O
or	O
greater	O
than	O
once	O
per	O
week	O
.	O

Despite	B
these	O
,	O
our	O
study	O
was	O
able	O
to	O
replicate	O
findings	O
reported	O
in	O
individuals	O
from	O
developed	O
countries	O
.	O

Furthermore	O
,	O
while	B
human	O
epidemiological	O
cohort	O
studies	O
can	O
demonstrate	O
association	O
,	O
they	O
do	O
not	O
prove	O
causality	O
.	O

Although	O
the	O
literature	O
from	O
rigorous	O
studies	O
of	O
smoking	O
cessation	O
,	O
treatment	O
adherence	O
,	O
and	O
some	O
other	O
chronic	O
disease	O
prevention	O
and	O
management	O
studies	O
show	O
that	O
mHealth	O
programs	O
can	O
promote	O
behavior	O
change	O
,	O
more	O
randomized	O
controlled	O
trials	O
(	O
RCTs	O
)	O
are	O
needed	O
[	O
11	O
].	O

The	O
search	O
generated	O
27	O
related	O
articles	O
in	O
the	O
following	O
categories	O
:	O
prevalence	O
—	O
2	O
,	O
treatments	O
—	O
8	O
,	O
reviews	O
—	O
6	O
,	O
interventions	O
/	O
trials	O
—	O
6	O
,	O
dosage	O
—	O
1	O
,	O
and	O
technical	O
reports	O
—	O
4	O
.	O

Transcriptional	O
excursions	O
regarding	O
stress	O
and	O
immune	O
response	O
The	O
biological	O
effect	O
of	O
glucocorticoids	O
is	O
modulated	O
by	O
glucocorticoid	O
receptors	O
.	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
was	O
determined	O
on	O
average	O
at	O
11	O
weeks	O
of	O
gestation	O
in	O
pregnancy	O
and	O
in	O
umbilical	O
cord	O
blood	O
(	O
UCB	O
)	O
at	O
birth	O
.	O

Human	O
studies	O
examining	O
the	O
role	O
of	O
paternal	O
micronutrient	O
supplementation	O
are	O
scant	O
.	O

We	O
present	O
that	O
the	O
hepatic	O
expression	O
profiles	O
showed	O
considerable	O
modulation	O
during	O
prenatal	O
and	O
postnatal	O
stages	O
,	O
i	O
.	O
e	O
.	O

Children	O
with	O
S	O
-	O
ECC	O
were	O
significantly	O
more	O
likely	O
to	O
have	O
vitamin	O
D	O
levels	O
below	O
recognized	O
thresholds	O
for	O
optimal	O
and	O
adequate	O
status	O
(	O
i	O
.	O
e	O
.	O

Due	O
to	O
the	O
guidelines	O
for	O
providing	O
vitamin	O
D	O
supplements	O
to	O
all	O
breast	O
-	O
fed	O
infants	O
,	O
it	O
is	O
not	O
ethically	O
possible	O
to	O
conduct	O
a	O
placebo	O
-	O
controlled	O
study	O
of	O
vitamin	O
D	O
supplementation	O
in	O
the	O
United	O
States	O
.	O

Compliance	O
with	O
study	O
medication	O
was	O
assessed	O
by	O
asking	O
participants	O
to	O
bring	O
any	O
remaining	O
study	O
medication	O
to	O
each	O
assessment	O
.	O

Confirmation	O
and	O
expansion	O
of	O
these	O
findings	O
in	O
additional	O
populations	O
,	O
with	O
additional	O
environmental	O
data	O
and	O
more	O
comprehensive	O
methylation	O
profiles	O
as	O
well	O
as	O
studies	O
of	O
the	O
mechanism	O
of	O
these	O
alterations	O
,	O
will	O
provide	O
additional	O
valuable	O
insights	O
into	O
the	O
epigenetic	O
mechanisms	O
controlling	O
fetal	O
growth	O
.	O

The	O
identification	O
of	O
external	O
factors	O
particularly	O
perinatal	O
risk	O
factors	O
forms	O
the	O
initial	O
critical	O
step	O
in	O
preventing	O
and	O
alleviating	O
risks	O
.	O

The	O
primary	O
analysis	O
was	O
powered	O
to	O
assess	O
changes	O
in	O
haemoglobin	O
concentration	O
,	O
which	O
limited	O
the	O
scope	O
of	O
this	O
study	O
to	O
the	O
functional	O
effect	O
of	O
MMN	O
supplementation	O
on	O
nutritional	O
anaemia	O
.	O

Ex	O
vivo	O
or	O
in	O
vitro	O
experiments	O
on	O
human	O
embryonic	O
tissue	O
and	O
cells	O
are	O
quite	O
rightly	O
restricted	O
by	O
ethics	O
,	O
and	O
can	O
only	O
model	O
a	O
small	O
part	O
of	O
the	O
in	O
vivo	O
situation	O
.	O

Current	O
coverage	O
levels	O
for	O
eight	O
indicators	O
across	O
the	O
continuum	O
of	O
care	O
,	O
chosen	O
by	O
the	O
United	O
Nations	O
Commission	O
on	O
Information	O
and	O
Accountability	O
for	O
Women	O
'	O
s	O
and	O
Children	O
'	O
s	O
Health	O
,	O
are	O
tracked	O
for	O
the	O
75	O
priority	O
Countdown	O
to	O
2015	O
countries	O
which	O
collectively	O
account	O
for	O
90	O
%	O
of	O
maternal	O
,	O
newborn	O
and	O
child	O
deaths	O
[	O
29	O
].	O

To	O
get	O
access	O
to	O
the	O
workers	O
,	O
the	O
researchers	O
had	O
to	O
strike	O
a	O
Faustian	O
bargain	O
with	O
the	O
mining	O
companies	O
:	O
They	O
could	O
not	O
inform	O
the	O
miners	O
of	O
the	O
potential	O
health	O
hazards	O
of	O
their	O
work	O
.	O
2Seeing	O
it	O
as	O
the	O
only	O
way	O
to	O
convince	O
government	O
regulators	O
to	O
improve	O
safety	O
in	O
the	O
mines	O
,	O
the	O
researchers	O
accepted	O
.	O
16By	O
1965	O
,	O
the	O
investigators	O
reported	O
an	O
association	O
between	O
cumulative	O
exposure	O
to	O
uranium	O
and	O
lung	O
cancer	O
among	O
white	O
miners	O
and	O
had	O
definitively	O
identified	O
the	O
cause	O
as	O
radiation	O
exposure	O
.	O
17	O
In	O
1984	O
another	O
team	O
published	O
results	O
of	O
a	O
case	O
–	O
control	O
study	O
that	O
further	O
implicated	O
uranium	O
mining	O
as	O
a	O
cause	O
of	O
lung	O
cancer	O
in	O
Navajo	O
men	O
.	O

Concerns	O
about	O
vitamin	O
D	O
have	O
resurfaced	B
in	O
medical	O
and	O
scientific	O
literature	O
owing	O
to	O
its	O
multiple	O
effects	O
on	O
human	O
health	O
.	O

(	O
A	O
)	O
female	O
offspring	O
of	O
all	O
groups	O
fed	O
a	O
chow	O
diet	O
;	O
(	O
B	O
,	O
C	O
,	O
D	O
)	O
female	O
offspring	O
fed	O
a	O
postnatal	O
high	O
-	O
fat	O
diet	O
.	O

The	O
different	O
dietary	O
exposure	O
of	O
the	O
offspring	O
during	O
prenatal	O
development	O
can	O
be	O
expected	O
to	O
cause	O
slight	O
shifts	O
of	O
the	O
developmental	O
age	O
of	O
the	O
offspring	O
that	O
may	O
be	O
reflected	O
by	O
subtle	O
changes	O
of	O
the	O
transcriptome	O
and	O
could	O
hamper	O
the	O
identification	O
of	O
direct	O
effects	O
of	O
the	O
gestational	O
diets	O
on	O
the	O
hepatic	O
expression	O
.	O

Vitamin	O
D	O
-	O
deficiency	O
in	O
mothers	O
have	O
significantly	O
increased	O
risk	O
of	O
infantile	O
rickets	O
due	O
to	O
inadequate	O
maternal	O
–	O
fetal	O
transfer	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
.[	O
32	O
]	O
Recent	O
retrospective	O
studies	O
found	O
a	O
significant	O
and	O
previously	O
undetected	O
association	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
with	O
rickets	O
-	O
associated	O
infant	O
heart	O
failure	O
and	O
with	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
,[	O
33	O
]	O
a	O
serious	O
complication	O
often	O
associated	O
with	O
sepsis	O
without	O
clinical	O
signs	O
of	O
rickets	O
.	O

The	O
lines	O
represent	O
the	O
weighted	O
regression	O
with	O
its	O
95	O
%	O
confidence	O
interval	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Multiple	O
Linear	O
Regression	O
Analyses	O
for	O
the	O
Dependent	O
Variables	O
RMSSD	O
,	O
PNN50	O
and	O
HF	O
index	O
.	O
βSECI	O
(	O
95	O
%)	O
P	O
Value	O
RMSSD	O
(	O
ms	O
)	O
Birth	O
Weight0	O
.	O
0110	O
.	O
004	O
(	O
0	O
.	O
002	O
to	O
0	O
.	O
019	O
)	O
0	O
.	O
018	O
PNN50	O
(%)	O
Birth	O
Weight0	O
.	O
0080	O
.	O
003	O
(	O
0	O
.	O
002	O
to	O
0	O
.	O
012	O
)	O
0	O
.	O
007Age1	O
.	O
3650	O
.	O
677	O
(	O
0	O
.	O
019	O
to	O
2	O
.	O
710	O
)	O
0	O
.	O
047BMI	O
-	O
0	O
.	O
7530	O
.	O
308	O
(-	O
1	O
.	O
364	O
to	O
-	O
0	O
.	O
142	O
)	O
0	O
.	O
016	O
HF	O
(	O
n	O
.	O
u	O
.)	O

Several	O
risk	O
factors	O
during	O
the	O
pregnancy	O
and	O
labor	O
periods	O
have	O
been	O
associated	O
with	O
autism	O
;	O
yet	O
further	O
studies	O
with	O
large	O
populations	O
are	O
needed	O
to	O
establish	O
definitive	O
associations	O
.	O

Discussion	O
Clinically	O
,	O
AAOC	O
appears	O
as	O
a	O
friable	O
erythematous	O
exophytic	O
papule	O
on	O
digits	O
,	O
palms	O
,	O
or	O
soles	O
and	O
can	O
develop	O
at	O
any	O
age	O
with	O
slight	O
female	O
predominance	O
.	O

GABA	O
,	O
γ	O
-	O
aminobutyric	O
acid	O
;	O
SGA	O
,	O
second	O
generation	O
antipsychotic	O
.	O

Conclusion	O
The	O
importance	O
of	O
nutritional	O
counseling	O
before	O
conception	O
and	O
during	O
pregnancy	O
should	O
be	O
emphasized	O
in	O
order	O
to	O
encourage	O
proper	O
PPBMI	O
and	O
avoidance	O
of	O
excessive	O
gestational	O
weight	O
gain	O
,	O
since	O
both	O
are	O
related	O
to	O
risk	O
for	O
GDM	O
.	O

Vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
has	O
been	O
shown	O
to	O
positively	O
affect	O
cord	O
blood	O
vitamin	O
D	O
levels	O
at	O
birth	O
.	O
43	O
,	O
44Studies	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
thus	O
far	O
have	O
shown	O
conflicting	B
results	O
with	O
respect	O
to	O
birth	O
weight	O
and	O
reduction	O
of	O
SGA	O
.	O
43	O
,	O
45	O
,	O
46	O
,	O
47	O
,	O
48Adequately	O
powered	O
and	O
randomized	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
are	O
needed	O
to	O
assess	O
the	O
impact	O
of	O
supplementation	O
on	O
SGA	O
as	O
well	O
as	O
the	O
appropriate	O
dose	O
and	O
timing	O
of	O
supplementation	O
.	O

Maternal	O
and	O
offspring	O
health	O
is	O
followed	O
-	O
up	O
at	O
6	O
weeks	O
,	O
as	O
well	O
as	O
at	O
6	O
,	O
≈	O
7	O
.	O
5	O
and	O
12	O
months	O
after	O
birth	O
.	O

Behaviourally	O
,	O
adult	O
DVD	O
-	O
deficient	O
rats	O
were	O
more	O
active	O
than	O
controls	O
(	O
i	O
.	O
e	O
.	O

The	O
existence	O
of	O
common	O
genomic	O
changes	O
between	O
DTC	O
and	O
anaplastic	O
carcinoma	O
may	O
provide	O
convincing	O
proof	O
of	O
the	O
multi	O
-	O
step	O
carcinogenesis	O
hypothesis	O
in	O
which	O
cancer	O
cells	O
are	O
produced	O
from	O
well	O
-	O
differentiated	O
benign	O
cells	O
by	O
transformation	O
caused	O
by	O
accumulating	O
damage	O
to	O
their	O
genome	O
Although	O
gene	O
expression	O
in	O
thyroid	O
cancer	O
reveals	O
highly	O
consistent	O
profiles	O
,	O
a	O
second	O
hypothesis	O
has	O
been	O
proposed	O
,	O
which	O
can	O
possibly	O
explain	O
other	B
"	O
non	O
-	O
RET	O
"	O
tumours	O
:	O
namely	O
foetal	O
cell	O
carcinogenesis	O
,	O
according	O
to	O
which	O
cancer	O
cells	O
are	O
derived	O
from	O
the	O
remnants	O
of	O
foetal	O
thyroid	O
cells	O
,	O
or	O
from	O
stem	O
cells	O
instead	B
of	O
differentiated	O
follicular	O
cells	O
.	O

The	O
size	O
of	O
each	O
point	O
indicates	O
the	O
log	O
-	O
ratio	O
transformed	O
relative	O
abundance	O
(	O
LRTA	O
)	O
of	O
each	O
OTU	O
(	O
LRTA	O
≥	O
30	O
,	O
LRTA	O
≥	O
20	O
,	O
or	O
LRTA	O
<	O
20	O
).	O

Blood	O
lead	O
concentration	O
was	O
associated	O
with	O
a	O
45	O
g	O
decrease	O
in	O
birth	O
weight	O
(	O
95	O
%	O
CI	O
(-	O
110	O
,	O
22	O
),	O
50	O
%	O
CI	O
(-	O
68	O
,	O
-	O
22	O
)),	O
while	O
mercury	O
exposure	O
was	O
associated	O
with	O
a	O
5	O
g	O
,	O
95	O
%	O
CI	O
(-	O
56	O
,	O
66	O
)	O
increase	O
in	O
birth	O
weight	O
.	O

We	O
decided	B
to	O
incorporate	O
GAS5	O
in	O
the	O
current	O
study	O
as	O
it	O
can	O
act	O
as	O
a	O
GR	O
DNA	O
binding	O
decoy	O
and	O
as	O
a	O
result	O
compromise	O
its	O
activity	O
[	O
8	O
].	O

Multiple	O
linear	O
and	O
logistic	O
regression	O
models	O
were	O
constructed	O
to	O
investigate	O
significant	O
predictors	O
of	O
the	O
outcomes	O
of	O
interest	O
.	O

The	O
Skm1	O
mutation	O
occurs	O
within	O
the	O
membrane	O
proximal	O
region	O
of	O
the	O
extracellular	O
domain	O
of	O
Npr3	O
,	O
suggesting	O
that	O
ligand	O
binding	O
may	O
be	O
altered	O
in	O
these	O
mice	O
.	O

The	O
biological	O
underpinnings	O
of	O
EAH	O
and	O
other	O
appetite	O
-	O
related	O
behaviors	O
are	O
not	O
well	O
understood	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
the	O
rate	O
of	O
major	O
malformations	O
reported	O
in	O
the	O
exposed	O
group	O
was	O
approximately	O
two	O
and	O
a	O
half	O
times	O
higher	O
than	O
in	O
the	O
comparison	O
group	O
(	O
6	O
.	O
2	O
%	O
vs	O
2	O
.	O
6	O
%).	O

The	O
heightened	O
preference	O
for	O
sweet	O
taste	O
,	O
which	O
is	O
evident	O
within	O
hours	O
after	O
birth	O
and	O
persists	O
until	O
adolescence	O
(	O
27	O
,	O
28	O
)	O
most	O
likely	O
evolved	O
because	O
sweet	O
-	O
tasting	O
foods	O
are	O
high	O
in	O
energy	O
.	O

Within	O
24	O
hours	O
of	O
delivery	O
,	O
each	O
litter	O
was	O
culled	O
to	O
10	O
pups	O
to	O
minimize	O
the	O
difference	O
in	O
milk	O
availability	O
.	O

However	B
,	O
it	O
must	O
be	O
borne	O
in	O
mind	O
that	O
a	O
proportion	O
of	O
children	O
who	O
develop	O
atopic	O
manifestations	O
in	O
the	O
first	O
years	O
of	O
life	O
come	O
from	O
families	O
in	O
which	O
neither	O
parents	O
nor	O
siblings	O
are	O
atopic	O
.	O

This	O
interpretation	O
also	O
agrees	O
with	O
the	O
down	O
-	O
regulation	O
of	O
the	O
endocannabinoid	O
metabolism	O
in	O
peripheral	O
tissues	O
.	O

Sample	O
Preparation	O
Tissue	O
was	O
sampled	O
from	O
8	O
control	O
and	O
8	O
DVD	O
deficient	O
male	O
adult	O
offspring	O
.	O

Maternal	O
Diet	O
During	O
Pregnancy	O
A	O
Cochrane	O
database	O
meta	O
-	O
analysis	O
of	O
4	O
clinical	O
studies	O
concluded	O
that	O
antigen	O
avoidance	O
during	O
pregnancy	O
is	O
unlikely	O
to	O
reduce	O
the	O
child	O
'	O
s	O
risk	O
of	O
developing	O
atopic	O
disease	O
,	O
and	O
dietary	O
restrictions	O
could	O
adversely	O
affect	O
maternal	O
or	O
fetal	O
nutrition	O
[	O
99	O
].	O

Growth	O
arrest	O
-	O
specific	O
transcript	O
5	O
(	O
GAS5	O
)	O
encodes	O
a	O
single	O
strand	O
noncoding	O
RNA	O
(	O
ncRNA	O
)	O
and	O
,	O
as	O
its	O
name	O
suggests	O
,	O
can	O
accumulate	O
in	O
growth	O
-	O
arrested	O
cells	O
[	O
7	O
].	O

Minority	O
women	O
are	O
at	O
increased	O
risk	O
for	O
excessive	O
GWG	O
,	O
yet	O
are	O
underrepresented	O
in	O
published	O
weight	O
control	O
interventions	O
.	O

Some	O
validation	O
rules	O
will	O
be	O
set	O
in	O
the	O
application	O
to	O
prevent	O
errors	O
during	O
data	O
collection	O
.	O

This	O
is	O
a	O
first	O
time	O
that	O
GAS5	O
localization	O
has	O
been	O
studied	O
in	O
human	O
placentas	O
.	O

Therefore	O
,	O
at	O
placental	O
level	O
,	O
the	O
contractile	O
status	O
does	O
not	O
really	O
affect	O
GR	O
transcription	O
.	O

Primarily	O
utilized	O
by	O
monocytes	O
,	O
macrophages	O
,	O
mucosal	O
epithelial	O
cells	O
,	O
and	O
keratinocytes	O
as	O
part	O
of	O
the	O
innate	O
immune	O
system	O
,	O
these	O
cells	O
release	O
cathelicidin	O
along	O
with	O
other	O
cytokines	O
and	O
signal	O
molecules	O
as	O
a	O
first	O
line	O
of	O
defense	O
[	O
5	O
].	O

Another	O
significant	O
factor	O
for	O
sample	O
loss	O
was	O
that	O
a	O
number	O
of	O
the	O
women	O
did	O
not	O
return	O
to	O
the	O
specified	O
hospital	O
for	O
childbirth	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
frequency	O
of	O
daily	O
“	O
between	O
-	O
meal	O
”	O
snacking	O
between	O
the	O
groups	O
(	O
93	O
.	O
8	O
%	O
S	O
-	O
ECC	O
vs	O
.	O
96	O
.	O
7	O
%	O
caries	O
-	O
free	O
,	O
p	O
=	O
0	O
.	O
39	O
,	O
Fisher	O
’	O
s	O
Exact	O
Test	O
).	O

Prenatal	O
vitamin	O
supplement	O
composition	O
varied	O
by	O
brand	O
;	O
however	O
,	O
most	O
brands	O
included	O
200	O
IU	O
vitamin	O
D	O
per	O
pill	O
.	O

Abstract	O
Background	O
Pet	O
keeping	O
has	O
been	O
linked	O
with	O
decreased	O
risk	O
of	O
allergic	O
sensitization	O
,	O
which	O
has	O
been	O
associated	O
with	O
the	O
Hygiene	O
Hypothesis	O
;	O
and	O
more	O
recently	O
,	O
by	O
ourselves	O
and	O
others	O
,	O
to	O
particular	O
home	O
microbiome	O
patterns	O
.	O

Compared	O
to	O
women	O
with	O
a	O
large	O
increase	O
in	O
25OHD	O
(≥	O
30	O
nmol	O
/	O
L	O
),	O
women	O
with	O
a	O
decrease	O
in	O
25OHD	O
had	O
significantly	O
higher	O
OR	O
of	O
having	O
a	O
child	O
born	O
SGA	O
(	O
OR	O
=	O
3	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
002	O
),	O
with	O
LBW	O
(	O
OR	O
=	O
4	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
014	O
)	O
as	O
well	O
as	O
a	O
trend	O
toward	O
higher	O
odds	O
of	O
preterm	O
delivery	O
(	O
OR	O
=	O
2	O
.	O
9	O
,	O
p	O
=	O
0	O
.	O
061	O
).	O

A	O
post	O
-	O
hoc	O
analysis	O
was	O
conducted	O
to	O
determine	O
if	B
BMI	O
and	O
percent	O
fat	O
had	O
an	O
effect	O
on	O
cathelicidin	O
concentration	O
.	O

Irisin	O
,	O
obtained	O
by	O
cleavage	O
from	O
the	O
precursor	O
protein	O
,	O
fibronectin	O
type	O
III	O
domain	O
containing	O
5	O
(	O
FNDC5	O
),	O
was	O
described	O
as	O
promoting	O
the	O
appearance	O
/	O
recruitment	O
of	O
“	O
brite	O
”	O
cells	O
in	O
white	O
adipose	O
depots	O
(	O
Bostrom	O
et	O
al	O
.,	O
2012	O
;	O
Lee	O
et	O
al	O
.,	O
2014a	O
).	O

Vitamin	O
and	O
mineral	O
supplements	O
are	O
recommended	O
for	O
women	O
with	O
multiple	O
pregnancy	O
,	O
those	O
who	O
misuse	O
alcohol	O
or	O
drugs	O
,	O
or	O
have	O
an	O
unbalanced	O
diet	O
[	O
32	O
].	O

A	O
total	O
of	O
70	O
.	O
3	O
%	O
(	O
663	O
/	O
943	O
)	O
of	O
the	O
participants	O
reported	O
being	O
married	O
.	O

Carbohydrate	O
should	O
be	O
restricted	O
to	O
35	O
%–	O
40	O
%	O
of	O
calories	O
.	O

This	O
was	O
also	O
observed	O
in	O
response	O
to	O
irisin	O
,	O
a	O
hormone	O
secreted	O
by	O
skeletal	O
muscles	O
.	O

In	O
the	O
term	O
group	O
,	O
the	O
only	O
significant	O
correlation	O
was	O
between	O
GAS5	O
and	O
maternal	O
stress	O
(	O
r	O
=	O
−	O
0	O
.	O
711	O
,	O
P	O
=	O
0	O
.	O
021	O
).	O

Whenever	B
possible	O
,	O
surgery	O
should	O
be	O
carried	O
out	O
during	O
the	O
second	O
trimester	O
or	O
after	O
delivery	O
,	O
as	O
for	O
newly	O
diagnosed	O
thyroid	O
cancer	O
.	O

The	O
meagre	O
body	O
of	O
literature	O
regarding	O
pregnancy	O
outcomes	O
following	O
the	O
maternal	O
use	O
of	O
SGAs	O
has	O
produced	O
conflicting	B
findings	O
,	O
which	O
may	O
be	O
attributed	O
to	O
the	O
different	B
methodologies	O
and	O
inadequate	O
control	O
for	O
confounding	O
variables	O
.	O
15A	O
number	O
of	O
studies	O
have	O
found	O
that	O
exposure	O
to	O
SGAs	O
is	O
associated	O
with	O
a	O
significantly	O
increased	O
risk	O
of	O
low	O
birth	O
weight16	O
–	O
18and	O
small	O
for	O
gestational	O
age	O
infants	O
,	O
in	O
comparison	O
to	O
healthy	O
controls	O
.	O
17Conversely	B
,	O
Lin	O
et	O
al	O
17found	O
that	O
the	O
risk	O
of	O
low	O
birth	O
weight	O
,	O
preterm	O
births	O
and	O
small	O
/	O
large	O
for	O
gestational	O
age	O
(	O
LGA	O
)	O
infants	O
did	O
not	O
differ	O
between	O
women	O
with	O
schizophrenia	O
receiving	O
SGAs	O
and	O
those	O
with	O
the	O
disorder	O
who	O
did	O
not	O
use	O
an	O
antipsychotic	O
drug	O
.	O

Pre	O
-	O
pregnancy	O
nutritional	O
status	O
and	O
weight	O
gain	O
were	O
classified	O
according	O
to	O
guidelines	O
by	O
the	O
Institute	O
of	O
Medicine	O
.	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
suggested	O
that	O
a	O
prolonged	O
feeding	O
period	O
gives	O
the	O
cattle	O
time	O
to	O
obtain	O
high	O
IMF	O
levels	O
because	O
time	O
is	O
needed	O
for	O
muscle	O
to	O
reach	O
maturity	O
,	O
followed	O
by	O
time	O
for	O
the	O
muscle	O
to	O
fill	O
up	O
with	O
IMF	O
.	O

Poor	O
nutrition	O
(	O
reduced	O
folate	O
),	O
detoxification	O
of	O
arsenic	O
and	O
consumption	O
of	O
glutathione	O
during	O
the	O
detoxification	O
of	O
reactive	O
oxygen	O
species	O
can	O
all	O
lead	O
to	O
reduced	O
levels	O
of	O
the	O
DNMT	O
co	O
-	O
substrate	O
S	O
-	O
adenosylmethionine	O
(	O
Hou	O
et	O
al	O
.	O
2012	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

The	O
DXA	O
instrument	O
undergoes	O
regularly	O
scheduled	O
quality	O
control	O
testing	O
for	O
phantom	O
reproducibility	O
and	O
signal	O
uniformity	O
.	O

PubMed	O
Central	O
:	O

This	O
statistical	O
pooling	O
of	O
several	O
studies	O
,	O
taking	O
into	O
account	O
the	O
size	O
of	O
individual	O
studies	O
,	O
confers	O
more	O
power	O
to	O
detect	O
a	O
potential	O
association	O
,	O
and	O
quantitative	O
meta	O
-	O
analyses	O
are	O
often	O
put	O
at	O
the	O
top	O
of	O
evidence	O
hierarchies	O
.	O

Transplacental	O
transfer	O
occurs	O
,	O
67	O
,	O
81and	O
until	O
studies	O
demonstrating	O
safety	O
are	O
performed	O
,	O
they	O
should	O
be	O
avoided	O
in	O
pregnancy	O
.	O

Maternal	O
and	O
Infant	O
GR	O
Polymorphisms	O
,	O
Maternal	O
Attitudes	O
,	O
and	O
Fetal	O
Birth	O
Weight	O
Four	O
GR	O
polymorphisms	O
were	O
investigated	O
:	O
Bcl	O
I	O
,	O
N363S	O
,	O
Tth111	O
I	O
,	O
and	O
ER22	O
/	O
23EK	O
(	O
Table	O
3	O
).	O

Nevertheless	B
,	O
three	O
of	O
four	O
recent	O
U	O
.	O
S	O
.	O
studies	O
found	O
a	O
higher	O
incidence	O
of	O
autism	O
in	O
black	O
children	O
,	O
sometimes	O
appreciably	O
higher	O
(	O
1	O
,	O
2	O
).	O

These	O
data	O
point	O
towards	O
an	O
interaction	O
between	O
stress	O
and	O
genetics	O
,	O
since	O
only	O
in	O
the	O
CC	O
polymorphic	O
GR	O
group	O
did	O
negative	O
maternal	O
attitude	O
predict	O
fetal	O
weight	O
reduction	O
,	O
but	B
not	I
in	O
the	O
CT	O
group	O
,	O
independent	O
of	O
confounders	O
.	O

A	O
sample	O
size	O
of	O
1350	O
infants	O
(	O
75	O
%	O
follow	O
-	O
up	O
)	O
would	O
provide	O
80	O
%	O
power	O
to	O
detect	O
at	O
least	O
a	O
difference	O
in	O
the	O
incidence	O
of	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
of	O
6	O
.	O
4	O
%	O
(	O
from	O
25	O
to	O
18	O
.	O
6	O
%;	O
alpha	O
0	O
.	O
05	O
).	O

Between	O
31	O
March	O
2011	O
when	O
the	O
first	O
potential	O
subject	O
with	O
the	O
opportunity	O
to	O
collect	O
a	O
6	O
-	O
week	O
infant	O
stool	O
sample	O
from	O
was	O
screened	O
for	O
eligibility	O
and	O
30	O
June	O
2015	O
when	O
the	O
data	O
were	O
frozen	O
for	O
this	O
analysis	O
,	O
6569	O
women	O
were	O
screened	O
for	O
eligibility	O
and	O
1334	O
were	O
eligible	O
.	O

While	O
vitamin	O
D	O
supplementation	O
in	O
pregnancy	O
has	O
previously	O
been	O
associated	O
with	O
reduced	O
risk	O
of	O
wheezing	O
and	O
type	O
1	O
diabetes	O
.	O

Larger	O
studies	O
are	O
needed	O
in	O
diverse	O
populations	O
at	O
various	O
latitudes	O
to	O
further	O
characterize	O
the	O
relationship	O
between	O
vitamin	O
D	O
supplementation	O
and	O
bone	O
mineral	O
content	O
.	O

The	O
increase	O
in	O
haemoglobin	O
concentration	O
in	O
the	O
intervention	O
group	O
relative	O
to	O
placebo	O
was	O
more	O
marked	O
in	O
women	O
who	O
were	O
anaemic	O
at	O
the	O
start	O
of	O
the	O
study	O
(	O
Figure	O
2	O
).	O

Given	O
the	O
suggestion	O
of	O
a	O
U	O
-	O
shaped	O
relation	O
between	O
sleep	O
duration	O
and	O
GDM	O
risk	O
(	O
with	O
elevated	O
risks	O
for	O
both	O
short	O
and	O
long	O
sleep	O
duration	O
),	O
and	O
given	O
suggestion	O
of	O
a	O
linear	O
trend	O
in	O
risk	O
of	O
GDM	O
for	O
sleep	O
duration	O
ranging	O
from	O
≤	O
4	O
to	O
5	O
-	O
8	O
hours	O
,	O
we	O
modeled	O
the	O
risk	O
of	O
GDM	O
in	O
relation	O
to	O
maternal	O
sleep	O
duration	O
as	O
a	O
continuous	O
variable	O
,	O
restricting	O
the	O
study	O
population	O
to	O
women	O
who	O
reported	O
sleeping	O
<	O
10	O
hours	O
.	O

Considering	O
the	O
HRV	O
analysis	O
,	O
there	O
was	O
no	O
significant	O
gender	O
effects	O
with	O
respect	O
to	O
the	O
time	O
-	O
domain	O
(	O
HR	O
:	O
P	O
=	O
0	O
.	O
098	O
;	O
MNN	O
:	O
P	O
=	O
0	O
.	O
271	O
;	O
SDNN	O
:	O
P	O
=	O
0	O
.	O
208	O
;	O
RMSSD	O
:	O
P	O
=	O
0	O
.	O
624	O
;	O
PNN50	O
:	O
P	O
=	O
0	O
.	O
882	O
)	O
or	O
frequency	O
-	O
domain	O
(	O
LF	O
:	O
P	O
=	O
0	O
.	O
294	O
;	O
HF	O
:	O
P	O
=	O
0	O
.	O
844	O
;	O
ratio	O
LF	O
/	O
HF	O
:	O
P	O
=	O
0	O
.	O
546	O
)	O
indices	O
;	O
therefore	O
,	O
analyses	O
were	O
performed	O
considering	O
boys	O
and	O
girls	O
together	O
.	O

(	O
2015	O
)*/†	O
Lin	O
et	O
al	O
.	O

Implement	O
•	O
Strengthen	O
community	O
and	O
local	O
capabilities	O
to	O
scale	O
up	O
implementation	O
of	O
interventions	O
for	O
preterm	O
birth	O
and	O
support	O
families	O
who	O
have	O
lost	O
babies	O
or	O
require	O
long	O
-	O
term	O
support	O
for	O
disability	O
.	O

Differences	O
in	O
25	O
(	O
OH	O
)	O
D	O
between	O
Hispanic	O
and	O
Caucasian	O
infants	O
may	O
be	O
related	O
to	O
lifestyle	O
including	O
sunshine	O
exposure	O
.	O

However	O
,	O
they	O
write	O
,	O
it	O
remains	O
prudent	O
for	O
women	O
who	O
are	O
pregnant	O
or	O
think	O
they	O
may	O
become	O
pregnant	O
to	O
eat	O
a	O
diet	O
rich	O
in	O
fruits	O
and	O
vegetables	O
.	O

A	O
number	O
of	O
specific	O
actions	O
,	O
pursued	O
by	O
all	O
partners	O
and	O
applied	O
across	O
the	O
RMNCH	O
continuum	O
of	O
care	O
,	O
will	O
help	O
prevent	O
preterm	O
birth	O
and	O
associated	O
mortality	O
,	O
and	O
have	O
an	O
immediate	O
,	O
profound	O
and	O
sustained	O
impact	O
on	O
human	O
capital	O
.	O

According	O
to	O
our	O
results	O
,	O
a	O
maternal	O
caloric	O
restriction	O
prior	O
to	O
mating	O
could	O
be	O
critical	O
for	O
the	O
less	O
compulsive	O
feeding	O
observed	O
in	O
female	O
offspring	O
.	O

These	O
groups	O
were	O
chosen	O
to	O
study	O
whether	B
vitamin	O-
D	O-
insufficiency	O-
(	O-
30	O-
–	O-
50	O-
nmol	O-
/	O-
L	O-
),	O-
sufficiency	O-
(≥	O-
50	O-
nmol	O-
/	O-
L	O-
)	O-
or	O-
high	O-
status	O-
(≥	O-
75	O-
or	O-
≥	O-
100	O-
nmol	O-
/	O-
L	O-
)	O-
was	O-
associated	O-
with	O-
the	O-
outcomes	O-
studied	O-
,	O-
compared	I
to	O
vitamin	O
D	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
).	O

While	B
,	O
any	O
statistically	O
significant	O
differences	O
were	O
not	O
observed	O
regarding	O
to	O
depression	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
Table	O
4	O
).	O

The	O
data	O
may	O
be	O
useful	O
as	O
comparison	O
with	O
human	O
health	O
care	O
studies	O
of	O
methyl	O
donor	O
supplementation	O
in	O
the	O
mothers	O
’	O
diets	O
.	O

For	O
busy	O
new	O
mothers	O
to	O
comply	O
with	O
handwashing	O
at	O
all	O
the	O
recommended	O
times	O
may	O
have	O
been	O
extremely	O
difficult	O
.	O

Verburg	O
et	O
al	O
.	O

Dysfunction	O
of	O
DA	O
signalling	O
has	O
been	O
strongly	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
schizophrenia	O
[	O
13	O
].	O

This	O
may	O
therefore	O
be	O
affecting	O
the	O
number	O
of	O
these	O
elements	O
in	O
the	O
genome	O
and	O
the	O
functional	O
relevance	O
of	O
their	O
methylation	O
,	O
particularly	O
in	O
the	O
placenta	O
.	O

Approximately	O
6	O
%	O
of	O
the	O
gestational	O
age	O
estimates	O
came	O
from	O
ultrasounds	O
in	O
the	O
last	O
trimester	O
,	O
which	O
have	O
higher	O
rates	O
of	O
estimate	O
error	O
than	O
estimates	O
calculated	O
in	O
early	O
pregnancy	O
.	O

It	O
has	O
been	O
noted36that	O
if	O
the	O
sexes	O
are	O
not	O
equal	O
in	O
phenotypic	O
variance	O
,	O
then	O
regression	O
of	O
daughters	O
on	O
fathers	O
,	O
for	O
example	O
,	O
must	O
be	O
adjusted	O
for	O
the	O
difference	O
in	O
variation	O
.	O

In	O
this	O
case	O
also	O
,	O
the	O
mutation	O
occurred	O
at	O
a	O
residue	O
highly	O
conserved	O
across	O
species	O
(	O
Figure	O
3B	O
,	O
bottom	O
panel	O
)	O
and	O
mouse	O
strains	O
(	O
data	O
not	O
shown	O
).	O

In	O
brief	O
,	O
community	O
leaders	O
and	O
health	O
staff	O
at	O
all	O
levels	O
were	O
sensitized	O
,	O
promotional	O
materials	O
were	O
developed	O
,	O
and	O
village	O
health	O
workers	O
were	O
trained	O
to	O
distribute	O
supplements	O
each	O
month	O
to	O
non	O
-	O
pregnant	O
women	O
.	O

Statistical	O
Analysis	O
The	O
homogeneity	O
of	O
the	O
two	O
groups	O
was	O
confirmed	O
through	O
statistical	O
tests	O
in	O
terms	O
of	O
underlying	O
and	O
demographic	O
variables	O
such	O
as	O
age	O
,	O
education	O
,	O
employment	O
,	O
household	O
size	O
,	O
and	O
neonatal	O
sex	O
,	O
fertility	O
status	O
,	O
income	O
,	O
childbirth	O
method	O
,	O
and	O
family	O
planning	O
,	O
the	O
time	O
presenting	O
for	O
postpartum	O
childcare	O
,	O
feeding	O
method	O
(	O
formula	O
,	O
breast	O
milk	O
,	O
or	O
both	O
),	O
hypothyroidism	O
,	O
neonatal	O
anemia	O
,	O
and	O
referral	O
to	O
physician	O
.	O

To	O
verify	O
physical	O
presence	O
of	O
the	O
data	O
collectors	O
at	O
the	O
households	O
we	O
will	O
record	O
a	O
Geographic	O
Information	O
System	O
(	O
GIS	O
)	O
data	O
point	O
.	O

2	O
-	O
D	O
gel	O
electrophoresis	O
-	O
based	O
proteomics	O
and	O
mass	O
spectroscopy	O
were	O
used	O
to	O
investigate	O
differential	O
protein	O
expression	O
.	O

PubMed	O
Central	O
:	O

Note	O
that	O
confidence	O
intervals	O
for	O
beta	O
coefficients	O
from	O
LASSO	O
and	O
Elastic	O
Net	O
are	O
not	O
available	O
using	O
standard	O
software	O
,	O
and	O
calculating	O
standard	O
errors	O
for	O
parameter	O
estimates	O
is	O
challenging	O
because	O
the	O
shrinkage	O
estimation	O
produces	O
biased	O
estimates	O
for	O
large	O
coefficients	O
.	O

1	O
Map	O
of	O
study	O
area	O
,	O
Shonjibon	O
Trial	O
(	O
created	O
by	O
the	O
authors	O
)	O
Cluster	O
selection	O
We	O
will	O
define	O
a	O
cluster	O
as	O
a	O
BRAC	O
PO	O
area	O
,	O
which	O
will	O
consist	O
of	O
a	O
pair	O
of	O
BRAC	O
village	O
field	O
workers	O
(	O
called	O
Shasthya	O
Kormi	O
or	O
SK	O
)	O
and	O
their	O
20	O
BRAC	O
village	O
volunteers	O
(	O
referred	O
to	O
as	O
Shasthya	O
Shebika	O
or	O
SS	O
)	O
who	O
are	O
supervised	O
by	O
a	O
single	O
BRAC	O
PO	O
.	O

As	O
with	O
asthma	O
,	O
preexisting	O
AR	O
can	O
worsen	O
,	O
improve	O
,	O
or	O
remain	O
unchanged	O
during	O
pregnancy	O
[	O
27	O
].	O

Women	O
who	O
suffered	O
a	O
stillbirth	O
or	O
neonatal	O
death	O
,	O
or	O
who	O
withdrew	O
from	O
participation	O
in	O
ongoing	O
follow	O
-	O
up	O
were	O
excluded	O
.	O

Gross	O
anatomical	O
abnormalities	O
were	O
greater	O
in	O
mice	O
fathered	O
by	O
FD	O
mice	O
(	O
27	O
%	O
vs	O
.	O
3	O
%)	O
which	O
included	O
craniofacial	O
,	O
hydrocephalus	O
,	O
limb	O
,	O
and	O
muscle	O
/	O
skeletal	O
defects	O
.	O

These	O
differences	B
cannot	O
be	O
compared	O
directly	O
due	O
to	O
discrepancies	B
in	O
national	O
guidelines	O
and	O
the	O
financial	O
barriers	O
in	O
some	O
regions	O
[	O
27	O
].	O

The	O
interest	O
of	O
OECD	O
member	O
countries	O
in	O
epigenetics	O
within	O
the	O
former	O
expert	O
group	O
is	O
particularly	O
strong	O
,	O
where	O
epigenetic	O
mechanisms	O
are	O
playing	O
a	O
pivotal	O
role	O
in	O
the	O
development	O
of	O
tools	O
for	O
improved	O
chemical	O
safety	O
assessment	O
(	O
Jacobs	O
et	O
al	O
.	O
2015	O
).	O

Between	O
fetal	O
and	O
perinatal	O
stages	O
(	O
period	O
I	O
),	O
there	O
were	O
1	O
,	O
034	O
(	O
503	O
1	O
dpn	O
≻	O
94	O
dpc	O
)	O
probe	O
-	O
sets	O
showing	O
levels	O
and	O
directions	O
of	O
regulation	O
in	O
the	O
AP	O
group	O
that	O
were	O
different	O
from	O
the	O
LP	O
group	O
.	O

These	O
findings	O
suggest	O
that	O
improvements	O
in	O
vitamin	O
D	O
status	O
may	O
decrease	O
the	O
disparity	O
in	O
PTB	O
rates	O
between	O
race	O
/	O
ethnic	O
groups	O
.	O

The	O
estimates	O
increased	O
rapidly	O
from	O
age	O
0	O
to	O
5	O
and	O
then	O
at	O
a	O
slower	O
rate	O
,	O
reaching	O
maximum	O
values	O
in	O
adulthood	O
.	O

It	O
would	O
have	O
been	O
worthwhile	O
to	O
include	O
some	O
more	O
topics	O
such	O
as	O
management	O
of	O
severely	O
acute	O
malnutrition	O
,	O
examples	O
of	O
high	O
,	O
low	O
and	O
moderate	O
glycaemic	O
index	O
foods	O
,	O
how	O
to	O
read	O
food	O
labels	O
(	O
with	O
examples	O
),	O
etc	O
and	O
also	O
additional	O
references	O
for	O
further	O
reading	O
would	O
have	O
been	O
beneficial	O
as	O
the	O
chapters	O
are	O
a	O
quick	O
guide	O
to	O
appraise	O
the	O
topic	O
.	O

Mothers	O
were	O
instructed	O
to	O
continue	O
the	O
supplements	O
as	O
long	O
as	O
they	O
were	O
breastfeeding	O
.	O

Therefore	O
meconium	O
aspiration	O
syndrome	O
cannot	O
be	O
the	O
cause	O
of	O
autistic	O
disorder	O
in	O
children	O
,	O
but	B
it	O
can	O
be	O
a	O
contributing	O
factor	O
[	O
57	O
].	O

There	O
is	O
sufficient	O
evidence	O
that	O
increased	O
PFAS	O
(	O
especially	O
PFOA	O
)	O
exposure	O
is	O
associated	O
with	O
low	O
birth	O
weight	O
[	O
18	O
–	O
20	O
],	O
but	B
mixed	B
results	I
are	O
reported	O
for	O
other	O
EDCs	O
and	O
birth	O
weight	O
[	O
18	O
,	O
21	O
].	O

Additionally	O
,	O
some	O
previously	O
published	O
studies	O
[	O
14	O
,	O
15	O
]	O
found	O
associations	O
between	O
gestational	O
EDC	O
exposure	O
and	O
birth	O
weight	O
.	O

Moreover	O
,	O
descriptive	O
analysis	O
showed	O
that	O
the	O
quantity	O
of	O
drinking	O
was	O
lower	O
among	O
text4baby	O
participants	O
postpartum	O
.	O

Analysis	O
conducted	O
by	O
Mortality	O
Reduction	O
Goal	O
Group	O
and	O
Boston	O
Consulting	O
Group	O
using	O
multiple	O
data	O
sources	O
(	O
Liu	O
et	O
al	O
.,	O
2012	O
;	O
EIU	O
GDP	O
projections	O
2010	O
to	O
2030	O
;	O
World	O
Population	O
Prospects	O
,	O
2010	O
;	O
UN	O
Department	O
of	O
Economic	O
and	O
Social	O
Affairs	O
;	O
LiST	O
analysis	O
)	O
[	O
50	O
,	O
52	O
,	O
53	O
].	O

Consequently	O
,	O
a	O
range	O
of	O
mechanisms	O
for	O
the	O
demethylation	O
of	O
DNA	O
have	O
been	O
proposed	O
(	O
described	O
in	O
relation	O
to	O
mammalian	O
development	O
in	O
Dean2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
,	O
2016	O
).	O

The	O
World	O
Health	O
Organization	O
recommends	O
a	O
daily	O
intake	O
of	O
60	O
mg	O
iron	O
and	O
400	O
μg	O
folic	O
acid	O
for	O
six	O
months	O
to	O
prevent	O
anaemia	O
[	O
33	O
].	O

We	O
acknowledge	O
that	O
our	O
sample	O
included	O
small	O
numbers	O
in	O
certain	O
categories	O
of	O
polymorphic	O
groups	O
.	O

Understanding	O
the	O
factors	O
affecting	O
IMF	O
deposition	O
and	O
the	O
mechanisms	O
responsible	O
for	O
its	O
deposition	O
is	O
important	O
when	O
manipulating	O
IMF	O
deposition	O
.	O

These	O
findings	O
support	O
the	O
inverse	O
association	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
risk	O
found	O
in	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

The	O
quality	O
and	O
accuracy	O
of	O
the	O
serum	O
25	O
(	O
OH	O
)	O
D	O
analysis	O
is	O
validated	O
on	O
an	O
ongoing	O
basis	O
by	O
participation	O
in	O
the	O
vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
(	O
DEQAS	O
,	O
Charing	O
Cross	O
Hospital	O
,	O
London	O
,	O
UK	O
).	O

Introduction	O
The	O
belief	O
that	O
the	O
sequence	O
of	O
our	O
DNA	O
(	O
our	O
genome	O
)	O
is	O
the	O
sole	O
determinant	O
of	O
our	O
life	O
-	O
long	O
development	O
and	O
health	O
has	O
long	O
been	O
regarded	O
as	O
too	B
simplistic	I
.	O

For	O
3	O
women	O
information	O
on	O
the	O
trimester	O
was	O
missing	O
.	O

Several	O
other	O
studies	O
,	O
however	B
,	O
have	O
found	O
associations	O
between	O
increased	O
exposure	O
to	O
phthalates	O
,	O
PCBs	O
,	O
PBDEs	O
or	O
OCPs	O
whereas	B
we	O
did	O
not	O
.	O

Children	O
with	O
S	O
-	O
ECC	O
had	O
significantly	O
lower	O
mean	O
25	O
(	O
OH	O
)	O
D	O
(	O
68	O
.	O
9	O
±	O
28	O
.	O
0	O
nmol	O
/	O
L	O
vs	O
.	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
001	O
),	O
calcium	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
albumin	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
,	O
and	O
significantly	O
higher	O
parathyroid	O
hormone	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
than	B
those	O
caries	O
-	O
free	O
.	O

Cathelicidin	O
concentrations	O
were	O
not	O
significantly	O
different	O
among	O
(	O
or	O
between	O
)	O
the	O
three	O
racial	O
/	O
ethnic	O
groups	O
(	O
p	O
=	O
0	O
.	O
999	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Bivariate	O
Analysis	O
between	O
Cathelicidin	O
and	O
Categorical	O
Variables	O
.	O

There	O
are	O
also	O
data	O
from	O
a	O
total	O
of	O
48	O
women	O
with	O
GDM	O
.	O
46	O
,	O
47To	O
date	O
no	O
randomized	O
controlled	O
studies	O
have	O
been	O
published	O
.	O

Infants	O
were	O
not	O
statistically	O
significantly	O
different	O
between	O
the	O
two	O
treatment	O
groups	O
with	O
regards	O
their	O
weight	O
(	O
Lifestyle	O
Advice	O
8	O
.	O
26	O
kg	O
(±	O
1	O
.	O
33	O
)	O
vs	O
.	O
Standard	O
Care	O
8	O
.	O
29	O
kg	O
(±	O
1	O
.	O
33	O
);	O
adjusted	O
mean	O
difference	O
(	O
aMD	O
)	O
−	O
0	O
.	O
05	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
16	O
to	O
0	O
.	O
06	O
;	O
p	O
=	O
0	O
.	O
38	O
),	O
weight	O
Z	O
-	O
score	O
(	O
Lifestyle	O
Advice	O
0	O
.	O
30	O
(±	O
1	O
.	O
13	O
)	O
vs	O
.	O
Standard	O
Care	O
0	O
.	O
34	O
(±	O
1	O
.	O
11	O
);	O
aMD	O
−	O
0	O
.	O
04	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
14	O
to	O
0	O
.	O
06	O
;	O
p	O
=	O
0	O
.	O
43	O
),	O
length	O
(	O
Lifestyle	O
Advice	O
68	O
.	O
24	O
cm	O
(±	O
3	O
.	O
76	O
)	O
vs	O
.	O
Standard	O
Care	O
68	O
.	O
28	O
cm	O
(±	O
4	O
.	O
13	O
);	O
aMD	O
−	O
0	O
.	O
12	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
41	O
to	O
0	O
.	O
16	O
;	O
p	O
=	O
0	O
.	O
41	O
),	O
length	O
Z	O
-	O
score	O
(	O
Lifestyle	O
Advice	O
0	O
.	O
06	O
(±	O
1	O
.	O
22	O
)	O
vs	O
.	O
Standard	O
Care	O
0	O
.	O
11	O
(±	O
1	O
.	O
28	O
);	O
aMD	O
−	O
0	O
.	O
04	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
16	O
to	O
0	O
.	O
07	O
;	O
p	O
=	O
0	O
.	O
46	O
),	O
weight	O
for	O
length	O
ratio	O
(	O
Lifestyle	O
Advice	O
0	O
.	O
12	O
(±	O
0	O
.	O
01	O
)	O
vs	O
.	O
Standard	O
Care	O
0	O
.	O
12	O
(±	O
0	O
.	O
01	O
);	O
aMD	O
−	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
00	O
to	O
0	O
.	O
00	O
;	O
p	O
=	O
0	O
.	O
72	O
),	O
or	O
weight	O
for	O
length	O
ratio	O
Z	O
-	O
score	O
(	O
Lifestyle	O
Advice	O
0	O
.	O
44	O
(±	O
1	O
.	O
18	O
)	O
vs	O
.	O
Standard	O
Care	O
0	O
.	O
48	O
(±	O
1	O
.	O
14	O
);	O
aMD	O
−	O
0	O
.	O
04	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
15	O
to	O
0	O
.	O
07	O
;	O
p	O
=	O
0	O
.	O
47	O
).	O

While	B
the	O
microbiome	O
-	O
wide	O
significance	O
of	O
maternal	O
dietary	O
factors	O
after	O
adjusting	O
p	O
values	O
using	O
the	O
false	O
discovery	O
rate	O
(	O
FDR	O
)	O
method	O
was	O
not	O
observed	O
,	O
OTUs	O
with	O
the	O
same	O
taxonomic	O
assignment	O
tended	O
to	O
appear	O
together	O
in	O
the	O
most	O
significant	O
results	O
,	O
supporting	O
a	O
true	O
association	O
of	O
maternal	O
dietary	O
factors	O
and	O
infant	O
gut	O
microbiota	O
.	O

Women	O
who	O
initially	O
called	O
the	O
service	O
to	O
inquire	O
about	O
the	O
safety	O
of	O
an	O
SGA	O
and	O
who	O
confirmed	O
the	O
use	O
of	O
this	O
medication	O
for	O
a	O
minimum	O
of	O
4	O
weeks	O
of	O
pregnancy	O
were	O
invited	O
to	O
participate	O
.	O

In	O
fact	O
,	O
the	O
rates	O
of	O
recurrence	O
or	O
the	O
disease	O
-	O
free	O
period	O
do	O
not	O
differ	O
between	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
affected	O
by	O
the	O
same	O
disease22729	O
-	O
32	O
.	O

Of	O
current	O
concern	O
in	O
developed	O
countries	O
are	O
the	O
rising	O
rates	O
of	O
obesity	O
[	O
30	O
]	O
and	O
gestational	O
diabetes	O
,	O
both	O
of	O
which	O
produce	O
offspring	O
who	O
develop	O
obesity	O
[	O
31	O
]–[	O
35	O
].	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Adjusted	O
analysis	O
confirmed	O
no	O
difference	O
in	O
mean	O
±	O
SEM	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
(	O
81	O
.	O
7	O
±	O
2	O
.	O
3	O
vs	O
81	O
.	O
7	O
±	O
0	O
.	O
8	O
nmol	O
/	O
L	O
,	O
P	O
=	O
0	O
.	O
99	O
).	O

The	O
diagnosis	O
is	O
made	O
with	O
an	O
oral	O
glucose	O
tolerance	O
test	O
,	O
though	O
the	O
criteria	O
vary	O
around	O
the	O
world	O
(	O
Table	O
1	O
).	O

Four	O
qualitative	O
methods	O
–	O
in	O
-	O
depth	O
interviews	O
(	O
35	O
pregnant	O
women	O
,	O
20	O
older	O
women	O
and	O
11	O
husbands	O
),	O
key	O
informant	O
interviews	O
(	O
20	O
with	O
CHWs	O
,	O
program	O
managers	O
,	O
informal	O
care	O
providers	O
,	O
gynaecologists	O
and	O
traditional	O
birth	O
attendants	O
),	O
focus	O
group	O
discussions	O
(	O
2	O
with	O
Shasthya	O
Shebika	O
and	O
1	O
with	O
female	O
college	O
students	O
)	O
and	O
observations	O
of	O
the	O
lowest	O
level	O
of	O
health	O
facility	O
(	O
community	O
clinics	O
)	O
(	O
2	O
)	O
were	O
conducted	O
.	O

An	O
adapted	O
questionnaire	O
previously	O
used	O
in	O
the	O
South	O
African	O
context	O
is	O
used	O
[	O
58	O
].	O

Women	O
with	O
a	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
≥	O
40	O
ng	O
/	O
mL	O
had	O
a	O
62	O
%	O
lower	O
risk	O
of	O
PTB	O
compared	B
to	I
those	O
with	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
.	O

At	O
weaning	O
,	O
renin	O
expression	O
did	O
not	O
differ	O
between	O
the	O
VitD	O
-	O
and	O
SC	O
mice	O
in	O
either	O
the	O
F1	O
or	O
F2	O
generations	O
.	O

The	O
Center	O
for	O
the	O
Protection	O
of	O
Human	O
Subjects	O
at	O
Dartmouth	O
provided	O
institutional	O
review	O
board	O
approval	O
.	O

35	O
±	O
26	O
.	O
13	O
nmol	O
/	O
L	O
and	O
60	O
.	O
45	O
±	O
23	O
.	O
63	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
and	O
the	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
intervention	O
group	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

This	O
was	O
independent	O
of	O
diet	O
and	O
lifestyles	O
factors	O
including	O
BMI	O
and	O
SEI	O
and	O
highlights	O
the	O
difficulty	O
in	O
understanding	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
in	O
human	O
cohort	O
studies	O
.	O

The	O
secondary	O
objective	O
was	O
to	O
further	O
clarify	O
the	O
effect	O
on	O
the	O
risk	O
of	O
eczema	O
,	O
wheezing	O
,	O
and	O
respiratory	O
tract	O
infections	O
in	O
early	O
life	O
.	O

Dermatologists	O
should	O
be	O
aware	O
of	O
the	O
distinguishing	O
features	O
of	O
scattered	O
bone	O
formation	O
and	O
diffuse	O
capillary	O
proliferation	O
of	O
AAOC	O
rather	B
than	O
the	O
lobular	O
aggregates	O
in	O
PG	O
.	O

Thus	O
,	O
the	O
primary	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
relationship	O
between	O
race	O
,	O
maternal	O
characteristics	O
,	O
cord	O
blood	O
vitamin	O
D	O
levels	O
and	O
SGA	O
status	O
among	O
infants	O
during	O
one	O
winter	O
season	O
in	O
a	O
Midwestern	O
US	O
population	O
.	O

Additionally	O
,	O
among	O
women	O
with	O
low	O
initial	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(<	O
40	O
ng	O
/	O
mL	O
),	O
PTB	O
rates	O
were	O
significantly	O
lower	O
(	O
60	O
%)	O
for	O
those	O
who	O
achieved	O
≥	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
vs	O
.	O
those	O
who	O
did	O
not	O
,	O
especially	O
for	O
non	O
-	O
white	O
women	O
(	O
78	O
%).	O

All	O
categorical	O
outcomes	O
were	O
analysed	O
using	O
Pearson	O
'	O
s	O
χ²	O
or	O
Fisher	O
'	O
s	O
exact	O
tests	O
.	O

We	O
will	O
have	O
a	O
total	O
number	O
of	O
112	O
BRAC	O
PO	O
for	O
randomisation	O
.	O

[	O
2	O
]	O
There	O
are	O
increasing	O
studies	O
worldwide	O
reporting	O
poor	O
vitamin	O
D	O
status	O
,	O
including	O
those	O
in	O
tropical	O
countries	O
.	O

(	O
2015	O
)*/†	O
CaffeineMouseInjection	O
(	O
ip	O
)	O
(	O
20	O
mg	O
/	O
kg	O
)	O
In	O
utero	O
Early	O
adulthood	O
F1offspringCardiac	O
abnormalitiesDNA	O
methylationBuscariollo	O
et	O
al	O
.	O

The	O
cost	O
per	O
woman	O
treated	O
(	O
defined	O
as	O
consuming	O
at	O
least	O
75	O
%	O
of	O
the	O
recommended	O
intake	O
)	O
was	O
USD0	O
.	O
76	O
per	O
annum	O
.	O

Although	O
farm	O
children	O
are	O
exposed	O
to	O
higher	O
concentrations	O
of	O
airborne	O
allergens	O
,	O
paradoxically	B
they	O
become	O
sensitized	O
less	O
often	O
and	O
manifest	O
a	O
weaker	O
sensitization	O
response	O
than	O
non	O
-	O
farm	O
controls	O
[	O
113	O
].	O

Adequate	O
intravascular	O
volume	O
repletion	O
and	O
oxygenation	O
are	O
particularly	O
important	O
in	O
the	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
to	O
prevent	O
both	O
maternal	O
and	O
fetal	O
complications	O
.	O

Transcriptional	O
excursions	O
regarding	O
lipid	O
-,	O
energy	O
-	O
and	O
N	O
-	O
metabolism	O
During	O
postnatal	O
development	O
a	O
remarkable	O
number	O
of	O
diet	O
-	O
and	O
stage	O
-	O
dependent	O
transcriptionally	O
regulated	O
pathways	O
were	O
related	O
to	O
lipid	O
metabolism	O
,	O
including	O
'	O
fatty	O
acid	O
metabolism	O
',	O
'	O
fatty	O
acid	O
elongation	O
in	O
mitochondria	O
',	O
'	O
synthesis	O
and	O
degradation	O
of	O
ketone	O
bodies	O
',	O
'	O
bile	O
acid	O
synthesis	O
'	O
and	O
'	O
biosynthesis	O
of	O
steroids	O
'.	O

Expression	O
of	O
anorexigenic	O
POMC	O
(	O
P	O
=	O
0	O
.	O
004	O
)	O
and	O
BDNF	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
was	O
higher	O
,	O
and	O
DopaR1	O
was	O
lower	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
in	O
pups	O
fed	O
the	O
HV	O
diet	O
.	O

Evidence	O
of	O
an	O
association	O
between	O
adult	O
-	O
onset	O
glioma	O
and	O
date	O
of	O
birth	O
suggests	O
an	O
etiologic	O
role	O
for	O
a	O
seasonally	O
variable	O
environmental	O
exposure	O
occurring	O
prenatally	O
around	O
the	O
time	O
of	O
birth	O
.	O

Women	O
of	O
Indian	O
origin	O
,	O
especially	O
pregnant	O
women	O
,	O
are	O
known	O
to	O
have	O
a	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
.	O

They	O
do	O
,	O
however	O
,	O
agree	O
with	O
previously	O
published	O
studies	O
[	O
14	O
,	O
39	O
,	O
45	O
,	O
46	O
].	O

Participants	O
in	O
the	O
study	O
received	O
3	O
text	O
messages	O
per	O
week	O
throughout	O
their	O
enrollment	O
,	O
which	O
were	O
tailored	O
to	O
the	O
date	O
of	O
enrollment	O
and	O
gestational	O
age	O
.	O

Authors	O
’	O
contributions	O
All	O
authors	O
listed	O
have	O
contributed	O
sufficiently	O
to	O
the	O
project	O
to	O
be	O
included	O
as	O
authors	O
,	O
and	O
all	O
those	O
who	O
are	O
qualified	O
to	O
be	O
authors	O
are	O
listed	O
in	O
the	O
author	O
byline	O
.	O

study	O
[	O
4	O
]	O
assessed	O
the	O
non	O
-	O
linear	O
relationship	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
,	O
both	O
identifying	O
a	O
decreasing	O
risk	O
of	O
PTB	O
as	O
25	O
(	O
OH	O
)	O
D	O
increased	O
to	O
approximately	O
40	O
ng	O
/	O
mL	O
.	O
Fig	O
1shows	O
that	O
the	O
increase	O
in	O
gestational	O
age	O
at	O
birth	O
with	O
rising	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
is	O
similar	O
between	O
the	O
general	O
obstetrical	O
population	O
at	O
MUSC	O
and	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Environmentally	O
induced	O
epigenetic	O
changes	O
in	O
the	O
sperm	O
or	O
egg	O
prior	O
to	O
conception	O
could	O
,	O
therefore	O
,	O
affect	O
embryo	O
viability	O
and	O
development	O
and	O
the	O
subsequent	O
future	O
health	O
and	O
fertility	O
of	O
the	O
next	O
generation	O
.	O

*	O
Studies	O
demonstrating	O
environmentally	O
-	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
were	O
reversed	O
by	O
an	O
inhibitor	O
/	O
treatment	O
,	O
absent	O
in	O
a	O
knock	O
out	O
/	O
down	O
model	O
,	O
and	O
/	O
or	O
mechanistically	O
linked	O
in	O
a	O
relevant	O
in	O
vitro	O
system	O
.	O

Implementation	O
research	O
and	O
program	O
evaluation	O
evaluates	O
how	O
best	O
to	O
achieve	O
wide	O
scale	O
coverage	O
of	O
interventions	O
,	O
including	O
prevention	O
particularly	O
family	O
planning	O
and	O
such	O
as	O
care	O
of	O
women	O
with	O
infectious	O
diseases	O
such	O
as	O
malaria	O
,	O
HIV	O
and	O
STIs	O
;	O
improved	O
nutrition	O
;	O
smoking	O
cessation	O
;	O
and	O
reducing	O
maternal	O
workload	O
.	O

JL	O
:	O
Acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
,	O
drafting	O
of	O
article	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

More	O
frequent	O
use	O
of	O
supplements	O
during	O
pregnancy	O
was	O
found	O
to	O
be	O
associated	O
with	O
a	O
higher	O
socio	O
-	O
economic	O
status	O
,	O
higher	O
level	O
of	O
education	O
and	O
use	O
of	O
prenatal	O
medical	O
services	O
in	O
studies	O
conducted	O
in	O
Finland	O
[	O
15	O
],	O
the	O
United	O
Kingdom	O
[	O
16	O
],	O
the	O
United	O
States	O
of	O
America	O
[	O
17	O
],	O
Denmark	O
[	O
18	O
]	O
and	O
Tanzania	O
[	O
19	O
].	O

These	O
speculations	O
relate	O
two	O
studies	O
in	O
which	O
supplementation	O
of	O
a	O
single	O
large	O
dose	O
(	O
300	O
00033or	O
500	O
00023IU	O
)	O
of	O
vitamin	O
D	O
for	O
reducing	O
fractures	O
in	O
elderly	O
women	O
led	O
to	O
an	O
increase	O
in	O
fractures	O
,	O
plus	O
similar	O
discrepancies	B
in	O
prostate	O
cancer	O
research	O
with	O
vitamin	O
D	O
.	O
22Our	O
findings	O
and	O
particularly	O
the	O
slightly	O
higher	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
vitamin	O
D	O
group	O
could	O
be	O
due	O
to	O
such	O
fluctuations	O
if	B
the	O
hypothesis	O
is	O
true	O
.	O

Synthesis	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2Din	O
the	O
kidney	O
increases	O
during	O
pregnancy	O
.	O

New	O
and	O
effective	O
methods	O
for	O
monitoring	O
and	O
management	O
of	O
maternal	O
complications	O
and	O
preterm	O
labour	O
could	O
make	O
a	O
major	O
contribution	O
.	O

More	O
than	B
the	O
total	O
body	O
weight	O
,	O
the	O
distribution	O
of	O
the	O
stored	O
fat	O
is	O
of	O
importance	O
for	O
the	O
development	O
of	O
obesity	O
and	O
its	O
comorbidities	O
.	O

The	O
strengths	O
of	O
our	O
study	O
include	O
its	O
thorough	O
diet	O
data	O
design	O
and	O
large	O
sample	O
size	O
.	O

Interestingly	O
,	O
GAS5	O
and	O
GR	O
α	O
were	O
the	O
predominant	O
transcripts	O
in	O
both	O
term	O
and	O
preterm	O
placentas	O
.	O

Eligible	O
women	O
initiated	O
prenatal	O
care	O
before	O
20	O
weeks	O
gestation	O
,	O
were	O
18	O
years	O
of	O
age	O
or	O
older	O
,	O
could	O
speak	O
and	O
read	O
English	O
,	O
and	O
planned	O
to	O
carry	O
the	O
pregnancy	O
to	O
term	O
and	O
to	O
deliver	O
at	O
either	O
hospital	O
.	O

(	O
2015	O
)*/†	O
Takeda	O
et	O
al	O
.	O

Smoking	O
increased	O
the	O
risk	O
of	O
both	O
vitamin	O
D	O
deficiency	O
and	O
severe	O
vitamin	O
D	O
deficiency	O
;	O
the	O
mechanism	O
for	O
this	O
appears	O
to	O
be	O
unclear	O
[	O
50	O
].	O

(	O
2014	O
)‡	O
Yang	O
et	O
al	O
.	O

Evidence	O
suggests	O
that	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
a	O
number	O
of	O
pregnancy	O
complications	O
including	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
and	O
spontaneous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
[	O
2	O
–	O
4	O
].	O

Blood	O
pressure	O
increased	O
continually	O
from	O
3	O
to	O
6	O
months	O
of	O
age	O
in	O
both	O
groups	O
.	O

It	O
was	O
described	O
that	O
long	O
-	O
term	O
undernutrition	O
from	O
early	O
stages	O
lead	O
to	O
higher	O
gene	O
expression	O
of	O
Cnr1	O
in	O
several	O
brain	O
regions	O
of	O
the	O
leptin	O
-	O
deficient	O
obese	O
Zucker	O
rats	O
(	O
Thanos	O
et	O
al	O
.,	O
2008	O
).	O

Twice	O
as	O
many	O
women	O
exposed	O
to	O
polytherapy	O
experienced	O
hypertension	O
and	O
gestational	O
diabetes	O
comorbidities	O
.	O

As	O
the	O
level	O
of	O
insulin	O
resistance	O
varies	B
from	O
person	O
to	O
person	O
,	O
it	O
is	O
common	O
practice	O
to	O
commence	O
the	O
woman	O
on	O
small	O
doses	O
of	O
insulin	O
,	O
and	O
then	O
to	O
increase	O
the	O
doses	O
at	O
frequent	O
intervals	O
until	O
target	O
glucose	O
levels	O
are	O
attained	O
.	O

Peptide	O
mass	O
maps	O
of	O
tryptic	O
peptides	O
were	O
generated	O
by	O
matrix	O
assisted	O
laser	O
desorption	O
/	O
ionisation	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
MS	O
)	O
using	O
an	O
Applied	O
Biosystems	O
Q	O
-	O
STAR	O
Pulsar	O
with	O
MALDI	O
source	O
(	O
APAF	O
,	O
University	O
of	O
Sydney	O
).	O

Fasting	O
glucose	O
and	O
HbA1cwere	O
lowest	O
among	O
Greek	O
patients	O
with	O
type	O
2	O
diabetes	O
during	O
August	O
and	O
September	O
[	O
23	O
].	O

In	O
Belgium	O
,	O
pregnant	O
women	O
who	O
reported	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
had	O
a	O
lower	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
and	O
women	O
who	O
reported	O
using	O
sunscreen	O
lotion	O
had	O
a	O
lower	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
.	O

The	O
strength	O
of	O
this	O
study	O
lies	O
in	O
its	O
comprehensive	O
sample	O
and	O
size	O
but	O
did	O
not	O
measure	O
some	O
other	B
maternal	O
factors	O
such	O
as	O
substance	O
abuse	O
and	O
nutritional	O
influence	O
[	O
47	O
].	O

The	O
LASSO	O
regression	O
coefficients	O
tended	O
to	O
be	O
larger	O
in	O
magnitude	O
than	O
BHLM	O
with	O
wider	O
and	O
less	O
precise	O
95	O
%	O
intervals	O
,	O
which	O
we	O
expected	O
because	O
LASSO	O
does	O
not	O
use	O
shrinkage	O
that	O
borrows	O
information	O
between	O
chemicals	O
within	O
a	O
particular	O
class	O
.	O

Model	O
2	O
:	O
model	O
controlled	O
for	O
BMI	O
(	O
kg	O
/	O
m2	O
),	O
education	O
>	O
secondary	O
school	O
,	O
being	O
part	O
of	O
the	O
ROLO	O
study	O
intervention	O
group	O
,	O
early	O
-	O
pregnancy	O
energy	O
(	O
kcal	O
),	O
early	O
-	O
pregnancy	O
protein	O
(	O
g	O
),	O
early	O
-	O
pregnancy	O
fat	O
(	O
g	O
),	O
moderate	O
-	O
vigorous	O
activity	O
,	O
well	O
-	O
being	O
score	O
and	O
dietary	O
supplements	O
Post	O
-	O
hoc	O
analysis	O
-	O
exploring	O
potential	O
confounders	O
Dietary	O
intakes	O
,	O
lifestyle	O
behaviours	O
,	O
and	O
emotional	O
well	O
-	O
being	O
were	O
analysed	O
by	O
season	O
of	O
first	O
antenatal	O
visit	O
(	O
Additional	O
file1	O
:	O
Table	O
S2	O
).	O

Radiographs	O
of	O
normal	O
(	O
A	O
,	O
B	O
),	O
Skm1	O
(	O
C	O
,	O
D	O
),	O
and	O
Skm2	O
(	O
E	O
,	O
F	O
)	O
mice	O
in	O
lateral	O
and	O
supine	O
positions	O
.	O

Development	O
of	O
robust	O
,	O
fit	O
-	O
for	O
-	O
purpose	O
equipment	O
,	O
is	O
a	O
critical	O
next	O
frontier	O
for	O
referral	O
care	O
for	O
premature	O
babies	O
in	O
the	O
settings	O
where	O
most	O
die	O
,	O
especially	O
for	O
care	O
in	O
hospitals	O
[	O
6	O
].	O

Infant	O
sex	O
uses	O
female	O
sex	O
as	O
the	O
referent	O
.	O

While	O
no	O
interaction	O
effect	O
was	O
observed	O
between	O
season	O
and	O
vitamin	O
D	O
with	O
regards	O
to	O
glucose	O
homeostasis	O
,	O
it	O
is	O
well	O
recognised	O
that	O
25OHD	O
declines	O
in	O
winter	O
,	O
and	O
is	O
a	O
modifiable	O
factor	O
.	O

Skm2	O
mice	O
in	O
the	O
supine	O
(	O
E	O
)	O
and	O
lateral	O
(	O
F	O
)	O
positions	O
.	O

In	O
a	O
population	O
-	O
based	O
prospective	O
study	O
,	O
it	O
has	O
been	O
shown	O
that	O
women	O
in	O
the	O
“	O
wheat	O
products	O
”	O
pattern	O
had	O
higher	O
odds	O
of	O
having	O
infants	O
with	O
the	O
low	O
birth	O
weight	O
and	O
head	O
circumference	O
compared	O
with	O
women	O
in	O
the	O
“	O
rice	O
,	O
fish	O
,	O
and	O
vegetables	O
”	O
pattern	O
[	O
24	O
].	O

After	O
adjustment	O
for	O
potential	O
confounders	O
,	O
there	O
was	O
weak	O
evidence	O
for	O
positive	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
childhood	O
doctor	O
-	O
diagnosed	O
asthma	O
and	O
childhood	O
wheeze	O
(	O
OR	O
comparing	O
highest	O
versus	O
lowest	O
quintile	O
1	O
.	O
31	O
,	O
95	O
%	O
CI	O
0	O
.	O
98	O
–	O
1	O
.	O
75	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
09	O
and	O
1	O
.	O
42	O
,	O
95	O
%	O
CI	O
1	O
.	O
05	O
–	O
1	O
.	O
92	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
08	O
,	O
respectively	O
),	O
and	O
stronger	O
evidence	O
for	O
a	O
positive	O
association	O
with	O
atopy	O
at	O
age	O
7	O
years	O
(	O
OR	O
1	O
.	O
38	O
,	O
95	O
%	O
CI	O
1	O
.	O
06	O
–	O
1	O
.	O
78	O
;	O
per	O
quintile	O
p	O
-	O
trend	O
=	O
0	O
.	O
006	O
)	O
(	O
table	O
2	O
).	O

In	O
order	O
not	O
to	O
deprive	O
the	O
participants	O
from	O
antenatal	O
supplements	O
all	O
participating	O
mothers	O
were	O
allowed	O
to	O
use	O
prescribed	O
supplementation	O
outside	O
this	O
study	O
’	O
s	O
protocol	O
.	O

Alterations	O
in	O
maternal	O
immunity	O
,	O
particularly	O
a	O
decrease	O
in	O
cell	O
-	O
mediated	O
immunity	O
,	O
may	O
predispose	O
the	O
pregnant	O
asthmatic	O
to	O
infections	O
and	O
thus	O
to	O
acute	O
exacerbations	O
of	O
asthma	O
.	O

1	O
Flow	O
of	O
participants	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Baseline	O
characteristics	O
for	O
6	O
month	O
participantsCharacteristicLifestyle	O
advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
care	O
(	O
N	O
=	O
1065	O
)	O
Total	O
(	O
N	O
=	O
2136e	O
)	O
Maternal	O
Age	O
(	O
Years	O
)	O
a29	O
.	O
6	O
(	O
5	O
.	O
4	O
)	O
29	O
.	O
8	O
(	O
5	O
.	O
3	O
)	O
29	O
.	O
7	O
(	O
5	O
.	O
4	O
)	O
Gestational	O
Age	O
at	O
Entry	O
(	O
Weeks	O
)	O
b14	O
.	O
3	O
(	O
12	O
.	O
0	O
–	O
17	O
.	O
0	O
)	O
14	O
.	O
3	O
(	O
12	O
.	O
1	O
–	O
17	O
.	O
1	O
)	O
14	O
.	O
3	O
(	O
12	O
.	O
0	O
–	O
17	O
.	O
4	O
)	O
Body	O
Mass	O
Index	O
(	O
kg	O
/	O
m2	O
)	O
b31	O
.	O
2	O
(	O
28	O
.	O
0	O
–	O
35	O
.	O
8	O
)	O
31	O
.	O
0	O
(	O
27	O
.	O
7	O
–	O
35	O
.	O
4	O
)	O
31	O
.	O
0	O
(	O
27	O
.	O
8	O
–	O
35	O
.	O
6	O
)	O
Body	O
Mass	O
Index	O
Categoryc	O
BMI	O
25	O
.	O
0	O
–	O
29	O
.	O
9358	O
(	O
41	O
.	O
2	O
)	O
381	O
(	O
43	O
.	O
1	O
)	O
739	O
(	O
42	O
.	O
1	O
)	O
BMI	O
30	O
.	O
0	O
–	O
34	O
.	O
9226	O
(	O
30	O
.	O
2	O
)	O
256	O
(	O
28	O
.	O
9	O
)	O
518	O
(	O
29	O
.	O
5	O
)	O
BMI	O
35	O
.	O
0	O
–	O
39	O
.	O
9159	O
(	O
18	O
.	O
3	O
)	O
148	O
(	O
16	O
.	O
7	O
)	O
307	O
(	O
17	O
.	O
5	O
)	O
BMI	O
>	O
=	O
40	O
.	O
090	O
(	O
10	O
.	O
4	O
)	O
100	O
(	O
11	O
.	O
3	O
)	O
190	O
(	O
10	O
.	O
8	O
)	O
Weight	O
(	O
kg	O
)	O
a88	O
.	O
3	O
(	O
16	O
.	O
6	O
)	O
88	O
·	O
0	O
(	O
17	O
.	O
6	O
)	O
88	O
.	O
1	O
(	O
17	O
.	O
1	O
)	O
Height	O
(	O
cm	O
)	O
a164	O
.	O
9	O
(	O
6	O
.	O
4	O
)	O
164	O
·	O
7	O
(	O
6	O
.	O
5	O
)	O
164	O
.	O
8	O
(	O
6	O
.	O
5	O
)	O
Racec	O
Caucasian790	O
(	O
90	O
.	O
9	O
)	O
802	O
(	O
90	O
.	O
6	O
)	O
1592	O
(	O
90	O
.	O
8	O
)	O
Asian19	O
(	O
2	O
.	O
2	O
)	O
31	O
(	O
3	O
.	O
5	O
)	O
50	O
(	O
2	O
.	O
9	O
)	O
Indian35	O
(	O
4	O
.	O
0	O
)	O
30	O
(	O
3	O
.	O
4	O
)	O
65	O
(	O
3	O
.	O
7	O
)	O
Other25	O
(	O
2	O
.	O
9	O
)	O
22	O
(	O
2	O
.	O
5	O
)	O
47	O
(	O
2	O
.	O
7	O
)	O
Smokerc98	O
(	O
11	O
.	O
3	O
)	O
91	O
(	O
10	O
.	O
3	O
)	O
189	O
(	O
10	O
.	O
8	O
)	O
Nulliparousc359	O
(	O
41	O
.	O
3	O
)	O
353	O
(	O
39	O
.	O
9	O
)	O
712	O
(	O
40	O
.	O
6	O
)	O
Index	O
of	O
Socio	O
-	O
economic	O
Disadvantaged	O
Unknown1	O
(	O
0	O
.	O
1	O
)	O
1	O
(	O
0	O
.	O
1	O
)	O
2	O
(	O
0	O
.	O
1	O
)	O
Quintile	O
1	O
(	O
Most	O
Disadvantaged	O
)	O
256	O
(	O
29	O
.	O
5	O
)	O
251	O
(	O
28	O
.	O
4	O
)	O
507	O
(	O
28	O
.	O
9	O
)	O
Quintile	O
2214	O
(	O
24	O
.	O
6	O
)	O
222	O
(	O
25	O
.	O
1	O
)	O
436	O
(	O
24	O
.	O
9	O
)	O
Quintile	O
3139	O
(	O
16	O
.	O
0	O
)	O
134	O
(	O
15	O
.	O
1	O
)	O
273	O
(	O
15	O
.	O
6	O
)	O
Quintile	O
4122	O
(	O
14	O
.	O
0	O
)	O
141	O
(	O
15	O
.	O
9	O
)	O
263	O
(	O
15	O
.	O
0	O
)	O
Quintile	O
5	O
(	O
Least	O
Disadvantaged	O
)	O
137	O
(	O
15	O
.	O
7	O
)	O
136	O
(	O
15	O
.	O
4	O
)	O
273	O
(	O
15	O
.	O
6	O
)	O
amean	O
and	O
standard	O
deviation	O
bmedian	O
and	O
interquartile	O
range	O
cnumber	O
and	O
%	O
dSocioeconomic	O
index	O
as	O
measured	O
by	O
SEIFA	O
IRSD	O
eIncludes	O
all	O
women	O
whose	O
infants	O
were	O
eligible	O
for	O
the	O
6	O
month	O
follow	O
-	O
up	O
study	O
There	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infants	O
born	O
to	O
women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
,	O
as	O
compared	O
with	O
those	O
born	O
to	O
women	O
in	O
the	O
Standard	O
Care	O
group	O
(	O
Lifestyle	O
Advice	O
233	O
(	O
21	O
.	O
71	O
%)	O
vs	O
.	O
Standard	O
Care	O
233	O
(	O
21	O
.	O
90	O
%);	O
adjusted	O
relative	O
risk	O
aRR	O
0	O
.	O
99	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
0	O
.	O
82	O
to	O
1	O
.	O
18	O
;	O
p	O
=	O
0	O
.	O
88	O
),	O
or	O
in	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
85th	O
centile	O
(	O
Lifestyle	O
Advice	O
299	O
(	O
27	O
.	O
88	O
%)	O
vs	O
.	O
Standard	O
Care	O
303	O
(	O
28	O
.	O
48	O
%);	O
aRR	O
0	O
.	O
97	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
0	O
.	O
84	O
to	O
1	O
.	O
13	O
;	O
p	O
=	O
0	O
.	O
71	O
)	O
(	O
Table	O
2	O
).	O

Conversely	B
,	O
high	O
vitamin	O
D	O
status	O
and	O
carrying	O
a	O
female	O
fetus	O
was	O
not	O
associated	O
with	O
changing	O
the	O
risk	O
of	O
having	O
any	O
pregnancy	O
complication	O
.	O

Many	O
interventions	O
have	O
been	O
evaluated	O
,	O
and	O
some	O
have	O
been	O
identified	O
as	O
beneficial	O
though	B
limited	O
in	O
public	O
health	O
impact	O
,	O
such	O
as	O
therapy	O
with	O
progestational	O
agents	O
,	O
which	O
have	O
only	O
been	O
studied	O
in	O
certain	O
high	O
-	O
risk	O
populations	O
.	O

Abstract	O
:	O
TEASER	O
Associations	O
between	O
SNPs	O
in	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
and	O
25	O
(	O
OH	O
)	O
D	O
were	O
assessed	O
before	O
and	O
after	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O

The	O
human	O
endometrial	O
decidua	O
makes	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
and	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
and	O
the	O
placenta	O
synthesizes	O
only	O
24	O
,	O
25	O
(	O
OH	O
)	O
2D	O
.	O

The	O
changes	O
in	O
gene	O
expression	O
were	O
not	O
persistent	O
in	O
terms	O
of	O
consistent	O
differential	O
expression	O
of	O
genes	O
at	O
all	O
stages	O
.	O

These	O
data	O
will	O
supply	O
information	O
on	O
the	O
nutritional	O
status	O
of	O
women	O
early	O
in	O
their	O
pregnancy	O
.	O

There	O
was	O
no	O
evidence	O
of	O
rickets	O
both	O
clinically	O
and	O
radiologically	O
.	O

This	O
leaves	O
the	O
important	O
question	O
of	O
exact	O
dosage	O
and	O
timing	O
of	O
delivery	O
requirements	O
for	O
future	O
studies	O
.	O

Associations	O
between	O
SNPs	O
and	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
from	O
14	O
to	O
34	O
weeks	O
of	O
gestation	O
following	O
supplementation	O
with	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
.	O

3	O
.	O
4	O
.	O

2007	O
;	O
Zhou	O
et	O
al	O
.	O

However	O
,	O
there	O
was	O
a	O
significant	O
increase	O
in	O
BM	O
in	O
both	O
generations	O
of	O
VitD	O
-	O
offspring	O
at	O
six	O
months	O
of	O
age	O
,	O
but	O
the	O
BM	O
was	O
higher	O
only	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
group	O
at	O
weaning	O
.	O

Programmatic	O
costs	O
included	O
cost	O
of	O
supplements	O
,	O
which	O
were	O
originally	O
distributed	O
in	O
tamper	O
-	O
proof	O
bottles	O
(	O
UNICEF	O
,	O
Copenhagen	O
),	O
and	O
after	O
12	O
months	O
sourced	O
domestically	O
in	O
blister	O
packs	O
consisting	O
of	O
6	O
tear	O
-	O
off	O
strips	O
of	O
5	O
tablets	O
,	O
each	O
strip	O
enough	O
for	O
one	O
month	O
(	O
Nam	O
Ha	O
Pharmaceutical	O
Company	O
,	O
Nam	O
Dinh	O
,	O
Vietnam	O
).	O

c	O
Linear	O
model	O
associations	O
between	O
maternal	O
aMED	O
score	O
and	O
relative	O
abundance	O
of	O
infant	O
stool	O
OTUs	O
.	O

However	B
,	O
due	O
to	O
the	O
lack	O
of	O
sufficient	O
information	O
about	O
the	O
physiologic	O
role	O
of	O
visfatin	O
in	O
adults	O
,	O
its	O
source	O
and	O
regulation	O
mechanism	O
in	O
fetal	O
and	O
neonatal	O
stages	O
cannot	O
be	O
argued	O
absolutely	O
.	O

Results	O
:	O
Only	O
rs12785878	O
(	O
DHCR7	O
)	O
was	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
[	O
β	O
=	O
3	O
.	O
1	O
nmol	O
/	O
L	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
),	O
1	O
.	O
0	O
to	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
<	O
0	O
.	O
004	O
].	O

There	O
is	O
evidence	O
that	O
angiotensin	O
II	O
inhibits	O
parasympathetic	O
modulation	O
[	O
51	O
].	O

Clients	O
with	O
a	O
high	O
educational	O
level	O
,	O
were	O
less	O
satisfied	O
with	O
the	O
health	O
talks	O
.	O

Larger	O
observational	O
studies	O
are	O
required	O
to	O
establish	O
a	O
true	O
link	O
between	O
the	O
use	O
of	O
SSRIs	O
and	O
autism	O
.	O

Moreover	O
,	O
40	O
subjects	O
with	O
samples	O
from	O
two	O
subsequent	O
years	O
showed	O
a	O
highly	O
significant	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
increase	O
in	O
cathelicidin	O
concentration	O
from	O
visit	O
one	O
to	O
visit	O
two	O
.	O

The	O
animal	O
studies	O
performed	O
by	O
Roullet	O
have	O
been	O
used	O
as	O
a	O
model	O
to	O
ameliorate	O
and	O
improve	O
upon	O
studies	O
that	O
focus	O
on	O
the	O
association	O
between	O
the	O
risk	O
of	O
autism	O
and	O
the	O
maternal	O
need	O
for	O
anticonvulsants	O
[	O
5	O
].	O

In	O
addition	O
,	O
10	O
%	O
of	O
the	O
questionnaires	O
were	O
doubled	O
-	O
checked	O
by	O
a	O
co	O
-	O
investigator	O
,	O
different	O
from	O
the	O
original	O
data	O
entry	O
person	O
.	O

However	O
,	O
as	O
these	O
different	O
cells	O
are	O
often	O
mixed	O
,	O
such	O
as	O
occurs	O
for	O
classical	O
and	O
“	O
brite	O
”	O
adipocytes	O
in	O
some	O
human	O
depots	O
(	O
Wu	O
et	O
al	O
.,	O
2012	O
;	O
Cypess	O
et	O
al	O
.,	O
2013	O
;	O
Jespersen	O
et	O
al	O
.,	O
2013	O
),	O
only	O
the	O
use	O
of	O
specific	O
cell	O
surface	O
markers	O
(	O
i	O
.	O
e	O
.,	O
ASC	O
-	O
1	O
,	O
PAT2	O
,	O
and	O
P2RX5	O
for	O
white	O
,	O
“	O
brite	O
”	O
and	O
brown	O
adipocytes	O
,	O
respectively	O
)	O
will	O
allow	O
for	O
their	O
identification	O
,	O
as	O
well	O
as	O
for	O
the	O
precise	O
understanding	O
of	O
their	O
respective	O
therapeutic	O
properties	O
(	O
Ussar	O
et	O
al	O
.,	O
2014	O
).	O

Based	O
on	O
an	O
extensive	O
review	O
of	O
the	O
literature	O
,	O
we	O
considered	O
this	O
hypothesis	O
for	O
the	O
3	O
nutritional	O
progressions	O
from	O
fetal	O
life	O
through	O
infancy	O
:	O
prenatal	O
nutrition	O
,	O
breastfeeding	O
and	O
introduction	O
of	O
solid	O
foods	O
.	O

Progesterone	O
Measures	O
Circulating	O
progesterone	O
concentrations	O
were	O
measured	O
in	O
adult	O
female	O
offspring	O
in	O
the	O
proestrous	O
stage	O
.	O

Finally	O
,	O
humans	O
are	O
continuously	O
exposed	O
to	O
a	O
mixture	O
of	O
different	O
environmental	O
factors	O
.	O

Abbreviations	O
25	O
(	O
OH	O
)	O
D	O
:	O
25	O
-	O
hydroxyvitamin	O
D	O
;	O
BMC	O
:	O
Bone	O
Mineral	O
Content	O
;	O
BMD	O
:	O
Bone	O
Mineral	O
Density	O
;	O
DXA	O
:	O
dual	O
-	O
energy	O
x	O
-	O
ray	O
absorptiometry	O
.	O

Finding	O
about	O
neonatal	O
weight	O
showed	O
that	O
those	O
in	O
the	O
top	O
quartile	O
of	O
adherence	O
to	O
western	O
dietary	O
pattern	O
had	O
marginally	O
significant	O
chance	O
of	O
having	O
low	O
weight	O
infant	O
compared	O
with	O
those	O
in	O
the	O
bottom	O
quartile	O
in	O
the	O
crude	O
model	O
[	O
OR	O
1	O
.	O
84	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
94	O
-	O
3	O
.	O
60	O
),	O
P	O
=	O
0	O
.	O
05	O
].	O

Slaughter	O
weight	O
IMF	O
content	O
or	O
MS	O
generally	O
increases	O
with	O
slaughter	O
weight	O
in	O
several	O
cattle	O
breeds	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
.	O

Survival	O
analysis	O
could	O
therefore	O
not	O
be	O
performed	O
,	O
as	O
time	O
to	O
event	O
data	O
were	O
missing	O
.	O

All	O
statistical	O
analyses	O
were	O
performed	O
using	O
the	O
R	O
statistical	O
package	O
(	O
version	O
2	O
.	O
10	O
;	O
http	O
://	O
www	O
.	O
r	O
-	O
project	O
.	O
org	O
),	O
and	O
the	O
R	O
function	O
was	O
made	O
available	O
on	O
the	O
GSEA	O
website	O
,	O
using	O
permutation	O
tests	O
as	O
described	O
bySubramanian	O
et	O
al	O
.	O

also	O
found	O
similar	O
reductions	O
in	O
PTB	O
risk	O
for	O
spontaneous	O
and	O
medically	O
indicated	O
PTBs	O
[	O
4	O
].	O

Although	B
earlier	O
studies	O
have	O
mostly	O
examined	O
the	O
effects	O
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
,	O
there	O
are	O
few	O
studies	O
regarding	O
the	O
association	O
of	O
dietary	O
patterns	O
and	O
mentioned	O
measurements	O
.	O

The	O
program	O
addresses	O
a	O
wide	B
range	I
of	O
health	O
topics	O
,	O
as	O
compared	B
to	I
other	O
studies	O
that	O
focused	O
on	O
1	O
or	O
a	O
few	O
closely	O
related	O
health	O
behaviors	O
.	O

Thus	O
the	O
experimental	O
data	O
will	O
complement	O
previous	O
findings	O
from	O
rodent	O
models	O
and	O
epidemiological	O
human	O
data	O
.	O

This	O
process	O
is	O
active	O
and	O
specific	O
,	O
much	O
like	O
the	O
process	O
of	O
sensitization	O
[	O
119	O
].	O

Three	O
factors	O
were	O
considered	O
major	O
dietary	O
patterns	O
.	O

According	O
to	O
the	O
recent	O
studies	O
[	O
47	O
],	O
we	O
can	O
suggest	O
that	O
it	O
was	O
not	O
a	O
result	O
of	O
direct	O
VD	O
action	O
,	O
but	O
its	O
role	O
in	O
ion	O
homeostasis	O
[	O
51	O
].	O

Topical	O
corticosteroid	O
treatment	O
should	O
be	O
initiated	O
when	O
clinically	O
indicated	O
,	O
with	O
the	O
least	O
potent	O
preparations	O
such	O
as	O
hydrocortisone	O
(	O
0	O
.	O
5	O
%	O
to	O
1	O
%),	O
reserving	O
more	O
potent	O
preparations	O
for	O
more	O
recalcitrant	O
areas	O
in	O
selected	O
patients	O
.	O

However	B
,	O
recent	O
studies	O
have	O
proposed	O
the	O
presence	O
of	O
a	O
relationship	O
between	O
maternal	O
serum	O
visfatin	O
level	O
and	O
fetal	O
growth	O
.	O

ADP	O
,	O
ON	O
,	O
LM	O
,	O
and	O
MG	O
contributed	O
to	O
the	O
study	O
conceptualization	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
and	O
writing	O
of	O
article	O
.	O

We	O
also	O
found	O
that	O
33	O
%	O
of	O
children	O
have	O
excess	O
weight	O
and	O
16	O
%	O
of	O
them	O
were	O
already	O
obese	O
.	O

Maternal	O
fatigue	O
is	O
assessed	O
at	O
the	O
same	O
time	O
points	O
using	O
the	O
Multidimensional	O
Assessment	O
of	O
Fatigue	O
(	O
MAF	O
)	O
scale	O
,	O
which	O
was	O
shown	O
to	O
be	O
a	O
reliable	O
and	O
valid	O
measure	O
of	O
fatigue	O
in	O
pregnant	O
and	O
postpartum	O
women	O
[	O
53	O
].	O

Further	O
study	O
is	O
needed	O
to	O
clarify	O
the	O
effects	O
of	O
dietary	O
vitamin	O
D	O
on	O
MS	O
and	O
QG	O
in	O
beef	O
cattle	O
.	O

In	O
normal	O
weight	O
mothers	O
,	O
higher	O
intake	O
of	O
soft	O
drinks	O
was	O
the	O
strongest	O
predictor	O
of	O
higher	O
offspring	O
weight	O
status	O
at	O
birth	O
but	O
was	O
not	O
a	O
significant	O
predictor	O
of	O
weight	O
at	O
6	O
months	O
.	O

The	O
program	O
is	O
branded	O
as	O
a	O
“	O
trusted	O
friend	O
and	O
advisor	O
”	O
and	O
promotes	O
a	O
broad	O
range	O
of	O
maternal	O
and	O
child	O
health	O
behaviors	O
[	O
30	O
].	O

We	O
found	O
no	O
significant	O
association	O
either	O
between	O
maternal	O
western	O
dietary	O
pattern	O
and	O
head	O
circumference	O
of	O
infant	O
or	O
between	O
healthy	O
or	O
traditional	O
dietary	O
pattern	O
and	O
mentioned	O
measure	O
.	O

Descriptive	O
analysis	O
will	O
be	O
performed	O
to	O
present	O
the	O
cause	O
of	O
death	O
.	O

Therefore	O
,	O
expression	O
profiles	O
at	O
weaning	O
and	O
adult	O
stages	O
point	O
to	O
an	O
alarm	O
alert	O
(	O
activated	O
defence	O
)	O
in	O
LP	O
offspring	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1472	O
-	O
6874	O
/	O
10	O
/	O
17	O
/	O
prepub	O
PubMed	O
Central	O
:	O

In	O
addition	O
to	O
associations	O
with	O
25	O
(	O
OH	O
)	O
D	O
,	O
rs2282679	O
in	O
GC	O
has	O
also	O
been	O
associated	O
with	O
serum	O
VDP	O
concentrations	O
,	O
with	O
carriers	O
of	O
the	O
low	O
-	O
frequency	O
C	O
allele	O
having	O
reduced	O
concentrations	O
of	O
VDP	O
and	O
25	O
(	O
OH	O
)	O
D	O
(	O
8	O
).	O

Details	O
of	O
assay	O
performance	O
and	O
quality	O
control	O
through	O
participation	O
in	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
,	O
National	O
Institute	O
of	O
Standards	O
and	O
Technology	O
,	O
and	O
UK	O
National	O
External	O
Quality	O
Assessment	O
Service	O
are	O
given	O
elsewhere	O
(	O
15	O
,	O
16	O
).	O

Access	O
to	O
data	O
All	O
collected	O
data	O
will	O
be	O
accessible	O
by	O
the	O
study	O
investigators	O
.	O

The	O
animal	O
experiment	O
was	O
performed	O
as	O
described	O
[	O
15	O
].	O

Blood	O
samples	O
were	O
briefly	O
collected	O
into	O
tubes	O
containing	O
EDTA	O
(	O
6	O
%)	O
and	O
centrifuged	O
(	O
1500	O
g	O
for	O
10	O
min	O
at	O
4	O
°	O
C	O
).	O

Results	O
Sample	O
Demographics	O
The	O
mean	O
age	O
of	O
respondents	O
(	O
N	O
=	O
123	O
)	O
was	O
26	O
.	O
3	O
years	O
(	O
SD	O
5	O
.	O
9	O
).	O

Their	O
studies	O
suggest	O
that	O
the	O
abnormal	O
growth	O
in	O
children	O
with	O
autism	O
spectrum	O
disorders	O
may	O
be	O
related	O
to	O
the	O
causal	O
factors	O
that	O
also	O
increase	O
the	O
risk	O
for	O
ASD	O
,	O
as	O
it	O
was	O
found	O
that	O
children	O
with	O
ASD	O
had	O
proportionally	O
smaller	O
head	O
circumference	O
compared	O
to	O
height	O
during	O
their	O
first	O
year	O
of	O
life	O
,	O
which	O
was	O
absent	O
in	O
premature	O
/	O
low	O
birth	O
weight	O
children	O
with	O
ASD	O
.	O

The	O
average	O
intake	O
of	O
food	O
items	O
from	O
the	O
FFQ	O
were	O
converted	O
into	O
average	O
intake	O
of	O
energy	O
and	O
nutrients	O
by	O
linkage	O
to	O
the	O
database	O
of	O
nutrients	O
created	O
by	O
the	O
Swedish	O
National	O
Food	O
Administration	O
[	O
27	O
].	O

However	B
these	O
socio	O
-	O
demographic	O
factors	O
were	O
not	O
independent	O
determinants	O
of	O
the	O
use	O
of	O
iron	O
supplements	O
.	O

Genes	O
participating	O
in	O
'	O
AMPK	O
signaling	O
'	O
and	O
'	O
fatty	O
acid	O
metabolism	O
'	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
while	O
genes	O
associated	O
with	O
'	O
mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinase	O
'	O
and	O
'	O
VEGF	O
signaling	O
'	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
AP	O
offspring	O
.	O

A	O
study	O
of	O
266	O
cases	O
and	O
matched	O
controls	O
among	O
Navajo	O
births	O
over	O
18	O
years	O
suggested	O
that	O
children	O
of	O
women	O
who	O
lived	O
near	O
abandoned	O
uranium	O
sites	O
were	O
1	O
.	O
83	O
times	O
more	O
likely	O
to	O
have	O
1	O
of	O
33	O
selected	O
defects	O
.	O

Groups	O
The	O
exogenous	O
Vitamin	O
D	O
came	O
from	O
Vitamin	O
D	O
supplement	O
or	O
Vitamin	O
D	O
rich	O
food	O
.	O

This	O
creates	O
a	O
hat	O
trick	O
of	O
DNA	O
damage	O
:	O
Uranium	O
’	O
s	O
radioactive42and	O
chemical43properties	O
both	O
can	O
harm	O
DNA	O
,	O
and	O
the	O
presence	O
of	O
arsenic	O
may	O
prevent	O
cells	O
from	O
repairing	O
the	O
damage	O
.	O

All	O
sows	O
were	O
fed	O
AP	O
lactation	O
diets	O
.	O

Conclusion	O
Our	O
findings	O
raise	O
a	O
possibility	O
that	O
adult	O
women	O
with	O
a	O
high	O
intake	O
of	O
fish	O
,	O
omega	O
-	O
3	O
or	O
omega	O
-	O
6	O
PUFA	O
and	O
vitamin	O
D	O
have	O
a	O
lower	O
rate	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Our	O
case	O
report	O
highlights	O
the	O
early	O
,	O
successful	O
diagnosis	O
and	O
surgical	O
repair	O
of	O
a	O
healthy	O
41	O
-	O
year	O
-	O
old	O
female	O
who	O
presented	O
with	O
an	O
acute	O
type	O
A	O
aortic	O
dissection	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Multianalyte	O
profiling	O
was	O
performed	O
on	O
the	O
Luminex	O
Magpix	O
system	O
(	O
Luminex	O
Corporation	O
Austin	O
,	O
USA	O
).	O

The	O
future	O
of	O
mHealth	O
will	O
include	O
going	O
beyond	O
small	O
-	O
scale	O
pilots	O
and	O
trials	O
and	O
reaching	O
population	O
-	O
level	O
effects	O
through	O
large	O
-	O
scale	O
implementation	O
.	O

Prior	O
to	O
cortisol	O
treatment	O
,	O
both	O
cell	O
lines	O
were	O
maintained	O
for	O
3	O
hours	O
in	O
phenol	O
red	O
-	O
free	O
media	O
containing	O
charcoal	O
stripped	O
FBS	O
.	O

These	O
data	O
were	O
processed	O
in	O
a	O
specific	O
previous	O
routine	O
designed	O
in	O
MatLab	O
(	O
Math	O
Works	O
,	O
6	O
.	O
0	O
version	O
,	O
USA	O
)	O
for	O
the	O
automatic	O
selection	O
of	O
5	O
minutes	O
RR	O
with	O
the	O
smallest	O
variance	O
[	O
29	O
].	O

Over	O
three	O
-	O
quarters	O
of	O
premature	O
babies	O
who	O
die	O
could	O
be	O
saved	O
if	O
basic	O
care	O
reached	O
them	O
and	O
their	O
mothers	O
.	O

Discussion	O
Ensuring	O
adequate	O
nutrition	O
during	O
pregnancy	O
is	O
one	O
of	O
the	O
key	O
actions	O
endorsed	O
by	O
the	O
South	O
African	O
Government	O
to	O
promote	O
optimal	O
early	O
childhood	O
development	O
in	O
an	O
effort	O
to	O
eradicate	O
poverty	O
.	O

This	O
can	O
include	O
pain	O
,	O
disturbed	O
sleep	O
and	O
behavioural	O
changes	O
[	O
6	O
-	O
8	O
].	O

[	O
8	O
]	O
The	O
active	O
form	O
of	O
vitamin	O
D	O
(	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
,	O
1	O
,	O
25	O
[	O
OH	O
]	O
2D3	O
)	O
has	O
well	O
-	O
established	O
effects	O
on	O
bone	O
metabolism	O
and	O
mineral	O
homeostasis	O
.	O

5	O
).	O

The	O
results	O
are	O
given	O
in	O
Additional	O
file1	O
:	O
Figure	O
S4	O
.	O

Stata	O
Statistical	O
Software	O
:	O
Release	O
12	O
.	O

Pregnancy	O
weight	O
gain	O
was	O
calculated	O
as	O
the	O
difference	O
between	O
the	O
weights	O
at	O
commencing	O
the	O
study	O
medication	O
and	O
at	O
34	O
weeks	O
of	O
gestation	O
.	O

Any	O
needed	O
dosing	O
adjustments	O
were	O
made	O
based	O
on	O
follow	O
-	O
up	O
testing	O
.	O

They	O
suggest	O
that	O
VD	O
changes	O
AMH	O
production	O
patterns	O
in	O
ovarian	O
granulose	O
cells	O
and	O
alters	O
follicle	O
stimulating	O
hormone	O
(	O
FHS	O
)	O
sensitivity	O
,	O
possibly	O
playing	O
a	O
role	O
in	O
ovarian	O
follicle	O
development	O
.	O

Mean	O
±	O
SD	O
SEI	O
of	O
the	O
Auckland	O
women	O
was	O
also	O
higher	O
compared	O
to	O
that	O
in	O
women	O
recruited	O
in	O
Adelaide	O
(	O
Auckland	O
:	O
48	O
.	O
0	O
±	O
14	O
.	O
8	O
vs	O
.	O
Adelaide	O
:	O
27	O
.	O
7	O
±	O
10	O
.	O
5	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

These	O
surveys	O
were	O
conducted	O
at	O
3	O
and	O
12	O
months	O
post	O
-	O
implementation	O
[	O
15	O
].	O

Smoking	O
during	O
pregnancy	O
was	O
rare	O
at	O
4	O
.	O
8	O
%,	O
and	O
the	O
population	O
was	O
slightly	O
overweight	O
with	O
an	O
average	O
pre	O
-	O
pregnancy	O
BMI	O
of	O
25	O
.	O
6	O
.	O

The	O
OR	O
was	O
2	O
.	O
2	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
88	O
,	O
5	O
.	O
4	O
)	O
for	O
black	O
neonates	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
25	O
to	O
50	O
nmol	O
l	O
−	O
1compared	O
with	O
⩾	O
50	O
nmol	O
l	O
−	O
1	O
.	O

For	O
the	O
Bcl	O
I	O
,	O
the	O
following	O
primers	O
were	O
used	O
:	O
5	O
′-	O
AAGCTTAACAATGGCCAT	O
-	O
3	O
′	O
and	O
5	O
′-	O
TGCTGCCTTATTTGTAAATTCGT	O
-	O
3	O
′.	O

Therefore	O
,	O
thyroxine	O
therapy	O
aims	O
at	O
suppressing	O
pituitary	O
secretion	O
of	O
TSH	O
,	O
as	O
indicated	O
by	O
serum	O
TSH	O
levels	O
below	O
0	O
.	O
05	O
mIU	O
/	O
L	O
.	O

The	O
castration	O
rate	O
of	O
bulls	O
has	O
been	O
increasing	O
in	O
Korea	O
in	O
the	O
21st	O
century	O
,	O
and	O
it	O
was	O
about	O
95	O
%	O
in	O
2013	O
[	O
59	O
].	O

Data	O
relating	O
to	O
pre	O
-	O
pregnancy	O
lifestyle	O
behaviours	O
were	O
not	O
collected	O
.	O

Statistical	O
analyses	O
were	O
performed	O
using	O
the	O
R	O
software	O
(	O
www	O
.	O
r	O
-	O
project	O
.	O
org	O
).	O

These	O
findings	O
preserved	O
even	O
after	O
adjusting	O
for	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
.	O

Regarding	O
the	O
time	O
exposure	O
to	O
diet	O
,	O
Palou	O
et	O
al	O
.	O

The	O
majority	O
of	O
S	O
-	O
ECC	O
children	O
came	O
from	O
lower	O
-	O
income	O
households	O
.	O

It	O
is	O
also	O
indicated	O
in	O
pregnant	O
women	O
whose	O
hemoglobin	O
level	O
is	O
required	O
to	O
be	O
restored	O
rapidly	O
such	O
as	O
those	O
who	O
present	O
too	O
close	O
to	O
term	O
and	O
those	O
who	O
have	O
severe	O
anemia	O
[	O
40	O
].	O

Maternal	O
diet	O
was	O
assessed	O
by	O
self	O
-	O
report	O
between	O
24	O
and	O
28	O
weeks	O
of	O
gestation	O
,	O
and	O
it	O
is	O
possible	O
that	O
dietary	O
patterns	O
change	O
near	O
the	O
end	O
of	O
pregnancy	O
or	O
during	O
lactation	O
.	O

Other	O
work	O
has	O
shown	O
that	O
generational	O
acculturation	O
was	O
positively	O
associated	O
with	O
excessive	O
GWG	O
[	O
10	O
].	O

Tissue	O
-	O
specific	O
FGF21	O
regulation	O
was	O
shown	O
to	O
occur	O
in	O
response	O
to	O
chronic	O
cold	O
exposure	O
in	O
mice	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

Information	O
obtained	O
included	O
the	O
infant	O
’	O
s	O
length	O
,	O
weight	O
,	O
weight	O
-	O
for	O
-	O
length	O
,	O
and	O
anthropometric	O
measurements	O
(	O
arm	O
,	O
thigh	O
,	O
waist	O
and	O
hip	O
circumferences	O
;	O
biceps	O
,	O
triceps	O
,	O
sub	O
-	O
scapular	O
,	O
abdominal	O
,	O
supra	O
-	O
iliac	O
and	O
thigh	O
skin	O
-	O
fold	O
thickness	O
).	O

Higher	O
VDR	O
/	O
RXR	O
binding	O
may	O
decrease	O
formation	O
of	O
the	O
PPARG	O
/	O
RXR	O
heterodimer	O
,	O
thus	O
inhibiting	O
adipogenesis	O
(	O
Figure	O
4	O
).	O

A	O
seasonal	O
peak	O
evident	O
in	O
the	O
general	O
population	O
may	O
not	O
behave	O
uniformly	O
within	O
certain	O
subpopulations	O
.	O

Pollutants	O
,	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
,	O
artificial	O
insemination	O
,	O
and	O
fertility	O
medications	O
may	O
have	O
a	O
link	O
,	O
but	O
results	O
are	O
often	O
conflicted	B
.	O

Low	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
more	O
prevalent	O
in	O
individuals	O
with	O
female	O
gender	O
,	O
younger	O
age	O
and	O
urban	O
versus	O
rural	O
residence	O
in	O
Thailand	O
.	O

Papillary	O
thyroid	O
cancer	O
is	O
the	O
most	O
common	O
histological	O
type	O
detected	O
in	O
pregnant	O
women	O
,	O
and	O
in	O
most	O
series	O
90	O
%	O
to	O
95	O
%	O
of	O
thyroid	O
carcinoma	O
diagnosed	O
are	O
Stage	O
I	O
disease	O
,	O
with	O
the	O
majority	O
found	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
during	O
the	O
first	O
antenatal	O
visit	O
.	O

It	O
has	O
been	O
suggested	O
that	O
vitamin	O
D	O
might	O
be	O
used	O
in	O
the	O
treatment	O
of	O
opportunistic	O
and	O
antibiotic	O
-	O
resistant	O
infections	O
.	O

In	O
unadjusted	O
analysis	O
,	O
T1	O
25OHD	O
was	O
associated	O
with	O
IUFD	O
and	O
women	O
with	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
at	O
T1	O
had	O
more	O
than	O
fourfold	O
higher	O
odds	O
of	O
IUFD	O
(	O
OR	O
=	O
4	O
.	O
52	O
,	O
p	O
=	O
0	O
.	O
034	O
).	O

It	O
has	O
been	O
suggested	O
that	O
foods	O
containing	O
allergy	O
-	O
provoking	O
proteins	O
such	O
as	O
milk	O
,	O
egg	O
,	O
peanuts	O
,	O
tree	O
nuts	O
,	O
fish	O
,	O
and	O
seafood	O
should	O
not	O
be	O
introduced	O
into	O
the	O
diet	O
of	O
the	O
child	O
before	O
the	O
age	O
of	O
6	O
months	O
to	O
3	O
years	O
[	O
117	O
].	O

In	O
the	O
study	O
,	O
the	O
majority	O
of	O
infants	O
with	O
transient	O
early	O
wheezing	O
had	O
diminished	O
airway	O
function	O
in	O
early	O
life	O
.	O

Early	O
identification	O
of	O
pregnancy	O
In	O
the	O
intervention	O
clusters	O
,	O
trained	O
SS	O
will	O
identify	O
pregnant	O
women	O
through	O
systematic	O
door	O
-	O
to	O
-	O
door	O
visits	O
of	O
the	O
households	O
in	O
her	O
catchment	O
area	O
and	O
follow	O
-	O
up	O
with	O
all	O
women	O
of	O
reproductive	O
age	O
about	O
their	O
recent	O
history	O
of	O
missed	O
menstrual	O
periods	O
.	O

After	O
physiological	O
fluctuations	O
in	O
childhood	O
,	O
AMH	O
is	O
stabilized	O
at	O
the	O
age	O
of	O
eight	O
and	O
later	O
begins	O
to	O
decrease	O
from	O
about	O
the	O
25th	O
year	O
of	O
life	O
up	O
to	O
the	O
beginning	O
of	O
menopause	O
[	O
42	O
].	O

The	O
first	O
sign	O
is	O
a	O
rise	O
in	O
the	O
ratio	O
of	O
calcium	O
to	O
creatinine	O
in	O
the	O
urine	O
,	O
which	O
precedes	O
hypercalcemia	O
.	O

Wistar	O
rats	O
(	O
age	O
100	O
±	O
5	O
days	O
)	O
were	O
time	O
mated	O
using	O
a	O
rat	O
estrous	O
cycle	O
monitor	O
to	O
assess	O
the	O
stage	O
of	O
estrous	O
before	O
introducing	O
the	O
male	O
.	O

Abstract	O
:	O
SHORT	O
Higher	O
maternal	O
intake	O
of	O
sugar	O
in	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
allergy	O
and	O
allergic	O
asthma	O
in	O
the	O
offspring	O
http	O
://	O
ow	O
.	O
ly	O
/	O
zehc30bFswP	O
Introduction	O
There	O
has	O
been	O
considerable	O
interest	O
in	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
in	O
the	O
aetiology	O
of	O
childhood	O
asthma	O
and	O
atopy	O
[	O
1	O
].	O

At	O
middle	O
or	O
late	O
term	O
of	O
pregnancy	O
;	O
3	O
).	O

Heat	O
stress	O
can	O
also	O
negatively	O
affect	O
animal	O
performance	O
,	O
including	O
growth	O
,	O
milk	O
production	O
,	O
reproduction	O
,	O
feed	O
intake	O
,	O
overall	O
health	O
,	O
and	O
well	O
-	O
being	O
in	O
cattle	O
[	O
79	O
,	O
80	O
].	O

In	O
addition	O
,	O
participating	O
women	O
were	O
surveyed	O
to	O
assess	O
their	O
estimate	O
of	O
costs	O
involved	O
in	O
accessing	O
the	O
supplements	O
.	O

Management	O
of	O
these	O
patients	O
and	O
providing	O
evidencebased	O
advice	O
are	O
obviously	B
extremely	O
difficult	O
tasks	O
.	O

Simple	O
and	O
multiple	O
regression	O
analysis	O
were	O
used	O
as	O
appropriate	O
.	O

Trial	O
registration	O
This	O
trial	O
has	O
been	O
registered	O
with	O
the	O
Australian	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ANZCTR	O
)	O
on	O
31	O
May	O
2012	O
.	O

In	O
infertility	O
studies	O
,	O
VD	O
level	O
was	O
described	O
as	O
a	O
predictor	O
for	O
ovulation	O
stimulation	O
success	O
with	O
the	O
use	O
of	O
clomiphene	O
citrate	O
(	O
CC	O
).	O

“	O
But	O
what	O
we	O
will	O
end	O
up	O
with	O
is	O
that	O
we	O
now	O
will	O
be	O
able	O
to	O
study	O
three	O
successive	O
generations	O
of	O
Navajos	O
that	O
have	O
been	O
exposed	O
.”	O
Although	O
the	O
literature	O
on	O
chronic	O
low	O
-	O
level	O
uranium	O
exposure	O
is	O
still	O
quite	O
small	O
,	O
by	O
2003	O
researchers	O
knew	O
that	O
the	O
dangers	O
these	O
exposures	O
posed	O
were	O
due	O
not	O
to	O
uranium	O
’	O
s	O
radioactivity	O
but	B
to	O
its	O
chemical	O
toxicity	O
.	O
24Both	O
animal25and	O
human26studies	O
have	O
found	O
uranium	O
to	O
be	O
primarily	O
toxic	O
to	O
the	O
kidneys	O
.	O

Artificial	O
Insemination	O
and	O
Fertility	O
Medications	O
There	O
is	O
an	O
increase	O
in	O
prevalence	O
in	O
the	O
number	O
of	O
women	O
utilizing	O
fertility	O
measures	O
,	O
thus	O
calling	O
for	O
studies	O
to	O
determine	O
the	O
association	O
between	O
assisted	O
reproductive	O
therapy	O
and	O
neurodevelopmental	O
complications	O
,	O
and	O
more	O
specifically	O
autism	O
.	O

Additionally	O
,	O
it	O
was	O
assessed	O
the	O
spontaneous	O
and	O
compulsive	O
feeding	O
behavior	O
,	O
growing	O
parameters	O
,	O
leptin	O
,	O
plasma	O
metabolites	O
,	O
and	O
adiposity	O
after	O
weaning	O
(	O
adolescence	O
and	O
adulthood	O
).	O

Low	O
adherence	O
with	O
advice	O
about	O
supplements	O
was	O
associated	O
with	O
unwanted	O
pregnancy	O
,	O
low	O
maternal	O
age	O
and	O
low	O
economic	O
status	O
in	O
the	O
United	O
Kingdom	O
[	O
36	O
],	O
unplanned	O
pregnancy	O
and	O
lack	O
of	O
education	O
regarding	O
the	O
role	O
of	O
folic	O
acid	O
in	O
South	O
Korea	O
[	O
37	O
].	O

Experimental	O
Section	O
2	O
.	O
1	O
.	O

In	O
two	O
separate	O
studies	O
,	O
early	O
-	O
weaned	O
steers	O
(	O
weaned	O
at	O
177	O
d	O
[	O
study	O
1	O
]	O
and	O
158	O
d	O
[	O
study	O
2	O
]	O
of	O
age	O
and	O
placed	O
on	O
a	O
finishing	O
diet	O
)	O
increased	O
MS	O
and	O
body	O
weight	O
gain	O
,	O
improved	O
feed	O
efficiency	O
,	O
and	O
improved	O
QG	O
of	O
the	O
beef	O
compared	O
with	O
normally	O
weaned	O
steers	O
or	O
normally	O
weaned	O
steers	O
supplemented	O
with	O
grain	O
[	O
51	O
].	O

Serum	O
calcium	O
concentrations	O
were	O
monitored	O
as	O
clinically	O
indicated	O
.	O

In	O
this	O
regard	O
,	O
developmental	O
plasticity	O
would	O
confer	O
a	O
phenotype	O
that	O
is	O
better	O
suited	O
for	O
the	O
environment	O
and	O
thereby	O
increase	O
the	O
organism	O
'	O
s	O
chances	O
of	O
reproducing	O
successfully	O
.	O

This	O
accounts	O
for	O
the	O
low	O
rate	O
of	O
these	O
health	O
talks	O
in	O
this	O
study	O
as	B
opposed	I
to	I
other	B
studies	O
[	O
26	O
].	O

There	O
is	O
limited	O
data	O
about	O
the	O
beliefs	O
of	O
Latinas	O
on	O
GWG	O
even	O
though	O
the	O
problem	O
of	O
excessive	O
weight	O
gain	O
during	O
pregnancy	O
is	O
particularly	O
important	O
for	O
this	O
group	O
which	O
now	O
comprises	O
20	O
%	O
of	O
new	O
mothers	O
in	O
the	O
US	O
[	O
1	O
].	O

In	O
fact	O
,	O
valproate	O
use	O
during	O
pregnancy	O
showed	O
an	O
11	O
.	O
3	O
%	O
increased	O
risk	O
in	O
developmental	O
malformations	O
,	O
and	O
it	O
relied	O
heavily	O
on	O
the	O
dosage	O
prescribed	O
[	O
64	O
].	O

The	O
oxygen	O
saturation	O
and	O
heart	O
rate	O
of	O
participants	O
were	O
monitored	O
with	O
pulse	O
oximeter	O
during	O
the	O
procedure	O
and	O
until	O
they	O
became	O
fully	O
awake	O
.	O

More	O
information	O
on	O
Voxiva	O
and	O
text4baby	O
has	O
been	O
published	O
elsewhere	O
[	O
24	O
].	O

Immediate	O
-	O
phase	O
type	O
I	O
allergic	O
symptoms	O
usually	O
occur	O
within	O
several	O
minutes	O
after	O
allergen	O
contact	O
.	O

During	O
the	O
subsequent	O
visits	O
,	O
the	O
app	O
will	O
provide	O
each	O
data	O
collector	O
with	O
a	O
list	O
of	O
women	O
,	O
for	O
whom	O
a	O
follow	O
-	O
up	O
visit	O
is	O
scheduled	O
within	O
seven	O
days	O
.	O

Demand	O
for	O
family	O
planning	O
satisfied	O
and	O
antenatal	O
care	O
coverage	O
,	O
even	O
though	O
feasible	O
through	O
primary	O
care	O
services	O
,	O
still	O
leave	O
out	O
many	O
women	O
,	O
especially	O
the	O
poorest	O
.	O

Data	O
represent	O
at	O
least	O
six	O
litters	O
per	O
maternal	O
dietary	O
group	O
.	O

The	O
production	O
of	O
highly	O
marbled	O
beef	O
in	O
Korea	O
is	O
essential	O
to	O
compete	O
with	O
cheap	O
imported	O
beef	O
that	O
has	O
a	O
relatively	O
low	O
marbling	O
score	O
(	O
MS	O
).	O

#:	O
adjusted	O
OR	O
for	O
total	O
number	O
of	O
prenatal	O
medical	O
visits	O
.	O

There	O
are	O
a	O
number	O
of	O
case	O
reports	O
and	O
small	O
case	O
series	O
of	O
glargine	O
being	O
utilized	O
without	O
the	O
development	O
of	O
pregnancy	O
complications	O
.	O

None	O
of	O
the	O
women	O
were	O
anemic	O
at	O
that	O
point	O
,	O
but	O
66	O
%	O
had	O
low	O
levels	O
of	O
ferritin	O
(	O
the	O
principal	O
form	O
of	O
stored	O
iron	O
),	O
suggesting	O
low	O
iron	O
nutritional	O
status	O
.	O

This	O
review	O
discusses	O
vitamin	O
D	O
metabolism	O
,	O
dietary	O
requirements	O
and	O
recommendations	O
and	O
implications	O
of	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
and	O
lactation	O
.	O

Reproductive	O
Toxicity	O
:	O
Too	O
Much	O
of	O
a	O
Good	O
Thing	O
?	O

Slaughter	O
age	O
IMF	O
content	O
increases	O
with	O
increasing	O
age	O
in	O
most	O
cattle	O
breeds	O
.	O

Do	O
these	O
mechanism	O
(	O
s	O
)	O
function	O
in	O
humans	O
?	O

Park	O
et	O
al	O
[	O
15	O
]	O
studied	O
Korean	O
infants	O
at	O
2	O
to	O
5	O
months	O
of	O
age	O
and	O
found	O
no	O
relationship	O
between	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
BMC	O
assessed	O
by	O
DXA	O
even	O
though	O
many	O
of	O
the	O
infants	O
had	O
very	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

All	O
continuous	O
variables	O
were	O
examined	O
for	O
normality	O
with	O
the	O
Shapiro	O
-	O
Wilk	O
test	O
and	O
expressed	O
as	O
the	O
mean	O
±	O
Standard	O
Deviation	O
(	O
SD	O
).	O

It	O
found	O
an	O
increase	O
in	O
stillbirth	O
and	O
perinatal	O
mortality	O
,	O
as	O
well	O
as	O
pre	O
-	O
eclampsia	O
amongst	O
those	O
treated	O
with	O
metformin	O
,	O
compared	O
to	O
women	O
treated	O
with	O
insulin	O
or	O
sulphonylureas	O
.	O

Comparisons	O
among	O
groups	O
were	O
performed	O
by	O
calculating	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
(	O
kcal	O
/	O
kg	O
)	O
at	O
each	O
time	O
point	O
.	O

Energy	O
recommendations	O
were	O
calculated	O
according	O
to	O
the	O
Dietary	O
Reference	O
Intakes	O
.	O

(	O
2007	O
),	O
and	O
/	O
orSquazzo	O
et	O
al	O
.	O

According	O
to	O
the	O
Lambda	O
test	O
,	O
this	O
correlation	O
was	O
significantly	O
greater	O
in	O
group	O
A	O
than	O
in	O
group	O
B	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
mean	O
number	O
of	O
glomeruli	O
varied	O
from	O
10897	O
±	O
614	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
14064	O
±	O
308	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
30	O
%	O
difference	O
;	O
P	O
<	O
0	O
.	O
0001	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
10466	O
±	O
867	O
for	O
the	O
F2	O
-	O
SC	O
mice	O
to	O
12015	O
±	O
785	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

For	O
PCB	O
exposure	O
,	O
the	O
μβposterior	O
mean	O
was	O
0	O
.	O
2	O
g	O
,	O
95	O
%	O
CI	O
(-	O
9	O
,	O
10	O
).	O

Twenty	O
-	O
four	O
of	O
the	O
participants	O
started	O
to	O
take	O
Vitamin	O
D	O
supplement	O
before	O
pregnancy	O
,	O
and	O
the	O
range	O
of	O
the	O
Vitamin	O
D	O
supplement	O
intake	O
duration	O
was	O
2	O
to	O
131	O
weeks	O
.	O

There	O
are	O
also	O
data	O
to	O
support	O
low	O
carbohydrate	O
diets	O
in	O
pregnancy	O
,	O
and	O
for	O
the	O
carbohydrate	O
to	O
be	O
of	O
low	O
glycemic	O
index	O
.	O

However	O
,	O
mothers	O
with	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
had	O
newborns	O
with	O
smaller	O
head	O
circumference	O
than	O
those	O
with	O
suboptimal	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
=	O
0	O
.	O
003	O
),	O
which	O
was	O
further	O
confirmed	O
as	O
a	O
linear	O
association	O
(	O
P	O
=	O
0	O
.	O
024	O
).	O

What	O
Might	O
Delay	O
Lactogenesis	O
?	O

Although	O
insulin	O
resistance	O
is	O
a	O
physiologic	O
hallmark	O
of	O
obesity	O
,	O
she	O
says	O
insulin	O
previously	O
was	O
thought	O
to	O
have	O
little	O
,	O
if	O
any	O
,	O
role	O
in	O
lactation	O
.	O

Methods	O
Setting	O
and	O
participants	O
This	O
randomized	O
clinical	O
trial	O
was	O
done	O
in	O
pregnant	O
women	O
who	O
were	O
under	O
prenatal	O
care	O
in	O
Hafez	O
hospital	O
which	O
is	O
a	O
tertiary	O
hospital	O
in	O
Shiraz	O
,	O
Iran	O
,	O
affiliated	O
to	O
Shiraz	O
University	O
of	O
Medical	O
Sciences	O
.	O

In	O
the	O
United	O
States	O
staple	O
foods	O
like	O
milk	O
,	O
breakfast	O
cereals	O
and	O
margarines	O
are	O
artificially	O
fortified	O
with	O
vitamin	O
D	O
.[	O
14	O
]	O
At	O
present	O
,	O
the	O
number	O
and	O
variety	O
of	O
vitamin	O
D	O
fortified	O
foods	O
available	O
on	O
the	O
market	O
differs	B
significantly	O
between	O
countries	O
and	O
is	O
attributed	O
to	O
the	O
country	O
-	O
specific	O
policies	O
on	O
food	O
fortification	O
which	O
are	O
not	O
yet	O
unified	O
.	O

After	O
adjusting	O
each	O
model	O
for	O
the	O
treatment	O
effect	O
,	O
no	O
predictors	O
were	O
significantly	O
associated	O
with	O
the	O
outcome	O
.	O

Epigenetic	O
modifications	O
have	O
been	O
suggested	O
to	O
occur	O
during	O
development	O
(	O
fetal	O
programming	O
),	O
growth	O
,	O
and	O
fat	O
deposition	O
in	O
cattle	O
[	O
13	O
,	O
18	O
,	O
159	O
].	O

Vitamin	O
D	O
Vitamin	O
D	O
is	O
a	O
fat	O
-	O
soluble	O
prohormone	O
which	O
operates	O
via	O
a	O
nuclear	O
receptor	O
[	O
145	O
].	O

Sensible	O
sun	O
exposure	O
and	O
education	O
of	O
the	O
public	O
about	O
the	O
beneficial	O
effects	O
of	O
some	O
limited	O
sun	O
exposure	O
to	O
satisfy	O
their	O
body	O
'	O
s	O
vitamin	O
D	O
requirements	O
should	O
be	O
implemented	O
.	O

However	B
,	O
as	O
there	O
was	O
no	O
evaluation	O
of	O
glycemic	O
control	O
early	O
in	O
pregnancy	O
,	O
and	O
more	O
women	O
on	O
metformin	O
had	O
pre	O
-	O
existing	O
type	O
2	O
diabetes	O
,	O
the	O
groups	O
do	O
not	O
appear	O
to	O
be	O
well	O
matched	O
.	O

MUSC	O
is	O
a	O
comprehensive	O
,	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
(~	O
3000	O
deliveries	O
/	O
year	O
).	O

It	O
was	O
determined	O
that	O
both	O
maternal	O
race	O
and	O
marital	O
status	O
(	O
both	O
missing	O
for	O
215	O
/	O
943	O
,	O
22	O
.	O
7	O
%	O
of	O
baseline	O
participants	O
)	O
were	O
potentially	O
variables	O
that	O
were	O
differentially	O
missing	O
for	O
women	O
of	O
certain	O
racial	O
and	O
marital	O
statuses	O
.	O

We	O
also	O
report	O
unadjusted	O
estimates	O
for	O
analyses	O
and	O
analyses	O
further	O
adjusted	O
for	O
infant	O
age	O
at	O
sample	O
collection	O
in	O
the	O
supplemental	O
information	O
.	O

This	O
study	O
reported	O
an	O
improved	O
verbal	O
Intelligence	O
Quotient	O
(	O
IQ	O
)	O
in	O
offspring	O
aged	O
nine	O
years	O
in	O
children	O
born	O
to	O
mothers	O
who	O
consumed	O
up	O
to	O
two	O
servings	O
of	O
fish	O
per	O
week	O
compared	O
with	O
children	O
born	O
to	O
mothers	O
who	O
had	O
not	O
consumed	O
any	O
fish	O
during	O
late	O
pregnancy	O
(	O
32	O
weeks	O
gestation	O
).	O

It	O
has	O
been	O
suggested	O
that	O
all	O
Hispanics	O
and	O
all	O
pregnant	O
and	O
lactating	O
women	O
have	O
their	O
25	O
(	O
OH	O
)	O
D	O
levels	O
monitored	O
[	O
4	O
].	O

The	O
PFAS	O
exhibited	O
a	O
minimum	O
GM	O
of	O
1	O
μg	O
/	O
L	O
(	O
PFNA	O
)	O
and	O
maximum	O
GM	O
of	O
13	O
.	O
6	O
μg	O
/	O
L	O
(	O
PFOS	O
).	O

Differences	O
in	O
the	O
distributions	O
of	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
by	O
race	O
were	O
evident	O
(	O
Figure	O
1	O
),	O
with	O
a	O
higher	O
proportion	O
of	O
vitamin	O
D	O
-	O
deficient	O
samples	O
found	O
in	O
the	O
black	O
population	O
.	O

Surgical	O
removal	O
of	O
AAOC	O
is	O
the	O
treatment	O
of	O
choice	O
.	O

However	B
,	O
thyroid	O
cancer	O
in	O
young	O
people	O
has	O
generally	O
an	O
excellent	O
prognosis	O
,	O
and	O
survival	O
among	O
women	O
with	O
thyroid	O
cancer	O
diagnosed	O
during	O
pregnancy	O
may	O
not	O
differ	O
from	O
that	O
in	O
age	O
-	O
matched	O
non	O
-	O
pregnant	O
women	O
with	O
similar	O
disease	O
.	O

But	B
she	O
will	O
need	O
to	O
consume	O
much	O
more	O
to	O
obtain	O
this	O
daily	O
requirement	O
(	O
i	O
.	O
e	O
.,	O
between	O
20	O
and	O
48	O
mg	O
of	O
dietary	O
iron	O
)	O
[	O
18	O
].	O

In	O
2008	O
,	O
Young	O
et	O
al	O
.	O

Indeed	O
,	O
18	O
human	O
cohort	O
and	O
20	O
rodent	O
studies	O
within	O
PubMed	O
reported	O
a	O
lack	O
of	O
epigenetically	O
related	O
toxicity	O
(	O
Supplementary	O
Table	O
4	O
).	O

Conclusion	O
Based	O
on	O
the	O
findings	O
of	O
this	O
study	O
,	O
we	O
conclude	O
that	O
:	O
•	O
Children	O
with	O
S	O
-	O
ECC	O
appear	O
to	O
be	O
at	O
significantly	O
greater	O
odds	O
of	O
having	O
low	O
vitamin	O
D	O
status	O
compared	B
to	I
their	O
caries	O
-	O
free	O
controls	O
.	O

The	O
upper	O
and	O
lower	O
edges	O
of	O
the	O
box	O
represent	O
the	O
75thpercentile	O
and	O
the	O
25thpercentile	O
of	O
cathelicidin	O
concentration	O
,	O
respectively	O
,	O
measured	O
by	O
ELISA	O
and	O
reported	O
in	O
ng	O
/	O
mL	O
.	O

In	O
a	O
separate	O
study	O
on	O
group	O
B	O
,	O
visfatin	O
levels	O
in	O
the	O
first	O
and	O
second	O
trimesters	O
showed	O
a	O
significant	O
negative	O
correlation	O
with	O
infant	O
’	O
s	O
weight	O
.	O

This	O
paper	O
evaluates	O
a	O
theory	O
-	O
informed	O
implementation	O
plan	O
to	O
translate	O
a	O
dietetic	O
model	O
of	O
care	O
based	O
on	O
the	O
American	O
guidelines	O
in	O
an	O
Australian	O
maternity	O
hospital	O
.	O

These	O
costs	O
were	O
identified	O
through	O
the	O
accounts	O
of	O
the	O
relevant	O
agencies	O
and	O
structured	O
interviews	O
with	O
health	O
staff	O
at	O
each	O
level	O
of	O
the	O
distribution	O
chain	O
.	O

Confirmatory	O
allergy	O
tests	O
for	O
folic	O
acid	O
were	O
not	O
available	O
for	O
any	O
of	O
the	O
cases	O
.	O

Conclusion	O
The	O
obesogenic	O
phenotype	O
in	O
offspring	O
from	O
HV	O
fed	O
dams	O
is	O
prevented	O
by	O
feeding	O
HV	O
or	O
HFol	O
pup	O
diets	O
,	O
possibly	O
due	O
to	O
post	O
-	O
weaning	O
modulation	O
of	O
food	O
intake	O
regulatory	O
mechanisms	O
.	O

The	O
newborn	O
in	O
this	O
case	O
also	O
had	O
hypernatremia	O
thereby	O
raising	O
possibilities	O
of	O
vasopressinase	O
crossing	O
the	O
placenta	O
.	O

(	O
2014	O
)	O
Nickel	O
(	O
Ni	O
)	O
LifetimeAdulthood	O
↓	O
NSCLC	O
overall	O
and	O
relapse	O
free	O
survivalmiRNAsChiou	O
et	O
al	O
.	O

The	O
benefits	O
of	O
such	O
inheritance	O
are	O
obvious	B
and	O
even	O
Darwin	O
himself	O
proposed	O
a	O
hypothetical	O
mechanism	O
for	O
the	O
transmission	O
of	O
somatic	O
tissue	O
characteristics	O
via	O
the	O
germ	O
cells	O
to	O
subsequent	O
generations	O
,	O
which	O
he	O
termed	O
pangenesis	O
(	O
Darwin1868	O
).	O

It	O
should	O
be	O
emphasized	O
that	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
included	O
a	O
fairly	O
homogeneous	O
cohort	O
of	O
Mediterranean	O
patients	O
from	O
Crete	O
.	O

The	O
pathophysiological	O
mechanisms	O
underlying	O
these	O
consistently	O
observed	O
associations	O
of	O
short	O
sleep	O
duration	O
,	O
sleep	O
-	O
related	O
breathing	O
disorders	O
,	O
including	O
snoring	O
,	O
with	O
altered	O
glucose	O
metabolism	O
and	O
diabetes	O
are	O
likely	O
to	O
be	O
multifactorial	B
[	O
2	O
,	O
43	O
,	O
44	O
].	O

A	O
low	O
protein	O
diet	O
during	O
pregnancy	O
provokes	O
a	O
lasting	O
shift	O
of	O
hepatic	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
throughout	O
ontogenesis	O
in	O
a	O
porcine	O
model	O
Abstract	O
Background	O
In	O
rodent	O
models	O
and	O
in	O
humans	O
the	O
impact	O
of	O
gestational	O
diets	O
on	O
the	O
offspring	O
'	O
s	O
phenotype	O
was	O
shown	O
experimentally	O
and	O
epidemiologically	O
.	O

The	O
risks	O
were	O
particularly	O
elevated	O
among	O
overweight	O
women	O
with	O
these	O
sleep	O
disorders	O
.	O

Table2shows	O
the	O
interventions	O
included	O
in	O
the	O
LiST	O
analysis	O
that	O
prevent	O
preterm	O
births	O
and	O
improve	O
survival	O
of	O
premature	O
babies	O
.	O

All	O
measurements	O
are	O
done	O
twice	O
and	O
recorded	O
to	O
the	O
nearest	O
0	O
.	O
05	O
kg	O
for	O
weight	O
,	O
0	O
.	O
1	O
cm	O
for	O
MUAC	O
and	O
height	O
.	O

Hamilton	O
Monte	O
Carlo	O
sampling	O
was	O
used	O
to	O
obtain	O
2	O
chains	O
of	O
20	O
,	O
000	O
iterations	O
with	O
500	O
warm	O
-	O
up	O
iterations	O
.	O

Although	B
iron	O
deficiency	O
is	O
the	O
commonest	O
cause	O
of	O
nutritional	O
morbidity	O
worldwide	O
(	O
Stoltzfus	O
2003	O
),	O
in	O
women	O
of	O
reproductive	O
age	O
concurrent	O
deficiencies	O
of	O
vitamins	O
A	O
,	O
C	O
,	O
B	O
and	O
folate	O
also	O
frequently	O
occur	O
and	O
all	O
contribute	O
to	O
an	O
increased	O
anaemia	O
risk	O
(	O
Huffman	O
SL	O
et	O
al	O
1998	O
).	O

There	O
were	O
five	O
deaths	O
to	O
6	O
months	O
of	O
age	O
(	O
4	O
neonatal	O
deaths	O
as	O
reported	O
previously	O
[	O
22	O
],	O
and	O
the	O
death	O
of	O
one	O
infant	O
prior	O
to	O
6	O
months	O
of	O
age	O
attributable	O
to	O
sudden	O
infant	O
death	O
syndrome	O
).	O

Such	O
desensitization	O
is	O
likely	O
occurring	O
in	O
situations	O
of	O
chronic	O
elevation	O
in	O
IL	O
-	O
6	O
levels	O
,	O
such	O
as	O
occurs	O
in	O
human	O
obesity	O
.	O

Another	O
study	O
describes	O
what	O
we	O
have	O
already	O
learned	O
from	O
the	O
paragraph	O
on	O
endometriosis	O
.	O

Other	O
allergic	O
diseases	O
that	O
may	O
complicate	O
pregnancy	O
include	O
conjunctivitis	O
,	O
acute	O
urticaria	O
,	O
anaphylaxis	O
,	O
food	O
allergy	O
,	O
and	O
drug	O
allergy	O
.	O

Of	O
course	O
,	O
birth	O
weight	O
is	O
likely	O
a	O
proxy	O
for	O
a	O
complex	O
interplay	O
of	O
underlying	O
etiologic	O
mechanisms	O
and	O
environmental	O
factors	O
that	O
overall	O
contribute	O
to	O
infant	O
health	O
at	O
birth	O
and	O
beyond	O
.	O

Our	O
research	O
would	O
be	O
strengthened	O
with	O
the	O
addition	O
of	O
HbA1cdata	O
in	O
pregnancy	O
and	O
additional	O
maternal	O
lifestyle	O
variables	O
to	O
allow	O
the	O
associations	O
to	O
be	O
teased	O
out	O
.	O

After	O
expert	O
review	O
,	O
the	O
final	O
questionnaire	O
used	O
had	O
29	O
items	O
(	O
see	O
Additional	O
file1	O
).	O

At	O
PND	O
22	O
–	O
23	O
,	O
offspring	O
were	O
weaned	O
,	O
housed	O
in	O
groups	O
(	O
2	O
–	O
3	O
rats	O
/	O
cage	O
)	O
according	O
to	O
the	O
litter	O
and	O
fed	O
ad	O
libitum	O
with	O
the	O
same	O
standard	O
chow	O
.	O

These	O
inconsistencies	B
may	O
be	O
due	O
to	O
a	O
shortage	O
of	O
statistical	O
tools	O
to	O
explore	O
the	O
effects	O
of	O
multiple	O
chemical	O
exposure	O
mixtures	O
on	O
birth	O
weight	O
.	O

DISCUSSION	O
Our	O
findings	O
support	O
the	O
hypothesis	O
that	O
HV	O
or	O
HFol	O
pup	O
diet	O
prevents	O
the	O
increase	O
in	O
food	O
intake	O
,	O
body	O
weight	O
and	O
glucose	O
response	O
to	O
a	O
glucose	O
load	O
in	O
offspring	O
of	O
the	O
HV	O
dams	O
,	O
possibly	O
by	O
post	O
-	O
weaning	O
changes	O
in	O
food	O
intake	O
regulatory	O
systems	O
.	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
MelbourneTraining	O
of	O
trainers	O
amortized	O
over	O
5	O
years	O
:	O
USD85	O
.	O
67	O
/	O
year	O
;	O
training	O
of	O
local	O
health	O
staff	O
USD10	O
/	O
person	O
,	O
2000	O
staff	O
,	O
amortized	O
over	O
5	O
years	O
.	O

Results	O
Of	O
the	O
160	O
women	O
surveyed	O
,	O
39	O
%	O
reported	O
using	O
herbs	O
and	O
61	O
%	O
did	O
not	O
.	O

(	O
2016	O
)*	O
2	O
-	O
amino	O
-	O
1	O
-	O
methyl	O
-	O
6	O
-	O
phenylimidazo	O
[	O
4	O
,	O
5	O
-	O
b	O
]	O
pyridine	O
(	O
PhIP	O
)	O
Mouse	O
(	O
Human	O
CYP1A2	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
200	O
mg	O
/	O
kg	O
)	O
Adolescence	O
/	O
early	O
adulthoodLater	O
adulthoodProstate	O
abnormalitiesDNA	O
methylation	O
Epigenetic	O
machineryLi	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Estimated	O
lives	O
saved	O
of	O
premature	O
babies	O
in	O
settings	O
with	O
universal	O
coverage	O
of	O
interventionsIntervention	O
reaching	O
95	O
%	O
coverageAlso	O
saves	O
mothers	O
or	O
other	O
babiesBy	O
2015By	O
2025	O
%	O
Deaths	O
avertedLives	O
saved	O
%	O
Deaths	O
avertedLives	O
savedFamily	O
planning	O
*	O
M	O
,	O
SB	O
,	O
N24228	O
,	O
00032345	O
,	O
000Antenatal	O
corticosteroidsN40373	O
,	O
00041444	O
,	O
000Antibiotics	O
for	O
pPRoMN985	O
,	O
0009101	O
,	O
000Immediate	O
assessment	O
and	O
simple	O
care	O
of	O
all	O
babiesN544	O
,	O
000553	O
,	O
000Neonatal	O
resuscitationN765	O
,	O
000777	O
,	O
000Thermal	O
careN15142	O
,	O
00016171	O
,	O
000Kangaroo	O
mother	O
careN48452	O
,	O
00048531	O
,	O
000Interventions	O
implemented	O
togetherM	O
,	O
SB	O
,	O
N81757	O
,	O
00084921	O
,	O
000	O
Note	O
:	O
interventions	O
marked	O
with	O
M	O
will	O
also	O
save	O
maternal	O
lives	O
,	O
SB	O
would	O
avert	O
stillbirth	O
,	O
and	O
N	O
will	O
save	O
newborns	O
dying	O
from	O
causes	O
other	O
than	O
preterm	O
birth	O
.	O

These	O
regulations	O
may	O
indicate	O
an	O
impaired	O
fetal	O
growth	O
performance	O
due	O
to	O
the	O
gestational	O
low	O
protein	O
diet	O
.	O

Control	O
□	O
group	O
;	O
■	O
Intervention	O
group	O
.	O

Also	O
,	O
impaired	O
fetal	O
growth	O
,	O
in	O
particular	O
in	O
head	O
circumference	O
,	O
is	O
associated	O
with	O
nonoptimal	O
neurodevelopmental	O
outcome	O
[	O
4	O
].	O

The	O
reasons	O
why	O
vitamin	O
D	O
deficiency	O
is	O
thought	O
to	O
be	O
a	O
risk	O
factor	O
for	O
MS	O
are	O
as	O
follows	O
:	O
First	O
,	O
MS	O
frequency	O
increases	O
with	O
increasing	O
latitude	O
,	O
which	O
is	O
strongly	O
inversely	O
correlated	O
with	O
duration	O
and	O
intensity	O
of	O
UVB	O
from	O
sunlight	O
and	O
vitamin	O
D	O
concentrations	O
.	O
2830	O
–	O
35Second	O
,	O
prevalence	O
of	O
MS	O
is	O
lower	O
than	O
expected	O
at	O
high	O
latitudes	O
in	O
populations	O
with	O
high	O
consumption	O
of	O
vitamin	O
-	O
D	O
-	O
rich	O
fatty	O
fish43536	O
.	O

Of	O
note	O
,	O
most	O
of	O
the	O
children	O
in	O
this	O
study	O
were	O
not	O
vitamin	O
D	O
deficient	O
and	O
the	O
vitamin	O
D	O
ranges	O
were	O
relatively	O
narrow	O
.	O

Levels	O
of	O
vitamin	O
D	O
are	O
known	O
to	O
fluctuate	O
depending	O
on	O
sunlight	O
exposure	O
,	O
which	O
is	O
highest	O
in	O
the	O
summer	O
for	O
the	O
northern	O
hemisphere	O
and	O
tends	O
to	O
increase	O
for	O
latitudes	O
nearer	O
the	O
equator	O
[	O
145	O
,	O
148	O
–	O
150	O
].	O

While	O
there	O
is	O
interest	O
in	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
prevention	O
of	O
multiple	O
sclerosis	O
,	O
following	O
epidemiological	O
studies	O
demonstrating	O
an	O
association	O
between	O
vitamin	O
D	O
supplementation	O
and	O
reduced	O
prevalence	O
of	O
the	O
disease	O
,	O
future	O
research	O
,	O
including	O
randomized	O
controlled	O
trials	O
in	O
pregnant	O
or	O
nonpregnant	O
individuals	O
,	O
is	O
awaited	O
to	O
confirm	O
or	B
refute	B
such	O
benefit	O
.	O

In	O
infants	O
,	O
sensitization	O
to	O
a	O
house	O
dust	O
mite	O
mixture	O
including	O
Dermatophagoides	O
farinae	O
,	O
German	O
cockroach	O
,	O
mould	O
mixture	O
,	O
cat	O
and	O
dog	O
dander	O
,	O
maize	O
pollen	O
,	O
Bermuda	O
grass	O
,	O
chicken	O
egg	O
,	O
cow	O
’	O
s	O
milk	O
,	O
cod	O
fish	O
,	O
peanuts	O
,	O
wheat	O
and	O
soy	O
bean	O
flour	O
and	O
potato	O
are	O
measured	O
.	O

This	O
multi	O
-	O
colinearity	O
is	O
expected	O
,	O
as	O
these	O
variables	O
are	O
physiologically	O
interrelated	O
.	O

'	O
s	O
analysis	O
showed	O
induction	O
increase	O
in	O
the	O
risk	O
of	O
autism	O
by	O
72	O
%	O
in	O
three	O
clinic	O
based	O
studies	O
,	O
while	B
the	O
selected	O
population	O
-	O
based	O
studies	O
reported	O
no	O
association	O
[	O
57	O
].	O

A	O
zoom	O
of	O
the	O
fitted	O
LOESS	O
curve	O
for	O
the	O
MUSC	O
cohort	O
with	O
confidence	O
bounds	O
superimposed	O
shows	O
gestational	O
age	O
at	O
birth	O
initially	O
rising	O
steadily	O
with	O
increasing	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
then	O
reaching	O
a	O
plateau	O
at	O
approximately	O
30	O
–	O
50	O
ng	O
/	O
mL	O
(	O
Fig	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
by	O
gestational	O
age	O
(	O
weeks	O
)	O
at	O
birth	O
.	O

For	O
descriptive	O
purposes	O
,	O
the	O
race	O
variable	O
was	O
defined	O
as	O
non	O
-	O
Hispanic	O
Caucasian	O
,	O
Latina	O
/	O
Hispanic	O
,	O
African	O
-	O
American	O
,	O
and	O
“	O
other	O
.”	O
In	O
other	O
analyses	O
,	O
race	O
was	O
categorized	O
as	O
non	O
-	O
Hispanic	O
Caucasian	O
versus	O
all	O
other	O
groups	O
combined	O
.	O

Phase	O
1	O
data	O
are	O
collected	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
(	O
as	O
confirmed	O
by	O
obstetric	O
ultrasound	O
).	O

Data	O
on	O
initial	O
costs	O
for	O
training	O
and	O
educational	O
materials	O
were	O
obtained	O
from	O
the	O
records	O
of	O
the	O
National	O
Institute	O
of	O
Malariology	O
,	O
Parasitology	O
and	O
Entomology	O
and	O
the	O
Yen	O
Bai	O
Malaria	O
Control	O
Program	O
.	O

Behavioral	O
and	O
Psychosocial	O
Factors	O
during	O
Pregnancy	O
Self	O
-	O
reported	O
measures	O
of	O
dietary	O
intake	O
and	O
exercise	O
expenditure	O
were	O
obtained	O
by	O
trained	O
assessors	O
at	O
study	O
entry	O
and	O
30	O
-	O
weeks	O
gestation	O
.	O

It	O
was	O
demonstrated	O
that	O
when	O
the	O
serotonin	O
levels	O
were	O
altered	O
by	O
SSRIs	O
during	O
early	O
development	O
of	O
brain	O
structure	O
,	O
the	O
functions	O
were	O
altered	O
.	O

Genes	O
associated	O
with	O
the	O
'	O
complement	O
system	O
'	O
showed	O
increased	O
mRNA	O
expression	O
levels	O
,	O
whereas	O
the	O
canonical	O
pathway	O
'	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
'	O
was	O
found	O
to	O
be	O
decreased	O
in	O
LP	O
offspring	O
.	O

The	O
largest	O
increase	O
in	O
the	O
OCP	O
class	O
was	O
seen	O
with	O
a	O
10	O
-	O
fold	O
increase	O
in	O
HCH	O
exposure	O
(	O
5	O
g	O
),	O
while	O
the	O
largest	O
birth	O
weight	O
decrease	O
was	O
seen	O
in	O
response	O
to	O
a	O
10	O
-	O
fold	O
increase	O
in	O
Nonachlor	O
exposure	O
(	O
10	O
g	O
).	O

Only	O
,	O
4	O
women	O
(	O
2	O
.	O
2	O
%)	O
were	O
sufficient	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
≥	O
30	O
ng	O
/	O
mL	O
).	O

Support	O
provided	O
by	O
NIMPE	O
:	O
source	O
NIMPE	O
financial	O
records	O
Health	O
care	O
system	O
costsNational	O
InstituteDistrict	O
Health	O
ServiceCommune	O
Health	O
ServiceVillage	O
Health	O
Workers	O
Source	O
:	O
NIMPE	O
financial	O
recordsAverage	O
DHW	O
income	O
(	O
USD260	O
/	O
month	O
)	O
X	O
share	O
of	O
monthly	O
hours	O
worked	O
on	O
project	O
(	O
11	O
%)	O
X	O
3	O
workers	O
/	O
district	O
X	O
7	O
districtsAverage	O
CHW	O
income	O
(	O
USD157	O
/	O
month	O
)	O
X	O
share	O
of	O
monthly	O
hours	O
worked	O
on	O
project	O
(	O
10	O
%)	O
X	O
175	O
communesAverage	O
VHW	O
income	O
(	O
USD13	O
/	O
month	O
)	O
X	O
share	O
of	O
monthly	O
hours	O
worked	O
on	O
project	O
(	O
30	O
%)	O
X	O
2000	O
individualsNon	O
-	O
salary	O
costs	O
are	O
also	O
incurred	O
at	O
each	O
level	O
(	O
obtained	O
from	O
worker	O
surveys	O
)	O
CHW	O
=	O
commune	O
health	O
worker	O
,	O
DHW	O
=	O
district	O
health	O
worker	O
,	O
VHW	O
=	O
village	O
health	O
worker	O
.	O

Statistical	O
theory	O
demonstrates	O
that	O
the	O
estimators	O
have	O
smaller	O
mean	O
squared	O
error	O
than	O
ordinary	O
least	O
squares	O
estimators	O
[	O
51	O
].	O

The	O
on	O
-	O
site	O
study	O
coordinator	O
assisted	O
treatment	O
participants	O
in	O
enrolling	O
in	O
text4baby	O
by	O
texting	O
“	O
DODBABY	O
”	O
to	O
a	O
designated	O
SMS	O
short	O
code	O
that	O
tagged	O
them	O
as	O
participants	O
in	O
the	O
study	O
.	O

Indeed	O
,	O
murine	O
spermatozoal	O
miRNAs	O
and	O
/	O
or	O
esiRNAs	O
have	O
been	O
shown	O
to	O
function	O
in	O
fertilization	O
and	O
early	O
embryo	O
development	O
(	O
Liu	O
et	O
al	O
.	O
2012	O
,	O
2016	O
;	O
Yuan	O
et	O
al	O
.	O
2016	O
),	O
and	O
to	O
influence	O
phenotypic	O
outcomes	O
in	O
subsequent	O
progeny	O
(	O
Rassoulzadegan	O
et	O
al	O
.	O
2006	O
;	O
Wagner	O
et	O
al	O
.	O
2008	O
;	O
Grandjean	O
et	O
al	O
.	O
2009	O
).	O

Although	O
SSRIs	O
are	O
not	O
contraindicated	O
for	O
use	O
during	O
pregnancy	O
,	O
the	O
effects	O
should	O
be	O
examined	O
more	O
carefully	O
[	O
66	O
].	O

Genes	O
influence	O
many	O
aspects	O
of	O
eating	O
behavior	O
,	O
including	O
taste	O
sensitivity	O
(	O
55	O
),	O
food	O
preference	O
(	O
56	O
),	O
intake	O
of	O
specific	O
foods	O
(	O
57	O
),	O
meal	O
patterns	O
(	O
58	O
),	O
energy	O
density	O
(	O
59	O
),	O
macronutrient	O
intake	O
(	O
60	O
,	O
61	O
),	O
and	O
meal	O
(	O
61	O
-	O
63	O
)	O
and	O
daily	O
energy	O
intake	O
(	O
61	O
).	O

The	O
2002	O
Feeding	O
Infants	O
and	O
Toddlers	O
Study	O
,	O
designed	O
to	O
update	O
knowledge	O
on	O
the	O
feeding	O
patterns	O
of	O
the	O
youngest	O
Americans	O
,	O
found	O
that	O
even	O
before	O
their	O
second	O
birthday	O
,	O
many	O
American	O
toddlers	O
develop	O
the	O
unhealthy	O
eating	O
habits	O
of	O
adults	O
(	O
35	O
).	O

Prepregnancy	O
BMI	O
,	O
GWG	O
,	O
and	O
parity	O
had	O
independent	O
effects	O
on	O
birth	O
size	O
(	O
Table2and	O
Fig	O
.	O
2	O
).	O

While	B
some	O
tests	O
in	O
the	O
OECD	O
Conceptual	O
Framework	O
do	O
cover	O
exposure	O
during	O
critical	O
periods	O
of	O
development	O
in	O
utero	O
,	O
to	O
date	O
,	O
they	O
may	O
not	O
address	O
effects	O
that	O
might	O
be	O
induced	O
by	O
exposure	O
during	O
neonatal	O
or	O
pubertal	O
development	O
,	O
and	O
/	O
or	O
emerge	O
during	O
later	O
life	O
stages	O
.	O

When	O
then	O
we	O
stratified	O
by	O
overweight	O
/	O
obesity	O
status	O
,	O
we	O
found	O
that	O
among	O
women	O
with	O
BMI	O
>	O
25	O
kg	O
/	O
m2	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
during	O
the	O
first	O
trimester	O
(	O
seasonally	O
-	O
adjusted	O
OR	O
4	O
.	O
1	O
,	O
95	O
%	O
CI	O
2	O
.	O
7	O
,	O
6	O
.	O
3	O
)	O
and	O
later	O
in	O
pregnancy	O
(	O
OR	O
2	O
.	O
5	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
6	O
,	O
3	O
.	O
7	O
).	O

Conclusions	O
Traditional	O
interventions	O
for	O
child	O
and	O
adolescent	O
obesity	O
often	O
focus	O
on	O
the	O
individual	O
child	O
,	O
with	O
or	O
without	O
family	O
involvement	O
,	O
and	O
include	O
education	O
,	O
modification	O
of	O
diet	O
,	O
and	O
increases	O
in	O
physical	O
activity	O
.	O

Exposing	O
fetal	O
rats	O
to	O
high	O
levels	O
of	O
glucocorticoids	O
reduces	O
birth	O
weight	O
and	O
results	O
in	O
adults	O
with	O
high	O
blood	O
levels	O
of	O
insulin	O
and	O
glucose	O
.	O

We	O
used	O
sensitive	O
and	O
specific	O
liquid	O
or	O
gas	O
chromatography	O
mass	O
spectrometry	O
[	O
34	O
]	O
to	O
measure	O
gestational	O
EDC	O
exposure	O
.	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
doi	O
:	O
10	O
.	O
1186	O
/	O
s12884	O
-	O
016	O
-	O
1024	O
-	O
7	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

These	O
five	O
interventions	O
were	O
:	O
smoking	O
cessation	O
(	O
0	O
·	O
01	O
rate	O
reduction	O
),	O
decreasing	O
multiple	O
embryo	O
transfers	O
during	O
assisted	O
reproductive	O
technologies	O
(	O
0	O
·	O
06	O
),	O
cervical	O
cerclage	O
(	O
0	O
·	O
15	O
),	O
use	O
of	O
progesterone	O
agents	O
(	O
0	O
·	O
01	O
),	O
and	O
reduction	O
of	O
elective	O
labour	O
induction	O
or	O
caesarean	O
delivery	O
without	O
medical	O
indication	O
(	O
0	O
·	O
29	O
).	O

We	O
have	O
previously	O
suggested	O
the	O
U	O
-	O
shaped	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
inflammatory	O
biomarkers	O
in	O
cord	O
blood	O
[	O
5	O
].	O

Mean	O
change	O
in	O
haemoglobin	O
concentration	O
was	O
+	O
0	O
.	O
6	O
±	O
1	O
.	O
4g	O
/	O
dL	O
in	O
the	O
intervention	O
arm	O
and	O
−	O
0	O
.	O
2	O
±	O
1	O
.	O
2g	O
/	O
dL	O
in	O
the	O
placebo	O
arm	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Iranian	O
usual	O
diet	O
also	O
contains	O
high	O
amounts	O
of	O
salt	O
,	O
which	O
means	O
that	O
salt	O
intake	O
among	O
them	O
is	O
almost	O
twofold	O
the	O
recommended	O
levels	O
.	O

Similarly	O
,	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
the	O
two	O
groups	O
with	O
regards	O
to	O
the	O
individual	O
components	O
of	O
the	O
Ages	O
and	O
Stages	O
score	O
(	O
Table	O
3	O
).	O

Following	O
medical	O
consultation	O
,	O
the	O
health	O
care	O
provider	O
asked	O
if	O
the	O
patient	O
would	O
be	O
willing	O
to	O
participate	O
in	O
the	O
research	O
study	O
and	O
those	O
who	O
agreed	O
underwent	O
informed	O
consent	O
and	O
then	O
were	O
offered	O
the	O
opportunity	O
to	O
complete	O
a	O
baseline	O
survey	O
on	O
a	O
secure	O
computer	O
in	O
a	O
private	O
setting	O
in	O
the	O
clinic	O
.	O

We	O
also	O
considered	O
vitamin	O
D	O
insufficiency	O
as	O
a	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
21	O
–	O
29	O
ng	O
/	O
ml	O
,	O
and	O
the	O
participants	O
who	O
had	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
≥	O
30	O
ng	O
/	O
ml	O
as	O
sufficient	O
[	O
19	O
,	O
46	O
].	O

There	O
has	O
been	O
increasing	O
concerns	O
by	O
consumers	O
about	O
the	O
negative	O
impact	O
of	O
extremely	O
highly	O
marbled	O
beef	O
on	O
human	O
health	O
,	O
such	O
as	O
cardiovascular	O
diseases	O
and	O
arteriosclerosis	O
.	O

Statistical	O
analysis	O
Concentrations	O
of	O
25OHD	O
at	O
T1	O
and	O
T3	O
were	O
used	O
as	O
categorical	O
variables	O
,	O
grouped	O
into	O
25OHD	O
<	O
30	O
(	O
used	O
as	O
reference	O
category	O
),	O
30	O
–	O
49	O
.	O
9	O
,	O
50	O
–	O
74	O
.	O
9	O
,	O
75	O
–	O
99	O
.	O
9	O
and	O
≥	O
100	O
nmol	O
/	O
L	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Countries	O
that	O
have	O
halved	O
their	O
deaths	O
due	O
to	O
preterm	O
birth	O
in	O
just	O
one	O
decade	O
.	O

It	O
has	O
been	O
proven	O
that	O
the	O
synthesis	O
of	O
VD	O
is	O
higher	O
in	O
the	O
1st	O
trimester	O
(	O
41	O
±	O
11	O
.	O
8	O
fMole	O
/	O
h	O
/	O
mg	O
)	O
compared	O
to	O
the	O
3rd	O
trimester	O
(	O
8	O
±	O
4	O
.	O
4	O
fMole	O
/	O
h	O
/	O
mg	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

Renin	O
expression	O
(	O
Figure	O
8	O
)	O
and	O
AT1r	O
expression	O
(	O
Figure	O
9	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g008	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
8	O
Western	O
blotting	O
analysis	O
of	O
renal	O
tissue	O
at	O
weaning	O
and	O
6	O
months	O
of	O
age	O
for	O
renin	O
expression	O
.	O

Of	O
these	O
,	O
448	O
probe	O
-	O
sets	O
were	O
up	O
-	O
regulated	O
and	O
543	O
probe	O
-	O
sets	O
showed	O
lower	O
expression	O
at	O
a	O
higher	O
age	O
.	O

Limited	O
information	O
is	O
available	O
on	O
the	O
effects	O
of	O
the	O
dietary	O
energy	O
-	O
to	O
-	O
protein	O
ratio	O
on	O
IMF	O
content	O
in	O
cattle	O
.	O

Iron	O
deficiency	O
is	O
an	O
important	O
risk	O
factor	O
for	O
increased	O
maternal	O
mortality	O
,	O
low	O
birth	O
weight	O
and	O
preterm	O
delivery	O
(	O
Brabin	O
et	O
al	O
2001	O
)	O
and	O
the	O
availability	O
of	O
calcium	O
,	O
iodine	O
,	O
folate	O
and	O
vitamins	O
A	O
and	O
D	O
may	O
modulate	O
fetal	O
development	O
(	O
Bartley	O
et	O
al	O
2005	O
).	O

The	O
absorption	O
of	O
dietary	O
vitamin	O
D	O
is	O
generally	O
high	O
at	O
all	O
stages	O
of	O
life	O
[	O
34	O
],	O
but	B
serum	O
levels	O
also	O
depend	O
on	O
the	O
endogenous	O
production	O
of	O
vitamin	O
D	O
due	O
to	O
sun	O
exposure	O
which	O
is	O
subject	O
to	O
seasonal	O
variations	O
.	O

We	O
used	O
multivariable	O
logistic	O
regression	O
to	O
analyze	O
associations	O
of	O
PNV	O
use	O
and	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
defined	O
as	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
.	O

Hyposensitization	O
(	O
immunotherapy	O
),	O
which	O
may	O
be	O
selectively	O
indicated	O
in	O
certain	O
patients	O
with	O
AR	O
,	O
bee	O
venom	O
sensitivity	O
,	O
and	O
asthma	O
should	O
not	O
be	O
initiated	O
during	O
pregnancy	O
because	O
of	O
the	O
risk	O
of	O
systemic	O
reactions	O
.	O

This	O
period	O
is	O
roughly	O
comparable	O
to	O
the	O
third	O
gestational	O
trimester	O
of	O
humans	O
[	O
27	O
].	O

The	O
emulsifier	O
PROSOL	O
(	O
sodium	O
stearoyl	O
-	O
2	O
-	O
lactylate	O
)	O
increases	O
IMF	O
deposition	O
and	O
QG	O
in	O
Korean	O
cattle	O
[	O
108	O
].	O

Manipulating	O
IMF	O
deposition	O
through	O
developmental	O
programming	O
via	O
metabolic	O
imprinting	O
is	O
a	O
recently	O
proposed	O
nutritional	O
method	O
to	O
change	O
potential	O
IMF	O
deposition	O
during	O
the	O
fetal	O
and	O
neonatal	O
periods	O
in	O
rodents	O
and	O
domestic	O
animals	O
.	O

IMF	O
deposition	O
can	O
positively	O
affect	O
beef	O
taste	O
including	O
tenderness	O
and	O
flavor	O
,	O
favoring	O
highly	O
marbled	O
beef	O
.	O

We	O
did	O
not	O
have	O
PTH	O
values	O
on	O
the	O
cord	O
blood	O
but	O
PTH	O
values	O
at	O
three	O
months	O
of	O
age	O
were	O
not	O
correlated	O
significantly	O
with	O
25	O
(	O
OH	O
)	O
D	O
values	O
at	O
birth	O
or	O
three	O
months	O
or	O
with	O
bone	O
mineral	O
outcomes	O
.	O

Consequently	O
,	O
the	O
Nutrition	O
during	O
Pregnancy	O
and	O
Early	O
Development	O
(	O
NuPED	O
)	O
cohort	O
study	O
was	O
initiated	O
to	O
investigate	O
nutritional	O
status	O
during	O
pregnancy	O
and	O
assess	O
early	O
nutrition	O
-	O
related	O
exposures	O
predictive	O
of	O
early	O
childhood	O
development	O
in	O
urban	O
South	O
Africa	O
.	O

We	O
aimed	O
to	O
study	O
the	O
relationship	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
and	O
respiratory	O
and	O
atopic	O
outcomes	O
in	O
the	O
offspring	O
in	O
a	O
population	O
-	O
based	O
birth	O
cohort	O
,	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
.	O

She	O
recently	O
presented	O
findings	O
showing	O
an	O
association	O
between	O
increased	O
levels	O
of	O
activated	O
T	O
cells	O
in	O
DiNEH	O
Project	O
participants	O
and	O
greater	O
residential	O
proximity	O
to	O
mine	O
waste	O
sites	O
.	O
36	O
“	O
If	O
we	O
see	O
any	O
of	O
these	O
activated	O
T	O
cells	O
,	O
we	O
know	O
that	O
the	O
immune	O
system	O
is	O
highly	O
reacting	O
to	O
something	O
,”	O
Erdei	O
says	O
.	O

Our	O
study	O
implementing	O
partner	O
BRAC	O
,	O
a	O
non	O
-	O
government	O
organisation	O
co	O
-	O
ordinates	O
a	O
community	O
-	O
based	O
maternal	O
,	O
neonatal	O
and	O
child	O
health	O
program	O
in	O
the	O
area	O
which	O
includes	O
a	O
prospective	O
pregnancy	O
surveillance	O
and	O
home	O
-	O
based	O
antenatal	O
care	O
program	O
.	O

Consistent	O
with	O
the	O
findings	O
from	O
the	O
qualitative	O
work	O
,	O
behavior	O
change	O
communicators	O
used	O
an	O
interactive	O
approach	O
to	O
validate	O
the	O
prevalent	O
perceived	O
susceptibility	O
of	O
the	O
neonatal	O
period	O
.	O

Comparisons	O
between	O
groups	O
were	O
performed	O
using	O
student	O
t	O
-	O
test	O
for	O
continuous	O
variables	O
,	O
and	O
Fisher	O
exact	O
test	O
for	O
categorical	O
variables	O
.	O

There	O
are	O
a	O
number	O
of	O
limitations	O
inherent	O
in	O
the	O
design	O
of	O
the	O
present	O
study	O
that	O
should	O
be	O
acknowledged	O
.	O

Over	O
the	O
last	O
two	O
decades	O
,	O
there	O
has	O
been	O
a	O
substantial	O
global	O
reduction	O
in	O
under	O
-	O
5	O
child	O
mortality	O
rates	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
The	O
influence	O
of	O
vitamin	O
D	O
on	O
the	O
activity	O
and	O
the	O
morphology	O
of	O
sperm	O
(	O
after	O
:	O
Grzechocinska	O
B	O
,	O
Dabrowski	O
FA	O
,	O
Cyganek	O
A	O
,	O
Wielgos	O
M	O
.	O
The	O
role	O
of	O
vitamin	O
D	O
in	O
impaired	O
fertility	O
treatment	O
[	O
2	O
]).	O

Maternal	O
allergy	O
assessment	O
The	O
International	O
Study	O
for	O
Asthma	O
and	O
Allergies	O
in	O
Childhood	O
(	O
ISAAC	O
)	O
questionnaire	O
[	O
48	O
]	O
is	O
used	O
to	O
assess	O
allergy	O
symptoms	O
in	O
maternal	O
participants	O
at	O
phases	O
1	O
to	O
3	O
during	O
pregnancy	O
,	O
and	O
7	O
postnatally	O
.	O

History	O
lessons	O
from	O
neonatal	O
mortality	O
reduction	O
in	O
high	O
income	O
countries	O
The	O
historical	O
data	O
from	O
the	O
United	O
States	O
and	O
United	O
Kingdom	O
(	O
Figure4	O
)	O
shows	O
that	O
a	O
moderate	O
increase	O
in	O
coverage	O
of	O
selected	O
interventions	O
results	O
in	O
a	O
mortality	O
reduction	O
,	O
even	O
in	O
the	O
absence	O
of	O
neonatal	O
intensive	O
care	O
.	O

Several	O
other	O
studies	O
have	O
focused	O
on	O
maternal	O
changes	O
during	O
pregnancy	O
and	O
their	O
association	O
with	O
autism	O
.	O

Subjects	O
/	O
Methods	O
:	O
The	O
study	O
in	O
293	O
women	O
aged	O
from	O
17	O
to	O
45	O
years	O
old	O
was	O
nested	O
within	O
a	O
double	O
-	O
blind	O
,	O
randomised	O
placebo	O
-	O
controlled	O
trial	O
of	O
periconceptional	O
MMN	O
supplementation	O
[	O
ISRCTN	O
13687662	O
],	O
using	O
the	O
United	O
Nations	O
International	O
Multiple	O
Micronutrient	O
Preparation	O
(	O
UNIMMAP	O
),	O
received	O
daily	O
for	O
one	O
year	O
or	O
until	O
conception	O
.	O

After	O
mating	O
,	O
the	O
presence	O
of	O
a	O
vaginal	O
plug	O
was	O
used	O
to	O
diagnose	O
pregnancy	O
.	O

Arsenic	O
is	O
chemically	O
very	O
similar	O
to	O
zinc	O
and	O
can	O
replace	O
zinc	O
in	O
proteins	O
that	O
are	O
important	O
in	O
DNA	O
repair	O
.	O
41	O
“	O
Arsenic	O
goes	O
in	O
and	O
kicks	O
zinc	O
out	O
,	O
but	O
the	O
arsenic	O
doesn	O
’	O
t	O
replace	O
the	O
function	O
of	O
zinc	O
.	O

Furthermore	O
,	O
studies	O
have	O
shown	O
that	O
vitamin	O
D	O
supports	O
early	O
placental	O
development	O
[	O
44	O
,	O
45	O
]	O
in	O
which	O
,	O
abnormal	O
placentation	O
can	O
be	O
a	O
characteristic	O
of	O
a	O
number	O
of	O
pregnancy	O
complications	O
including	O
GDM	O
,	O
PE	O
,	O
sPTB	O
and	O
SGA	O
[	O
46	O
].	O

One	O
child	O
had	O
a	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
above	O
four	O
SD	O
from	O
the	O
mean	O
and	O
was	O
excluded	O
from	O
subsequent	O
analyses	O
.	O

Results	O
For	O
a	O
10	O
-	O
fold	O
increase	O
in	O
chemical	O
concentration	O
,	O
the	O
mean	O
differences	O
in	O
birth	O
weights	O
(	O
95	O
%	O
credible	O
intervals	O
(	O
CI	O
))	O
were	O
1	O
g	O
(-	O
20	O
,	O
23	O
)	O
for	O
phthalates	O
,	O
-	O
11	O
g	O
(-	O
52	O
,	O
34	O
)	O
for	O
PFAS	O
,	O
0	O
.	O
2	O
g	O
(-	O
9	O
,	O
10	O
)	O
for	O
PCBs	O
,	O
-	O
4	O
g	O
(-	O
30	O
,	O
22	O
)	O
for	O
PBDEs	O
,	O
and	O
7	O
g	O
(-	O
25	O
,	O
40	O
)	O
for	O
OCPs	O
.	O

c	O
Linear	O
model	O
associations	O
between	O
maternal	O
aMED	O
score	O
and	O
relative	O
abundance	O
of	O
infant	O
stool	O
OTUs	O
.	O

Invest	O
Bring	O
both	O
financial	O
and	O
other	O
resources	O
to	O
address	O
maternal	O
and	O
newborn	O
health	O
and	O
the	O
burden	O
of	O
preterm	O
birth	O
.	O

Linear	O
regression	O
analysis	O
revealed	O
that	O
first	O
and	O
second	O
trimester	O
visfatin	O
levels	O
were	O
significant	O
independent	O
predictors	O
of	O
infant	O
’	O
s	O
weight	O
in	O
group	O
B	O
and	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
.	O

However	B
,	O
in	O
that	O
study	O
neurodevelopment	O
was	O
assessed	O
when	O
the	O
infant	O
was	O
only	O
three	O
days	O
old	O
.	O

Pre	O
-	O
Pregnancy	O
Body	O
Mass	O
Index	O
(	O
BMI	O
)	O
Self	O
-	O
reported	O
pre	O
-	O
pregnancy	O
weight	O
and	O
measured	O
height	O
collected	O
at	O
baseline	O
were	O
used	O
to	O
calculate	O
pre	O
-	O
pregnancy	O
BMI	O
[	O
9	O
].	O

The	O
binding	O
of	O
this	O
to	O
vitamin	O
D	O
receptors	O
in	O
turn	O
results	O
in	O
increased	O
intracellular	O
formation	O
of	O
antimicrobial	O
compounds	O
,	O
such	O
as	O
cathelicidins	O
.	O
5The	O
generation	O
of	O
intracellular	O
antimicrobial	O
compounds	O
is	O
impaired	O
in	O
patients	O
who	O
are	O
vitamin	O
D	O
deficient	O
(	O
ie	O
,	O
low	O
serum	O
concentrations	O
of	O
calcifediol	O
).	O

Thus	O
,	O
season	O
at	O
pregnancy	O
blood	O
sampling	O
and	O
at	O
birth	O
was	O
coded	O
using	O
dummy	O
variables	O
(	O
with	O
autumn	O
as	O
a	O
reference	O
)	O
in	O
ANCOVA	O
and	O
used	O
as	O
a	O
covariate	O
.	O

In	O
the	O
multivariable	O
analysis	O
with	O
change	O
in	O
25OHD	O
as	O
the	O
independent	O
variable	O
,	O
T1	O
25OHD	O
was	O
also	O
included	O
as	O
a	O
confounder	O
.	O

Maternal	O
undernutrition	O
Fetal	O
growth	O
restriction	O
as	O
a	O
consequence	O
of	O
impaired	O
intrauterine	O
conditions	O
can	O
be	O
interpreted	O
as	O
part	O
of	O
a	O
life	O
history	O
strategy	O
in	O
which	O
the	O
organism	O
anticipates	O
a	O
shorter	O
life	O
because	O
of	O
a	O
higher	O
risk	O
of	O
extrinsic	O
mortality	O
,	O
and	O
therefore	O
invests	O
less	O
into	O
growth	O
but	B
accelerates	O
maturation	O
to	O
ensure	O
reproductive	O
fitness	O
[	O
10	O
],[	O
36	O
],[	O
39	O
]–[	O
41	O
].	O

Thus	O
,	O
the	O
association	O
between	O
vitamin	O
D	O
status	O
and	O
neonatal	O
birth	O
size	O
is	O
not	O
clear	O
and	O
warrants	O
further	O
investigation	O
.	O

Results	O
We	O
report	O
descriptive	O
statistics	O
including	O
dosage	O
of	O
text	O
messages	O
delivered	O
.	O

In	O
the	O
studies	O
conducted	O
to	O
date	O
,	O
risk	O
estimates	O
and	O
p	O
-	O
values	O
for	O
the	O
association	O
between	O
season	O
of	O
birth	O
and	O
glioma	O
risk	O
have	O
been	O
nominal	O
to	O
borderline	O
in	O
strength	O
.	O

Sequencing	O
of	O
genomic	O
DNA	O
revealed	O
a	O
T	O
-	O
to	O
-	O
A	O
transversion	O
at	O
nucleotide	O
position	O
1151	O
,	O
causing	O
a	O
mutation	O
from	O
an	O
isoleucine	O
residue	O
to	O
an	O
asparagine	O
residue	O
(	O
I384N	O
)	O
(	O
Figure	O
3A	O
,	O
left	O
panel	O
).	O

Statistical	O
analyses	O
were	O
performed	O
using	O
SAS	O
9	O
.	O
3	O
.	O

Besides	O
,	O
P	O
-	O
values	O
<	O
0	O
.	O
05	O
were	O
considered	O
as	O
statistically	O
significant	O
.	O

The	O
secondary	O
trial	O
outcomes	O
will	O
include	O
:	O
(	O
1	O
)	O
percentage	O
of	O
women	O
using	O
IFA	O
supplements	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
;	O
(	O
2	O
)	O
percentage	O
of	O
live	O
births	O
with	O
low	O
birth	O
weight	O
and	O
with	O
preterm	O
delivery	O
;	O
(	O
3	O
)	O
percentage	O
of	O
neonatal	O
deaths	O
attributable	O
to	O
preterm	O
delivery	O
,	O
and	O
to	O
birth	O
asphyxia	O
;	O
(	O
4	O
)	O
mean	O
marginal	O
additional	O
expenditure	O
associated	O
with	O
early	O
IFA	O
supplements	O
,	O
and	O
the	O
mean	O
cost	O
per	O
neonatal	O
death	O
prevented	O
;	O
(	O
5	O
)	O
the	O
percentage	O
of	O
pregnant	O
women	O
reporting	O
side	O
effects	O
including	O
nausea	O
and	O
vomiting	O
.	O

Therefore	O
,	O
there	O
is	O
an	O
urgent	O
need	O
of	O
randomised	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
to	O
investigate	O
the	O
maternal	O
and	O
neonatal	O
health	O
benefits	O
of	O
correcting	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
[	O
24	O
].	O

Consent	O
/	O
Assent	O
Process	O
Eligible	O
women	O
were	O
informed	O
of	O
the	O
study	O
and	O
,	O
if	O
interested	O
,	O
consented	O
in	O
their	O
language	O
of	O
preference	O
(	O
Spanish	O
/	O
English	O
).	O

These	O
agents	O
include	O
terbutaline	O
,	O
which	O
is	O
commonly	O
used	O
as	O
a	O
tocolytic	O
and	O
a	O
bronchodilator	O
in	O
obstetrics	O
.	O

Our	O
age	O
limits	O
were	O
15	O
to	O
55	O
years	O
and	O
those	O
patients	O
with	O
estimated	O
expanded	O
disability	O
status	O
scale	O
less	O
than	O
5	O
were	O
introduced	O
to	O
the	O
study	O
.	O

The	O
contents	O
were	O
resuspended	O
in	O
100	O
µL	O
of	O
mobile	O
phase	O
(	O
80	O
%	O
methanol	O
and	O
20	O
%	O
water	O
)	O
and	O
transferred	O
into	O
high	O
performance	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
injector	O
vials	O
.	O

We	O
used	O
the	O
same	O
test	O
frame	O
size	O
over	O
the	O
photomicrographs	O
of	O
the	O
two	O
groups	O
to	O
emphasize	O
that	O
the	O
number	O
of	O
glomeruli	O
was	O
greater	O
in	O
the	O
VitD	O
-	O
group	O
than	O
in	O
the	O
SC	O
group	O
.	O

However	O
,	O
it	O
will	O
be	O
increasingly	O
important	O
to	O
examine	O
,	O
in	O
larger	O
studies	O
,	O
how	O
additional	O
specific	O
exposures	O
,	O
such	O
as	O
lead	O
as	O
has	O
been	O
done	O
by	O
previous	O
researchers	O
(	O
Pilsner	O
et	O
al	O
.	O

It	O
cannot	O
be	O
assumed	O
that	O
in	O
a	O
growing	O
child	O
these	O
relationships	O
with	O
family	O
members	O
would	O
remain	O
consistently	O
the	O
same	O
,	O
in	O
that	O
environmental	O
factors	O
would	O
come	O
more	O
into	O
play	O
as	O
the	O
child	O
grows	O
up	O
.	O
29As	O
children	O
grow	O
older	O
in	O
this	O
study	O
,	O
the	O
BMI	O
relationship	O
strengthens	O
,	O
presumably	O
because	O
of	O
shared	O
dietary	O
environments	O
,	O
and	O
to	O
reinforce	O
this	O
,	O
both	O
grandparent	O
couples	O
also	O
have	O
significantly	O
correlated	O
BMI	O
relationships	O
.	O

In	O
general	O
,	O
height	O
correlations	O
of	O
the	O
child	O
with	O
each	O
parent	O
increased	O
with	O
age	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
case	O
is	O
the	O
first	O
report	O
of	O
AAOC	O
in	O
pregnancy	O
.	O

Social	O
context	O
can	O
range	O
from	O
family	O
,	O
to	O
school	O
,	O
to	O
the	O
broader	O
community	O
.	O

Visible	O
skeletal	O
malformations	O
in	O
Skm1	O
(	O
B	O
)	O
mice	O
and	O
Skm2	O
(	O
C	O
)	O
mice	O
.	O

Despite	O
these	O
limitations	O
,	O
the	O
strengths	O
of	O
our	O
study	O
include	O
having	O
access	O
to	O
birth	O
outcomes	O
from	O
medical	O
records	O
as	O
well	O
as	O
having	O
available	O
influenza	O
surveillance	O
data	O
.	O

There	O
are	O
few	O
large	O
intervention	O
trials	O
of	O
multiple	O
micronutrient	O
supplementation	O
in	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
and	O
none	O
have	O
been	O
conducted	O
in	O
Africa	O
.	O

[	O
20	O
]	O
measured	O
supplement	O
usage	O
during	O
pregnancy	O
.	O

Here	O
,	O
no	O
confounders	O
were	O
included	O
due	O
to	O
the	O
small	O
number	O
of	O
cases	O
(	O
N	O
=	O
9	O
).	O

Between	O
March	O
and	O
July	O
2006	O
,	O
resident	O
females	O
aged	O
17	O
-	O
45y	O
were	O
identified	O
from	O
the	O
demographic	O
database	O
and	O
pre	O
-	O
randomised	O
to	O
receive	O
daily	O
supplementation	O
with	O
UNIMMAP	O
or	O
placebo	O
.	O

Vitamin	O
C	O
,	O
which	O
is	O
mostly	O
found	O
in	O
seasonal	O
fruits	O
and	O
vegetables	O
,	O
can	O
react	O
with	O
and	O
then	O
inhibit	O
nitrite	O
formation	O
of	O
nitrosamines	O
[	O
163	O
].	O

The	O
early	O
expansion	O
of	O
neurons	O
initiates	O
with	O
neurite	O
process	O
elongation	O
pursued	O
by	O
axon	O
differentiation	O
,	O
dendritic	O
arborization	O
,	O
and	O
synapse	O
formation	O
.	O

In	O
another	O
study	O
,	O
Graugnard	O
et	O
al	O
[	O
56	O
]	O
reported	O
that	O
a	O
high	O
-	O
starch	O
diet	O
induced	O
precocious	O
upregulation	O
of	O
the	O
adipogenic	O
gene	O
network	O
in	O
the	O
longissimus	O
lumborum	O
of	O
early	O
-	O
weaned	O
(	O
average	O
155	O
d	O
)	O
Angus	O
cattle	O
.	O

Infant	O
psychomotor	O
and	O
socio	O
-	O
emotional	O
development	O
Psychomotor	O
and	O
socio	O
-	O
emotional	O
development	O
of	O
the	O
offspring	O
is	O
being	O
assessed	O
using	O
the	O
Protocol	O
for	O
Child	O
Monitoring	O
–	O
Infant	O
version	O
(	O
PCM	O
-	O
I	O
),	O
which	O
combines	O
both	O
parental	O
report	O
and	O
direct	O
observation	O
by	O
trained	O
assessors	O
to	O
provide	O
a	O
comprehensive	O
evaluation	O
of	O
a	O
child	O
’	O
s	O
motor	O
skills	O
,	O
cognition	O
,	O
language	O
,	O
personal	O
and	O
socio	O
-	O
emotional	O
development	O
[	O
62	O
].	O

Vitamin	O
D	O
deficiency	O
has	O
been	O
linked	O
to	O
pro	O
-	O
inflammatory	O
disease	O
.	O

Rats	O
had	O
ad	O
libitum	O
access	O
to	O
the	O
standard	O
chow	O
and	O
water	O
,	O
and	O
had	O
limited	O
access	O
to	O
the	O
chocolate	O
for	O
1	O
h	O
during	O
the	O
light	O
phase	O
.	O

Exclusion	O
Criteria	O
were	O
:	O
the	O
participants	O
with	O
the	O
EPDS	O
baseline	O
scores	O
of	O
>	O
13	O
,	O
not	O
providing	O
blood	O
sample	O
at	O
the	O
onset	O
of	O
the	O
study	O
,	O
and	O
less	O
than	O
8	O
weeks	O
consumption	O
of	O
vitamin	O
D3supplementations	O
(	O
for	O
example	O
due	O
to	O
preterm	O
labor	O
or	O
stopping	O
consumption	O
),	O
irregular	O
consumption	O
(	O
for	O
example	O
every	O
two	O
/	O
three	O
days	O
instead	O
of	O
daily	O
consumption	O
).	O

Given	O
that	O
the	O
month	O
in	O
which	O
the	O
serum	O
was	O
sampled	O
heavily	O
influences	O
vitamin	O
D	O
status	O
,	O
“	O
standardised	O
”	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
calculated	O
as	O
previously	O
described	O
[	O
34	O
]	O
in	O
order	O
to	O
normalise	O
against	O
seasonal	O
variation	O
.	O

CC	O
and	O
RC	O
females	O
showed	O
a	O
lower	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
than	O
those	O
of	O
the	O
respective	O
CC	O
and	O
RC	O
males	O
.	O

These	O
data	O
suggest	O
that	O
prenatal	O
care	O
providers	O
of	O
low	O
-	O
income	O
,	O
minority	O
women	O
in	O
particular	O
should	O
make	O
healthy	O
maternal	O
weight	O
gain	O
targets	O
a	O
priority	O
in	O
their	O
care	O
to	O
prevent	O
excessive	O
weight	O
gain	O
during	O
pregnancy	O
and	O
the	O
associated	O
complications	O
.	O

Because	O
9	O
.	O
75	O
g	O
of	O
sucrose	O
is	O
added	O
as	O
a	O
carrier	O
in	O
the	O
10	O
g	O
of	O
vitamin	O
mix	O
in	O
the	O
RV	O
diet	O
,	O
we	O
reduced	O
the	O
added	O
sucrose	O
to	O
only	O
10	O
g	O
in	O
the	O
HV	O
diet	O
to	O
adjust	O
for	O
the	O
97	O
.	O
5	O
g	O
of	O
sucrose	O
from	O
the	O
100	O
g	O
of	O
vitamin	O
mix	O
.	O
Figure	O
1adepicts	O
the	O
study	O
design	O
.	O

The	O
measurement	O
is	O
taken	O
with	O
the	O
infant	O
lying	O
on	O
his	O
/	O
her	O
back	O
on	O
the	O
infantometer	O
,	O
legs	O
extended	O
with	O
the	O
head	O
and	O
foot	O
board	O
making	O
contact	O
with	O
the	O
infant	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Between	O
groups	O
comparisons	O
of	O
depression	O
scores	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrationsVariablesmean	O
±	O
sdDepression	O
score	O
,	O
N	O
(%)	O
Vitamin	O
D	O
groupControl	O
group	O
P	O
-	O
valueVitamin	O
D	O
groupControl	O
group	O
<	O
99	O
–	O
13	O
>	O
13	O
<	O
99	O
–	O
13	O
>	O
13	O
P	O
-	O
value	O
*	O
Depression	O
score	O
at	O
baseline8	O
.	O
44	O
±	O
3	O
.	O
898	O
.	O
64	O
±	O
3	O
.	O
810	O
.	O
74737	O
(	O
49	O
.	O
3	O
)	O
38	O
(	O
50	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
33	O
(	O
42	O
.	O
3	O
)	O
45	O
(	O
57	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
383Depression	O
score	O
at	O
38	O
–	O
40w	O
gestation6	O
.	O
17	O
±	O
3	O
.	O
477	O
.	O
77	O
±	O
3	O
.	O
920	O
.	O
0149	O
(	O
72	O
.	O
1	O
)	O
18	O
(	O
26	O
.	O
5	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
37	O
(	O
50	O
.	O
7	O
)	O
30	O
(	O
41	O
.	O
1	O
)	O
6	O
(	O
8	O
.	O
2	O
)	O
0	O
.	O
024Depression	O
score	O
at	O
post	O
partum	O
(	O
4w	O
)	O
4	O
.	O
59	O
±	O
3	O
.	O
297	O
.	O
36	O
±	O
4	O
.	O
27	O
<	O
0	O
.	O
00158	O
(	O
90	O
.	O
6	O
)	O
6	O
(	O
9	O
.	O
4	O
)	O
0	O
(	O
0	O
)	O
43	O
(	O
59	O
.	O
7	O
)	O
23	O
(	O
31	O
.	O
9	O
)	O
6	O
(	O
8	O
.	O
3	O
)<	O
0	O
.	O
001Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
19	O
±	O
3	O
.	O
767	O
.	O
18	O
±	O
3	O
.	O
99	O
<	O
0	O
.	O
00157	O
(	O
89	O
.	O
1	O
)	O
7	O
(	O
10	O
.	O
9	O
)	O
0	O
(	O
0	O
)	O
46	O
(	O
63	O
.	O
9	O
)	O
22	O
(	O
30	O
.	O
6	O
)	O
4	O
(	O
5	O
.	O
6	O
)	O
0	O
.	O
001Categorized	O
25	O
(	O
OH	O
)	O
D	O
,	O
N	O
(%)<	O
2020	O
–	O
29	O
≥	O
30	O
<	O
2020	O
–	O
29	O
≥	O
30	O
P	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
12	O
.	O
84	O
±	O
7	O
.	O
9111	O
.	O
89	O
±	O
6	O
.	O
400	O
.	O
63a65	O
(	O
86	O
.	O
7	O
)	O
7	O
(	O
9	O
.	O
3	O
)	O
3	O
(	O
4	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
8	O
(	O
10	O
.	O
3	O
)	O
1	O
(	O
1	O
.	O
3	O
)	O
0	O
.	O
6125	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
17	O
.	O
46	O
±	O
10	O
.	O
0912	O
.	O
07	O
±	O
5	O
.	O
980	O
.	O
001a41	O
(	O
66	O
.	O
1	O
)	O
15	O
(	O
24	O
.	O
2	O
)	O
6	O
(	O
9	O
.	O
7	O
)	O
58	O
(	O
85	O
.	O
3	O
)	O
10	O
(	O
14	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
006	O
*	O
Fisher	O
’	O
s	O
Exact	O
Test	O
aMann	O
-	O
Whitney	O
U	O
test	O
The	O
mean	O
depression	O
score	O
of	O
184	O
participants	O
was	O
9	O
.	O
20	O
±	O
4	O
.	O
44	O
at	O
baseline	O
.	O

Early	O
pregnancy	O
registration	O
was	O
significantly	O
associated	O
with	O
the	O
intake	O
of	O
folic	O
acid	O
(	O
aOR	O
,	O
3	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
11	O
.	O
9	O
).	O

All	O
12	O
%	O
of	O
the	O
instrumental	O
deliveries	O
were	O
observed	O
in	O
the	O
polytherapy	O
subgroup	O
.	O

One	O
of	O
the	O
studies	O
looked	O
at	O
serum	O
levels	O
in	O
samples	O
collected	O
from	O
Mexican	O
mothers	O
within	O
a	O
day	O
of	O
birth	O
,	O
17while	B
the	O
other	B
used	O
maternal	O
serum	O
samples	O
collected	O
during	O
the	O
second	O
trimester	O
from	O
Mexican	O
-	O
American	O
women	O
who	O
lived	O
in	O
California	O
’	O
s	O
Salinas	O
Valley	O
,	O
a	O
major	O
agricultural	O
region	O
.	O
18	O
Reverse	O
causality	O
is	O
a	O
major	O
concern	O
in	O
environmental	O
health	O
research	O
,	O
and	O
Amalie	O
Timmermann	O
,	O
a	O
research	O
assistant	O
in	O
the	O
Department	O
of	O
Environmental	O
Medicine	O
at	O
the	O
University	O
of	O
Southern	O
Denmark	O
,	O
points	O
it	O
out	O
as	O
a	O
potential	O
explanation	O
for	O
findings	O
in	O
studies	O
such	O
as	O
these	O
.	O

We	O
also	O
examined	O
GWG	O
as	O
an	O
independent	O
predictor	O
and	O
potential	O
mediator	O
of	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
weight	O
outcomes	O
(	O
Table	O
4	O
).	O

Previous	O
findings	O
from	O
the	O
GraviD	O
study	O
show	O
lower	O
odds	O
of	O
preeclampsia	O
among	O
women	O
with	O
a	O
large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
)	O
in	O
25OHD	O
[	O
3	O
].	O

The	O
Block	O
Food	O
Frequency	O
questionnaire	O
was	O
used	O
to	O
assess	O
daily	O
caloric	O
intake	O
,	O
calories	O
from	O
sugar	O
-	O
sweetened	O
beverages	O
,	O
and	O
percent	O
intake	O
from	O
fat	O
,	O
protein	O
,	O
carbohydrates	O
,	O
and	O
sweets	O
.	O

Leptin	O
is	O
a	O
permissive	O
neuro	O
-	O
regulatory	O
factor	O
for	O
the	O
onset	O
of	O
puberty	O
[	O
43	O
],[	O
44	O
].	O

However	O
,	O
the	O
overall	O
proportion	O
of	O
events	O
accompanied	O
by	O
handwashing	O
was	O
low	O
in	O
the	O
intervention	O
arm	O
compared	O
with	O
the	O
times	O
that	O
we	O
recommended	O
for	O
handwashing	O
.	O

More	O
than	O
60	O
%	O
of	O
all	O
premature	O
babies	O
are	O
born	O
in	O
South	O
Asia	O
and	O
sub	O
-	O
Saharan	O
Africa	O
which	O
have	O
the	O
highest	O
preterm	O
birth	O
rates	O
[	O
15	O
]	O
and	O
half	O
of	O
births	O
are	O
currently	O
in	O
facilities	O
.	O

As	O
with	O
any	O
longitudinal	O
study	O
,	O
we	O
cannot	B
rule	I
out	I
the	O
possibility	O
that	O
exclusion	O
of	O
mother	O
–	O
child	O
pairs	O
without	O
complete	O
information	O
might	O
have	O
biased	O
our	O
findings	O
.	O

Abdomen	O
was	O
gravid	O
,	O
consistent	O
with	O
gestational	O
age	O
.	O

Rats	O
exposed	O
to	O
low	O
prenatal	O
vitamin	O
D	O
have	O
a	O
broad	O
range	O
of	O
neurobiological	O
outcomes	O
that	O
are	O
informative	O
for	O
schizophrenia	O
research	O
.	O

gave	O
2000	O
IU	O
of	O
vitamin	O
D	O
per	O
day	O
to	O
non	O
-	O
pregnant	O
women	O
in	O
form	O
of	O
oral	O
drops	O
for	O
105	O
days	O
.	O

The	O
3	O
′	O
UTR	O
of	O
GR	O
gene	O
(	O
NR3C1	O
)	O
were	O
acquired	O
from	O
NCBI	O
database	O
(	O
NM_001008481	O
.	O
1	O
).	O

We	O
have	O
chosen	O
the	O
current	O
usual	O
programs	O
as	O
our	O
comparator	O
.	O

It	O
is	O
a	O
well	O
-	O
known	O
hormone	O
increasing	O
BAT	O
activity	O
and	O
inducing	O
“	O
browning	O
”	O
of	O
WAT	O
via	O
activation	O
of	O
the	O
sympathetic	O
nervous	O
system	O
and	O
resulting	O
increased	O
β3	O
adrenoceptor	O
signaling	O
(	O
Haynes	O
et	O
al	O
.,	O
1997	O
;	O
Commins	O
et	O
al	O
.,	O
2000	O
).	O

The	O
average	O
number	O
of	O
visits	O
to	O
the	O
general	O
practitioner	O
was	O
4	O
.	O
8	O
±	O
2	O
.	O
54	O
.	O

Serum	O
visfatin	O
levels	O
were	O
measured	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
with	O
human	O
visfatin	O
(	O
ZellBio	O
GmbH	O
,	O
Germany	O
;	O
Ulm	O
kit	O
,	O
Cat	O
No	O
:	O
ZB	O
-	O
3408	O
-	O
H9648	O
).	O

Zinc	O
concentrations	O
are	O
determined	O
in	O
serum	O
using	O
atomic	O
absorption	O
spectrometry	O
[	O
74	O
].	O

The	O
frequency	O
-	O
domain	O
components	O
were	O
also	O
evaluated	O
by	O
a	O
2	O
power	O
spectrum	O
.	O

In	O
contrast	O
,	O
LP	O
fetuses	O
showed	O
an	O
increased	O
expression	O
of	O
transcripts	O
associated	O
with	O
cell	O
division	O
within	O
the	O
corresponding	O
developmental	O
period	O
.	O

Eventually	O
,	O
as	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
increases	O
to	O
toxic	O
concentrations	O
,	O
the	O
classic	O
situation	O
of	O
hypercalciuria	O
,	O
hypercalcemia	O
,	O
and	O
,	O
finally	O
,	O
extraskeletal	O
calcification	O
becomes	O
evident	O
.	O

Additionally	O
,	O
we	O
detected	O
interaction	O
between	O
time	O
and	O
diet	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
2	O
.	O
19	O
,	O
P	O
<	O
0	O
.	O
05	O
],	O
time	O
,	O
and	O
sex	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
13	O
.	O
28	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
time	O
,	O
diet	O
,	O
and	O
sex	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
1	O
.	O
92	O
,	O
P	O
<	O
0	O
.	O
05	O
].	O

Interestingly	O
,	O
epidemiological	O
studies	O
in	O
women	O
showed	O
that	O
maternal	O
malnutrition	O
during	O
pregnancy	O
can	O
result	O
in	O
fetal	O
growth	O
retardation	O
[	O
11	O
,	O
12	O
].	O

Statistical	O
significance	O
was	O
accepted	O
at	O
the	O
p	O
<	O
0	O
.	O
05	O
level	O
.	O

However	O
,	O
these	O
children	O
represent	O
a	O
small	O
proportion	O
of	O
the	O
individuals	O
with	O
a	O
suboptimal	O
vitamin	O
D	O
status	O
in	O
the	O
population	O
.	O

Adipose	O
tissue	O
is	O
also	O
believed	O
to	O
be	O
associated	O
with	O
vitamin	O
D	O
[	O
26	O
–	O
29	O
].	O

While	B
such	O
studies	O
are	O
more	O
difficult	O
to	O
interpret	O
with	O
respect	O
to	O
epigenetic	O
toxicity	O
(	O
and	O
so	O
were	O
not	O
included	O
in	O
this	O
review	O
),	O
they	O
may	O
still	O
provide	O
useful	O
mechanistic	O
data	O
.	O

Nutritional	O
knowledge	O
was	O
significantly	O
associated	O
with	O
the	O
intake	O
of	O
these	O
supplements	O
,	O
regardless	O
of	O
the	O
frequency	O
of	O
prenatal	O
visits	O
or	O
socio	O
-	O
demographic	O
characteristics	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
no	O
one	O
has	O
evaluated	O
the	O
impact	O
of	O
sleep	O
duration	O
and	O
snoring	O
on	O
maternal	O
glucose	O
metabolism	O
in	O
pregnancy	O
.	O

Immediately	O
after	O
delivery	O
the	O
weight	O
of	O
the	O
newborn	O
was	O
recorded	O
.	O

Improve	O
adherence	O
and	O
monitor	O
compliance	O
To	O
improve	O
adherence	O
,	O
a	O
local	O
pharmaceutical	O
company	O
(	O
Eskayef	O
Bangladesh	O
Limited	O
)	O
will	O
produce	O
IFA	O
supplements	O
in	O
an	O
attractive	O
capsule	O
shell	O
and	O
special	O
blister	O
package	O
.	O

However	B
,	O
defining	O
the	O
limits	O
of	O
normal	O
variation	O
for	O
specific	O
epigenetic	O
changes	O
of	O
relevance	O
would	O
be	O
a	O
sensible	O
and	O
pragmatic	O
starting	O
point	O
.	O

Recent	O
data	O
has	O
extended	O
this	O
list	O
to	O
include	O
specific	O
regions	O
not	O
associated	O
with	O
TEs	O
that	O
are	O
preferentially	O
located	O
within	O
CGIs	O
,	O
enhancers	O
,	O
promoters	O
and	O
gene	O
bodies	O
(	O
Seisenberger	O
et	O
al	O
.	O
2012	O
;	O
Hackett	O
et	O
al	O
.	O
2013	O
;	O
Tang	O
et	O
al	O
.	O
2015	O
).	O

There	O
was	O
no	O
difference	O
in	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
(	O
82	O
vs	O
82	O
nmol	O
/	O
L	O
,	O
P	O
=	O
0	O
.	O
99	O
).	O

Investigators	O
estimated	O
the	O
odds	O
of	O
change	O
over	O
time	O
in	O
response	O
to	O
each	O
of	O
the	O
behavioral	O
outcome	O
variables	O
as	O
a	O
function	O
of	O
text4baby	O
text	O
message	O
exposure	O
through	O
use	O
of	O
an	O
interaction	O
term	O
including	O
program	O
exposure	O
and	O
progression	O
to	O
follow	O
-	O
up	O
measurement	O
.	O

Recent	O
surveys	O
in	O
Bangladesh	O
indicate	O
that	O
only	O
52	O
%	O
of	O
rural	O
women	O
reported	O
any	O
use	O
of	O
IFA	O
supplements	O
in	O
their	O
last	O
pregnancy	O
,	O
but	O
this	O
falls	O
to	O
39	O
%	O
for	O
the	O
poorest	O
households	O
,	O
and	O
to	O
34	O
%	O
for	O
women	O
with	O
no	O
education	O
[	O
5	O
].	O

The	O
weight	O
of	O
the	O
supplements	O
bottles	O
at	O
this	O
visit	O
compared	O
to	O
when	O
they	O
were	O
given	O
to	O
the	O
mothers	O
at	O
the	O
first	O
visit	O
was	O
used	O
as	O
a	O
measure	O
of	O
compliance	O
of	O
how	O
often	O
the	O
drops	O
were	O
given	O
to	O
the	O
infant	O
.	O

The	O
majority	O
(	O
84	O
%)	O
of	O
respondents	O
in	O
the	O
intervention	O
arm	O
and	O
44	O
%	O
of	O
respondents	O
in	O
the	O
control	O
arm	O
reported	O
that	O
the	O
primary	O
handwashing	O
station	O
used	O
by	O
the	O
respondent	O
was	O
located	O
in	O
the	O
baby	O
'	O
s	O
sleeping	O
area	O
,	O
at	O
postnatal	O
days	O
4	O
-	O
5	O
(	O
RR	O
=	O
2	O
.	O
2	O
,	O
95	O
%	O
CI	O
1	O
.	O
72	O
–	O
2	O
.	O
92	O
,	O
p	O
<	O
.	O
0001	O
),	O
decaying	O
to	O
51	O
%	O
of	O
respondents	O
in	O
the	O
intervention	O
arm	O
and	O
9	O
%	O
of	O
respondents	O
in	O
the	O
control	O
arm	O
during	O
the	O
last	O
week	O
of	O
the	O
neonatal	O
period	O
(	O
RR	O
=	O
4	O
.	O
7	O
,	O
95	O
%	O
CI	O
2	O
.	O
53	O
–	O
8	O
.	O
76	O
,	O
p	O
<	O
.	O
0001	O
).	O

Maternal	O
Disease	O
In	O
addition	O
to	O
environmental	O
factors	O
,	O
infection	O
and	O
disease	O
may	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
autism	O
.	O

Moreover	O
,	O
CC	O
and	O
RC	O
adult	O
females	O
displayed	O
higher	O
caloric	O
intake	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adult	O
males	O
(	O
day	O
1	O
,	O
2	O
,	O
and	O
4	O
;	O
Figure3D	O
).	O

Comparable	O
results	O
were	O
documented	O
with	O
dietary	O
supplements	O
containing	O
iron	O
and	O
ironfortified	O
milk	O
[	O
30	O
,	O
31	O
].	O

Biologically	O
,	O
the	O
stress	O
hormone	O
cortisol	O
acts	O
by	O
activating	O
glucocorticoid	O
receptors	O
(	O
GRs	O
).	O

(	O
2015	O
)*/†	O
Carlin	O
et	O
al	O
.	O

The	O
vitamin	O
D3and	O
the	O
placebo	O
were	O
the	O
same	O
colour	O
(	O
pale	O
yellow	O
),	O
taste	O
,	O
and	O
quantity	O
(	O
0	O
·	O
5	O
mL	O
)	O
and	O
therefore	O
the	O
study	O
staff	O
and	O
the	O
families	O
did	O
not	O
know	O
to	O
which	O
group	O
the	O
children	O
were	O
assigned	O
.	O

Lignell	O
et	O
al	O
.	O

Recent	O
studies	O
,	O
however	B
,	O
have	O
shown	O
that	O
exposure	O
to	O
valproate	O
during	O
pregnancy	O
indicates	O
a	O
significantly	O
increased	O
risk	O
of	O
autism	O
spectrum	O
disorder	O
,	O
even	O
after	O
adjusting	O
for	O
maternal	O
epilepsy	O
.	O

Illicit	O
Drug	O
Exposure	O
,	O
Smoking	O
,	O
and	O
Pollutants	O
Drug	O
exposure	O
may	O
have	O
very	O
serious	O
complications	O
during	O
pregnancy	O
.	O

The	O
latter	O
has	O
been	O
found	O
also	O
among	O
Korean	O
men	O
[	O
51	O
].	O

Given	O
that	O
all	O
these	O
factors	O
significantly	O
influenced	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
the	O
linear	O
regression	O
model	O
,	O
it	O
was	O
unsurprising	O
that	O
vitamin	O
D	O
status	O
of	O
the	O
women	O
was	O
significantly	O
different	O
between	O
the	O
two	O
recruitment	O
sites	O
.	O

Women	O
in	O
the	O
highest	O
compared	O
with	O
the	O
lowest	O
quartile	O
of	O
vitamin	O
D	O
consumption	O
experienced	O
a	O
37	O
%	O
(	O
95	O
%	O
CI	O
,	O
22	O
-	O
50	O
%)	O
lower	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Results	O
All	O
15	O
cases	O
of	O
anaphylaxis	O
involved	O
multi	O
ingredient	O
products	O
with	O
NHP	O
doses	O
(	O
up	O
to	O
and	O
including	O
1	O
mg	O
).	O

Despite	O
we	O
found	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Ppar	O
γ	O
,	O
opposite	B
results	O
after	O
the	O
exposure	O
to	O
undernutrition	O
(	O
Bispham	O
et	O
al	O
.,	O
2005	O
)	O
and	O
similar	O
results	O
after	O
malnutrition	O
during	O
early	O
development	O
have	O
been	O
documented	O
(	O
Ahmad	O
et	O
al	O
.,	O
2013	O
;	O
Reynolds	O
et	O
al	O
.,	O
2014	O
).	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
when	O
compared	O
to	O
the	O
women	O
recruited	O
in	O
Auckland	O
and	O
remained	O
lower	O
after	O
adjusting	O
for	O
covariates	O
including	O
maternal	O
body	O
mass	O
index	O
and	O
socioeconomic	O
index	O
(	O
Adelaide	O
:	O
58	O
.	O
4	O
±	O
50	O
.	O
3	O
vs	O
.	O
Auckland	O
:	O
70	O
.	O
2	O
±	O
54	O
.	O
5	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

[	O
37	O
–	O
41	O
].	O

Reactive	O
oxygen	O
species	O
are	O
also	O
proposed	O
to	O
stimulate	O
the	O
production	O
of	O
alpha	O
-	O
ketoglutarate	O
,	O
a	O
co	O
-	O
substrate	O
for	O
TETs	O
and	O
one	O
of	O
the	O
two	O
main	O
classes	O
of	O
histone	O
demethylases	O
(	O
Chervona	O
&	O
Costa2012	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

Dams	O
(	O
and	O
corresponding	O
litters	O
)	O
were	O
placed	O
under	O
control	O
conditions	O
for	O
the	O
remainder	O
of	O
the	O
experiment	O
.	O

Animals	O
,	O
housing	O
,	O
mating	O
,	O
and	O
feeding	O
Adolescent	O
female	O
Wistar	O
rats	O
(	O
Harlan	O
,	O
Barcelona	O
,	O
Spain	O
)	O
weighing	O
191	O
.	O
7	O
±	O
2	O
.	O
6	O
g	O
were	O
individually	O
housed	O
in	O
standard	O
cages	O
and	O
maintained	O
in	O
controlled	O
room	O
conditions	O
at	O
21	O
±	O
1	O
°	O
C	O
room	O
temperature	O
,	O
40	O
±	O
5	O
%	O
relative	O
humidity	O
and	O
a	O
12	O
-	O
h	O
light	O
-	O
dark	O
cycle	O
(	O
lights	O
off	O
8	O
:	O
00	O
p	O
.	O
m	O
.).	O

Ancient	O
Chinese	O
Cancer	O
Secret	O
?	O

Estimates	O
of	O
BAT	O
mass	O
and	O
activity	O
from	O
FDG	O
-	O
PET	O
studies	O
suggest	O
that	O
humans	O
have	O
,	O
on	O
average	O
,	O
50	O
–	O
80	O
g	O
of	O
BAT	O
(	O
Peirce	O
et	O
al	O
.,	O
2014	O
).	O

Furthermore	O
,	O
in	O
this	O
study	O
,	O
we	O
performed	O
analysis	O
only	O
of	O
candidate	O
SNPs	O
previously	O
identified	O
to	O
be	O
associated	O
with	O
differences	O
in	O
25	O
(	O
OH	O
)	O
D	O
status	O
.	O

PCBs	O
,	O
PBDEs	O
,	O
OCPs	O
and	O
OPPs	O
were	O
lipid	O
-	O
normalized	O
in	O
units	O
of	O
ng	O
/	O
g	O
serum	O
lipid	O
.	O

[	O
13	O
]	O
Kruavit	O
et	O
al	O
.	O

As	O
S	O
-	O
ECC	O
is	O
influenced	O
by	O
the	O
social	O
determinants	O
of	O
health	O
,	O
there	O
were	O
differences	O
in	O
parental	O
education	O
levels	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
household	O
income	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
between	O
groups	O
,	O
with	O
lower	O
levels	O
of	O
both	O
education	O
and	O
household	O
income	O
in	O
the	O
S	O
-	O
ECC	O
group	O
.	O

We	O
conducted	O
stratified	O
analyses	O
by	O
parity	O
status	O
to	O
assess	O
whether	B
the	O
trend	O
of	O
effectiveness	O
is	O
different	O
among	O
the	O
two	O
nulliparous	O
and	O
multiparous	O
subgroups	O
.	O

Vitamin	O
D	O
deficiency	O
is	O
closely	O
associated	O
with	O
Gestational	O
Diabetes	O
Mellitus	O
(	O
GDM	O
).	O

To	O
examine	O
whether	B
“	O
global	O
methylation	O
”	O
represented	O
as	O
an	O
average	O
of	O
gene	O
-	O
associated	O
methylation	O
identified	O
in	O
a	O
genomewide	O
manner	O
was	O
associated	O
with	O
infant	O
growth	O
,	O
we	O
tested	O
for	O
an	O
association	O
between	O
birth	O
weight	O
percentile	O
and	O
mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
autosomal	O
loci	O
measured	O
using	O
the	O
Illumina	O
Infinium	O
array	O
in	O
a	O
subset	O
of	O
184	O
placenta	O
samples	O
.	O

However	O
,	O
at	O
least	O
two	O
old	O
papers	O
have	O
addressed	O
it	O
(	O
10	O
,	O
11	O
),	O
both	O
published	O
before	O
Kanner	O
described	O
autism	O
in	O
1943	O
.	O

Whereas	B
in	O
pregnancy	O
,	O
serum	O
ferritin	O
levels	O
decline	O
even	O
in	O
women	O
ingesting	O
daily	O
supplements	O
of	O
iron	O
[	O
22	O
–	O
24	O
].	O

Peer	O
-	O
reviewed	O
journal	O
articles	O
published	O
between	O
January	O
2000	O
and	O
March	O
2014	O
were	O
included	O
.	O

No	O
specific	O
etiologic	O
agent	O
to	O
date	O
has	O
been	O
identified	O
to	O
support	O
such	O
a	O
long	O
induction	O
period	O
for	O
this	O
cancer	O
.	O

We	O
also	O
did	O
not	O
find	O
any	O
significant	O
relationship	O
between	O
cord	O
25	O
(	O
OH	O
)	O
D	O
values	O
and	O
growth	O
outcomes	O
.	O

Association	O
between	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
and	O
OGTT	O
results	O
/	O
birth	O
weight	O
,	O
and	O
between	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
and	O
head	O
circumference	O
at	O
birth	O
were	O
tested	O
with	O
univariate	O
linear	O
regression	O
.	O

Analysis	O
of	O
the	O
pathways	O
involved	O
was	O
carried	O
out	O
using	O
Ingenuity	O
Pathway	O
Analysis	O
[	O
67	O
].	O

Other	O
factors	O
include	O
poor	O
nutrition	O
,	O
crowding	O
,	O
seasonal	O
travel	O
,	O
hygiene	O
practices	O
,	O
cultural	O
practices	O
in	O
food	O
consumption	O
/	O
preparation	O
,	O
changes	O
in	O
herd	O
immunity	O
,	O
or	O
evolution	O
of	O
the	O
infectious	O
agent	O
over	O
time	O
.	O

We	O
analyzed	O
maternal	O
plasma	O
glucose	O
concentrations	O
1	O
hour	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
as	O
part	O
of	O
routine	O
mid	O
-	O
pregnancy	O
screening	O
for	O
GDM	O
.	O

The	O
increased	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
in	O
neonates	O
relative	O
to	O
maternal	O
BMI	O
level	O
were	O
seen	O
in	O
both	O
blacks	O
and	O
whites	O
in	O
our	O
study	O
population	O
and	O
supports	O
similar	O
findings	O
seen	O
in	O
a	O
study	O
done	O
by	O
Bodnar	O
et	O
al	O
.	O
38Although	O
prenatal	O
vitamin	O
use	O
was	O
not	O
significantly	O
different	O
between	O
blacks	O
and	O
whites	O
in	O
our	O
study	O
,	O
prenatal	O
vitamin	O
use	O
was	O
significant	O
among	O
those	O
with	O
and	O
without	O
vitamin	O
D	O
deficiency	O
.	O

Yet	B
,	O
our	O
main	O
results	O
were	O
repeated	O
in	O
a	O
subgroup	O
analysis	O
of	O
only	O
those	O
women	O
to	O
whom	O
an	O
OGTT	O
was	O
performed	O
.	O

Interestingly	O
,	O
caloric	O
restriction	O
induced	O
a	O
higher	O
reduction	O
in	O
total	O
intake	O
in	O
the	O
female	O
offspring	O
treated	O
with	O
AM251	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Baseline	O
sample	O
descriptive	O
statistics	O
(	O
N	O
=	O
943	O
).	O
VariablesParticipantsAge	O
(	O
years	O
),	O
mean	O
(	O
SD	O
)	O
943	O
(	O
26	O
.	O
5	O
)	O
Age	O
range	O
(	O
years	O
),	O
n	O
(%)<	O
2031	O
(	O
3	O
.	O
3	O
)	O
20	O
-	O
34837	O
(	O
88	O
.	O
8	O
)≥	O
3575	O
(	O
7	O
.	O
9	O
)	O
Race	O
,	O
n	O
(%)	O
White656	O
(	O
69	O
.	O
6	O
)	O
Black75	O
(	O
7	O
.	O
9	O
)	O
Asian	O
-	O
Pacific	O
Islander25	O
(	O
2	O
.	O
6	O
)	O
Western	O
Hemisphere	O
Indians2	O
(	O
0	O
.	O
2	O
)	O
Other	O
/	O
unknown185	O
(	O
19	O
.	O
6	O
)	O
Ethnicity	O
,	O
n	O
(%)	O
Filipino206	O
(	O
21	O
.	O
8	O
)	O
Hispanic53	O
(	O
5	O
.	O
6	O
)	O
Other	O
Asian	O
/	O
Pacific	O
Islander19	O
(	O
2	O
.	O
0	O
)	O
Southeast	O
Asian6	O
(	O
0	O
.	O
6	O
)	O
Other	O
/	O
unknown	O
/	O
non	O
-	O
Hispanic659	O
(	O
69	O
.	O
9	O
)	O
Marital	O
status	O
,	O
n	O
(%)	O
Single	O
/	O
never	O
married72	O
(	O
7	O
.	O
6	O
)	O
Married663	O
(	O
70	O
.	O
3	O
)	O
Separated	O
/	O
divorced	O
/	O
widowed7	O
(	O
0	O
.	O
7	O
)	O
Unknown	O
/	O
null201	O
(	O
21	O
.	O
3	O
)	O
Sponsor	O
rank	O
,	O
n	O
(%)	O
Enlisted819	O
(	O
86	O
.	O
8	O
)	O
Commissioned	O
officers107	O
(	O
11	O
.	O
3	O
)	O
Warrant	O
officers13	O
(	O
1	O
.	O
4	O
)	O
Other4	O
(	O
0	O
.	O
4	O
)	O
Parity	O
,	O
n	O
(%)	O
No492	O
(	O
52	O
.	O
2	O
)	O
Yes451	O
(	O
47	O
.	O
8	O
)	O
Prepregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
mean	O
(	O
SD	O
)	O
327	O
(	O
27	O
.	O
2	O
)	O
BMI	O
category	O
,	O
n	O
(%)	O
Underweight7	O
(	O
0	O
.	O
7	O
)	O
Normal154	O
(	O
16	O
.	O
4	O
)	O
Overweight97	O
(	O
10	O
.	O
3	O
)	O
Obese63	O
(	O
6	O
.	O
7	O
)	O
Ever	O
participated	O
in	O
WIC	O
program	O
,	O
n	O
(%)	O
320	O
(	O
33	O
.	O
9	O
)	O
Currently	O
in	O
school	O
or	O
working	O
outside	O
the	O
home	O
,	O
n	O
(%)	O
595	O
(	O
63	O
.	O
1	O
)	O
Ever	O
gone	O
online	O
to	O
search	O
for	O
prenatal	O
care	O
information	O
,	O
n	O
(%)	O
711	O
(	O
75	O
.	O
4	O
)	O
Equivalence	O
of	O
means	O
at	O
baseline	O
was	O
tested	O
by	O
comparing	O
the	O
baseline	O
treatment	O
and	O
control	O
condition	O
samples	O
.	O

Because	O
the	O
risk	O
of	O
developing	O
GDM	O
gradually	O
increases	O
in	O
overweight	O
and	O
obese	O
women	O
,	O
the	O
total	O
sample	O
was	O
divided	O
into	O
three	O
pre	O
-	O
pregnancy	O
BMI	O
groups	O
for	O
comparison	O
:	O
BMI	O
<	O
25	O
kg	O
/	O
m2	O
,	O
BMI	O
≥	O
25	O
kg	O
/	O
m2and	O
<	O
30	O
kg	O
/	O
m2and	O
BMI	O
≥	O
30	O
kg	O
/	O
m2	O
.	O

The	O
current	O
recommendation	O
of	O
health	O
care	O
professionals	O
is	O
to	O
avoid	O
anticonvulsant	O
drug	O
use	O
such	O
as	O
valproate	O
during	O
pregnancy	O
.	O

The	O
steers	O
of	O
the	O
normally	O
weaned	O
steers	O
supplemented	O
with	O
grain	O
were	O
raised	O
under	O
the	O
same	O
conditions	O
as	O
the	O
normally	O
weaned	O
animals	O
,	O
but	O
they	O
were	O
supplemented	O
with	O
grain	O
for	O
55	O
d	O
on	O
pasture	O
(	O
study	O
1	O
,	O
177	O
to	O
231	O
d	O
of	O
age	O
;	O
study	O
2	O
,	O
158	O
to	O
213	O
d	O
of	O
age	O
).	O

Furthermore	O
,	O
the	O
propensity	O
score	O
analyses	O
minimized	O
biases	O
introduced	O
by	O
differences	O
in	O
baseline	O
characteristics	O
between	O
unvaccinated	O
and	O
vaccinated	O
pregnant	O
women	O
by	O
accounting	O
for	O
the	O
probability	O
of	O
vaccination	O
based	O
on	O
these	O
characteristics	O
[	O
43	O
].	O

We	O
intended	O
to	O
recruit	O
a	O
minimum	O
of	O
250	O
participants	O
.	O

Although	O
calcium	O
and	O
phosphorus	O
are	O
transported	O
transplacentally	O
without	O
vitamin	O
D	O
,	O
the	O
effects	O
of	O
low	O
vitamin	O
D	O
in	O
utero	O
or	O
shortly	O
after	O
birth	O
are	O
uncertain	O
[	O
7	O
].	O

The	O
mother	O
was	O
correlated	O
with	O
the	O
MGM	O
and	O
with	O
the	O
MGF	O
,	O
while	O
the	O
father	O
was	O
also	O
correlated	O
with	O
his	O
mother	O
and	O
father	O
.	O

The	O
above	O
studies	O
provide	O
reassurance	O
that	O
moderate	O
intensity	O
activities	O
such	O
as	O
walking	O
for	O
20	O
–	O
30	O
minutes	O
each	O
day	O
,	O
and	O
attendance	O
at	O
antenatal	O
exercise	O
classes	O
can	O
be	O
safely	O
encouraged	O
,	O
and	O
that	O
modest	O
improvements	O
in	O
glycemic	O
control	O
might	O
be	O
achieved	O
.	O

They	O
reported	O
that	O
the	O
average	O
breed	O
type	O
list	O
included	O
purebred	O
or	O
crossbred	O
Angus	O
,	O
Brahman	O
,	O
Simmental	O
,	O
Charolais	O
,	O
Hereford	O
,	O
Jersey	O
,	O
Korean	O
Brown	O
cattle	O
,	O
Maine	O
Anjou	O
,	O
Pinzgauer	O
,	O
Sahiwal	O
,	O
Salers	O
,	O
and	O
South	O
Devon	O
with	O
estimates	O
MS	O
heritability	O
of	O
0	O
.	O
37	O
(	O
range	O
0	O
.	O
30	O
to	O
0	O
.	O
57	O
).	O

Radunz	O
et	O
al	O
[	O
156	O
]	O
tested	O
the	O
effects	O
of	O
three	O
maternal	O
late	O
-	O
gestational	O
dietary	O
energy	O
sources	O
(	O
grass	O
hay	O
,	O
corn	O
,	O
and	O
dried	O
corn	O
distillers	O
grains	O
with	O
solubles	O
)	O
on	O
progeny	O
postnatal	O
growth	O
and	O
beef	O
MS	O
in	O
an	O
Angus	O
cross	O
-	O
breed	O
.	O

Client	O
satisfaction	O
remained	O
high	O
over	O
the	O
project	O
,	O
between	O
4	O
.	O
3	O
-	O
4	O
.	O
7	O
/	O
5	O
.	O

VD	O
analog	O
supplementation	O
proved	O
to	O
be	O
effective	O
not	O
only	O
in	O
fertility	O
treatment	O
but	O
also	O
in	O
the	O
prevention	O
of	O
type	O
1	O
diabetes	O
in	O
non	O
-	O
obese	O
diabetic	O
(	O
NOD	O
)	O
mice	O
and	O
the	O
prolongation	O
of	O
survival	O
of	O
syngeneic	O
islets	O
grafts	O
[	O
58	O
].	O

These	O
alterations	O
are	O
primarily	O
the	O
result	O
of	O
hormonal	O
effects	O
.	O

Other	O
studies	O
found	O
a	O
significant	O
correlation	O
between	O
low	O
birth	O
weight	O
and	O
increased	O
sympathetic	O
activity	O
in	O
adolescent	O
twin	O
pairs	O
and	O
young	O
adults	O
;	O
however	B
,	O
this	O
result	O
did	O
not	O
observed	O
gender	O
differences	B
[	O
37	O
,	O
38	O
].	O

Different	B
factors	O
can	O
partially	O
explain	O
the	O
discrepancies	B
found	O
in	O
food	O
preferences	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
fishDietary	O
intakePositive	O
psychotic	O
-	O
like	O
symptomsaLow	O
level	O
groupMiddle	O
level	O
groupHigh	O
level	O
groupEnergy	O
adjustedMultivariatebEnergy	O
adjustedMultivariatebNo	O
.	O
No	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CINo	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CI	O
Salmon	O
-	O
type	O
fish	O
and	O
herring	O
/	O
mackerel	O
,	O
frequency	O
never5	O
027Ref	O
.	O
4	O
0902521	O
-	O
3	O
per	O
month5	O
9624	O
5470	O
.	O
930	O
.	O
88	O
-	O
0	O
.	O
980	O
.	O
99c0	O
.	O
93	O
-	O
1	O
.	O
052160	O
.	O
720	O
.	O
60	O
-	O
0	O
.	O
860	O
.	O
81c0	O
.	O
66	O
-	O
0	O
.	O
981	O
per	O
week6	O
3814	O
7270	O
.	O
900	O
.	O
85	O
-	O
0	O
.	O
950	O
.	O
99c0	O
.	O
93	O
-	O
1	O
.	O
052480	O
.	O
760	O
.	O
64	O
-	O
0	O
.	O
900	O
.	O
92c0	O
.	O
75	O
-	O
1	O
.	O
12	O
≥	O
2	O
per	O
week4945261	O
.	O
271	O
.	O
12	O
-	O
1	O
.	O
431	O
.	O
32c1	O
.	O
15	O
-	O
1	O
.	O
51481	O
.	O
741	O
.	O
26	O
-	O
2	O
.	O
391	O
.	O
90c1	O
.	O
34	O
-	O
2	O
.	O
70	O
Cod	O
/	O
saithe	O
/	O
pike	O
,	O
frequency	O
never1	O
289Ref	O
.	O
1	O
136961	O
-	O
3	O
per	O
month7	O
0095	O
3110	O
.	O
850	O
.	O
78	O
-	O
0	O
.	O
930	O
.	O
89d0	O
.	O
82	O
-	O
0	O
.	O
983220	O
.	O
620	O
.	O
49	O
-	O
0	O
.	O
780	O
.	O
70d0	O
.	O
55	O
-	O
0	O
.	O
891	O
per	O
week8	O
0966	O
1850	O
.	O
840	O
.	O
77	O
-	O
0	O
.	O
920	O
.	O
87d0	O
.	O
80	O
-	O
0	O
.	O
952700	O
.	O
430	O
.	O
34	O
-	O
0	O
.	O
550	O
.	O
46d0	O
.	O
36	O
-	O
0	O
.	O
59	O
≥	O
2	O
per	O
week1	O
4701	O
2580	O
.	O
930	O
.	O
83	O
-	O
1	O
.	O
040	O
.	O
90d0	O
.	O
81	O
-	O
1	O
.	O
01760	O
.	O
690	O
.	O
50	O
-	O
0	O
.	O
930	O
.	O
57d0	O
.	O
41	O
-	O
0	O
.	O
79	O
Shellfish	O
,	O
frequency	O
never4	O
540Ref	O
.	O
3	O
8152431	O
-	O
3	O
per	O
month11	O
0758	O
2190	O
.	O
880	O
.	O
84	O
-	O
0	O
.	O
930	O
.	O
90e0	O
.	O
85	O
-	O
0	O
.	O
954120	O
.	O
700	O
.	O
59	O
-	O
0	O
.	O
820	O
.	O
78e0	O
.	O
66	O
-	O
0	O
.	O
931	O
per	O
week1	O
8931	O
4530	O
.	O
910	O
.	O
84	O
-	O
0	O
.	O
990	O
.	O
92e0	O
.	O
84	O
-	O
1	O
.	O
00780	O
.	O
770	O
.	O
59	O
-	O
1	O
.	O
000	O
.	O
84e0	O
.	O
64	O
-	O
1	O
.	O
11	O
≥	O
2	O
per	O
week3564031	O
.	O
341	O
.	O
15	O
-	O
1	O
.	O
551	O
.	O
28e1	O
.	O
09	O
-	O
1	O
.	O
49311	O
.	O
701	O
.	O
16	O
-	O
2	O
.	O
481	O
.	O
42e0	O
.	O
94	O
-	O
2	O
.	O
14	O
All	O
fish	O
and	O
seafood	O
,	O
frequency	O
never533Ref	O
.	O
476441	O
-	O
3	O
per	O
month1	O
1319960	O
.	O
960	O
.	O
82	O
-	O
1	O
.	O
110	O
.	O
96	O
f0	O
.	O
83	O
-	O
1	O
.	O
12840	O
.	O
870	O
.	O
60	O
-	O
1	O
.	O
270	O
.	O
89	O
f0	O
.	O
61	O
-	O
1	O
.	O
311	O
per	O
week7	O
0255	O
4500	O
.	O
830	O
.	O
73	O
-	O
0	O
.	O
950	O
.	O
86	O
f0	O
.	O
76	O
-	O
0	O
.	O
892900	O
.	O
480	O
.	O
34	O
-	O
0	O
.	O
670	O
.	O
51	O
f0	O
.	O
36	O
-	O
0	O
.	O
712	O
per	O
week7	O
2155	O
2610	O
.	O
770	O
.	O
68	O
-	O
0	O
.	O
880	O
.	O
82	O
f0	O
.	O
71	O
-	O
0	O
.	O
932640	O
.	O
420	O
.	O
30	O
-	O
0	O
.	O
580	O
.	O
45	O
f0	O
.	O
32	O
-	O
0	O
.	O
643	O
-	O
4	O
per	O
week1	O
9871	O
6680	O
.	O
880	O
.	O
77	O
-	O
1	O
.	O
020	O
.	O
93	O
f0	O
.	O
80	O
-	O
1	O
.	O
07800	O
.	O
450	O
.	O
31	O
-	O
0	O
.	O
660	O
.	O
47	O
f0	O
.	O
31	O
-	O
0	O
.	O
70	O
>	O
5	O
per	O
week5205411	O
.	O
090	O
.	O
92	O
-	O
1	O
.	O
301	O
.	O
13	O
f0	O
.	O
94	O
-	O
1	O
.	O
35551	O
.	O
190	O
.	O
78	O
-	O
1	O
.	O
811	O
.	O
12	O
f0	O
.	O
72	O
-	O
1	O
.	O
74	O
aParticipants	O
categorized	O
into	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
;	O
low	O
,	O
middle	O
,	O
high	O
(	O
see	O
methods	O
section	O
)	O
bIn	O
the	O
multivariate	O
analysis	O
presented	O
,	O
we	O
initially	O
tested	O
the	O
effects	O
of	O
adjusting	O
also	O
for	O
BMI	O
,	O
level	O
of	O
education	O
,	O
country	O
of	O
birth	O
,	O
smoking	O
,	O
dietary	O
intake	O
of	O
meat	O
,	O
dairy	O
products	O
,	O
fruits	O
,	O
cereals	O
and	O
refined	O
sugar	O
,	O
rheumatoid	O
arthritis	O
,	O
gluten	O
intolerance	O
,	O
diabetes	O
and	O
multivitamin	O
supplement	O
.	O

Castrating	O
bulls	O
gener	O
ally	O
increases	O
IMF	O
content	O
in	O
several	O
breeds	O
,	O
including	O
Korean	O
cattle	O
and	O
Holstein	O
[	O
9	O
,	O
38	O
–	O
40	O
].	O

These	O
findings	O
are	O
supported	O
by	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

The	O
mean	O
duration	O
of	O
fetal	O
exposure	O
to	O
an	O
SGA	O
was	O
31	O
.	O
2	O
weeks	O
and	O
ranged	O
from	O
4	O
to	O
42	O
weeks	O
.	O

Since	O
the	O
maternal	O
attitude	O
towards	O
the	O
pregnancy	O
was	O
a	O
significant	O
predictor	O
of	O
fetal	O
birth	O
weight	O
,	O
we	O
reexamined	O
this	O
association	O
as	O
a	O
function	O
of	O
the	O
GR	O
genepolymorphisms	O
,	O
resembling	O
a	O
gene	O
-	O
environment	O
interaction	O
and	O
statistically	O
controlling	O
for	O
mothers	O
'	O
age	O
,	O
BMI	O
,	O
pregnancy	O
planning	O
,	O
and	O
pregnancy	O
nutritional	O
habits	O
,	O
to	O
remove	O
any	O
potential	O
sources	O
of	O
statistical	O
bias	O
that	O
could	O
skew	O
our	O
data	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
between	O
overall	O
satisfaction	O
and	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
study	O
populationSocio	O
–	O
demographic	O
characteristicsLevel	O
of	O
satisfactionX2	O
;	O
P	O
-	O
valueSatisfied	O
(%)	O
Not	O
satisfied	O
(%)	O
marital	O
statussingle99	O
(	O
87	O
.	O
6	O
)	O
14	O
(	O
12	O
.	O
4	O
)	O
1	O
.	O
99	O
;	O
p	O
=	O
0	O
.	O
159married218	O
(	O
80	O
.	O
1	O
)	O
54	O
(	O
19	O
.	O
9	O
)	O
Age	O
group15	O
–	O
2061	O
(	O
85	O
.	O
9	O
)	O
10	O
(	O
14	O
.	O
1	O
)	O
5	O
.	O
66	O
;	O
p	O
=	O
0	O
.	O
22621	O
–	O
25125	O
(	O
79	O
.	O
6	O
)	O
32	O
(	O
20	O
.	O
4	O
)	O
26	O
–	O
3087	O
(	O
88	O
.	O
8	O
)	O
11	O
(	O
11	O
.	O
2	O
)	O
31	O
–	O
3536	O
(	O
85	O
.	O
7	O
)	O
6	O
(	O
14	O
.	O
3	O
)	O
36	O
–	O
4014	O
(	O
82	O
.	O
4	O
)	O
3	O
(	O
17	O
.	O
6	O
)	O
Pregnancy	O
groupprimigravida138	O
(	O
87	O
.	O
9	O
)	O
19	O
(	O
12	O
.	O
1	O
)	O
4	O
.	O
217	O
;	O
p	O
=	O
0	O
.	O
042	O
–	O
7	O
pregnancies214	O
(	O
93	O
.	O
6	O
)	O
14	O
(	O
6	O
.	O
4	O
)	O
Number	O
of	O
visit2105	O
(	O
82	O
.	O
7	O
)	O
22	O
(	O
17	O
.	O
3	O
)	O
1	O
.	O
249	O
;	O
p	O
=	O
0	O
.	O
333	O
–	O
9222	O
(	O
86	O
)	O
36	O
(	O
14	O
)	O
Educational	O
levelPrimary98	O
(	O
92	O
.	O
5	O
)	O
8	O
(	O
7	O
.	O
5	O
)	O
8	O
.	O
714	O
;	O
p	O
=	O
0	O
.	O
01Secondary190	O
(	O
94	O
.	O
1	O
)	O
12	O
(	O
5	O
.	O
9	O
)	O
Tertiary64	O
(	O
83	O
.	O
1	O
)	O
13	O
(	O
16	O
.	O
9	O
)	O
Recommendations	O
from	O
the	O
study	O
participants	O
Of	O
the	O
385	O
respondents	O
,	O
less	O
than	O
half	O
,	O
42	O
.	O
3	O
%	O
(	O
163	O
)	O
proposed	O
a	O
recommendation	O
to	O
ameliorate	O
or	O
improve	O
service	O
delivery	O
by	O
the	O
health	O
centres	O
.	O

The	O
size	O
of	O
the	O
correlation	O
between	O
the	O
child	O
and	O
the	O
mother	O
at	O
this	O
age	O
was	O
similar	O
to	O
that	O
between	O
the	O
mother	O
and	O
the	O
MGM	O
and	O
the	O
father	O
and	O
the	O
PGM	O
.	O

Statistical	O
analysis	O
We	O
assumed	O
that	O
the	O
incidence	O
of	O
the	O
first	O
or	O
the	O
only	O
episode	O
of	O
pneumonia	O
(	O
first	O
episode	O
)	O
in	O
our	O
placebo	O
group	O
would	O
be	O
0	O
·	O
0585	O
per	O
child	O
per	O
year	O
based	O
on	O
the	O
report	O
that	O
the	O
incidence	O
of	O
acute	O
lower	O
respiratory	O
infections	O
in	O
developing	O
countries	O
was	O
greater	O
than	O
0	O
·	O
65	O
per	O
child	O
per	O
year	O
,	O
18that	O
12	O
%	O
of	O
these	O
episodes	O
were	O
pneumonia	O
,	O
and	O
75	O
%	O
were	O
first	O
episodes	O
.	O

This	O
observation	O
is	O
similar	O
to	O
studies	O
carried	O
out	O
in	O
Kenya	O
[	O
13	O
]	O
and	O
South	O
Africa	O
[	O
14	O
]	O
where	O
women	O
started	O
clinic	O
late	O
because	O
of	O
perceived	O
lack	O
of	O
benefit	O
,	O
limited	O
facility	O
access	O
,	O
uncertainty	O
about	O
pregnancy	O
and	O
“	O
laziness	O
”	O
to	O
go	O
for	O
many	O
visits	O
.	O

Introduction	O
In	O
2009	O
,	O
the	O
Institute	O
of	O
Medicine	O
(	O
IOM	O
)	O
revised	O
its	O
guidelines	O
for	O
appropriate	O
weight	O
gain	O
during	O
pregnancy	O
,	O
taking	O
into	O
account	O
the	O
growing	O
prevalence	O
of	O
obesity	O
in	O
women	O
of	O
childbearing	O
age	O
[	O
1	O
].	O

Wrote	O
the	O
paper	O
:	O
MO	O
KW	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
A	O
research	O
pipeline	O
advancing	O
knowledge	O
to	O
address	O
preterm	O
birth	O
.	O
DescriptionDiscoveryDevelopmentDeliveryCharacterise	O
the	O
problemUnderstand	O
the	O
problemCreate	O
and	O
develop	O
new	O
interventionsAdvance	O
equitable	O
access	O
to	O
interventionsResearch	O
aimDescriptive	O
epidemiology	O
to	O
understand	O
determinants	O
,	O
advance	O
definitionsDevelopment	O
of	O
new	O
interventions	O
or	O
adapting	O
or	O
improving	O
existing	O
interventionsDevelopment	O
of	O
new	O
interventions	O
or	O
adapting	O
or	O
improving	O
existing	O
interventionsDelivery	O
of	O
interventions	O
at	O
scale	O
through	O
innovative	O
approachesPreterm	O
prevention	O
research	O
themes	O
•	O
Improve	O
collection	O
,	O
analysis	O
,	O
interpretation	O
,	O
application	O
of	O
epidemiological	O
data	O
for	O
:•	O
Refining	O
,	O
disseminating	O
standard	O
definitions	O
of	O
exposures	O
,	O
outcomes	O
and	O
phenotypes	O
•	O
Further	O
understanding	O
of	O
risk	O
factors	O
for	O
preterm	O
birth	O
•	O
Monitoring	O
and	O
evaluating	O
impact	O
of	O
interventions	O
•	O
Improving	O
the	O
estimates	O
and	O
data	O
collection	O
systems	O
•	O
Increase	O
knowledge	O
of	O
the	O
biology	O
of	O
normal	O
and	O
abnormal	O
pregnancy	O
•	O
Better	O
understand	O
modifiable	O
mechanisms	O
contributing	O
to	O
preterm	O
birth	O
(	O
e	O
.	O
g	O
.,	O
preconceptual	O
or	O
antenatal	O
nutrition	O
,	O
infection	O
and	O
immune	O
response	O
)•	O
Advance	O
understanding	O
of	O
underlying	O
pathophysiology	O
of	O
preterm	O
newborns	O
and	O
impact	O
of	O
co	O
-	O
morbidities	O
on	O
outcomes	O
in	O
different	O
country	O
settings	O
•	O
Create	O
,	O
develop	O
new	O
interventions	O
(	O
e	O
.	O
g	O
.,	O
novel	O
approaches	O
to	O
preventing	O
preterm	O
birth	O
)•	O
Adapt	O
existing	O
interventions	O
to	O
increase	O
effect	O
,	O
reduce	O
cost	O
,	O
or	O
expand	O
utilisation	O
and	O
access	O
•	O
Evaluate	O
impact	O
,	O
cost	O
and	O
process	O
of	O
known	O
interventions	O
to	O
reduce	O
preterm	O
birth	O
(	O
e	O
.	O
g	O
.,	O
family	O
planning	O
,	O
STI	O
management	O
,	O
malaria	O
prevention	O
)•	O
Social	O
behaviour	O
change	O
research	O
to	O
address	O
lifestyle	O
factors	O
and	O
other	O
risks	O
for	O
preterm	O
birth	O
•	O
Effective	O
approaches	O
to	O
increase	O
use	O
of	O
antenatal	O
steroids	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
settingsPremature	O
baby	O
care	O
research	O
themes	O
•	O
Create	O
new	O
devices	O
and	O
drugs	O
for	O
preterm	O
babies	O
that	O
are	O
feasible	O
to	O
use	O
in	O
low	O
-	O
income	O
settings	O
•	O
Adapt	O
existing	O
interventions	O
to	O
increase	O
effect	O
,	O
reduce	O
cost	O
,	O
and	O
/	O
or	O
improve	O
deliverability	O
in	O
challenging	O
settings	O
or	O
at	O
community	O
level	O
(	O
e	O
.	O
g	O
.,	O
robust	O
,	O
simpler	O
technologies	O
)•	O
Implementation	O
research	O
to	O
adapt	O
and	O
scale	O
up	O
context	O
-	O
specific	O
packages	O
of	O
care	O
for	O
preterm	O
babies	O
(	O
e	O
.	O
g	O
.,	O
examining	O
task	O
shifting	O
,	O
innovative	O
commodities	O
,	O
etc	O
.	O

Inclusion	O
of	O
older	O
children	O
and	O
young	O
adults	O
would	O
allow	O
cathelicidin	O
to	O
be	O
followed	O
throughout	O
a	O
longer	O
period	O
of	O
childhood	O
development	O
and	O
further	O
describe	O
how	O
cathelicidin	O
and	O
innate	O
immune	O
function	O
develop	O
over	O
time	O
.	O

The	O
first	O
national	O
micronutrients	O
status	O
survey	O
,	O
published	O
in	O
early	O
2013	O
,	O
reported	O
that	O
iron	O
deficiency	O
among	O
non	O
-	O
pregnant	O
non	O
-	O
lactating	O
women	O
was	O
7	O
.	O
1	O
%.	O

The	O
text4baby	O
program	O
also	O
offers	O
an	O
example	O
of	O
using	O
behavioral	O
theory	O
to	O
the	O
design	O
mHealth	O
interventions	O
[	O
1	O
].	O

In	O
order	O
to	O
survey	O
expression	O
of	O
the	O
liver	O
tissue	O
samples	O
,	O
total	O
transcript	O
levels	O
of	O
selected	O
target	O
and	O
reference	O
genes	O
(	O
Table5	O
)	O
were	O
quantified	O
by	O
real	O
-	O
time	O
quantitative	O
PCR	O
(	O
qPCR	O
)	O
performed	O
on	O
a	O
LightCycler	O
®	O
480	O
system	O
using	O
the	O
LightCycler	O
480	O
SYBR	O
Green	O
I	O
Master	O
(	O
Roche	O
,	O
Mannheim	O
,	O
Germany	O
).	O

Accumulation	O
of	O
Vitamin	O
D2	O
in	O
food	O
chain	O
,	O
such	O
as	O
from	O
poultry	O
fed	O
with	O
Vitamin	O
D2	O
fortified	O
feeds	O
and	O
their	O
eggs	O
,	O
also	O
contribute	O
to	O
elevated	O
Vitamin	O
D2	O
levels	O
in	O
human	O
bodies	O
.	O

Even	O
those	O
countries	O
with	O
higher	O
mortality	O
rates	O
that	O
are	O
not	O
yet	O
ready	O
to	O
scale	O
up	O
intensive	O
care	O
could	O
see	O
a	O
50	O
%	O
reduction	O
as	O
shown	O
in	O
the	O
mid	O
-	O
20th	O
century	O
in	O
the	O
United	O
States	O
and	O
the	O
United	O
Kingdom	O
.	O

In	O
particular	O
the	O
Denver	O
test	O
,	O
utilised	O
in	O
the	O
ALSPAC	O
study	O
[	O
18	O
]	O
has	O
been	O
criticised	B
for	O
its	O
low	O
specificity	O
and	O
potentially	O
outdated	O
‘	O
norm	O
’	O
as	O
it	O
was	O
standardised	O
in	O
1980	O
[	O
30	O
].	O

Of	O
all	O
women	O
included	O
,	O
62	O
.	O
0	O
%	O
reported	O
taking	O
vitamin	O
D	O
-	O
containing	O
multivitamins	O
,	O
of	O
which	O
only	O
24	O
.	O
2	O
%	O
started	O
taking	O
those	O
before	O
pregnancy	O
.	O

It	O
was	O
remarkably	O
observed	O
that	O
preparation	O
for	O
hibernation	O
was	O
characterized	O
by	O
striking	O
increases	O
in	O
body	O
weight	O
and	O
in	O
fat	O
mass	O
.	O

2007	O
).	O

The	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
exhibited	O
higher	O
plasma	O
levels	O
of	O
LDL	O
and	O
glucose	O
as	O
well	O
as	O
a	O
reduction	O
in	O
chocolate	O
and	O
caloric	O
intake	O
at	O
post	O
-	O
weaning	O
periods	O
in	O
the	O
feeding	O
tests	O
.	O

Lower	O
vitamin	O
D	O
status	O
has	O
also	O
been	O
associated	O
with	O
a	O
medical	O
history	O
of	O
recurrent	O
miscarriage	O
[	O
12	O
]	O
but	O
only	O
two	O
prospective	O
studies	O
have	O
investigated	O
this	O
,	O
without	O
finding	O
that	O
lower	O
25OHD	O
concentrations	O
increases	O
the	O
risk	O
of	O
pregnancy	O
loss	O
[	O
5	O
,	O
13	O
].	O

Other	B
trials	O
assessing	O
infections	O
of	O
the	O
upper	O
respiratory	O
tract	O
also	O
had	O
mixed	B
findings	O
:	O
one	O
trial	O
in	O
post	O
-	O
menopausal	O
women26identified	O
reduced	O
self	O
-	O
reported	O
episodes	O
of	O
infection	O
of	O
the	O
upper	O
respiratory	O
tract	O
,	O
specifically	O
in	O
winter	O
,	O
whereas	B
two	O
others	O
in	O
elderly24and	O
general	O
adults27did	O
not	O
identify	O
a	O
difference	O
between	O
the	O
groups	O
with	O
regards	O
to	O
self	O
-	O
reported	O
episodes	O
.	O

Behavior	O
change	O
communicators	O
used	O
a	O
participatory	O
approach	O
to	O
motivate	O
maternal	O
handwashing	O
with	O
soap	O
and	O
provided	O
soap	O
and	O
handwashing	O
stations	O
.	O

Regression	O
analysis	O
confirmed	O
no	O
association	O
between	O
oral	O
glucose	O
tolerance	O
test	O
results	O
and	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
>	O
0	O
.	O
53	O
).	O

Further	O
studies	O
should	O
be	O
performed	O
to	O
clarify	O
the	O
role	O
of	O
the	O
endocannabinoid	O
system	O
and	O
other	B
homeostatic	O
mechanisms	O
implicated	O
in	O
the	O
process	O
of	O
nutritional	O
programming	O
.	O

Thyroid	O
hormones	O
are	O
major	O
factors	O
for	O
the	O
normal	O
development	O
of	O
foetal	O
brain	O
,	O
and	O
until	O
the	O
end	O
of	O
the	O
first	O
trimester	O
,	O
when	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
thyroid	O
axis	O
becomes	O
functional	O
,	O
the	O
foetal	O
brain	O
is	O
strictly	O
dependent	O
on	O
local	O
deiodination	O
of	O
maternal	O
thyroxine7	O
-	O
12	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
with	O
an	O
online	O
miRNA	O
prediction	O
tool	O
[	O
4	O
].	O

In	O
previous	O
studies	O
,	O
mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
generally	O
higher	O
than	O
20	O
ng	O
/	O
ml	O
in	O
maternal	O
serum	O
[	O
6	O
,	O
8	O
,	O
9	O
].	O

Forty	O
two	O
females	O
and	O
8	O
males	O
were	O
included	O
in	O
each	O
group	O
.	O

Research	O
on	O
the	O
reliability	O
of	O
parental	O
reports	O
on	O
child	O
development	O
is	O
conflicting	B
[	O
31	O
],	O
Daniels	O
et	O
al	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Body	O
weight	O
(	O
g	O
)	O
and	O
caloric	O
intake	O
(	O
kcal	O
/	O
kg	O
)	O
in	O
dams	O
(	O
A	O
)	O
and	O
their	O
offspring	O
(	O
B	O
–	O
D	O
)	O
in	O
gestation	O
,	O
lactation	O
and	O
/	O
or	O
postweaning	O
periods	O
.	O

There	O
are	O
few	O
data	O
from	O
India	O
about	O
the	O
prevalence	O
of	O
hypovitaminosis	O
D	O
in	O
pregnancy	O
and	O
in	O
the	O
newborn	O
.	O

For	O
now	O
,	O
though	O
,	O
600	O
IU	O
in	O
prenatal	O
vitamins	O
remains	O
the	O
recommended	O
daily	O
intake	O
for	O
pregnant	O
women	O
.	O

All	O
women	O
received	O
prenatal	O
care	O
in	O
their	O
dominant	O
language	O
(	O
Spanish	O
/	O
English	O
)	O
(	O
Table	O
2	O
).	O

These	O
results	O
are	O
in	O
keeping	O
with	O
data	O
showing	O
a	O
physiological	O
role	O
of	O
BAT	O
in	O
whole	O
-	O
body	O
energy	O
expenditure	O
,	O
glucose	O
homeostasis	O
,	O
and	O
insulin	O
sensitivity	O
in	O
humans	O
during	O
prolonged	O
cold	O
exposure	O
(	O
Chondronikola	O
et	O
al	O
.,	O
2014	O
).	O

Maternal	O
anaphylaxis	O
has	O
been	O
associated	O
with	O
fetal	O
distress	O
,	O
brain	O
injury	O
,	O
and	O
fetal	O
loss	O
(	O
presumably	O
because	O
of	O
diminished	O
uteroplacental	O
perfusion	O
),	O
as	O
well	O
as	O
neonatal	O
death	O
[	O
32	O
-	O
35	O
].	O

Subjects	O
who	O
could	O
not	O
be	O
traced	O
by	O
the	O
field	O
teams	O
or	O
who	O
did	O
not	O
attend	O
after	O
direct	O
invitation	O
were	O
not	O
recruited	O
(	O
n	O
=	O
128	O
).	O

All	O
data	O
were	O
anonymised	O
to	O
maintain	O
participant	O
confidentiality	O
.	O

Research	O
indicates	O
that	O
adequate	O
vitamin	O
D	O
intake	O
in	O
pregnancy	O
is	O
optimal	O
for	O
maternal	O
,	O
fetal	O
and	O
child	O
health	O
.	O

Smith	O
and	O
Johnson	O
[	O
57	O
]	O
suggested	O
that	O
the	O
glucose	O
contribution	O
to	O
fat	O
synthesis	O
decreases	O
as	O
cattle	O
become	O
fatter	O
,	O
whereas	B
acetate	O
use	O
increases	O
,	O
especially	O
in	O
the	O
IMF	O
area	O
.	O

We	O
found	O
that	O
48	O
.	O
0	O
%	O
of	O
women	O
took	O
folic	O
acid	O
at	O
some	O
stage	O
during	O
pregnancy	O
,	O
compared	O
with	O
27	O
.	O
0	O
%	O
in	O
the	O
IOMC	O
study	O
.	O

Genes	O
also	O
can	O
affect	O
vitamin	O
D	O
metabolism	O
,	O
skin	O
color	O
,	O
and	O
behavior	O
,	O
all	O
of	O
which	O
can	O
influence	O
circulating	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

Albumin	O
is	O
a	O
serum	O
protein	O
that	O
can	O
be	O
used	O
as	O
an	O
additional	O
indicator	O
of	O
overall	O
nutritional	O
status	O
and	O
malnutrition	O
[	O
34	O
].	O

Inform	O
•	O
Support	O
the	O
production	O
,	O
dissemination	O
and	O
use	O
of	O
coverage	O
data	O
for	O
evidence	O
-	O
based	O
interventions	O
through	O
the	O
Countdown	O
to	O
2015	O
and	O
Commission	O
for	O
Information	O
and	O
Accountability	O
through	O
the	O
independent	O
Expert	O
Review	O
Group	O
.	O

Such	O
results	O
may	O
be	O
considered	O
in	O
context	O
with	O
exposure	O
to	O
psychotropic	O
drugs	O
.	O

However	B
,	O
there	O
may	O
have	O
been	O
some	O
recall	O
bias	O
and	O
head	O
circumference	O
could	O
only	O
be	O
measured	O
on	O
the	O
first	O
year	O
of	O
life	O
all	O
within	O
a	O
modest	O
sample	O
size	O
,	O
indicating	O
a	O
need	O
for	O
replicating	O
the	O
study	O
in	O
a	O
larger	O
cohort	O
[	O
45	O
].	O

Our	O
goal	O
was	O
to	O
identify	O
specific	O
high	O
-	O
risk	O
subsets	O
of	O
pregnant	O
women	O
who	O
may	O
benefit	O
from	O
vitamin	O
D	O
supplementation	O
in	O
order	O
to	O
mitigate	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
SGA	O
.	O

The	O
vast	O
majority	O
of	O
mothers	O
reported	O
prenatal	O
vitamin	O
use	O
;	O
only	O
three	O
subjects	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
.	O

The	O
DOHaD	O
hypothesis	O
evolved	O
from	O
Barker	O
’	O
s	O
“	O
thrifty	O
phenotype	O
”	O
hypothesis	O
originally	O
proposed	O
over	O
25	O
years	O
ago	O
(	O
reviewed	O
in	O
Barker2007	O
),	O
and	O
was	O
formed	O
“	O
to	O
recognise	O
….	O
the	O
concept	O
that	O
the	O
early	O
life	O
environment	O
has	O
widespread	O
consequences	O
for	O
later	O
health	O
”	O
(	O
Wadhwa	O
et	O
al	O
.	O
2009	O
).	O

PcG	O
targets	O
are	O
a	O
family	O
of	O
developmentally	O
related	O
genes	O
that	O
can	O
remodel	O
chromatin	O
and	O
are	O
responsible	O
for	O
silencing	O
HOX	O
genes	O
,	O
which	O
are	O
critical	O
in	O
embryonic	O
development	O
as	O
well	O
as	O
potentially	O
hundreds	O
of	O
other	O
genes	O
involved	O
in	O
cellular	O
differentiation	O
(	O
Kirmizis	O
et	O
al	O
.	O

Litter	O
size	O
during	O
suckling	O
was	O
standardised	O
to	O
11	O
piglets	O
per	O
sow	O
.	O

It	O
indicated	O
that	O
X	O
linked	O
epigenetic	O
inheritance	O
via	O
spermatozoa	O
seemed	O
to	O
be	O
plausible	O
,	O
with	O
the	O
transmission	O
,	O
limited	O
to	O
being	O
through	O
the	O
father	O
,	O
possibly	O
explained	O
by	O
the	O
sex	O
differences	O
in	O
the	O
meiosis	O
stage	O
of	O
cell	O
reproduction	O
.	O

This	O
overview	O
of	O
the	O
developmental	O
influences	O
on	O
childhood	O
overweight	O
and	O
obesity	O
suggests	O
opportunities	O
for	O
intervention	O
.	O

Conclusion	O
:	O
Maternal	O
serum	O
visfatin	O
level	O
shows	O
a	O
relationship	O
with	O
fetal	O
and	O
infant	O
anthropometric	O
indicators	O
,	O
with	O
different	B
effects	O
in	O
the	O
two	O
groups	O
,	O
suggesting	O
visfatin	O
dysfunction	O
in	O
the	O
overweight	O
group	O
before	O
pregnancy	O
.	O

There	O
was	O
a	O
65	O
%	O
lower	O
risk	O
of	O
PTB	O
among	O
white	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
<	O
20	O
ng	O
/	O
mL	O
(	O
OR	O
=	O
0	O
.	O
35	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
13	O
–	O
0	O
.	O
92	O
,	O
p	O
=	O
0	O
.	O
03	O
;	O
AAR	O
=	O
13	O
.	O
8	O
%;	O
NNT	O
=	O
7	O
)	O
and	O
a	O
68	O
%	O
lower	O
risk	O
among	O
non	O
-	O
white	O
women	O
(	O
OR	O
=	O
0	O
.	O
32	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
14	O
–	O
0	O
.	O
74	O
,	O
p	O
=	O
0	O
.	O
008	O
;	O
AAR	O
=	O
11	O
.	O
7	O
%;	O
NNT	O
=	O
9	O
).	O

Two	O
have	O
concluded	O
that	O
metformin	O
is	O
as	O
effective	O
as	O
insulin	O
for	O
glycemic	O
control	O
in	O
GDM	O
,	O
and	O
that	O
it	O
is	O
safe	O
.	O

We	O
recommended	O
handwashing	O
after	O
respiratory	O
secretion	O
contact	O
,	O
before	O
umbilical	O
cord	O
care	O
,	O
before	O
breastfeeding	O
,	O
after	O
fecal	O
contact	O
,	O
and	O
before	O
food	O
preparation	O
.	O

There	O
is	O
increasing	O
evidence	O
that	O
nutrients	O
[	O
12	O
]	O
and	O
some	O
foods	O
[	O
13	O
,	O
14	O
]	O
play	O
an	O
important	O
role	O
in	O
the	O
fetal	O
growth	O
.	O

Results	O
Of	O
1078	O
women	O
who	O
presented	O
for	O
care	O
during	O
the	O
study	O
period	O
,	O
996	O
met	O
criteria	O
and	O
were	O
asked	O
to	O
participate	O
(	O
92	O
.	O
39	O
%).	O

Methods	O
:	O
We	O
conducted	O
a	O
retrospective	O
cohort	O
study	O
to	O
evaluate	O
associations	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
.	O

Thus	O
,	O
there	O
is	O
a	O
lack	O
of	O
published	O
information	O
regarding	O
the	O
efficacy	O
of	O
perinatal	O
handwashing	O
promotion	O
interventions	O
on	O
maternal	O
handwashing	O
behavior	O
in	O
the	O
neonatal	O
period	O
and	O
on	O
neonatal	O
mortality	O
.	O

Food	O
restriction	O
in	O
dams	O
produced	O
a	O
decrease	O
in	O
caloric	O
intake	O
of	O
female	O
offspring	O
treated	O
with	O
AM251	O
(	O
Figure3H	O
).	O

In	O
Romania	O
,	O
almost	O
all	O
women	O
are	O
hospitalised	O
for	O
at	O
least	O
3	O
days	O
post	O
-	O
partum	O
during	O
which	O
time	O
the	O
newborn	O
is	O
immunised	O
against	O
tuberculosis	O
and	O
hepatitis	O
B	O
;	O
it	O
is	O
very	O
uncommon	O
to	O
leave	O
the	O
hospital	O
earlier	O
.	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
Melbourne	O
/	O
NIMPE	O
.	O

Introduction	O
Aortic	O
dissection	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
with	O
significant	O
morbidity	O
and	O
mortality	O
for	O
both	O
the	O
mother	O
and	O
infant	O
.	O

To	O
complete	O
the	O
network	O
,	O
DNA	O
/	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
can	O
both	O
inhibit	O
or	O
promote	O
gene	O
expression	O
whilst	O
their	O
own	O
expression	O
is	O
under	O
the	O
control	O
of	O
the	O
DNA	O
modifications	O
and	O
ncRNAs	O
they	O
promote	O
and	O
/	O
or	O
interact	O
with	O
.	O

PubMed	O
Central	O
:	O

There	O
are	O
some	O
potential	O
limitations	O
to	O
our	O
findings	O
.	O

According	O
to	O
the	O
Institute	O
of	O
Medicine	O
(	O
IOM	O
),	O
we	O
considered	O
vitamin	O
D	O
deficiency	O
as	O
a	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
of	O
less	O
than	O
20	O
ng	O
/	O
ml	O
.	O

However	B
,	O
attitudes	O
are	O
changing	O
towards	O
the	O
“	O
minimum	O
of	O
4	O
visits	O
”	O
recommended	O
by	O
the	O
WHO	O
after	O
the	O
work	O
of	O
Nigenda	O
et	O
al	O
[	O
21	O
]	O
and	O
Langer	O
et	O
al	O
.	O

An	O
elevated	O
risk	O
remained	O
after	O
adjustment	O
for	O
pre	O
-	O
pregnancy	O
BMI	O
(	O
RR	O
=	O
1	O
.	O
54	O
;	O
95	O
%	O
CI	O
0	O
.	O
71	O
-	O
3	O
.	O
35	O
).	O

There	O
were	O
no	O
differences	O
between	O
these	O
two	O
groups	O
with	O
respect	O
to	O
maternal	O
age	O
at	O
conception	O
,	O
pre	O
-	O
pregnancy	O
weight	O
,	O
prenatal	O
vitamin	O
use	O
,	O
alcohol	O
use	O
,	O
smoking	O
,	O
maternal	O
weight	O
gain	O
in	O
pregnancy	O
and	O
duration	O
of	O
fetal	O
exposure	O
to	O
SGA	O
.	O

Our	O
pilot	O
study	O
was	O
also	O
limited	O
by	O
the	O
relatively	O
small	O
sample	O
of	O
GDM	O
cases	O
(	O
n	O
=	O
68	O
)	O
and	O
the	O
imprecision	O
of	O
relative	O
risk	O
estimates	O
which	O
were	O
reflected	O
by	O
their	O
wide	O
95	O
%	O
confidence	O
intervals	O
.	O

A	O
considerable	O
amount	O
of	O
glucose	O
is	O
absorbed	O
from	O
the	O
small	O
intestine	O
when	O
high	O
-	O
starch	O
diets	O
are	O
fed	O
,	O
especially	O
during	O
the	O
beef	O
cattle	O
fattening	O
period	O
.	O

Treatment	O
with	O
calcium	O
usually	O
reverses	O
the	O
symptoms	O
rapidly	O
.	O

Some	O
have	O
speculated	O
that	O
the	O
excess	O
of	O
winter	O
births	O
in	O
autism	O
is	O
explained	O
by	O
wintertime	O
maternal	O
viral	O
infections	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
combined	O
or	O
system	O
-	O
specific	O
morbidity	O
profiles	O
between	O
study	O
groups	O
(	O
data	O
not	O
shown	O
).	O

In	O
addition	O
,	O
individuals	O
with	O
the	O
risk	O
factors	O
that	O
we	O
have	O
identified	O
may	O
benefit	O
even	O
more	O
from	O
supplementation	O
or	O
higher	O
dose	O
supplementation	O
.	O

Thus	O
,	O
managing	O
maternal	O
nutrition	O
is	O
a	O
potentially	O
effective	O
way	O
to	O
promote	O
adipogenesis	O
in	O
fetal	O
muscle	O
[	O
16	O
].	O

Average	O
daily	O
intake	O
of	O
dairy	O
products	O
,	O
egg	O
,	O
animal	O
organ	O
and	O
seafood	O
was	O
calculated	O
based	O
on	O
participants	O
’	O
dietary	O
record	O
.	O

As	O
long	O
as	O
the	O
proposed	O
values	O
are	O
not	O
validated	O
in	O
clinical	O
trials	O
the	O
controversy	B
will	O
remain	O
[	O
28	O
].	O

Euglycemia	O
is	O
maintained	O
through	O
a	O
compensatory	O
increase	O
in	O
insulin	O
secretion	O
.	O

However	B
,	O
due	O
to	O
a	O
wide	B
range	I
of	O
nutrient	O
interactions	O
,	O
maternal	O
dietary	O
patterns	O
should	O
be	O
explored	O
to	O
achieve	O
the	O
association	O
between	O
maternal	O
nutrition	O
and	O
fetal	O
growth	O
.	O

Although	B
a	O
circulating	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
less	O
than	O
20	O
ng	O
/	O
mL	O
is	O
defined	O
as	O
vitamin	O
D	O
deficiency	O
[	O
27	O
,	O
28	O
],	O
the	O
mean	O
levels	O
may	O
vary	O
among	O
different	B
populations	O
[	O
29	O
].	O

No	O
specific	O
article	O
examined	O
specific	O
aspects	O
such	O
as	O
room	O
temperature	O
,	O
lack	O
of	O
equipment	O
,	O
time	O
spent	O
with	O
the	O
mother	O
,	O
or	B
proximity	O
to	O
other	O
neonates	O
.	O

The	O
hemivertebrae	O
and	O
fused	O
vertebrae	O
are	O
indicated	O
by	O
arrowheads	O
.	O

However	O
,	O
the	O
main	O
strengths	O
of	O
the	O
current	O
study	O
include	O
its	O
multidisciplinary	O
scope	O
including	O
epidemiology	O
,	O
statistics	O
,	O
pediatrics	O
,	O
maternity	O
,	O
and	O
nutrition	O
.	O

Notably	O
,	O
at	O
stage	O
1	O
dpn	O
no	O
regulation	O
of	O
a	O
distinct	O
pathway	O
was	O
found	O
in	O
LP	O
offspring	O
.	O

Greenland	O
and	O
colleagues	O
found	O
maternal	O
handwashing	O
in	O
the	O
neonatal	O
period	O
in	O
Indonesia	O
to	O
be	O
infrequent	O
,	O
with	O
handwashing	O
occurring	O
typically	O
because	O
of	O
discomfort	O
(	O
e	O
.	O
g	O
.,	O
due	O
to	O
sticky	O
substances	O
)	O
or	O
disgust	O
-	O
related	O
motivators	O
(	O
such	O
as	O
apparent	O
smell	O
)	O
[	O
10	O
].	O

Mitotic	O
roles	O
of	O
PLK	O
,	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
,	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulation	O
).	O

According	O
to	O
the	O
World	O
Health	O
Organization	O
,	O
347	O
millions	O
of	O
people	O
are	O
diabetic	O
in	O
the	O
world	O
,	O
and	O
it	O
is	O
predicted	O
that	O
in	O
2030	O
,	O
diabetes	O
will	O
be	O
the	O
7th	O
cause	O
of	O
death	O
considering	O
the	O
worldwide	O
population	O
(	O
WHO	O
,	O
2014	O
).	O

What	O
are	O
the	O
potential	O
human	O
disease	O
outcome	O
(	O
s	O
)?	O

Preeclampsia	O
rates	O
are	O
elevated	O
during	O
winter	O
months	O
,	O
when	O
sunlight	O
-	O
dependent	O
25	O
(	O
OH	O
)	O
D	O
productions	O
are	O
reduced	O
.	O

Based	O
on	O
1000	O
simulations	O
when	O
requirement	O
one	O
-	O
to	O
-	O
two	O
vaccinated	O
-	O
to	O
-	O
unvaccinated	O
proportion	O
for	O
good	O
propensity	O
score	O
matching	O
was	O
not	O
met	O
;	O
point	O
estimate	O
and	O
lower	O
and	O
upper	O
confidence	O
interval	O
represent	O
50th	O
,	O
25th	O
and	O
97	O
.	O
5th	O
percentiles	O
of	O
point	O
estimates	O
(	O
n	O
=	O
1000	O
),	O
respectively	O
.	O

The	O
Korean	O
Feeding	O
Standard	O
for	O
Hanwoo	O
[	O
160	O
]	O
describes	O
how	O
to	O
feed	O
Korean	O
cattle	O
at	O
each	O
stage	O
(	O
growth	O
,	O
early	O
fattening	O
,	O
and	O
late	O
fattening	O
stages	O
).	O

Materials	O
and	O
methods	O
The	O
planned	O
implementation	O
consisted	O
of	O
a	O
9	O
-	O
month	O
pre	O
(	O
usual	O
care	O
)/	O
post	O
(	O
new	O
model	O
of	O
care	O
)	O
design	O
with	O
a	O
month	O
for	O
‘	O
integration	O
’	O
across	O
2012	O
-	O
2013	O
.	O

